'phlébite'
(id=325 ; fe=phlébite ; type=1 ; niveau=55.9044 ; luminosité=102 ; somme entrante=94007 creation date=2007-06-21 touchdate=2025-08-14 00:38:18.000)

≈ 2619 relations sortantes phlébite -- r_associated #0: 240 / 1 -> médecine n1=phlébite | n2=médecine | rel=r_associated | relid=0 | w=240 phlébite -- r_associated #0: 125 / 0.521 -> maladie n1=phlébite | n2=maladie | rel=r_associated | relid=0 | w=125 phlébite -- r_associated #0: 100 / 0.417 -> en:thrombophlebitis n1=phlébite | n2=en:thrombophlebitis | rel=r_associated | relid=0 | w=100 phlébite -- r_associated #0: 92 / 0.383 -> processus pathologique n1=phlébite | n2=processus pathologique | rel=r_associated | relid=0 | w=92 phlébite -- r_associated #0: 89 / 0.371 -> maladie (médecine) n1=phlébite | n2=maladie (médecine) | rel=r_associated | relid=0 | w=89 phlébite -- r_associated #0: 89 / 0.371 -> thrombose veineuse profonde n1=phlébite | n2=thrombose veineuse profonde | rel=r_associated | relid=0 | w=89 phlébite -- r_associated #0: 86 / 0.358 -> en:peripheral vascular disorder n1=phlébite | n2=en:peripheral vascular disorder | rel=r_associated | relid=0 | w=86 phlébite -- r_associated #0: 86 / 0.358 -> en:thrombosis of cerebral veins n1=phlébite | n2=en:thrombosis of cerebral veins | rel=r_associated | relid=0 | w=86 phlébite -- r_associated #0: 86 / 0.358 -> thrombose veineuse n1=phlébite | n2=thrombose veineuse | rel=r_associated | relid=0 | w=86 phlébite -- r_associated #0: 84 / 0.35 -> maladies n1=phlébite | n2=maladies | rel=r_associated | relid=0 | w=84 phlébite -- r_associated #0: 81 / 0.338 -> en:angiitis, cerebral n1=phlébite | n2=en:angiitis, cerebral | rel=r_associated | relid=0 | w=81 phlébite -- r_associated #0: 81 / 0.338 -> en:vascular disorder n1=phlébite | n2=en:vascular disorder | rel=r_associated | relid=0 | w=81 phlébite -- r_associated #0: 81 / 0.338 -> TVP n1=phlébite | n2=TVP | rel=r_associated | relid=0 | w=81 phlébite -- r_associated #0: 77 / 0.321 -> thrombose n1=phlébite | n2=thrombose | rel=r_associated | relid=0 | w=77 phlébite -- r_associated #0: 76 / 0.317 -> en:aspects of mortality statistics n1=phlébite | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:aspects of radionuclide imaging n1=phlébite | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:av fistula thrombosis n1=phlébite | n2=en:av fistula thrombosis | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:av graft stenosis n1=phlébite | n2=en:av graft stenosis | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:budd-chiari syndrome n1=phlébite | n2=en:budd-chiari syndrome | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:complication aspects n1=phlébite | n2=en:complication aspects | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:congenital mesh qualifier n1=phlébite | n2=en:congenital mesh qualifier | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:deep vein thrombosis n1=phlébite | n2=en:deep vein thrombosis | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:diabetic vascular disorder n1=phlébite | n2=en:diabetic vascular disorder | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:diagnosis aspect n1=phlébite | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:disorder of the circulatory system n1=phlébite | n2=en:disorder of the circulatory system | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:embryologic n1=phlébite | n2=en:embryologic | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:enzymology n1=phlébite | n2=en:enzymology | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:epidemiologic n1=phlébite | n2=en:epidemiologic | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:ethnologic n1=phlébite | n2=en:ethnologic | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:etiology aspects n1=phlébite | n2=en:etiology aspects | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:exposure as collected domain n1=phlébite | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:genetic aspects n1=phlébite | n2=en:genetic aspects | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:historical aspects qualifier n1=phlébite | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:in blood n1=phlébite | n2=en:in blood | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:in cerebrospinal fluid n1=phlébite | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:in urine n1=phlébite | n2=en:in urine | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:microbiological n1=phlébite | n2=en:microbiological | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:nursing therapy n1=phlébite | n2=en:nursing therapy | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:nutritional management n1=phlébite | n2=en:nutritional management | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:parasitology n1=phlébite | n2=en:parasitology | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:pathological aspects n1=phlébite | n2=en:pathological aspects | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:patient problem codes fda cdrh n1=phlébite | n2=en:patient problem codes fda cdrh | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:pediatric adverse events terminology n1=phlébite | n2=en:pediatric adverse events terminology | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:pediatric terminology n1=phlébite | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:pharmacotherapeutic n1=phlébite | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:polyarteritis nodosa n1=phlébite | n2=en:polyarteritis nodosa | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:portal vein thrombosis n1=phlébite | n2=en:portal vein thrombosis | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:postthrombotic syndrome n1=phlébite | n2=en:postthrombotic syndrome | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:pseudoaneurysm n1=phlébite | n2=en:pseudoaneurysm | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:psychology qualifier n1=phlébite | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:pulmonary thrombosis n1=phlébite | n2=en:pulmonary thrombosis | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:radiotherapeutic n1=phlébite | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:raynaud phenomenon n1=phlébite | n2=en:raynaud phenomenon | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:rehabilitation aspects n1=phlébite | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:superficial thrombophlebitis n1=phlébite | n2=en:superficial thrombophlebitis | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:taxonomic n1=phlébite | n2=en:taxonomic | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:therapeutic aspects n1=phlébite | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:use of ultrasonography n1=phlébite | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:varicose vein n1=phlébite | n2=en:varicose vein | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:vascular graft thrombosis n1=phlébite | n2=en:vascular graft thrombosis | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:vascular pseudoaneurysm thrombosis n1=phlébite | n2=en:vascular pseudoaneurysm thrombosis | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:vasculitis n1=phlébite | n2=en:vasculitis | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:venous malformation n1=phlébite | n2=en:venous malformation | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 76 / 0.317 -> en:venous thrombosis n1=phlébite | n2=en:venous thrombosis | rel=r_associated | relid=0 | w=76 phlébite -- r_associated #0: 75 / 0.313 -> phlébite seule n1=phlébite | n2=phlébite seule | rel=r_associated | relid=0 | w=75 phlébite -- r_associated #0: 73 / 0.304 -> inflammation n1=phlébite | n2=inflammation | rel=r_associated | relid=0 | w=73 phlébite -- r_associated #0: 73 / 0.304 -> phlébites n1=phlébite | n2=phlébites | rel=r_associated | relid=0 | w=73 phlébite -- r_associated #0: 72 / 0.3 -> phlébite superficielle n1=phlébite | n2=phlébite superficielle | rel=r_associated | relid=0 | w=72 phlébite -- r_associated #0: 71 / 0.296 -> inflammation d'une veine n1=phlébite | n2=inflammation d'une veine | rel=r_associated | relid=0 | w=71 phlébite -- r_associated #0: 71 / 0.296 -> thrombophlébite n1=phlébite | n2=thrombophlébite | rel=r_associated | relid=0 | w=71 phlébite -- r_associated #0: 70 / 0.292 -> en:abnormal biochemistry finding n1=phlébite | n2=en:abnormal biochemistry finding | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:abnormal blood coagulation studies (prolonged pt and ptt) n1=phlébite | n2=en:abnormal blood coagulation studies (prolonged pt and ptt) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:abnormal finding on cytological and histological examination of urine n1=phlébite | n2=en:abnormal finding on cytological and histological examination of urine | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:abnormality of coagulation n1=phlébite | n2=en:abnormality of coagulation | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:accidental cut, puncture, perforation or hemorrhage during blood sampling n1=phlébite | n2=en:accidental cut, puncture, perforation or hemorrhage during blood sampling | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:acquired phlebectasia n1=phlébite | n2=en:acquired phlebectasia | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:affected arteries show loss of smooth muscle cells n1=phlébite | n2=en:affected arteries show loss of smooth muscle cells | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:alpha-thalassemia silent carrier (3 normal genes) n1=phlébite | n2=en:alpha-thalassemia silent carrier (3 normal genes) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:alpha-thalassemia with microcytosis and hemolysis, hb h disease (1 normal gene) n1=phlébite | n2=en:alpha-thalassemia with microcytosis and hemolysis, hb h disease (1 normal gene) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:anemia (rare) n1=phlébite | n2=en:anemia (rare) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:anemia, severe n1=phlébite | n2=en:anemia, severe | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:aneurysms of right internal carotid artery, intracranial segment n1=phlébite | n2=en:aneurysms of right internal carotid artery, intracranial segment | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:antenatal syphilis screening categorized by action status n1=phlébite | n2=en:antenatal syphilis screening categorized by action status | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:antithrombin iii deficiency (in 1 patient) n1=phlébite | n2=en:antithrombin iii deficiency (in 1 patient) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:aorta arises from right ventricle n1=phlébite | n2=en:aorta arises from right ventricle | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:arterial vessel disorders n1=phlébite | n2=en:arterial vessel disorders | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:arteries show medial hypertrophy n1=phlébite | n2=en:arteries show medial hypertrophy | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:arteriovenous fistulas of celiac and mesenteric vessels n1=phlébite | n2=en:arteriovenous fistulas of celiac and mesenteric vessels | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:arthrocentesis of intermediate joint n1=phlébite | n2=en:arthrocentesis of intermediate joint | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:assessment scales re-sc n1=phlébite | n2=en:assessment scales re-sc | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:autoimmune hemolytic anemia n1=phlébite | n2=en:autoimmune hemolytic anemia | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:autoimmune neutropenia n1=phlébite | n2=en:autoimmune neutropenia | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:blood platelet disorders n1=phlébite | n2=en:blood platelet disorders | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:blood vessel occlusion n1=phlébite | n2=en:blood vessel occlusion | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:blood vessel viewed microscopically n1=phlébite | n2=en:blood vessel viewed microscopically | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:bone marrow disorder n1=phlébite | n2=en:bone marrow disorder | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:bone marrow failure (in some patients) n1=phlébite | n2=en:bone marrow failure (in some patients) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:bone marrow shows gaucher cells n1=phlébite | n2=en:bone marrow shows gaucher cells | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:bone-marrow foam cells n1=phlébite | n2=en:bone-marrow foam cells | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:buccal administration of treatment n1=phlébite | n2=en:buccal administration of treatment | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:cardiovascular fistula due to endocarditis n1=phlébite | n2=en:cardiovascular fistula due to endocarditis | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:chlorhexidine a-h n1=phlébite | n2=en:chlorhexidine a-h | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:chronic anemia (in 1 patient) n1=phlébite | n2=en:chronic anemia (in 1 patient) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:chronic lymphocytic leukemia n1=phlébite | n2=en:chronic lymphocytic leukemia | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:coagulation defects (1 patient) n1=phlébite | n2=en:coagulation defects (1 patient) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:coagulopathy secondary to liver failure n1=phlébite | n2=en:coagulopathy secondary to liver failure | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:coelozoic parasite n1=phlébite | n2=en:coelozoic parasite | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:congenital vascular anomaly n1=phlébite | n2=en:congenital vascular anomaly | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:decreased coagulation factors ix, xi, xii n1=phlébite | n2=en:decreased coagulation factors ix, xi, xii | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:decreased hemoglobin oxygen saturation n1=phlébite | n2=en:decreased hemoglobin oxygen saturation | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:defective platelet calcium mobilization n1=phlébite | n2=en:defective platelet calcium mobilization | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:dermal neoplasm n1=phlébite | n2=en:dermal neoplasm | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:diagnostic imaging and nuclear medicine procedures n1=phlébite | n2=en:diagnostic imaging and nuclear medicine procedures | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:digestive tract and abdominal organs n1=phlébite | n2=en:digestive tract and abdominal organs | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:dilatation of the aortic arch n1=phlébite | n2=en:dilatation of the aortic arch | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:disorder of pregnancy / labor / delivery / puerperium n1=phlébite | n2=en:disorder of pregnancy / labor / delivery / puerperium | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:dysplastic erythroblasts with internuclear chromatin strands n1=phlébite | n2=en:dysplastic erythroblasts with internuclear chromatin strands | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:elevated venous pressure n1=phlébite | n2=en:elevated venous pressure | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:elongated, tortuous carotid arteries n1=phlébite | n2=en:elongated, tortuous carotid arteries | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:emboli, pulmonary (in some patients) n1=phlébite | n2=en:emboli, pulmonary (in some patients) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:erythrocyte morphology - elliptocytes (lab test) n1=phlébite | n2=en:erythrocyte morphology - elliptocytes (lab test) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:generalized bone marrow fibrosis n1=phlébite | n2=en:generalized bone marrow fibrosis | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:great blood vessel n1=phlébite | n2=en:great blood vessel | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:haematotoxicity n1=phlébite | n2=en:haematotoxicity | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:hematologic disorder in newborn n1=phlébite | n2=en:hematologic disorder in newborn | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:hematology test categorized by action status n1=phlébite | n2=en:hematology test categorized by action status | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:hepatosplenomegaly, with extramedullary hematopoiesis (rare) n1=phlébite | n2=en:hepatosplenomegaly, with extramedullary hematopoiesis (rare) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:heterochromatin clumps with spongy, 'swiss cheese' appearance n1=phlébite | n2=en:heterochromatin clumps with spongy, 'swiss cheese' appearance | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:household product causing toxic effect n1=phlébite | n2=en:household product causing toxic effect | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:hypereosinophilia n1=phlébite | n2=en:hypereosinophilia | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:hypertension (variable) n1=phlébite | n2=en:hypertension (variable) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:hypervolemia n1=phlébite | n2=en:hypervolemia | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:hypoplastic pulmonary veins n1=phlébite | n2=en:hypoplastic pulmonary veins | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:hypotension due to volume depletion n1=phlébite | n2=en:hypotension due to volume depletion | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:impaired platelet function n1=phlébite | n2=en:impaired platelet function | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:impingement n1=phlébite | n2=en:impingement | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:increased bleeding after trauma, surgery, or injury n1=phlébite | n2=en:increased bleeding after trauma, surgery, or injury | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:increased red blood cell membrane permeability to univalent cations n1=phlébite | n2=en:increased red blood cell membrane permeability to univalent cations | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:inflammatory and/or infective disease of the central nervous system n1=phlébite | n2=en:inflammatory and/or infective disease of the central nervous system | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:intracranial bleeding (in some patients) n1=phlébite | n2=en:intracranial bleeding (in some patients) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:jugular hypoplasia n1=phlébite | n2=en:jugular hypoplasia | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:kinking of descending aorta n1=phlébite | n2=en:kinking of descending aorta | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:leukocytosis with eosinophilia during stage 1 n1=phlébite | n2=en:leukocytosis with eosinophilia during stage 1 | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:low flow state n1=phlébite | n2=en:low flow state | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:low to normal reticulocyte count n1=phlébite | n2=en:low to normal reticulocyte count | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:lung trematode n1=phlébite | n2=en:lung trematode | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:lupus anticoagulant (in some patients) n1=phlébite | n2=en:lupus anticoagulant (in some patients) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:lymphangioma n1=phlébite | n2=en:lymphangioma | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:macrocytic anemia in manifesting females n1=phlébite | n2=en:macrocytic anemia in manifesting females | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:macrocytosis (in some patients) n1=phlébite | n2=en:macrocytosis (in some patients) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:malignant melanoma of trunk, excluding scrotum n1=phlébite | n2=en:malignant melanoma of trunk, excluding scrotum | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:maternal hypertension (after 20th week gestation, resolved postpartum) n1=phlébite | n2=en:maternal hypertension (after 20th week gestation, resolved postpartum) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:maternal pregnancy problem n1=phlébite | n2=en:maternal pregnancy problem | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:melanaemia n1=phlébite | n2=en:melanaemia | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:microcytic anemia n1=phlébite | n2=en:microcytic anemia | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:miscellaneous products n1=phlébite | n2=en:miscellaneous products | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:multisystem disorder g-h n1=phlébite | n2=en:multisystem disorder g-h | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:myelodysplastic syndrome n1=phlébite | n2=en:myelodysplastic syndrome | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:negative biochemistry finding n1=phlébite | n2=en:negative biochemistry finding | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:neutropenia (in some patients) n1=phlébite | n2=en:neutropenia (in some patients) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:no leukocyte inclusion bodies on giemsa staining n1=phlébite | n2=en:no leukocyte inclusion bodies on giemsa staining | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:nonclonal myeloproliferation n1=phlébite | n2=en:nonclonal myeloproliferation | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:normal microbiology finding n1=phlébite | n2=en:normal microbiology finding | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:normal thrombospondin n1=phlébite | n2=en:normal thrombospondin | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:normal von willebrand factor n1=phlébite | n2=en:normal von willebrand factor | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:obligate parasite n1=phlébite | n2=en:obligate parasite | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:organic compounds s-z n1=phlébite | n2=en:organic compounds s-z | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:overriding aorta n1=phlébite | n2=en:overriding aorta | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:panarteritis (rare) n1=phlébite | n2=en:panarteritis (rare) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:patent ductus arteriosus (2 patients) n1=phlébite | n2=en:patent ductus arteriosus (2 patients) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:peripheral pulmonary vessel aplasia n1=phlébite | n2=en:peripheral pulmonary vessel aplasia | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:persistent left superior vena cava (rare) n1=phlébite | n2=en:persistent left superior vena cava (rare) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:phlebitis (following medical procedure) n1=phlébite | n2=en:phlebitis (following medical procedure) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:platelets have decreased alpha-granules n1=phlébite | n2=en:platelets have decreased alpha-granules | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:platelets.large n1=phlébite | n2=en:platelets.large | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:poisoning by antiallergic and antiemetic drugs n1=phlébite | n2=en:poisoning by antiallergic and antiemetic drugs | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:postural hypotension without compensatory tachycardia n1=phlébite | n2=en:postural hypotension without compensatory tachycardia | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:procedure by colostomy approach n1=phlébite | n2=en:procedure by colostomy approach | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:procedure by perineal approach n1=phlébite | n2=en:procedure by perineal approach | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:pulmonary artery atresia (rare) n1=phlébite | n2=en:pulmonary artery atresia (rare) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:pulmonary hypertension (1 patient) n1=phlébite | n2=en:pulmonary hypertension (1 patient) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:rare compression of inferior vena cava (secondary lower extremity edema) n1=phlébite | n2=en:rare compression of inferior vena cava (secondary lower extremity edema) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:reactive microbiology finding n1=phlébite | n2=en:reactive microbiology finding | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:refractory macrocytic anemia n1=phlébite | n2=en:refractory macrocytic anemia | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:renal artery thrombosis n1=phlébite | n2=en:renal artery thrombosis | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:salmonella group c1 and c4 phase 1 f-r n1=phlébite | n2=en:salmonella group c1 and c4 phase 1 f-r | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:salmonella group c2 and c3 phase 1 a-e n1=phlébite | n2=en:salmonella group c2 and c3 phase 1 a-e | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:salmonella group g1 and g2 phase 1 y-z n1=phlébite | n2=en:salmonella group g1 and g2 phase 1 y-z | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:sea-blue histiocyte (bone marrow) n1=phlébite | n2=en:sea-blue histiocyte (bone marrow) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:secondary syphilis of viscera or bone n1=phlébite | n2=en:secondary syphilis of viscera or bone | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:separation (morphologic abnormality) n1=phlébite | n2=en:separation (morphologic abnormality) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:septic embolus n1=phlébite | n2=en:septic embolus | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:severe thrombocytopenia (birth) n1=phlébite | n2=en:severe thrombocytopenia (birth) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:site specific embolism and thrombosis nec n1=phlébite | n2=en:site specific embolism and thrombosis nec | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:smoking and/or drinking habits n1=phlébite | n2=en:smoking and/or drinking habits | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:soft tissue n1=phlébite | n2=en:soft tissue | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:solvent s - z n1=phlébite | n2=en:solvent s - z | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:stoma site thrombosis n1=phlébite | n2=en:stoma site thrombosis | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:stroke (in some patients) n1=phlébite | n2=en:stroke (in some patients) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:structure of vitelline blood vessel of placenta n1=phlébite | n2=en:structure of vitelline blood vessel of placenta | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:sudden infant death syndrome n1=phlébite | n2=en:sudden infant death syndrome | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:suicide and selfinflicted injury by jumping before moving object n1=phlébite | n2=en:suicide and selfinflicted injury by jumping before moving object | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:suicide and selfinflicted injury by jumping from residential premises n1=phlébite | n2=en:suicide and selfinflicted injury by jumping from residential premises | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:suicide or attempted suicide by hanging n1=phlébite | n2=en:suicide or attempted suicide by hanging | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:suicide or self injury by exposure to cold n1=phlébite | n2=en:suicide or self injury by exposure to cold | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:suicide or self injury by jumping from a height n1=phlébite | n2=en:suicide or self injury by jumping from a height | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:suicide or self injury by placing self in path of moving vehicle n1=phlébite | n2=en:suicide or self injury by placing self in path of moving vehicle | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:sulfhemoglobinemia n1=phlébite | n2=en:sulfhemoglobinemia | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:thoracic aortic aneurysm n1=phlébite | n2=en:thoracic aortic aneurysm | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:thrombocytopenia (rare) n1=phlébite | n2=en:thrombocytopenia (rare) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:thrombocytopenic purpura n1=phlébite | n2=en:thrombocytopenic purpura | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:thrombocytosis (in some patients) n1=phlébite | n2=en:thrombocytosis (in some patients) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:thrombosis of thoracic aorta n1=phlébite | n2=en:thrombosis of thoracic aorta | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:thrombotic vascular disease n1=phlébite | n2=en:thrombotic vascular disease | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:thrombus n1=phlébite | n2=en:thrombus | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:transferrin saturation increased n1=phlébite | n2=en:transferrin saturation increased | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:transposition of great vessels n1=phlébite | n2=en:transposition of great vessels | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:trilineage dysplasia (in some patients) n1=phlébite | n2=en:trilineage dysplasia (in some patients) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:truncus arteriosus communis (rare) n1=phlébite | n2=en:truncus arteriosus communis (rare) | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:tumor-like lesion of intestine n1=phlébite | n2=en:tumor-like lesion of intestine | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:tunica intima n1=phlébite | n2=en:tunica intima | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:ulceration n1=phlébite | n2=en:ulceration | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:unreliable laboratory result n1=phlébite | n2=en:unreliable laboratory result | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:vascular stenosis n1=phlébite | n2=en:vascular stenosis | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:venous recanalisation n1=phlébite | n2=en:venous recanalisation | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:venous thrombosis in pregnancy n1=phlébite | n2=en:venous thrombosis in pregnancy | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:von willebrand disease n1=phlébite | n2=en:von willebrand disease | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> en:white blood cell abnormality n1=phlébite | n2=en:white blood cell abnormality | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> sang n1=phlébite | n2=sang | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> thromboser n1=phlébite | n2=thromboser | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 70 / 0.292 -> thrombotique n1=phlébite | n2=thrombotique | rel=r_associated | relid=0 | w=70 phlébite -- r_associated #0: 69 / 0.288 -> angéite n1=phlébite | n2=angéite | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:aberrant subclavian artery n1=phlébite | n2=en:aberrant subclavian artery | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:abnormal cytologic finding in specimen from digestive organ and abdominal cavity n1=phlébite | n2=en:abnormal cytologic finding in specimen from digestive organ and abdominal cavity | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:abnormal histological finding in specimen from digestive organ and abdominal cavity n1=phlébite | n2=en:abnormal histological finding in specimen from digestive organ and abdominal cavity | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:abnormality of the vasculature n1=phlébite | n2=en:abnormality of the vasculature | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:absence of platelet dense bodies n1=phlébite | n2=en:absence of platelet dense bodies | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:absent dense bodies in platelets n1=phlébite | n2=en:absent dense bodies in platelets | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:absent platelet aggregation response to epinephrine n1=phlébite | n2=en:absent platelet aggregation response to epinephrine | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:accidental cut, puncture, perforation or hemorrhage during medical care n1=phlébite | n2=en:accidental cut, puncture, perforation or hemorrhage during medical care | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:adrenal gland myelolipoma n1=phlébite | n2=en:adrenal gland myelolipoma | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:adverse reaction to local astringents and local detergents n1=phlébite | n2=en:adverse reaction to local astringents and local detergents | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:alpha polypeptide hemoglobin chain n1=phlébite | n2=en:alpha polypeptide hemoglobin chain | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:analgesics and non-steroidal anti-inflammatory drug allergy n1=phlébite | n2=en:analgesics and non-steroidal anti-inflammatory drug allergy | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:anemia (with bone marrow involvement) n1=phlébite | n2=en:anemia (with bone marrow involvement) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:anemia, dyserythropoietic (in some patients) n1=phlébite | n2=en:anemia, dyserythropoietic (in some patients) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:aneurysms (internal carotid artery, cerebral artery, subclavian) n1=phlébite | n2=en:aneurysms (internal carotid artery, cerebral artery, subclavian) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:anterior spinal artery thrombosis n1=phlébite | n2=en:anterior spinal artery thrombosis | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:antithrombin iii deficiency n1=phlébite | n2=en:antithrombin iii deficiency | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:aortic isthmus stenosis (in some patients) n1=phlébite | n2=en:aortic isthmus stenosis (in some patients) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:aortic root dilation n1=phlébite | n2=en:aortic root dilation | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:arteriovenous shunt n1=phlébite | n2=en:arteriovenous shunt | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:assessment scales aa-az n1=phlébite | n2=en:assessment scales aa-az | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:autoimmune hemolytic anemia (in some patients) n1=phlébite | n2=en:autoimmune hemolytic anemia (in some patients) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:bleeding, mild n1=phlébite | n2=en:bleeding, mild | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:blood clot n1=phlébite | n2=en:blood clot | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:bone marrow biopsy shows increased numbers of normal to small megakaryocytes n1=phlébite | n2=en:bone marrow biopsy shows increased numbers of normal to small megakaryocytes | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:bone marrow biopsy shows megaloblastic erythroblasts n1=phlébite | n2=en:bone marrow biopsy shows megaloblastic erythroblasts | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:bone marrow hypercellularity n1=phlébite | n2=en:bone marrow hypercellularity | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:bone marrow ischemia n1=phlébite | n2=en:bone marrow ischemia | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:bone marrow megaloblastic (finding) n1=phlébite | n2=en:bone marrow megaloblastic (finding) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:bone marrow smear shows erythroid hyperplasia n1=phlébite | n2=en:bone marrow smear shows erythroid hyperplasia | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:borderline microbiology finding n1=phlébite | n2=en:borderline microbiology finding | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:carboxyhemoglobinemia n1=phlébite | n2=en:carboxyhemoglobinemia | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:carotid artery embolism n1=phlébite | n2=en:carotid artery embolism | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:carotid string sign n1=phlébite | n2=en:carotid string sign | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:cerebral thrombosis n1=phlébite | n2=en:cerebral thrombosis | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:cerebral thrombosis (rare) n1=phlébite | n2=en:cerebral thrombosis (rare) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:cerebrovascular embolism and thrombosis n1=phlébite | n2=en:cerebrovascular embolism and thrombosis | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:chronic disease of hematopoietic system n1=phlébite | n2=en:chronic disease of hematopoietic system | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:chronic total occlusion vessel n1=phlébite | n2=en:chronic total occlusion vessel | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:clostridium species q-z n1=phlébite | n2=en:clostridium species q-z | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:clotting increased n1=phlébite | n2=en:clotting increased | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:coagulopathy in those with liver failure n1=phlébite | n2=en:coagulopathy in those with liver failure | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:coagulopathy secondary to liver disease n1=phlébite | n2=en:coagulopathy secondary to liver disease | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:coarctation of aorta (rare) n1=phlébite | n2=en:coarctation of aorta (rare) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:complication for medication therapy n1=phlébite | n2=en:complication for medication therapy | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:compound antidepressants a-z n1=phlébite | n2=en:compound antidepressants a-z | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:congenital hematological disorder n1=phlébite | n2=en:congenital hematological disorder | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:congenital thrombocytopenia n1=phlébite | n2=en:congenital thrombocytopenia | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:decreased expression of cd44 and aqp1 on red cells n1=phlébite | n2=en:decreased expression of cd44 and aqp1 on red cells | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:defective nk cell activity n1=phlébite | n2=en:defective nk cell activity | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:device related thrombosis n1=phlébite | n2=en:device related thrombosis | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:dilated pulmonary arteries n1=phlébite | n2=en:dilated pulmonary arteries | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:dilation of the sinuses of valsalva n1=phlébite | n2=en:dilation of the sinuses of valsalva | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:disorder of the third, fourth and sixth nerves and of eye movements n1=phlébite | n2=en:disorder of the third, fourth and sixth nerves and of eye movements | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:dissection, ascending aorta (in some patients) n1=phlébite | n2=en:dissection, ascending aorta (in some patients) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:easy bruising n1=phlébite | n2=en:easy bruising | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:embolism and thrombosis of other specified artery n1=phlébite | n2=en:embolism and thrombosis of other specified artery | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:ent test finding n1=phlébite | n2=en:ent test finding | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:eosinophilia n1=phlébite | n2=en:eosinophilia | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:erythroblast morphologic abnormalities n1=phlébite | n2=en:erythroblast morphologic abnormalities | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:extracellular volume depletion (rare, in severe cases only) n1=phlébite | n2=en:extracellular volume depletion (rare, in severe cases only) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:extramedullary erythropoiesis n1=phlébite | n2=en:extramedullary erythropoiesis | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:facial capillary hemangioma n1=phlébite | n2=en:facial capillary hemangioma | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:fetal cardiovascular disorder n1=phlébite | n2=en:fetal cardiovascular disorder | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:gingival administration of treatment n1=phlébite | n2=en:gingival administration of treatment | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:hemangiomatosis with thrombocytopenia n1=phlébite | n2=en:hemangiomatosis with thrombocytopenia | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:hematology finding n1=phlébite | n2=en:hematology finding | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:heparin cofactor ii deficiency (disorder) n1=phlébite | n2=en:heparin cofactor ii deficiency (disorder) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:hepatic and portal embolism and thrombosis n1=phlébite | n2=en:hepatic and portal embolism and thrombosis | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:hyperlipidemia n1=phlébite | n2=en:hyperlipidemia | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:hypertension, mild n1=phlébite | n2=en:hypertension, mild | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:hypochromia n1=phlébite | n2=en:hypochromia | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:impaired platelet aggregation and spreading n1=phlébite | n2=en:impaired platelet aggregation and spreading | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:impaired release of platelet adenosine diphosphate (adp) n1=phlébite | n2=en:impaired release of platelet adenosine diphosphate (adp) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:inanimate samples and substances n1=phlébite | n2=en:inanimate samples and substances | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:increased bleeding (menorrhagia, gastrointestinal bleeding, hemarthroses) n1=phlébite | n2=en:increased bleeding (menorrhagia, gastrointestinal bleeding, hemarthroses) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:increased mean corpuscular hemoglobin concentration n1=phlébite | n2=en:increased mean corpuscular hemoglobin concentration | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:increased plasma thrombopoietin (tpo) n1=phlébite | n2=en:increased plasma thrombopoietin (tpo) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:increased retinal vascular permeability n1=phlébite | n2=en:increased retinal vascular permeability | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:increased sister chromatid exchange n1=phlébite | n2=en:increased sister chromatid exchange | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:injection site thrombosis n1=phlébite | n2=en:injection site thrombosis | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:injury due to unintentional cut, puncture, perforation or haemorrhage during aspiration, puncture and other catheterization n1=phlébite | n2=en:injury due to unintentional cut, puncture, perforation or haemorrhage during aspiration, puncture and other catheterization | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:lateral sinus thrombosis n1=phlébite | n2=en:lateral sinus thrombosis | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:macrocytic anemia (1 patient) n1=phlébite | n2=en:macrocytic anemia (1 patient) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:malignant tumor of mesothelial and soft tissue n1=phlébite | n2=en:malignant tumor of mesothelial and soft tissue | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:megakaryocytes with hypolobulated nuclei or separated nuclei n1=phlébite | n2=en:megakaryocytes with hypolobulated nuclei or separated nuclei | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:microangiopathic hemolytic anemia (coomb negative) n1=phlébite | n2=en:microangiopathic hemolytic anemia (coomb negative) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:miscellaneous topical preparations allergy n1=phlébite | n2=en:miscellaneous topical preparations allergy | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:mosquito-borne infectious disease n1=phlébite | n2=en:mosquito-borne infectious disease | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:multisystem disorder q-r n1=phlébite | n2=en:multisystem disorder q-r | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:multisystem disorder u-v n1=phlébite | n2=en:multisystem disorder u-v | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:musculoskeletal functions and activities n1=phlébite | n2=en:musculoskeletal functions and activities | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:neonatal research network terminology n1=phlébite | n2=en:neonatal research network terminology | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:nevus araneus n1=phlébite | n2=en:nevus araneus | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:no abnormal biochemistry finding detected n1=phlébite | n2=en:no abnormal biochemistry finding detected | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:no raynaud phenomenon n1=phlébite | n2=en:no raynaud phenomenon | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:non-site specific embolism and thrombosis n1=phlébite | n2=en:non-site specific embolism and thrombosis | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:obstruction of right atrial conduit after prior total cavopulmonary connection procedure n1=phlébite | n2=en:obstruction of right atrial conduit after prior total cavopulmonary connection procedure | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:oral dermatological agent allergy n1=phlébite | n2=en:oral dermatological agent allergy | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:organic blood flow disorder n1=phlébite | n2=en:organic blood flow disorder | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:orthostatic hypotension, severe, recurrent n1=phlébite | n2=en:orthostatic hypotension, severe, recurrent | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:pancytopenia (in 2 of 3 siblings) n1=phlébite | n2=en:pancytopenia (in 2 of 3 siblings) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:parasite n1=phlébite | n2=en:parasite | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:parasitic fluke n1=phlébite | n2=en:parasitic fluke | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:pathologic perinuclear mitochondrial iron deposits in erythrocyte precursors n1=phlébite | n2=en:pathologic perinuclear mitochondrial iron deposits in erythrocyte precursors | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:perinatal hematologic problems n1=phlébite | n2=en:perinatal hematologic problems | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:persistent ductus arteriosus (rare) n1=phlébite | n2=en:persistent ductus arteriosus (rare) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:phlebotomy n1=phlébite | n2=en:phlebotomy | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:platelet aggregation normal n1=phlébite | n2=en:platelet aggregation normal | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:platelet count normal n1=phlébite | n2=en:platelet count normal | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:poisoning by vaccine and/or biological substance n1=phlébite | n2=en:poisoning by vaccine and/or biological substance | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:post transplant distal limb syndrome n1=phlébite | n2=en:post transplant distal limb syndrome | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:prolonged appt (in 1 patient) n1=phlébite | n2=en:prolonged appt (in 1 patient) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:prolonged bleeding time due to quantitative decrease of vwf protein n1=phlébite | n2=en:prolonged bleeding time due to quantitative decrease of vwf protein | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:prominent abdominal venous pattern n1=phlébite | n2=en:prominent abdominal venous pattern | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:protozoan parasite n1=phlébite | n2=en:protozoan parasite | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:pseudomonas species g-r n1=phlébite | n2=en:pseudomonas species g-r | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:pseudomonas species s-z n1=phlébite | n2=en:pseudomonas species s-z | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:pulmonary artery hypertension (in one patient) n1=phlébite | n2=en:pulmonary artery hypertension (in one patient) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:pulmonary hypertension (neonatal period) n1=phlébite | n2=en:pulmonary hypertension (neonatal period) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:radial pulse absent n1=phlébite | n2=en:radial pulse absent | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:red blood cells lack h- antigen n1=phlébite | n2=en:red blood cells lack h- antigen | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:regional vascular structure n1=phlébite | n2=en:regional vascular structure | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:renal artery stenosis n1=phlébite | n2=en:renal artery stenosis | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:retrobulbar venous varix n1=phlébite | n2=en:retrobulbar venous varix | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:rupture of artery n1=phlébite | n2=en:rupture of artery | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:salmonella group g1 and g2 phase 1 a-e n1=phlébite | n2=en:salmonella group g1 and g2 phase 1 a-e | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:salmonella group h phase 1 y-z n1=phlébite | n2=en:salmonella group h phase 1 y-z | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:saprozoonosis n1=phlébite | n2=en:saprozoonosis | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:serum complement decreased n1=phlébite | n2=en:serum complement decreased | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:site of (i-z) n1=phlébite | n2=en:site of (i-z) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:skull and/or spine and/or bone and/or joint operations n1=phlébite | n2=en:skull and/or spine and/or bone and/or joint operations | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:small platelet size n1=phlébite | n2=en:small platelet size | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:stricture of artery n1=phlébite | n2=en:stricture of artery | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:suicide and self inflicted injury by amylobarbital n1=phlébite | n2=en:suicide and self inflicted injury by amylobarbital | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:suicide or self injury by igniting gasoline soaked clothing n1=phlébite | n2=en:suicide or self injury by igniting gasoline soaked clothing | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:suicide or selfinflicted injury by military firearm n1=phlébite | n2=en:suicide or selfinflicted injury by military firearm | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:thrombocytopenia purpura (in some patients) n1=phlébite | n2=en:thrombocytopenia purpura (in some patients) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:tick-borne hemorrhagic fever n1=phlébite | n2=en:tick-borne hemorrhagic fever | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:tick-borne orbivirus fever n1=phlébite | n2=en:tick-borne orbivirus fever | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:tick-borne viral encephalitis n1=phlébite | n2=en:tick-borne viral encephalitis | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:tissue nematode n1=phlébite | n2=en:tissue nematode | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:tranexamic acid pwdr n1=phlébite | n2=en:tranexamic acid pwdr | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:transfusion and related procedures n1=phlébite | n2=en:transfusion and related procedures | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:trousseau's syndrome n1=phlébite | n2=en:trousseau's syndrome | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:type attribute g - l n1=phlébite | n2=en:type attribute g - l | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:unspecified hematological disorder specific to newborn n1=phlébite | n2=en:unspecified hematological disorder specific to newborn | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:vaccine and biological substance n1=phlébite | n2=en:vaccine and biological substance | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:variable bleeding episodes (menorrhagia, easy bruisability, postoperative hemorrhage) n1=phlébite | n2=en:variable bleeding episodes (menorrhagia, easy bruisability, postoperative hemorrhage) | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:vascular headache n1=phlébite | n2=en:vascular headache | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:vascular stasis n1=phlébite | n2=en:vascular stasis | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:vasodilation disorder n1=phlébite | n2=en:vasodilation disorder | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> en:vibrio species n-z n1=phlébite | n2=en:vibrio species n-z | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> périphlébite n1=phlébite | n2=périphlébite | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> thrombo-phlébite n1=phlébite | n2=thrombo-phlébite | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> thrombose du tronc basilaire n1=phlébite | n2=thrombose du tronc basilaire | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 69 / 0.288 -> thrombose veineuse ovarienne n1=phlébite | n2=thrombose veineuse ovarienne | rel=r_associated | relid=0 | w=69 phlébite -- r_associated #0: 68 / 0.283 -> en:'leukemoid' granulocytosis n1=phlébite | n2=en:'leukemoid' granulocytosis | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:aberrant left subclavian n1=phlébite | n2=en:aberrant left subclavian | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:abnormal pulmonary venous return to right atria (in some patients) n1=phlébite | n2=en:abnormal pulmonary venous return to right atria (in some patients) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:activities, functions and processes n1=phlébite | n2=en:activities, functions and processes | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:additional pain and sensation observations n1=phlébite | n2=en:additional pain and sensation observations | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:allergy to bases and inactive substances n1=phlébite | n2=en:allergy to bases and inactive substances | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:anemia n1=phlébite | n2=en:anemia | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:aneurysm of popliteal artery n1=phlébite | n2=en:aneurysm of popliteal artery | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:angitis kidney n1=phlébite | n2=en:angitis kidney | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:antenatal blood group screening status n1=phlébite | n2=en:antenatal blood group screening status | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:aortic rupture (rare) n1=phlébite | n2=en:aortic rupture (rare) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:arterial aneurysm n1=phlébite | n2=en:arterial aneurysm | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:atherosclerosis n1=phlébite | n2=en:atherosclerosis | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:atypical mycobacteria species n-z n1=phlébite | n2=en:atypical mycobacteria species n-z | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:avian schistosome n1=phlébite | n2=en:avian schistosome | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:bleeding tendency (e.g., epistaxis) n1=phlébite | n2=en:bleeding tendency (e.g., epistaxis) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:bleeding tendency due to platelet defect n1=phlébite | n2=en:bleeding tendency due to platelet defect | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:blood and tissue microsporidian n1=phlébite | n2=en:blood and tissue microsporidian | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:blood procedure and/or transfusion n1=phlébite | n2=en:blood procedure and/or transfusion | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:bombay (hh) blood phenotype n1=phlébite | n2=en:bombay (hh) blood phenotype | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:bone marrow biopsy shows megaloblastic erythroid hyperplasia n1=phlébite | n2=en:bone marrow biopsy shows megaloblastic erythroid hyperplasia | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:bone marrow oedema n1=phlébite | n2=en:bone marrow oedema | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:calcium embolism n1=phlébite | n2=en:calcium embolism | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:cardiovascular occlusion n1=phlébite | n2=en:cardiovascular occlusion | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:cardiovascular system hereditary disorder n1=phlébite | n2=en:cardiovascular system hereditary disorder | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:category a biological agent n1=phlébite | n2=en:category a biological agent | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:category c biological agent n1=phlébite | n2=en:category c biological agent | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:cd43 (sialophorin) defectively expressed on surface of blood cells n1=phlébite | n2=en:cd43 (sialophorin) defectively expressed on surface of blood cells | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:cerebral aneurysm n1=phlébite | n2=en:cerebral aneurysm | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:cerebrovascular aneurysm (in some patients) n1=phlébite | n2=en:cerebrovascular aneurysm (in some patients) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:cerebrovascular disorder n1=phlébite | n2=en:cerebrovascular disorder | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:chest tube entrapment n1=phlébite | n2=en:chest tube entrapment | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:coagulation process n1=phlébite | n2=en:coagulation process | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:commensal parasite n1=phlébite | n2=en:commensal parasite | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:compound antispasmodics a-z n1=phlébite | n2=en:compound antispasmodics a-z | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:congenital hypoplastic anemia n1=phlébite | n2=en:congenital hypoplastic anemia | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:decreased number of small megakaryocytes (1 patient) n1=phlébite | n2=en:decreased number of small megakaryocytes (1 patient) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:defective platelet activation and aggregation in response to collagen n1=phlébite | n2=en:defective platelet activation and aggregation in response to collagen | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:defective platelet adhesion with normal platelet count n1=phlébite | n2=en:defective platelet adhesion with normal platelet count | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:diuretics+potassium supplement a-z n1=phlébite | n2=en:diuretics+potassium supplement a-z | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:division of bone of thorax, ribs or sternum n1=phlébite | n2=en:division of bone of thorax, ribs or sternum | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:ductus arteriosus dependent systemic circulation n1=phlébite | n2=en:ductus arteriosus dependent systemic circulation | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:ektacytometric osmotic gradient curve shifted to the left n1=phlébite | n2=en:ektacytometric osmotic gradient curve shifted to the left | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:elevated diastolic blood pressure n1=phlébite | n2=en:elevated diastolic blood pressure | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:elevated pulmonary artery pressure n1=phlébite | n2=en:elevated pulmonary artery pressure | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:emperipolesis n1=phlébite | n2=en:emperipolesis | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:entire blood vessel n1=phlébite | n2=en:entire blood vessel | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:epidemic encephalitis n1=phlébite | n2=en:epidemic encephalitis | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:equivocal laboratory finding n1=phlébite | n2=en:equivocal laboratory finding | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:equivocal microbiology finding n1=phlébite | n2=en:equivocal microbiology finding | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:erythroblasts show atypical cytoplasmic inclusions n1=phlébite | n2=en:erythroblasts show atypical cytoplasmic inclusions | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:essential thrombocythemia n1=phlébite | n2=en:essential thrombocythemia | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:exposure to electric current and radiation n1=phlébite | n2=en:exposure to electric current and radiation | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:fainting spells n1=phlébite | n2=en:fainting spells | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:fetal and newborn blood disorders n1=phlébite | n2=en:fetal and newborn blood disorders | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:food, vitamin, electrolyte and inorganic salt overdose n1=phlébite | n2=en:food, vitamin, electrolyte and inorganic salt overdose | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:gangrene n1=phlébite | n2=en:gangrene | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:hematologic and lymphocytic disorder n1=phlébite | n2=en:hematologic and lymphocytic disorder | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:hematopoietic toxicity develops on standard doses of thiopurine drugs n1=phlébite | n2=en:hematopoietic toxicity develops on standard doses of thiopurine drugs | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:hemolytic anemia in approximately 60% of patients n1=phlébite | n2=en:hemolytic anemia in approximately 60% of patients | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:hemolytic disease of the newborn n1=phlébite | n2=en:hemolytic disease of the newborn | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:hemorrhage n1=phlébite | n2=en:hemorrhage | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:human parasite n1=phlébite | n2=en:human parasite | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:hypergammaglobulinemia n1=phlébite | n2=en:hypergammaglobulinemia | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:hypertension (compression of renal arteries) n1=phlébite | n2=en:hypertension (compression of renal arteries) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:hypertension (hcp) n1=phlébite | n2=en:hypertension (hcp) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:hypertensive episode n1=phlébite | n2=en:hypertensive episode | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:hypertrophy of branches of the hepatic artery n1=phlébite | n2=en:hypertrophy of branches of the hepatic artery | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:hypotension may occur late in disease due to salt wasting n1=phlébite | n2=en:hypotension may occur late in disease due to salt wasting | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:increased megakaryocyte colony forming units (cfu-mk) n1=phlébite | n2=en:increased megakaryocyte colony forming units (cfu-mk) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:increased megakaryocyte precursor cells n1=phlébite | n2=en:increased megakaryocyte precursor cells | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:increased red cell hemolysis by shear stress n1=phlébite | n2=en:increased red cell hemolysis by shear stress | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:injury due to unintentional cut, puncture, perforation or haemorrhage during heart catheterization n1=phlébite | n2=en:injury due to unintentional cut, puncture, perforation or haemorrhage during heart catheterization | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:internal parasite n1=phlébite | n2=en:internal parasite | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:ischemic bowel disease n1=phlébite | n2=en:ischemic bowel disease | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:leukocytosis n1=phlébite | n2=en:leukocytosis | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:lutheran negative phenotype n1=phlébite | n2=en:lutheran negative phenotype | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:macrocytic hemolytic anemia, appears in infancy (in 1 family) n1=phlébite | n2=en:macrocytic hemolytic anemia, appears in infancy (in 1 family) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:malignant neoplasm of digestive organs and peritoneum n1=phlébite | n2=en:malignant neoplasm of digestive organs and peritoneum | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:mast cell activation syndrome n1=phlébite | n2=en:mast cell activation syndrome | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:megaloblastic erythropoiesis n1=phlébite | n2=en:megaloblastic erythropoiesis | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:menstrual disorder n1=phlébite | n2=en:menstrual disorder | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:methemoglobinemia (e.g. hb m boston 141800.0092) n1=phlébite | n2=en:methemoglobinemia (e.g. hb m boston 141800.0092) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:microangiopathic hemolytic anemia n1=phlébite | n2=en:microangiopathic hemolytic anemia | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:microcirculatory bed n1=phlébite | n2=en:microcirculatory bed | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:mosquito-borne bunyamwera group virus fever n1=phlébite | n2=en:mosquito-borne bunyamwera group virus fever | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:mosquito-borne guama group virus fever n1=phlébite | n2=en:mosquito-borne guama group virus fever | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:multisystem disorder e-f n1=phlébite | n2=en:multisystem disorder e-f | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:muscle spasm n1=phlébite | n2=en:muscle spasm | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:muscle, smooth, vascular n1=phlébite | n2=en:muscle, smooth, vascular | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:myelokathexis (retention of neutrophils in the bone marrow) n1=phlébite | n2=en:myelokathexis (retention of neutrophils in the bone marrow) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:neonatal cardiovascular disorder n1=phlébite | n2=en:neonatal cardiovascular disorder | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:no 'swiss cheese' abnormality n1=phlébite | n2=en:no 'swiss cheese' abnormality | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:normal platelet size (normal mpv) n1=phlébite | n2=en:normal platelet size (normal mpv) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:normal pulmonary vein pressures n1=phlébite | n2=en:normal pulmonary vein pressures | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:normal red cell osmotic fragility n1=phlébite | n2=en:normal red cell osmotic fragility | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:other specified disorders of circulatory system n1=phlébite | n2=en:other specified disorders of circulatory system | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:pancytopenia (4 patients) n1=phlébite | n2=en:pancytopenia (4 patients) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:peripheral blood smear shows polychromasia n1=phlébite | n2=en:peripheral blood smear shows polychromasia | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:petechia n1=phlébite | n2=en:petechia | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:platelet anisocytosis n1=phlébite | n2=en:platelet anisocytosis | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:platelets have paucity of granules n1=phlébite | n2=en:platelets have paucity of granules | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:platelets show defective adhesion to collagen and subendothelium n1=phlébite | n2=en:platelets show defective adhesion to collagen and subendothelium | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:poisoning by uric acid metabolism drug n1=phlébite | n2=en:poisoning by uric acid metabolism drug | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:possible thrombus n1=phlébite | n2=en:possible thrombus | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:pregnancy complications, hematologic n1=phlébite | n2=en:pregnancy complications, hematologic | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:presence of i erythrocyte antigen n1=phlébite | n2=en:presence of i erythrocyte antigen | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:procedure by intravesical approach n1=phlébite | n2=en:procedure by intravesical approach | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:procedure by posterior approach n1=phlébite | n2=en:procedure by posterior approach | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:procedure by sublabial approach n1=phlébite | n2=en:procedure by sublabial approach | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:procedure by suprapubic approach n1=phlébite | n2=en:procedure by suprapubic approach | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:procedure by transoral approach n1=phlébite | n2=en:procedure by transoral approach | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:procedure by transsphenoidal approach n1=phlébite | n2=en:procedure by transsphenoidal approach | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:prothrombin time increased n1=phlébite | n2=en:prothrombin time increased | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:pulmonary arteries show medial hypertrophy n1=phlébite | n2=en:pulmonary arteries show medial hypertrophy | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:pulmonary artery stenosis (in some patients) n1=phlébite | n2=en:pulmonary artery stenosis (in some patients) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:pulmonary hypertension, severe (in end-stage disease) n1=phlébite | n2=en:pulmonary hypertension, severe (in end-stage disease) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:purpura and other haemorrhagic conditions n1=phlébite | n2=en:purpura and other haemorrhagic conditions | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:raised microbiology finding n1=phlébite | n2=en:raised microbiology finding | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:respiratory test categorized by action status n1=phlébite | n2=en:respiratory test categorized by action status | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:reticulocyte count increased n1=phlébite | n2=en:reticulocyte count increased | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:salmonella group d1 phase 1 a-e n1=phlébite | n2=en:salmonella group d1 phase 1 a-e | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:salmonella group e4 phase 1 a-e n1=phlébite | n2=en:salmonella group e4 phase 1 a-e | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:salmonella group g1 and g2 phase 1 f-r n1=phlébite | n2=en:salmonella group g1 and g2 phase 1 f-r | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:schistocyte n1=phlébite | n2=en:schistocyte | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:skin, hair and nail finding n1=phlébite | n2=en:skin, hair and nail finding | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:small cerebral arteries show arteriosclerotic changes n1=phlébite | n2=en:small cerebral arteries show arteriosclerotic changes | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:structure of blood vessel of retina n1=phlébite | n2=en:structure of blood vessel of retina | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:suicide and self inflicted injury by quinalbarbitone n1=phlébite | n2=en:suicide and self inflicted injury by quinalbarbitone | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:suicide and selfinflicted poisoning by analgesics, antipyretics and anti-rheumatics n1=phlébite | n2=en:suicide and selfinflicted poisoning by analgesics, antipyretics and anti-rheumatics | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:suicide or self injury by jumping from high building n1=phlébite | n2=en:suicide or self injury by jumping from high building | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:suicide or self injury by placing self in path of moving railway vehicle n1=phlébite | n2=en:suicide or self injury by placing self in path of moving railway vehicle | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:sustained eosinophilia (greater than 1,500/cubic mm) for greater than 6 months n1=phlébite | n2=en:sustained eosinophilia (greater than 1,500/cubic mm) for greater than 6 months | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:techniques a-l n1=phlébite | n2=en:techniques a-l | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:thrombocytopenia (birth) n1=phlébite | n2=en:thrombocytopenia (birth) | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:thrombosis of mesenteric artery n1=phlébite | n2=en:thrombosis of mesenteric artery | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:thrombosis of posterior communicating artery n1=phlébite | n2=en:thrombosis of posterior communicating artery | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:thrombosis of retinal artery n1=phlébite | n2=en:thrombosis of retinal artery | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:thrombotic infarction n1=phlébite | n2=en:thrombotic infarction | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:tick-borne diseases n1=phlébite | n2=en:tick-borne diseases | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:tick-borne flavivirus hemorrhagic fever n1=phlébite | n2=en:tick-borne flavivirus hemorrhagic fever | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:tick-borne orbivirus encephalitis n1=phlébite | n2=en:tick-borne orbivirus encephalitis | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:tick-borne rickettsiosis n1=phlébite | n2=en:tick-borne rickettsiosis | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:transient neonatal hematological disorder n1=phlébite | n2=en:transient neonatal hematological disorder | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:tumor-like lesion of skin n1=phlébite | n2=en:tumor-like lesion of skin | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:type attribute m - p n1=phlébite | n2=en:type attribute m - p | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:unintentional cut, puncture, perforation or haemorrhage during surgical and medical care n1=phlébite | n2=en:unintentional cut, puncture, perforation or haemorrhage during surgical and medical care | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:variable platelet functional defects n1=phlébite | n2=en:variable platelet functional defects | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:vascular hemorrhagic disorder n1=phlébite | n2=en:vascular hemorrhagic disorder | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:vascular tortuosity n1=phlébite | n2=en:vascular tortuosity | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:vasculitis adverse event n1=phlébite | n2=en:vasculitis adverse event | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:veno-occlusive disease n1=phlébite | n2=en:veno-occlusive disease | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:visual test categorized by action status n1=phlébite | n2=en:visual test categorized by action status | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> en:zooparasitic portal cirrhosis n1=phlébite | n2=en:zooparasitic portal cirrhosis | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> enflure n1=phlébite | n2=enflure | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> obstruction n1=phlébite | n2=obstruction | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> thrombose du sinus caverneux n1=phlébite | n2=thrombose du sinus caverneux | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> thromboses n1=phlébite | n2=thromboses | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> thrombus antémortem n1=phlébite | n2=thrombus antémortem | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 68 / 0.283 -> tuméfaction n1=phlébite | n2=tuméfaction | rel=r_associated | relid=0 | w=68 phlébite -- r_associated #0: 67 / 0.279 -> artérite n1=phlébite | n2=artérite | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:abnormal retraction n1=phlébite | n2=en:abnormal retraction | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:abnormality of internal carotid artery n1=phlébite | n2=en:abnormality of internal carotid artery | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:accelerated atherosclerosis n1=phlébite | n2=en:accelerated atherosclerosis | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:accidental cut, puncture, perforation or hemorrhage during administration of enema n1=phlébite | n2=en:accidental cut, puncture, perforation or hemorrhage during administration of enema | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:accidental cut, puncture, perforation or hemorrhage during thoracentesis n1=phlébite | n2=en:accidental cut, puncture, perforation or hemorrhage during thoracentesis | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:adverse reaction to mixed bacterial vaccines, excluding combinations with a pertussis component n1=phlébite | n2=en:adverse reaction to mixed bacterial vaccines, excluding combinations with a pertussis component | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:alpha-thalassemia with fatal hb bart's hydrops fetalis (no normal gene) n1=phlébite | n2=en:alpha-thalassemia with fatal hb bart's hydrops fetalis (no normal gene) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:alternative medicine poisoning n1=phlébite | n2=en:alternative medicine poisoning | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:anemia (less common) n1=phlébite | n2=en:anemia (less common) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:anemia, unresponsive to oral iron and only partially responsive to parenteral iron n1=phlébite | n2=en:anemia, unresponsive to oral iron and only partially responsive to parenteral iron | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:angina n1=phlébite | n2=en:angina | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:anomalous pulmonary drainage n1=phlébite | n2=en:anomalous pulmonary drainage | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:anthroposophical agent n1=phlébite | n2=en:anthroposophical agent | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:anthroposophical medicine (regime/therapy) n1=phlébite | n2=en:anthroposophical medicine (regime/therapy) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:anthropozoonosis n1=phlébite | n2=en:anthropozoonosis | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:arterial aneurysms, multiple n1=phlébite | n2=en:arterial aneurysms, multiple | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:arterial embolus and thrombosis n1=phlébite | n2=en:arterial embolus and thrombosis | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:arterial vessels show fragmentation of the internal elastic membrane n1=phlébite | n2=en:arterial vessels show fragmentation of the internal elastic membrane | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:arteriovenous fistula n1=phlébite | n2=en:arteriovenous fistula | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:arthropathies and related disorders n1=phlébite | n2=en:arthropathies and related disorders | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:ascending aortic dissection n1=phlébite | n2=en:ascending aortic dissection | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:associated with iron deficiency anemia n1=phlébite | n2=en:associated with iron deficiency anemia | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:atherothrombosis n1=phlébite | n2=en:atherothrombosis | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:autoimmune cytopenia n1=phlébite | n2=en:autoimmune cytopenia | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:barrier preparation adverse reaction n1=phlébite | n2=en:barrier preparation adverse reaction | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:basophilic stippling n1=phlébite | n2=en:basophilic stippling | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:benign tumor of mesothelial and soft tissue n1=phlébite | n2=en:benign tumor of mesothelial and soft tissue | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:birth trauma, asphyxia and hypoxia n1=phlébite | n2=en:birth trauma, asphyxia and hypoxia | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:bleeding tendency due to defect in prothrombin and inability to form fibrin clot n1=phlébite | n2=en:bleeding tendency due to defect in prothrombin and inability to form fibrin clot | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:blood product reservation, release, transfusion or disposition n1=phlébite | n2=en:blood product reservation, release, transfusion or disposition | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:bone marrow transplant rejection n1=phlébite | n2=en:bone marrow transplant rejection | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:cerebrovascular accident n1=phlébite | n2=en:cerebrovascular accident | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:chemical pathology test categorized by action status n1=phlébite | n2=en:chemical pathology test categorized by action status | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:clinical test result n1=phlébite | n2=en:clinical test result | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:coagulation defect due to decreased liver function n1=phlébite | n2=en:coagulation defect due to decreased liver function | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:compound analgesics m-z n1=phlébite | n2=en:compound analgesics m-z | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:coronary thrombosis n1=phlébite | n2=en:coronary thrombosis | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:cutaneous extramedullary haemopoiesis n1=phlébite | n2=en:cutaneous extramedullary haemopoiesis | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:cystourethroscopy with ureteroscopy and pyeloscopy n1=phlébite | n2=en:cystourethroscopy with ureteroscopy and pyeloscopy | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:decreased mean platelet volume (mpv) n1=phlébite | n2=en:decreased mean platelet volume (mpv) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:decreased platelet expression of gp6 n1=phlébite | n2=en:decreased platelet expression of gp6 | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:descending aortic aneurysm (uncommon) n1=phlébite | n2=en:descending aortic aneurysm (uncommon) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:device embolization n1=phlébite | n2=en:device embolization | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:dyserythropoietic anemia n1=phlébite | n2=en:dyserythropoietic anemia | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:dysglobulinemia n1=phlébite | n2=en:dysglobulinemia | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:ear, nose and throat/auditory test categorized by action status n1=phlébite | n2=en:ear, nose and throat/auditory test categorized by action status | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:empty delta sign n1=phlébite | n2=en:empty delta sign | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:enlarged pulmonary trunk (in some patients) n1=phlébite | n2=en:enlarged pulmonary trunk (in some patients) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:epistaxis n1=phlébite | n2=en:epistaxis | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:equivocal biochemistry finding n1=phlébite | n2=en:equivocal biochemistry finding | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:evagination n1=phlébite | n2=en:evagination | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:finding / observation / clinical history n1=phlébite | n2=en:finding / observation / clinical history | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:food, vitamin, electrolyte and inorganic salt poisoning n1=phlébite | n2=en:food, vitamin, electrolyte and inorganic salt poisoning | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:foreign body of cardiovascular structure n1=phlébite | n2=en:foreign body of cardiovascular structure | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:fragmented erythrocytes n1=phlébite | n2=en:fragmented erythrocytes | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:gray polymorphonuclear neutrophils n1=phlébite | n2=en:gray polymorphonuclear neutrophils | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:gray-to-gray-blue platelet on wright-giemsa stain n1=phlébite | n2=en:gray-to-gray-blue platelet on wright-giemsa stain | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:heart: muscle/valve n1=phlébite | n2=en:heart: muscle/valve | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:hemolysis biological process n1=phlébite | n2=en:hemolysis biological process | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:histopathology test categorized by action status n1=phlébite | n2=en:histopathology test categorized by action status | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:human arthropod parasite n1=phlébite | n2=en:human arthropod parasite | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:hypersegmented neutrophil n1=phlébite | n2=en:hypersegmented neutrophil | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:increased level (laboratory finding) n1=phlébite | n2=en:increased level (laboratory finding) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:increased red cell osmotic resistance n1=phlébite | n2=en:increased red cell osmotic resistance | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:ineffective erythropoiesis n1=phlébite | n2=en:ineffective erythropoiesis | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:inhalations a-z n1=phlébite | n2=en:inhalations a-z | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:intracerebral hemorrhage (secondary) n1=phlébite | n2=en:intracerebral hemorrhage (secondary) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:intracranial developmental venous anomalies n1=phlébite | n2=en:intracranial developmental venous anomalies | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:intracranial thrombosis n1=phlébite | n2=en:intracranial thrombosis | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:intravesical administration of treatment n1=phlébite | n2=en:intravesical administration of treatment | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:leukemia in remission n1=phlébite | n2=en:leukemia in remission | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:leukocytosis with predominant granulocytosis (20,000-100,000 /mm3) common n1=phlébite | n2=en:leukocytosis with predominant granulocytosis (20,000-100,000 /mm3) common | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:low to low-normal platelet count n1=phlébite | n2=en:low to low-normal platelet count | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:lymphatic malformation (low flow) (most cases) n1=phlébite | n2=en:lymphatic malformation (low flow) (most cases) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:macrothrombocytopenia n1=phlébite | n2=en:macrothrombocytopenia | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:mcv - raised n1=phlébite | n2=en:mcv - raised | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:mechanical lesion n1=phlébite | n2=en:mechanical lesion | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:median platelet volume 15.5fl n1=phlébite | n2=en:median platelet volume 15.5fl | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:megakaryocytes increased in bone marrow n1=phlébite | n2=en:megakaryocytes increased in bone marrow | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:megakaryocytes show ultrastructural defects with abnormal membranes n1=phlébite | n2=en:megakaryocytes show ultrastructural defects with abnormal membranes | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:melanocytic nevi of scalp and neck n1=phlébite | n2=en:melanocytic nevi of scalp and neck | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:menorrhagia n1=phlébite | n2=en:menorrhagia | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:methemoglobinemia n1=phlébite | n2=en:methemoglobinemia | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:microbiology finding present n1=phlébite | n2=en:microbiology finding present | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:microembolism n1=phlébite | n2=en:microembolism | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:micromegakaryocytes (in some patients) n1=phlébite | n2=en:micromegakaryocytes (in some patients) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:mild hypochromic microcytic anemia n1=phlébite | n2=en:mild hypochromic microcytic anemia | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:mild thrombocytopenia (before age 50) n1=phlébite | n2=en:mild thrombocytopenia (before age 50) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:minor skin infection preparations a-z n1=phlébite | n2=en:minor skin infection preparations a-z | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:mite-borne infectious disease n1=phlébite | n2=en:mite-borne infectious disease | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:mosquito-borne alphavirus fever n1=phlébite | n2=en:mosquito-borne alphavirus fever | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:mouth, abdomen and bowel observations n1=phlébite | n2=en:mouth, abdomen and bowel observations | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:multisystem disorder o-p n1=phlébite | n2=en:multisystem disorder o-p | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:myeloproliferative disease n1=phlébite | n2=en:myeloproliferative disease | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:nasogastric administration of treatment n1=phlébite | n2=en:nasogastric administration of treatment | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:neonatal alloimmune thrombocytopenia (nait) n1=phlébite | n2=en:neonatal alloimmune thrombocytopenia (nait) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:neonatal hypertension n1=phlébite | n2=en:neonatal hypertension | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:non-neoplastic cardiovascular disorder n1=phlébite | n2=en:non-neoplastic cardiovascular disorder | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:normal biochemistry finding n1=phlébite | n2=en:normal biochemistry finding | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:normal platelet size and morphology n1=phlébite | n2=en:normal platelet size and morphology | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:normocytic anemia n1=phlébite | n2=en:normocytic anemia | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:normocytic hypoplastic anemia n1=phlébite | n2=en:normocytic hypoplastic anemia | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:nursing attributes t - z n1=phlébite | n2=en:nursing attributes t - z | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:orthostatic hypotension n1=phlébite | n2=en:orthostatic hypotension | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:other cardiovascular diseases of mother, delivered, with or without mention of antepartum condition n1=phlébite | n2=en:other cardiovascular diseases of mother, delivered, with or without mention of antepartum condition | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:other specified diseases of blood and blood-forming organs n1=phlébite | n2=en:other specified diseases of blood and blood-forming organs | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:patent ductus arteriosus (less common) n1=phlébite | n2=en:patent ductus arteriosus (less common) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:pathologic hemolysis n1=phlébite | n2=en:pathologic hemolysis | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:physiological functions and activities n1=phlébite | n2=en:physiological functions and activities | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:platelet aggregation decreased n1=phlébite | n2=en:platelet aggregation decreased | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:platelet morphology normal n1=phlébite | n2=en:platelet morphology normal | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:platelets show decreased gpia/gpiia surface complex n1=phlébite | n2=en:platelets show decreased gpia/gpiia surface complex | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:platelets show defective activation n1=phlébite | n2=en:platelets show defective activation | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:positive immunology finding n1=phlébite | n2=en:positive immunology finding | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:postpartum venous thrombosis n1=phlébite | n2=en:postpartum venous thrombosis | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:procedure by transcrotal approach n1=phlébite | n2=en:procedure by transcrotal approach | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:procedure by transurethral approach n1=phlébite | n2=en:procedure by transurethral approach | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:prolapsed arterial valve n1=phlébite | n2=en:prolapsed arterial valve | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:prolonged bleeding after surgery or trauma n1=phlébite | n2=en:prolonged bleeding after surgery or trauma | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:prolonged bleeding time n1=phlébite | n2=en:prolonged bleeding time | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:prolonged bleeding time 15-to->30 minutes n1=phlébite | n2=en:prolonged bleeding time 15-to->30 minutes | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:promyelocytes have atypical nuclei and vacuolization of the cytoplasm n1=phlébite | n2=en:promyelocytes have atypical nuclei and vacuolization of the cytoplasm | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:proprietary cough compounds a-l n1=phlébite | n2=en:proprietary cough compounds a-l | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:protein c decreased n1=phlébite | n2=en:protein c decreased | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:reactive vascular proliferation n1=phlébite | n2=en:reactive vascular proliferation | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:renal hypertension n1=phlébite | n2=en:renal hypertension | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:renovascular hypertension (rare) n1=phlébite | n2=en:renovascular hypertension (rare) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:reticulocytopenia n1=phlébite | n2=en:reticulocytopenia | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:salmonella group c1 and c4 phase 1 a-e n1=phlébite | n2=en:salmonella group c1 and c4 phase 1 a-e | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:salmonella group c1 and c4 phase 1 y-z n1=phlébite | n2=en:salmonella group c1 and c4 phase 1 y-z | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:salmonella group m phase 1 f-r n1=phlébite | n2=en:salmonella group m phase 1 f-r | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:salmonella group m phase 1 y-z n1=phlébite | n2=en:salmonella group m phase 1 y-z | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:short medullary arteries of the brain n1=phlébite | n2=en:short medullary arteries of the brain | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:sky-blue leukocyte inclusion bodies (dohle-like bodies) that contain clusters of ribosomes oriented along parallel microfilaments n1=phlébite | n2=en:sky-blue leukocyte inclusion bodies (dohle-like bodies) that contain clusters of ribosomes oriented along parallel microfilaments | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:stomatocyte (cell) n1=phlébite | n2=en:stomatocyte (cell) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:suicide and self inflicted poisoning by barbiturates n1=phlébite | n2=en:suicide and self inflicted poisoning by barbiturates | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:suicide and selfinflicted injury by hanging, strangulation and suffocation n1=phlébite | n2=en:suicide and selfinflicted injury by hanging, strangulation and suffocation | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:suicide or self injury associated with moving vehicles n1=phlébite | n2=en:suicide or self injury associated with moving vehicles | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:suicide or self injury by jumping from bridge n1=phlébite | n2=en:suicide or self injury by jumping from bridge | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:suicide or selfinflicted injury by firearms and explosives n1=phlébite | n2=en:suicide or selfinflicted injury by firearms and explosives | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:systemic vascular structure n1=phlébite | n2=en:systemic vascular structure | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:thrombocytopenia (less common) n1=phlébite | n2=en:thrombocytopenia (less common) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:thrombocytopenia, isolated (1 patient) n1=phlébite | n2=en:thrombocytopenia, isolated (1 patient) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:thrombosis multiple n1=phlébite | n2=en:thrombosis multiple | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:thrombosis of arteries of the extremities n1=phlébite | n2=en:thrombosis of arteries of the extremities | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:thrombotic microangiopathy (hyaline thrombi of platelets and fibrin in terminal arterioles and capillaries) n1=phlébite | n2=en:thrombotic microangiopathy (hyaline thrombi of platelets and fibrin in terminal arterioles and capillaries) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:transposition of great vessels (rare) n1=phlébite | n2=en:transposition of great vessels (rare) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:treatment via bladder catheter n1=phlébite | n2=en:treatment via bladder catheter | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:tumor-like lesion of nervous system n1=phlébite | n2=en:tumor-like lesion of nervous system | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:tunica media n1=phlébite | n2=en:tunica media | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:type attribute d - f n1=phlébite | n2=en:type attribute d - f | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:type attribute r - s n1=phlébite | n2=en:type attribute r - s | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:type i - methemoglobin concentration 10-35% n1=phlébite | n2=en:type i - methemoglobin concentration 10-35% | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:vascular anomalies (50% of patients) n1=phlébite | n2=en:vascular anomalies (50% of patients) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:vascularization increased in upper dermis n1=phlébite | n2=en:vascularization increased in upper dermis | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:vasospasm n1=phlébite | n2=en:vasospasm | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:vein n1=phlébite | n2=en:vein | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:venous varicosities of celiac and mesenteric vessels n1=phlébite | n2=en:venous varicosities of celiac and mesenteric vessels | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:zooanthroponosis n1=phlébite | n2=en:zooanthroponosis | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> en:zoonotic bacterial infection n1=phlébite | n2=en:zoonotic bacterial infection | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> inflammation (médecine) n1=phlébite | n2=inflammation (médecine) | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> lymphangite n1=phlébite | n2=lymphangite | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> maladie thrombo-embolique n1=phlébite | n2=maladie thrombo-embolique | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> maladie thromboembolique n1=phlébite | n2=maladie thromboembolique | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> maladie thromboembolique veineuse n1=phlébite | n2=maladie thromboembolique veineuse | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> thromboembolie n1=phlébite | n2=thromboembolie | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 67 / 0.279 -> thrombose veineuse rénale n1=phlébite | n2=thrombose veineuse rénale | rel=r_associated | relid=0 | w=67 phlébite -- r_associated #0: 66 / 0.275 -> en:abnormal microbiological finding in specimen from respiratory organ and thorax n1=phlébite | n2=en:abnormal microbiological finding in specimen from respiratory organ and thorax | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:absent platelet delta granules n1=phlébite | n2=en:absent platelet delta granules | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:accidental alternative medicine overdose n1=phlébite | n2=en:accidental alternative medicine overdose | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:acute disease of hematopoietic system n1=phlébite | n2=en:acute disease of hematopoietic system | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:administration of treatment via specific route n1=phlébite | n2=en:administration of treatment via specific route | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:affected arteries have electron-dense granular material close to vascular smooth muscle cell membranes n1=phlébite | n2=en:affected arteries have electron-dense granular material close to vascular smooth muscle cell membranes | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:agenesis of pulmonary vessels n1=phlébite | n2=en:agenesis of pulmonary vessels | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:alternative arterial hierarchy n1=phlébite | n2=en:alternative arterial hierarchy | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:anemia (in some) n1=phlébite | n2=en:anemia (in some) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:aneurysm of other aortic segments rare n1=phlébite | n2=en:aneurysm of other aortic segments rare | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:anomalous branches of internal carotid artery n1=phlébite | n2=en:anomalous branches of internal carotid artery | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:antenatal sickle cell screening categorized by action status n1=phlébite | n2=en:antenatal sickle cell screening categorized by action status | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:anteversion n1=phlébite | n2=en:anteversion | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:antiphospholipid syndrome n1=phlébite | n2=en:antiphospholipid syndrome | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:aortic aneurysm n1=phlébite | n2=en:aortic aneurysm | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:aortic coarctation (rare) n1=phlébite | n2=en:aortic coarctation (rare) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:aortic root dilatation n1=phlébite | n2=en:aortic root dilatation | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:aplastic anemia (in some patients) n1=phlébite | n2=en:aplastic anemia (in some patients) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:arthropod-borne infectious disease n1=phlébite | n2=en:arthropod-borne infectious disease | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:ascending aorta dilatation n1=phlébite | n2=en:ascending aorta dilatation | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:av fistula stenosis n1=phlébite | n2=en:av fistula stenosis | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:benign neutropenia n1=phlébite | n2=en:benign neutropenia | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:bleeding associated with peptic ulcer disease n1=phlébite | n2=en:bleeding associated with peptic ulcer disease | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:bleeding diathesis n1=phlébite | n2=en:bleeding diathesis | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:bone marrow foam cells (type ii) n1=phlébite | n2=en:bone marrow foam cells (type ii) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:bone marrow haemorrhage n1=phlébite | n2=en:bone marrow haemorrhage | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:bone marrow may show hemophagocytosis n1=phlébite | n2=en:bone marrow may show hemophagocytosis | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:cardiogenic shock n1=phlébite | n2=en:cardiogenic shock | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:cardiovascular abnormality due to bilateral arterial ducts n1=phlébite | n2=en:cardiovascular abnormality due to bilateral arterial ducts | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:cardiovascular injury n1=phlébite | n2=en:cardiovascular injury | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:causes of injury and poisoning n1=phlébite | n2=en:causes of injury and poisoning | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:cerebral degenerations usually manifest in childhood n1=phlébite | n2=en:cerebral degenerations usually manifest in childhood | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:cerebrovascular ischemic attacks n1=phlébite | n2=en:cerebrovascular ischemic attacks | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:chronic hemolytic anemia n1=phlébite | n2=en:chronic hemolytic anemia | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:clostridium species g-p n1=phlébite | n2=en:clostridium species g-p | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:coagulation disorder n1=phlébite | n2=en:coagulation disorder | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:coccidian parasite n1=phlébite | n2=en:coccidian parasite | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:congenital atresia of pulmonary artery n1=phlébite | n2=en:congenital atresia of pulmonary artery | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:coronary artery aneurysm (in some patients) n1=phlébite | n2=en:coronary artery aneurysm (in some patients) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:coronary atherosclerosis n1=phlébite | n2=en:coronary atherosclerosis | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:decreased myeloperoxidase activity in neutrophils and monocytes n1=phlébite | n2=en:decreased myeloperoxidase activity in neutrophils and monocytes | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:decreased platelet count n1=phlébite | n2=en:decreased platelet count | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:degraded platelet alpha-granule proteins n1=phlébite | n2=en:degraded platelet alpha-granule proteins | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:emollients/barrier creams: a-e n1=phlébite | n2=en:emollients/barrier creams: a-e | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:emollients/barrier creams: f-o n1=phlébite | n2=en:emollients/barrier creams: f-o | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:episodic bleeding n1=phlébite | n2=en:episodic bleeding | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:erythrocytosis n1=phlébite | n2=en:erythrocytosis | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:erythropoietic hyperplasia of bone marrow n1=phlébite | n2=en:erythropoietic hyperplasia of bone marrow | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:facultative parasite n1=phlébite | n2=en:facultative parasite | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:fh: thrombosis n1=phlébite | n2=en:fh: thrombosis | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:fusiform dilation and tortuosity of cerebrovascular arteries n1=phlébite | n2=en:fusiform dilation and tortuosity of cerebrovascular arteries | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:gastrointestinal tract test categorized by action status n1=phlébite | n2=en:gastrointestinal tract test categorized by action status | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:gray platelets n1=phlébite | n2=en:gray platelets | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:hematology n1=phlébite | n2=en:hematology | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:hereditary hemolytic anemia n1=phlébite | n2=en:hereditary hemolytic anemia | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:hypercellular bone marrow n1=phlébite | n2=en:hypercellular bone marrow | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:hypertension (in some patients) n1=phlébite | n2=en:hypertension (in some patients) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:hypertension adverse event n1=phlébite | n2=en:hypertension adverse event | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:hypolobulated (bilobed or rod-like) granulocyte nuclei (heterozygote) n1=phlébite | n2=en:hypolobulated (bilobed or rod-like) granulocyte nuclei (heterozygote) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:hypoplastic myelodysplasia n1=phlébite | n2=en:hypoplastic myelodysplasia | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:hypoplastic pulmonary artery n1=phlébite | n2=en:hypoplastic pulmonary artery | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:hypotension adverse event n1=phlébite | n2=en:hypotension adverse event | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:imbalanced hemoglobin chain synthesis n1=phlébite | n2=en:imbalanced hemoglobin chain synthesis | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:immunology test categorized by action status n1=phlébite | n2=en:immunology test categorized by action status | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:impaired platelet aggregation (in some patients) n1=phlébite | n2=en:impaired platelet aggregation (in some patients) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:increased erythrocyte zinc- and metal-free protoporphyrin n1=phlébite | n2=en:increased erythrocyte zinc- and metal-free protoporphyrin | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:increased micromegakaryocytes (bone marrow) n1=phlébite | n2=en:increased micromegakaryocytes (bone marrow) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:increased number of abnormal megakaryocytes seen on bone marrow biopsy n1=phlébite | n2=en:increased number of abnormal megakaryocytes seen on bone marrow biopsy | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:increased red blood cell mass n1=phlébite | n2=en:increased red blood cell mass | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:infectious agent n1=phlébite | n2=en:infectious agent | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:inferior vena cava interruption with azygos continuation n1=phlébite | n2=en:inferior vena cava interruption with azygos continuation | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:inner leaf hole n1=phlébite | n2=en:inner leaf hole | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:intermittent thrombocytopenia n1=phlébite | n2=en:intermittent thrombocytopenia | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:internuclear chromatin bridges n1=phlébite | n2=en:internuclear chromatin bridges | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:intestinal microsporidian n1=phlébite | n2=en:intestinal microsporidian | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:intestinal nematode n1=phlébite | n2=en:intestinal nematode | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:intimal thickening in the coronary arteries n1=phlébite | n2=en:intimal thickening in the coronary arteries | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:iron deficiency n1=phlébite | n2=en:iron deficiency | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:iron deficiency anemia (adults) n1=phlébite | n2=en:iron deficiency anemia (adults) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:iron-deficiency anemia n1=phlébite | n2=en:iron-deficiency anemia | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:laboratory finding absent n1=phlébite | n2=en:laboratory finding absent | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:leukocyte disorders n1=phlébite | n2=en:leukocyte disorders | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:leukopenia (less common) n1=phlébite | n2=en:leukopenia (less common) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:lewis a- and b- negative cells n1=phlébite | n2=en:lewis a- and b- negative cells | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:malformation or hamartoma of pilosebaceous apparatus n1=phlébite | n2=en:malformation or hamartoma of pilosebaceous apparatus | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:malignant neoplasm, overlapping lesion of connective and soft tissue n1=phlébite | n2=en:malignant neoplasm, overlapping lesion of connective and soft tissue | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:malposition of pulmonary vein branches adjacent to pulmonary artery branches (mpv) n1=phlébite | n2=en:malposition of pulmonary vein branches adjacent to pulmonary artery branches (mpv) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:mastocytosis n1=phlébite | n2=en:mastocytosis | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:medullary blast count of less than 5% n1=phlébite | n2=en:medullary blast count of less than 5% | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:mild reticulocytosis in carrier females n1=phlébite | n2=en:mild reticulocytosis in carrier females | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:mild-significant bleeding episodes (epistaxis, easy bruisability, postoperative hemorrhage, menorrhagia) n1=phlébite | n2=en:mild-significant bleeding episodes (epistaxis, easy bruisability, postoperative hemorrhage, menorrhagia) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:miscellaneous topical agents n1=phlébite | n2=en:miscellaneous topical agents | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:mosquito-borne arboviral fever n1=phlébite | n2=en:mosquito-borne arboviral fever | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:mosquito-borne flavivirus fever n1=phlébite | n2=en:mosquito-borne flavivirus fever | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:mosquito-borne hemorrhagic fever n1=phlébite | n2=en:mosquito-borne hemorrhagic fever | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:multinucleated erythroblasts n1=phlébite | n2=en:multinucleated erythroblasts | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:multisystem disorder a-b n1=phlébite | n2=en:multisystem disorder a-b | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:multisystem disorder i-j n1=phlébite | n2=en:multisystem disorder i-j | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:neonatal pulmonary hypertension n1=phlébite | n2=en:neonatal pulmonary hypertension | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:neoplasm of heart and/or pericardium n1=phlébite | n2=en:neoplasm of heart and/or pericardium | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:neurological test categorized by action status n1=phlébite | n2=en:neurological test categorized by action status | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:no abnormal laboratory finding detected n1=phlébite | n2=en:no abnormal laboratory finding detected | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:no childhood hypertension n1=phlébite | n2=en:no childhood hypertension | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:no increased risk of thrombotic vascular events n1=phlébite | n2=en:no increased risk of thrombotic vascular events | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:non-medicinal substance n1=phlébite | n2=en:non-medicinal substance | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:non-neoplastic hematologic and lymphocytic disorder n1=phlébite | n2=en:non-neoplastic hematologic and lymphocytic disorder | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:normal or increased platelet count n1=phlébite | n2=en:normal or increased platelet count | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:normal serum thromboxane b2 n1=phlébite | n2=en:normal serum thromboxane b2 | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:other anaemias n1=phlébite | n2=en:other anaemias | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:pancytopenia (in 50% of patients) n1=phlébite | n2=en:pancytopenia (in 50% of patients) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:patent ductus arteriosus (rare) n1=phlébite | n2=en:patent ductus arteriosus (rare) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:peripheral blood smear shows abnormal red cells n1=phlébite | n2=en:peripheral blood smear shows abnormal red cells | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:persistence of fetal hemoglobin n1=phlébite | n2=en:persistence of fetal hemoglobin | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:platelet aggregation abnormal n1=phlébite | n2=en:platelet aggregation abnormal | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:platelet function test normal n1=phlébite | n2=en:platelet function test normal | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:platelets fail to inhibit the rise of camp levels in response to adp n1=phlébite | n2=en:platelets fail to inhibit the rise of camp levels in response to adp | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:poikilocytosis n1=phlébite | n2=en:poikilocytosis | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:poisoning of undetermined intent by non-drug substance n1=phlébite | n2=en:poisoning of undetermined intent by non-drug substance | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:potassium sparing compound diuretics a-z n1=phlébite | n2=en:potassium sparing compound diuretics a-z | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:procedure by intranasal approach n1=phlébite | n2=en:procedure by intranasal approach | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:procedure by transvascular approach n1=phlébite | n2=en:procedure by transvascular approach | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:procedure recommendation categorized by action status n1=phlébite | n2=en:procedure recommendation categorized by action status | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:prolonged activated partial thromboplastin time (aptt) n1=phlébite | n2=en:prolonged activated partial thromboplastin time (aptt) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:prolonged bleeding time (less common) n1=phlébite | n2=en:prolonged bleeding time (less common) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:protuberance n1=phlébite | n2=en:protuberance | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:pulmonary arterial hypertension n1=phlébite | n2=en:pulmonary arterial hypertension | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:pulmonary artery thrombosis n1=phlébite | n2=en:pulmonary artery thrombosis | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:recurrent hemorrhagic events n1=phlébite | n2=en:recurrent hemorrhagic events | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:recurrent thrombophlebitis n1=phlébite | n2=en:recurrent thrombophlebitis | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:salmonella group h phase 1 f-r n1=phlébite | n2=en:salmonella group h phase 1 f-r | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:salmonella group i phase 1 a-e n1=phlébite | n2=en:salmonella group i phase 1 a-e | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:salmonella group i phase 1 f-r n1=phlébite | n2=en:salmonella group i phase 1 f-r | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:salmonella group i phase 1 y-z n1=phlébite | n2=en:salmonella group i phase 1 y-z | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:salmonella group r phase 1 a-e n1=phlébite | n2=en:salmonella group r phase 1 a-e | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:severe congenital neutropenia n1=phlébite | n2=en:severe congenital neutropenia | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:sideroblastic anemia n1=phlébite | n2=en:sideroblastic anemia | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:small vessel cerebrovascular disease (rare) n1=phlébite | n2=en:small vessel cerebrovascular disease (rare) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:solvent h - i n1=phlébite | n2=en:solvent h - i | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:solvent p n1=phlébite | n2=en:solvent p | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:suicide and self inflicted injury by pentabarbitone n1=phlébite | n2=en:suicide and self inflicted injury by pentabarbitone | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:suicide or self injury by arson n1=phlébite | n2=en:suicide or self injury by arson | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:suicide or self injury by placing self in path of moving motor vehicle n1=phlébite | n2=en:suicide or self injury by placing self in path of moving motor vehicle | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:suicide or selfinflicted injury by crashing motor vehicle n1=phlébite | n2=en:suicide or selfinflicted injury by crashing motor vehicle | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:suicide or selfinflicted injury by cutting n1=phlébite | n2=en:suicide or selfinflicted injury by cutting | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:techniques m-z n1=phlébite | n2=en:techniques m-z | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:thrombocytopenia (reported in 1 patient) n1=phlébite | n2=en:thrombocytopenia (reported in 1 patient) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:thrombosis in situ n1=phlébite | n2=en:thrombosis in situ | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:thrombosis of iliac artery n1=phlébite | n2=en:thrombosis of iliac artery | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:tick-borne coltivirus encephalitis n1=phlébite | n2=en:tick-borne coltivirus encephalitis | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:tranexamic acid 100mg/ml intravenous solution 10ml vial n1=phlébite | n2=en:tranexamic acid 100mg/ml intravenous solution 10ml vial | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:upper respiratory fluids and spaces n1=phlébite | n2=en:upper respiratory fluids and spaces | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:vacuolization in myeloid cell lines in the bone marrow n1=phlébite | n2=en:vacuolization in myeloid cell lines in the bone marrow | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:veins/lymphatics n1=phlébite | n2=en:veins/lymphatics | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:venous thrombosis/embolism (rare) n1=phlébite | n2=en:venous thrombosis/embolism (rare) | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> en:zoonotic infection n1=phlébite | n2=en:zoonotic infection | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> grumeau n1=phlébite | n2=grumeau | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> oedème n1=phlébite | n2=oedème | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 66 / 0.275 -> thrombose de la veine hépatique n1=phlébite | n2=thrombose de la veine hépatique | rel=r_associated | relid=0 | w=66 phlébite -- r_associated #0: 65 / 0.271 -> en:abnormal immunological finding in specimen from respiratory organ and thorax n1=phlébite | n2=en:abnormal immunological finding in specimen from respiratory organ and thorax | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:abnormal platelet morphology with paucity of granules (in some patients) n1=phlébite | n2=en:abnormal platelet morphology with paucity of granules (in some patients) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:accidental cut, puncture, perforation or hemorrhage during aspirating needle biopsy n1=phlébite | n2=en:accidental cut, puncture, perforation or hemorrhage during aspirating needle biopsy | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:accidental cut, puncture, perforation or hemorrhage during transfusion n1=phlébite | n2=en:accidental cut, puncture, perforation or hemorrhage during transfusion | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:acute hemolytic transfusion reaction when transfused with vel-positive blood n1=phlébite | n2=en:acute hemolytic transfusion reaction when transfused with vel-positive blood | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:alpha-thalassemia with microcytosis (2 normal genes) n1=phlébite | n2=en:alpha-thalassemia with microcytosis (2 normal genes) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:alternative medicines adverse reaction n1=phlébite | n2=en:alternative medicines adverse reaction | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:anemia (in some patients) n1=phlébite | n2=en:anemia (in some patients) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:anemia (not responsive to pyridoxine supplementation) n1=phlébite | n2=en:anemia (not responsive to pyridoxine supplementation) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:anemia due to poor nutrition n1=phlébite | n2=en:anemia due to poor nutrition | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:anisopoikilocytosis n1=phlébite | n2=en:anisopoikilocytosis | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:antineoplastic/immunosuppressant/immunostimulant overdose n1=phlébite | n2=en:antineoplastic/immunosuppressant/immunostimulant overdose | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:aortic arch calcification n1=phlébite | n2=en:aortic arch calcification | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:arterial tortuosity n1=phlébite | n2=en:arterial tortuosity | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:arterial tortuosity (large and medium-sized arteries including aorta) n1=phlébite | n2=en:arterial tortuosity (large and medium-sized arteries including aorta) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:arterial tortuosity, generalized n1=phlébite | n2=en:arterial tortuosity, generalized | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:arthrocentesis and injection of intermediate joint n1=phlébite | n2=en:arthrocentesis and injection of intermediate joint | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:assessment scales mi-oz n1=phlébite | n2=en:assessment scales mi-oz | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:assessment scales sw-va n1=phlébite | n2=en:assessment scales sw-va | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:assessment scales ve-zu n1=phlébite | n2=en:assessment scales ve-zu | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:asymptomatic bleeding tendencies (petechiae, epistaxis, mucosal bleeding) n1=phlébite | n2=en:asymptomatic bleeding tendencies (petechiae, epistaxis, mucosal bleeding) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:asymptomatic to mild bleeding episodes (epistaxis, postoperative hemorrhage) n1=phlébite | n2=en:asymptomatic to mild bleeding episodes (epistaxis, postoperative hemorrhage) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:atypical lymphocytosis n1=phlébite | n2=en:atypical lymphocytosis | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:blood and tissue coccidia n1=phlébite | n2=en:blood and tissue coccidia | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:bone marrow biopsy shows erythroid hyperplasia n1=phlébite | n2=en:bone marrow biopsy shows erythroid hyperplasia | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:bone marrow failure (classic feature, nola3 patient) n1=phlébite | n2=en:bone marrow failure (classic feature, nola3 patient) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:bone marrow fibrosis n1=phlébite | n2=en:bone marrow fibrosis | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:borderline biochemistry finding n1=phlébite | n2=en:borderline biochemistry finding | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:borderline laboratory finding n1=phlébite | n2=en:borderline laboratory finding | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:capillary hemangioma on face n1=phlébite | n2=en:capillary hemangioma on face | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:cerebrovascular occlusions n1=phlébite | n2=en:cerebrovascular occlusions | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:circulating orthochromatic erythroblasts n1=phlébite | n2=en:circulating orthochromatic erythroblasts | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:coagulation and hemorrhagic disorders n1=phlébite | n2=en:coagulation and hemorrhagic disorders | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:coagulopathy due to hepatic failure n1=phlébite | n2=en:coagulopathy due to hepatic failure | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:compound analgesics a-l n1=phlébite | n2=en:compound analgesics a-l | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:compound proprietary antacids a-c n1=phlébite | n2=en:compound proprietary antacids a-c | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:compound proprietary antacids m-z n1=phlébite | n2=en:compound proprietary antacids m-z | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:congenital anomaly - oral/respiratory n1=phlébite | n2=en:congenital anomaly - oral/respiratory | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:congenital neutropenia n1=phlébite | n2=en:congenital neutropenia | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:consolidation n1=phlébite | n2=en:consolidation | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:coronary artery disease (in some patients) n1=phlébite | n2=en:coronary artery disease (in some patients) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:decreased platelet function n1=phlébite | n2=en:decreased platelet function | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:disseminated intravascular coagulation in newborn n1=phlébite | n2=en:disseminated intravascular coagulation in newborn | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:elongated arteries (large and medium-sized arteries including aorta) n1=phlébite | n2=en:elongated arteries (large and medium-sized arteries including aorta) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:embolism, paradoxical n1=phlébite | n2=en:embolism, paradoxical | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:embryonic vascular structure n1=phlébite | n2=en:embryonic vascular structure | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:enteropathogenic virus n1=phlébite | n2=en:enteropathogenic virus | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:fat embolism (disorder) n1=phlébite | n2=en:fat embolism (disorder) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:fetal / neonatal / perinatal disorder n1=phlébite | n2=en:fetal / neonatal / perinatal disorder | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:foam cells on bone marrow biopsy n1=phlébite | n2=en:foam cells on bone marrow biopsy | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:foreign body n1=phlébite | n2=en:foreign body | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:gastric antral vascular ectasia n1=phlébite | n2=en:gastric antral vascular ectasia | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:giant platelet alpha granules (peripheral blood) n1=phlébite | n2=en:giant platelet alpha granules (peripheral blood) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:graft thrombosis n1=phlébite | n2=en:graft thrombosis | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:heart disorder n1=phlébite | n2=en:heart disorder | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:helminth n1=phlébite | n2=en:helminth | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:hematopoietic and lymphoid cell neoplasm n1=phlébite | n2=en:hematopoietic and lymphoid cell neoplasm | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:hematozoic parasite n1=phlébite | n2=en:hematozoic parasite | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:hemoglobin f increased n1=phlébite | n2=en:hemoglobin f increased | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:hormones and their metabolites and precursors a - g n1=phlébite | n2=en:hormones and their metabolites and precursors a - g | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:hrg gene n1=phlébite | n2=en:hrg gene | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:hypertension n1=phlébite | n2=en:hypertension | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:hypertension (1 family) n1=phlébite | n2=en:hypertension (1 family) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:hypotension, postural, due to autonomic dysfunction n1=phlébite | n2=en:hypotension, postural, due to autonomic dysfunction | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:idiopathic pulmonary hypertension n1=phlébite | n2=en:idiopathic pulmonary hypertension | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:immunology finding present n1=phlébite | n2=en:immunology finding present | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:increased risk of thrombosis n1=phlébite | n2=en:increased risk of thrombosis | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:injury due to unintentional cut, puncture, perforation or haemorrhage during injection or immunization n1=phlébite | n2=en:injury due to unintentional cut, puncture, perforation or haemorrhage during injection or immunization | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:intentional alternative medicine poisoning n1=phlébite | n2=en:intentional alternative medicine poisoning | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:intestinal coccidia n1=phlébite | n2=en:intestinal coccidia | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:intracranial aneurysms (in some patients) n1=phlébite | n2=en:intracranial aneurysms (in some patients) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:intraspinal administration of treatment n1=phlébite | n2=en:intraspinal administration of treatment | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:labile blood pressure n1=phlébite | n2=en:labile blood pressure | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:laboratory finding present n1=phlébite | n2=en:laboratory finding present | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:laboratory test result n1=phlébite | n2=en:laboratory test result | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:leukopenia n1=phlébite | n2=en:leukopenia | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:macrothrombocytes occasionally noted in carrier female peripheral blood smear n1=phlébite | n2=en:macrothrombocytes occasionally noted in carrier female peripheral blood smear | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:megakaryocytes show large and irregular bleb protrusions n1=phlébite | n2=en:megakaryocytes show large and irregular bleb protrusions | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:melanocytic nevi of eyelid, including canthus n1=phlébite | n2=en:melanocytic nevi of eyelid, including canthus | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:microbiology finding absent n1=phlébite | n2=en:microbiology finding absent | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:microbleeds (less than 5 mm in diameter) occur at the gray-white matter junction in the cerebral hemispheres and cerebellum and do not occur in the thalamus, basal ganglia, or brainstem n1=phlébite | n2=en:microbleeds (less than 5 mm in diameter) occur at the gray-white matter junction in the cerebral hemispheres and cerebellum and do not occur in the thalamus, basal ganglia, or brainstem | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:microcytosis n1=phlébite | n2=en:microcytosis | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:mild bleeding episodes (epistaxis, gi bleeding, menorrhagia) n1=phlébite | n2=en:mild bleeding episodes (epistaxis, gi bleeding, menorrhagia) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:miscellaneous chemical agent n1=phlébite | n2=en:miscellaneous chemical agent | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:miscellaneous drug n1=phlébite | n2=en:miscellaneous drug | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:mitral valve, double orifice (rare) n1=phlébite | n2=en:mitral valve, double orifice (rare) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:monocytosis n1=phlébite | n2=en:monocytosis | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:mosquito-borne orthobunyavirus fever n1=phlébite | n2=en:mosquito-borne orthobunyavirus fever | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:multisystem disorder k-l n1=phlébite | n2=en:multisystem disorder k-l | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:multisystem disorder w-x n1=phlébite | n2=en:multisystem disorder w-x | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:neoplasm of uncertain behavior of histiocytic and mast cells n1=phlébite | n2=en:neoplasm of uncertain behavior of histiocytic and mast cells | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:neoplasm of uncertain behavior of trachea, bronchus and lung n1=phlébite | n2=en:neoplasm of uncertain behavior of trachea, bronchus and lung | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:neutropenia, mild n1=phlébite | n2=en:neutropenia, mild | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:neutrophilia n1=phlébite | n2=en:neutrophilia | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:no abnormal microbiology finding detected n1=phlébite | n2=en:no abnormal microbiology finding detected | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:no hemolysis n1=phlébite | n2=en:no hemolysis | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:normal immunology finding n1=phlébite | n2=en:normal immunology finding | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:normal platelet fibrinogen n1=phlébite | n2=en:normal platelet fibrinogen | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:normal platelet size n1=phlébite | n2=en:normal platelet size | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:normal prothrombin and partial chromoplastin times n1=phlébite | n2=en:normal prothrombin and partial chromoplastin times | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:organic compounds a-c n1=phlébite | n2=en:organic compounds a-c | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:other cardiovascular diseases of mother, delivered, with mention of postpartum complication n1=phlébite | n2=en:other cardiovascular diseases of mother, delivered, with mention of postpartum complication | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:other deficiency anemias n1=phlébite | n2=en:other deficiency anemias | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:outcome n1=phlébite | n2=en:outcome | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:oval macrocyte n1=phlébite | n2=en:oval macrocyte | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:ovoid granulocyte nuclei (homozygote) n1=phlébite | n2=en:ovoid granulocyte nuclei (homozygote) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:patent ductus arteriosus (in 1 reported case) n1=phlébite | n2=en:patent ductus arteriosus (in 1 reported case) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:peripheral pulmonary artery stenosis n1=phlébite | n2=en:peripheral pulmonary artery stenosis | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:peripheral pulse absent n1=phlébite | n2=en:peripheral pulse absent | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:pigmented reticuloendothelial cells n1=phlébite | n2=en:pigmented reticuloendothelial cells | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:platelet factor 4 decreased n1=phlébite | n2=en:platelet factor 4 decreased | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:platelets have decreased or absent alpha-granules n1=phlébite | n2=en:platelets have decreased or absent alpha-granules | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:poisoning by water and/or mineral metabolism drug n1=phlébite | n2=en:poisoning by water and/or mineral metabolism drug | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:portal vein thrombosis (rare) n1=phlébite | n2=en:portal vein thrombosis (rare) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:post-surgical bleeding n1=phlébite | n2=en:post-surgical bleeding | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:postpartum thrombosis n1=phlébite | n2=en:postpartum thrombosis | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:postural hypotension (in some patients) n1=phlébite | n2=en:postural hypotension (in some patients) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:premature coronary artery disease n1=phlébite | n2=en:premature coronary artery disease | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:procedure by transthoracic approach n1=phlébite | n2=en:procedure by transthoracic approach | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:procedure by vaginal approach n1=phlébite | n2=en:procedure by vaginal approach | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:prominent subcutaneous venous patterning n1=phlébite | n2=en:prominent subcutaneous venous patterning | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:pseudomonas species a-f n1=phlébite | n2=en:pseudomonas species a-f | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:psoriasis and similar disorders n1=phlébite | n2=en:psoriasis and similar disorders | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:pulmonary artery root dilation (rare) n1=phlébite | n2=en:pulmonary artery root dilation (rare) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:pulmonary artery stenosis, bilateral branch n1=phlébite | n2=en:pulmonary artery stenosis, bilateral branch | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:reduced leukocyte alkaline phosphatase n1=phlébite | n2=en:reduced leukocyte alkaline phosphatase | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:retention abnormality n1=phlébite | n2=en:retention abnormality | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:reticulin fibrosis of the bone marrow n1=phlébite | n2=en:reticulin fibrosis of the bone marrow | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:retraction (finding) n1=phlébite | n2=en:retraction (finding) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:right pulmonary isomerism n1=phlébite | n2=en:right pulmonary isomerism | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:salmonella group b phase 1 a-e n1=phlébite | n2=en:salmonella group b phase 1 a-e | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:salmonella group b phase 1 y-z n1=phlébite | n2=en:salmonella group b phase 1 y-z | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:salmonella group d2 phase 1 a-e n1=phlébite | n2=en:salmonella group d2 phase 1 a-e | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:sea-blue histiocyte n1=phlébite | n2=en:sea-blue histiocyte | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:self hanging, strangulation or suffocation n1=phlébite | n2=en:self hanging, strangulation or suffocation | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:site of (a-h) n1=phlébite | n2=en:site of (a-h) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:stenosis n1=phlébite | n2=en:stenosis | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:subvalvular aortic stenosis n1=phlébite | n2=en:subvalvular aortic stenosis | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:suicide and self inflicted injury by barbiturates n1=phlébite | n2=en:suicide and self inflicted injury by barbiturates | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:suicide and selfinflicted injury n1=phlébite | n2=en:suicide and selfinflicted injury | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:suicide or self injury by burning or fire n1=phlébite | n2=en:suicide or self injury by burning or fire | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:suicide or selfinflicted injury by shotgun n1=phlébite | n2=en:suicide or selfinflicted injury by shotgun | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:sunscreening preparations a-z n1=phlébite | n2=en:sunscreening preparations a-z | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:thrombectomy n1=phlébite | n2=en:thrombectomy | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:thrombocytosis n1=phlébite | n2=en:thrombocytosis | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:thromboembolism (25%) n1=phlébite | n2=en:thromboembolism (25%) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:thrombosis of left circumflex artery n1=phlébite | n2=en:thrombosis of left circumflex artery | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:thrombotic microangiopathy n1=phlébite | n2=en:thrombotic microangiopathy | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:tick-borne bunyavirus hemorrhagic fever n1=phlébite | n2=en:tick-borne bunyavirus hemorrhagic fever | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:tissue fluke n1=phlébite | n2=en:tissue fluke | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:toxic effect of organophosphate and/or carbamate pesticide n1=phlébite | n2=en:toxic effect of organophosphate and/or carbamate pesticide | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:tranexamic acid 650mg tablet n1=phlébite | n2=en:tranexamic acid 650mg tablet | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:tumor-like lesion of esophagus n1=phlébite | n2=en:tumor-like lesion of esophagus | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:types of drugs t-z n1=phlébite | n2=en:types of drugs t-z | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:vacuolated macrophages n1=phlébite | n2=en:vacuolated macrophages | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:vasa nervorum n1=phlébite | n2=en:vasa nervorum | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:vascular endothelium n1=phlébite | n2=en:vascular endothelium | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:venous malformation (low flow) (most cases) n1=phlébite | n2=en:venous malformation (low flow) (most cases) | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> en:venous tortuosity n1=phlébite | n2=en:venous tortuosity | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 65 / 0.271 -> veine n1=phlébite | n2=veine | rel=r_associated | relid=0 | w=65 phlébite -- r_associated #0: 64 / 0.267 -> en:aberrant origin vertebral artery n1=phlébite | n2=en:aberrant origin vertebral artery | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:abnormal immunological finding in specimen from digestive organ and abdominal cavity n1=phlébite | n2=en:abnormal immunological finding in specimen from digestive organ and abdominal cavity | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:absence (morphologic abnormality) n1=phlébite | n2=en:absence (morphologic abnormality) | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:absence of hb h inclusions in red blood cells n1=phlébite | n2=en:absence of hb h inclusions in red blood cells | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:absent bone marrow myeloid elements n1=phlébite | n2=en:absent bone marrow myeloid elements | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:absent or hypoplastic megakaryocytes n1=phlébite | n2=en:absent or hypoplastic megakaryocytes | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:acquired n1=phlébite | n2=en:acquired | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:administration, topical n1=phlébite | n2=en:administration, topical | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:adverse reaction to premedication n1=phlébite | n2=en:adverse reaction to premedication | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:agenesis of pulmonary artery n1=phlébite | n2=en:agenesis of pulmonary artery | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:alternative medicine overdose of undetermined intent n1=phlébite | n2=en:alternative medicine overdose of undetermined intent | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:amemia n1=phlébite | n2=en:amemia | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:amphixenosis n1=phlébite | n2=en:amphixenosis | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:aneurysm of aortic root n1=phlébite | n2=en:aneurysm of aortic root | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:aneurysm of ascending aorta n1=phlébite | n2=en:aneurysm of ascending aorta | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:antithrombin iii decreased n1=phlébite | n2=en:antithrombin iii decreased | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:aortic embolism and thrombosis n1=phlébite | n2=en:aortic embolism and thrombosis | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:arrhythmia n1=phlébite | n2=en:arrhythmia | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:arterial aneurysm of celiac and mesenteric vessels n1=phlébite | n2=en:arterial aneurysm of celiac and mesenteric vessels | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:arterial hypertension (in 1 patient) n1=phlébite | n2=en:arterial hypertension (in 1 patient) | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:arterial thrombosis related to vascular access complication n1=phlébite | n2=en:arterial thrombosis related to vascular access complication | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:arteriole n1=phlébite | n2=en:arteriole | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:arteriosclerosis n1=phlébite | n2=en:arteriosclerosis | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:assessment scales ba-bz n1=phlébite | n2=en:assessment scales ba-bz | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:assessment scales ca-de n1=phlébite | n2=en:assessment scales ca-de | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:assessment scales pa-ra n1=phlébite | n2=en:assessment scales pa-ra | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:biochemistry interpretation n1=phlébite | n2=en:biochemistry interpretation | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:blood capillary n1=phlébite | n2=en:blood capillary | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:blood vessel structure of skin n1=phlébite | n2=en:blood vessel structure of skin | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:bone marrow biopsy shows increased eosinophils without myeloblasts n1=phlébite | n2=en:bone marrow biopsy shows increased eosinophils without myeloblasts | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:bone marrow infiltration n1=phlébite | n2=en:bone marrow infiltration | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:bone marrow involvement may cause pancytopenia n1=phlébite | n2=en:bone marrow involvement may cause pancytopenia | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:camouflaging preparations a-z n1=phlébite | n2=en:camouflaging preparations a-z | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:cardiovascular abnormalities n1=phlébite | n2=en:cardiovascular abnormalities | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:cardiovascular abnormality due to anomalous origin of coronary artery orifice n1=phlébite | n2=en:cardiovascular abnormality due to anomalous origin of coronary artery orifice | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:carotid artery obstruction n1=phlébite | n2=en:carotid artery obstruction | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:carotid artery thrombosis n1=phlébite | n2=en:carotid artery thrombosis | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:celiac artery thrombosis n1=phlébite | n2=en:celiac artery thrombosis | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:cerebral arterial aneurysm n1=phlébite | n2=en:cerebral arterial aneurysm | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:cerebral infarction n1=phlébite | n2=en:cerebral infarction | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:cerebrovascular hemorrhagic attacks n1=phlébite | n2=en:cerebrovascular hemorrhagic attacks | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:chronic disease of cardiovascular system n1=phlébite | n2=en:chronic disease of cardiovascular system | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:chronic disseminated intravascular coagulation n1=phlébite | n2=en:chronic disseminated intravascular coagulation | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:chronic myelogenous leukemia, bcr-abl1 positive n1=phlébite | n2=en:chronic myelogenous leukemia, bcr-abl1 positive | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:claudication n1=phlébite | n2=en:claudication | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:compound proprietary antacids d-l n1=phlébite | n2=en:compound proprietary antacids d-l | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:coronary artery stenosis n1=phlébite | n2=en:coronary artery stenosis | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:cutaneous t-cell dyscrasia n1=phlébite | n2=en:cutaneous t-cell dyscrasia | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:cyclozoonosis n1=phlébite | n2=en:cyclozoonosis | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:defective nk cell degranulation n1=phlébite | n2=en:defective nk cell degranulation | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:disseminated intravascular coagulation, episodic n1=phlébite | n2=en:disseminated intravascular coagulation, episodic | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:diverticulum n1=phlébite | n2=en:diverticulum | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:ectozoic parasite n1=phlébite | n2=en:ectozoic parasite | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:elevated hba(2) n1=phlébite | n2=en:elevated hba(2) | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:embolus leg n1=phlébite | n2=en:embolus leg | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:encephalitis due to tick-borne encephalitis virus subgroup n1=phlébite | n2=en:encephalitis due to tick-borne encephalitis virus subgroup | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:endocrine / nutritional / metabolic disorder n1=phlébite | n2=en:endocrine / nutritional / metabolic disorder | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:endocrine, breast and special senses n1=phlébite | n2=en:endocrine, breast and special senses | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:enteropathogenic bacteria n1=phlébite | n2=en:enteropathogenic bacteria | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:entozoic parasite n1=phlébite | n2=en:entozoic parasite | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:enzymes m - z n1=phlébite | n2=en:enzymes m - z | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:erythroid hyperplasia seen on bone marrow biopsy n1=phlébite | n2=en:erythroid hyperplasia seen on bone marrow biopsy | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:experimental hematology n1=phlébite | n2=en:experimental hematology | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:flea-borne infectious disease n1=phlébite | n2=en:flea-borne infectious disease | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:foods, vitamins, electrolytes and inorganic salts allergy n1=phlébite | n2=en:foods, vitamins, electrolytes and inorganic salts allergy | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:foreign body embolism n1=phlébite | n2=en:foreign body embolism | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:glanzmann thrombasthenia n1=phlébite | n2=en:glanzmann thrombasthenia | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:hb h inclusions in red blood cells n1=phlébite | n2=en:hb h inclusions in red blood cells | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:heavy metal agonist poisoning n1=phlébite | n2=en:heavy metal agonist poisoning | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:hematologic tests n1=phlébite | n2=en:hematologic tests | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:hematology, other n1=phlébite | n2=en:hematology, other | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:heparin induced thrombocytopenia n1=phlébite | n2=en:heparin induced thrombocytopenia | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:hernia n1=phlébite | n2=en:hernia | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:history/symptoms n1=phlébite | n2=en:history/symptoms | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:howell-jolly bodies n1=phlébite | n2=en:howell-jolly bodies | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:hypersplenism n1=phlébite | n2=en:hypersplenism | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:hypertension (with pheochromocytoma) n1=phlébite | n2=en:hypertension (with pheochromocytoma) | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:hypolobulation of granulocyte nuclei (pelger-huet anomaly) n1=phlébite | n2=en:hypolobulation of granulocyte nuclei (pelger-huet anomaly) | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:impaired platelet aggregation n1=phlébite | n2=en:impaired platelet aggregation | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:increased pulmonary vascular resistance n1=phlébite | n2=en:increased pulmonary vascular resistance | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:increased total white blood count n1=phlébite | n2=en:increased total white blood count | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:instability n1=phlébite | n2=en:instability | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:instability vasomotor n1=phlébite | n2=en:instability vasomotor | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:intermittent claudication n1=phlébite | n2=en:intermittent claudication | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:interrupted aortic arch n1=phlébite | n2=en:interrupted aortic arch | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:intestinal flagellate n1=phlébite | n2=en:intestinal flagellate | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:intimal dissection of blood vessel n1=phlébite | n2=en:intimal dissection of blood vessel | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:intraabdominal venous thrombosis n1=phlébite | n2=en:intraabdominal venous thrombosis | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:intracavernous administration of treatment n1=phlébite | n2=en:intracavernous administration of treatment | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:intracranial hemorrhage n1=phlébite | n2=en:intracranial hemorrhage | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:intracranial hypertension (2 of 7 patients) n1=phlébite | n2=en:intracranial hypertension (2 of 7 patients) | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:intravenous administration of treatment n1=phlébite | n2=en:intravenous administration of treatment | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:low-to-normal blood pressure n1=phlébite | n2=en:low-to-normal blood pressure | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:lowered microbiology finding n1=phlébite | n2=en:lowered microbiology finding | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:lymphatic abnormalities n1=phlébite | n2=en:lymphatic abnormalities | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:medial calcification of medium-sized and major arteries n1=phlébite | n2=en:medial calcification of medium-sized and major arteries | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:megakaryocytes have dysplastic features n1=phlébite | n2=en:megakaryocytes have dysplastic features | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:megakaryocytopenia n1=phlébite | n2=en:megakaryocytopenia | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:megaloblastic anemia n1=phlébite | n2=en:megaloblastic anemia | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:melanocytic nevi of ear and external auditory canal n1=phlébite | n2=en:melanocytic nevi of ear and external auditory canal | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:metastatic malignant neoplasm in the bone marrow n1=phlébite | n2=en:metastatic malignant neoplasm in the bone marrow | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:mildly decreased to low-normal platelet count (80-150 x 10(9)/l) n1=phlébite | n2=en:mildly decreased to low-normal platelet count (80-150 x 10(9)/l) | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:mosquito-borne bunyavirus hemorrhagic fever n1=phlébite | n2=en:mosquito-borne bunyavirus hemorrhagic fever | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:mosquito-borne orbivirus fever n1=phlébite | n2=en:mosquito-borne orbivirus fever | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:mosquito-borne orthobunyavirus encephalitis n1=phlébite | n2=en:mosquito-borne orthobunyavirus encephalitis | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:mosquito-borne viral encephalitis n1=phlébite | n2=en:mosquito-borne viral encephalitis | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:myocardial bridging n1=phlébite | n2=en:myocardial bridging | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:negative immunology finding n1=phlébite | n2=en:negative immunology finding | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:noninfectious, erythematous, papular and/or squamous disease n1=phlébite | n2=en:noninfectious, erythematous, papular and/or squamous disease | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:noninfectious, vesicular and/or bullous disease n1=phlébite | n2=en:noninfectious, vesicular and/or bullous disease | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:normocytic pancytopenia following sulfa use n1=phlébite | n2=en:normocytic pancytopenia following sulfa use | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:nursing attributes m - s n1=phlébite | n2=en:nursing attributes m - s | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:other cardiovascular diseases of mother, postpartum condition or complication n1=phlébite | n2=en:other cardiovascular diseases of mother, postpartum condition or complication | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:pancytopenia, episodic n1=phlébite | n2=en:pancytopenia, episodic | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:paroxysmal nocturnal hemoglobinuria n1=phlébite | n2=en:paroxysmal nocturnal hemoglobinuria | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:patent ductus arteriosus (in some patients) n1=phlébite | n2=en:patent ductus arteriosus (in some patients) | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:perforation n1=phlébite | n2=en:perforation | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:perinatal cardiovascular disorders n1=phlébite | n2=en:perinatal cardiovascular disorders | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:pharmaceutical excipient poisoning n1=phlébite | n2=en:pharmaceutical excipient poisoning | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:platelets cannot synthesize thromboxane a2 from arachidonic acid n1=phlébite | n2=en:platelets cannot synthesize thromboxane a2 from arachidonic acid | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:platelets may show reduced adp binding activity n1=phlébite | n2=en:platelets may show reduced adp binding activity | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:poisoning by dietetic drug n1=phlébite | n2=en:poisoning by dietetic drug | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:positive microbiology finding n1=phlébite | n2=en:positive microbiology finding | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:postural hypotension with compensatory tachycardia n1=phlébite | n2=en:postural hypotension with compensatory tachycardia | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:pregnancy complications, cardiovascular n1=phlébite | n2=en:pregnancy complications, cardiovascular | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:presyncope n1=phlébite | n2=en:presyncope | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:procedure by anterior approach n1=phlébite | n2=en:procedure by anterior approach | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:procedure by extraoral approach n1=phlébite | n2=en:procedure by extraoral approach | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:procedure by transanal approach n1=phlébite | n2=en:procedure by transanal approach | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:prominent, slightly corkscrew appearance of branches of hepatic artery on mri (in one patient) n1=phlébite | n2=en:prominent, slightly corkscrew appearance of branches of hepatic artery on mri (in one patient) | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:protein s deficiency disease n1=phlébite | n2=en:protein s deficiency disease | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:pulmonary arterial hypertension (in 3 patients) n1=phlébite | n2=en:pulmonary arterial hypertension (in 3 patients) | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:pulmonary arterial medial hypertrophy n1=phlébite | n2=en:pulmonary arterial medial hypertrophy | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:pulmonary artery stenosis n1=phlébite | n2=en:pulmonary artery stenosis | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:pulmonary circulation obstruction n1=phlébite | n2=en:pulmonary circulation obstruction | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:pulmonary embolism and thrombosis n1=phlébite | n2=en:pulmonary embolism and thrombosis | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:recurrent thrombophlebitis (e.g. homozygous 107300.0008 at-iii toyama) n1=phlébite | n2=en:recurrent thrombophlebitis (e.g. homozygous 107300.0008 at-iii toyama) | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:renal allograft thrombosis n1=phlébite | n2=en:renal allograft thrombosis | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:reticulocytosis n1=phlébite | n2=en:reticulocytosis | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:salmonella group b phase 1 f-r n1=phlébite | n2=en:salmonella group b phase 1 f-r | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:salmonella group e4 phase 1 y-z n1=phlébite | n2=en:salmonella group e4 phase 1 y-z | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:salmonella group h phase 1 a-e n1=phlébite | n2=en:salmonella group h phase 1 a-e | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:schistosomatidae n1=phlébite | n2=en:schistosomatidae | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:single umbilical artery n1=phlébite | n2=en:single umbilical artery | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:small-vessel disease n1=phlébite | n2=en:small-vessel disease | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:solvent a - c n1=phlébite | n2=en:solvent a - c | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:structure of small blood vessel (organ) n1=phlébite | n2=en:structure of small blood vessel (organ) | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:structure of transplanted blood vessel n1=phlébite | n2=en:structure of transplanted blood vessel | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:subarachnoid hemorrhage n1=phlébite | n2=en:subarachnoid hemorrhage | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:subvalvular aortic stenosis (rare) n1=phlébite | n2=en:subvalvular aortic stenosis (rare) | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:superior vena cava left-sided, draining into left atrium n1=phlébite | n2=en:superior vena cava left-sided, draining into left atrium | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:symptoms involving cardiovascular system n1=phlébite | n2=en:symptoms involving cardiovascular system | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:systolic hypertension, mild n1=phlébite | n2=en:systolic hypertension, mild | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:test categorized by action status n1=phlébite | n2=en:test categorized by action status | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:thromboembolism n1=phlébite | n2=en:thromboembolism | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:tissue ameba n1=phlébite | n2=en:tissue ameba | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:topical preparation n1=phlébite | n2=en:topical preparation | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:variable reductions in platelet aggregation n1=phlébite | n2=en:variable reductions in platelet aggregation | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:vasa vasorum n1=phlébite | n2=en:vasa vasorum | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:venule n1=phlébite | n2=en:venule | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> en:vertebrobasilar artery tortuosity (rare) n1=phlébite | n2=en:vertebrobasilar artery tortuosity (rare) | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> phlébite profonde n1=phlébite | n2=phlébite profonde | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> thrombo-embolie n1=phlébite | n2=thrombo-embolie | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 64 / 0.267 -> thrombose veineuse superficielle n1=phlébite | n2=thrombose veineuse superficielle | rel=r_associated | relid=0 | w=64 phlébite -- r_associated #0: 63 / 0.263 -> en:abdominal aortic aneurysm (in some patients) n1=phlébite | n2=en:abdominal aortic aneurysm (in some patients) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:abnormal immunology finding n1=phlébite | n2=en:abnormal immunology finding | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:abnormal laboratory test result n1=phlébite | n2=en:abnormal laboratory test result | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:abnormal platelet n1=phlébite | n2=en:abnormal platelet | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:abnormal platelets with giant morphology n1=phlébite | n2=en:abnormal platelets with giant morphology | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:acanthocytosis n1=phlébite | n2=en:acanthocytosis | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:acquired cardiovascular abnormality associated with atrioventricular septal defect n1=phlébite | n2=en:acquired cardiovascular abnormality associated with atrioventricular septal defect | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:acute disease of cardiovascular system n1=phlébite | n2=en:acute disease of cardiovascular system | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:alternative medicines allergy n1=phlébite | n2=en:alternative medicines allergy | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:alveolar capillary dysplasia (acd) n1=phlébite | n2=en:alveolar capillary dysplasia (acd) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:anemia, congenital hypoplastic, moderate-severe (normochromic, macrocytic) n1=phlébite | n2=en:anemia, congenital hypoplastic, moderate-severe (normochromic, macrocytic) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:aortic dilatation (1 family) n1=phlébite | n2=en:aortic dilatation (1 family) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:architectural distortion n1=phlébite | n2=en:architectural distortion | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:arterial stenosis due to myointimal proliferation n1=phlébite | n2=en:arterial stenosis due to myointimal proliferation | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:arterial thrombosis of spinal cord n1=phlébite | n2=en:arterial thrombosis of spinal cord | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:arterial vessels show disruption of the elastic fibers of the tunica media n1=phlébite | n2=en:arterial vessels show disruption of the elastic fibers of the tunica media | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:arteriovenous malformation (cerebral, spinal, pulmonary, liver) n1=phlébite | n2=en:arteriovenous malformation (cerebral, spinal, pulmonary, liver) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:assessment scales se-su n1=phlébite | n2=en:assessment scales se-su | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:asymptomatic (easy bruisability, postoperative hemorrhage) n1=phlébite | n2=en:asymptomatic (easy bruisability, postoperative hemorrhage) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:azygous connection n1=phlébite | n2=en:azygous connection | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:bilateral stenoses of the terminal internal carotid artery n1=phlébite | n2=en:bilateral stenoses of the terminal internal carotid artery | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:biochemical finding n1=phlébite | n2=en:biochemical finding | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:bleeding time normal to mildly prolonged n1=phlébite | n2=en:bleeding time normal to mildly prolonged | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:blood and tissue protozoan n1=phlébite | n2=en:blood and tissue protozoan | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:blood sporozoan n1=phlébite | n2=en:blood sporozoan | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:blood vessel n1=phlébite | n2=en:blood vessel | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:blood/lymphatic neoplasm n1=phlébite | n2=en:blood/lymphatic neoplasm | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:calcification of the aorta n1=phlébite | n2=en:calcification of the aorta | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:capillary malformation (disorder) n1=phlébite | n2=en:capillary malformation (disorder) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:cardiovascular disorder n1=phlébite | n2=en:cardiovascular disorder | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:cardiovascular system complication of procedure n1=phlébite | n2=en:cardiovascular system complication of procedure | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:cerebral artery amyloidosis (amyloid deposition in cerebral arteries) n1=phlébite | n2=en:cerebral artery amyloidosis (amyloid deposition in cerebral arteries) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:clostridium species a-f n1=phlébite | n2=en:clostridium species a-f | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:coagulation factor deficiency n1=phlébite | n2=en:coagulation factor deficiency | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:coarse granulocyte chromatin n1=phlébite | n2=en:coarse granulocyte chromatin | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:common eye and/or eyelid symptom n1=phlébite | n2=en:common eye and/or eyelid symptom | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:congenital anomaly of aortic arch n1=phlébite | n2=en:congenital anomaly of aortic arch | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:congenital cardiovascular abnormality n1=phlébite | n2=en:congenital cardiovascular abnormality | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:congenital heinz body anemia (e.g. hb toyama 141800.0152) n1=phlébite | n2=en:congenital heinz body anemia (e.g. hb toyama 141800.0152) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:congenital leptomeningeal angiomatosis n1=phlébite | n2=en:congenital leptomeningeal angiomatosis | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:coronary artery disease n1=phlébite | n2=en:coronary artery disease | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:deep vein thromoboses n1=phlébite | n2=en:deep vein thromoboses | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:dilated aortic root n1=phlébite | n2=en:dilated aortic root | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:dilation of vein of galen (rare) n1=phlébite | n2=en:dilation of vein of galen (rare) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:disorder of blood / lymphatics / immune system n1=phlébite | n2=en:disorder of blood / lymphatics / immune system | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:drug groups primarily used in obstetrics, gynecological and urinary tract disorders overdose n1=phlébite | n2=en:drug groups primarily used in obstetrics, gynecological and urinary tract disorders overdose | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:eccentrocytes (in some patients) n1=phlébite | n2=en:eccentrocytes (in some patients) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:elevated thrombopoietin (tpo) n1=phlébite | n2=en:elevated thrombopoietin (tpo) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:embolism n1=phlébite | n2=en:embolism | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:embolism and thrombosis n1=phlébite | n2=en:embolism and thrombosis | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:embolus n1=phlébite | n2=en:embolus | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:embolus arm n1=phlébite | n2=en:embolus arm | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:emollients/barrier creams: p-z n1=phlébite | n2=en:emollients/barrier creams: p-z | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:episodic hypertension n1=phlébite | n2=en:episodic hypertension | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:erythrocytes have defects in cation permeability n1=phlébite | n2=en:erythrocytes have defects in cation permeability | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:foods, vitamins, electrolytes inorganic salts adverse reaction n1=phlébite | n2=en:foods, vitamins, electrolytes inorganic salts adverse reaction | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:generalized calcification of arteries, including aorta and intraparenchymal arteries n1=phlébite | n2=en:generalized calcification of arteries, including aorta and intraparenchymal arteries | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:genetic, molecular and/or cellular finding n1=phlébite | n2=en:genetic, molecular and/or cellular finding | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:hemorrhagic diathesis, mild n1=phlébite | n2=en:hemorrhagic diathesis, mild | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:hereditary factor xiii deficiency n1=phlébite | n2=en:hereditary factor xiii deficiency | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:hypertension, moderate, secondary to renal disease n1=phlébite | n2=en:hypertension, moderate, secondary to renal disease | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:hypertension, severe n1=phlébite | n2=en:hypertension, severe | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:hyperuricemia n1=phlébite | n2=en:hyperuricemia | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:hyperviscosity syndrome n1=phlébite | n2=en:hyperviscosity syndrome | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:hypoglobulinemia n1=phlébite | n2=en:hypoglobulinemia | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:hypotension, severe n1=phlébite | n2=en:hypotension, severe | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:hypovolemia n1=phlébite | n2=en:hypovolemia | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:implant site thrombosis n1=phlébite | n2=en:implant site thrombosis | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:increase in jugular venous pressure n1=phlébite | n2=en:increase in jugular venous pressure | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:increased alpha/beta globin ratio in reticulocytes n1=phlébite | n2=en:increased alpha/beta globin ratio in reticulocytes | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:infusion site thrombosis n1=phlébite | n2=en:infusion site thrombosis | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:intermittent claudication (30%) n1=phlébite | n2=en:intermittent claudication (30%) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:internal carotid artery tortuosity (rare) n1=phlébite | n2=en:internal carotid artery tortuosity (rare) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:intracranial arterial narrowing n1=phlébite | n2=en:intracranial arterial narrowing | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:leukocyte inclusion bodies (dohle-like bodies) n1=phlébite | n2=en:leukocyte inclusion bodies (dohle-like bodies) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:leukocytosis (mean leukocyte count 18.7 x 10(9)/l) n1=phlébite | n2=en:leukocytosis (mean leukocyte count 18.7 x 10(9)/l) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:low serum transferrin n1=phlébite | n2=en:low serum transferrin | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:lymphopenia n1=phlébite | n2=en:lymphopenia | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:macrothrombocyte n1=phlébite | n2=en:macrothrombocyte | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:malformation or hamartoma of eccrine sweat gland apparatus n1=phlébite | n2=en:malformation or hamartoma of eccrine sweat gland apparatus | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:malformation or hamartoma of skin appendage n1=phlébite | n2=en:malformation or hamartoma of skin appendage | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:melanocytic nevi of lower limb, including hip n1=phlébite | n2=en:melanocytic nevi of lower limb, including hip | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:methods of tracheal or bronchial intubation n1=phlébite | n2=en:methods of tracheal or bronchial intubation | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:monosomy 7 of bone marrow n1=phlébite | n2=en:monosomy 7 of bone marrow | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:mosquito-borne rhabdovirus fever n1=phlébite | n2=en:mosquito-borne rhabdovirus fever | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:mosquito-borne simbu group virus fever n1=phlébite | n2=en:mosquito-borne simbu group virus fever | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:mucocutaneous bleeding due to platelet dysfunction n1=phlébite | n2=en:mucocutaneous bleeding due to platelet dysfunction | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:multisystem disorder s-t n1=phlébite | n2=en:multisystem disorder s-t | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:negative microbiology finding n1=phlébite | n2=en:negative microbiology finding | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:neutropenia, chronic or cyclic n1=phlébite | n2=en:neutropenia, chronic or cyclic | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:neutropenia, variable n1=phlébite | n2=en:neutropenia, variable | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:no abnormality n1=phlébite | n2=en:no abnormality | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:no hemophagocytosis n1=phlébite | n2=en:no hemophagocytosis | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:no neutrophil inclusions n1=phlébite | n2=en:no neutrophil inclusions | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:no thrombus n1=phlébite | n2=en:no thrombus | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:normal hematology finding n1=phlébite | n2=en:normal hematology finding | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:normal levels of known coagulation factors n1=phlébite | n2=en:normal levels of known coagulation factors | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:normal oxygen affinity of hemoglobin n1=phlébite | n2=en:normal oxygen affinity of hemoglobin | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:normal peripheral red blood cell survival time n1=phlébite | n2=en:normal peripheral red blood cell survival time | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:obstructive morphology n1=phlébite | n2=en:obstructive morphology | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:occlusion n1=phlébite | n2=en:occlusion | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:oral cavity, salivary glands and jaw diseases n1=phlébite | n2=en:oral cavity, salivary glands and jaw diseases | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:organ or tissue harvesting and transplantation procedures n1=phlébite | n2=en:organ or tissue harvesting and transplantation procedures | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:organic compounds i-r n1=phlébite | n2=en:organic compounds i-r | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:osteitis deformans and osteopathies associated with other diseases n1=phlébite | n2=en:osteitis deformans and osteopathies associated with other diseases | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:other diseases of blood and blood-forming organs n1=phlébite | n2=en:other diseases of blood and blood-forming organs | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:pancytopenia (childhood) n1=phlébite | n2=en:pancytopenia (childhood) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:pancytopenia (in some patients) n1=phlébite | n2=en:pancytopenia (in some patients) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:peripheral blood vessel n1=phlébite | n2=en:peripheral blood vessel | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:pernicious anemia n1=phlébite | n2=en:pernicious anemia | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:persistence of fetal hemoglobin (5-30% hbf) n1=phlébite | n2=en:persistence of fetal hemoglobin (5-30% hbf) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:platelets have decreased expression of glycoprotein ib-alpha (cd42b) n1=phlébite | n2=en:platelets have decreased expression of glycoprotein ib-alpha (cd42b) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:platelets have increased expression of cd34 n1=phlébite | n2=en:platelets have increased expression of cd34 | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:platelets have increased smooth endoplasmic reticulum n1=phlébite | n2=en:platelets have increased smooth endoplasmic reticulum | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:plexiform vascular lesions n1=phlébite | n2=en:plexiform vascular lesions | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:poisoning by mixed bacterial vaccine except combinations with a pertussis component n1=phlébite | n2=en:poisoning by mixed bacterial vaccine except combinations with a pertussis component | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:porphyria n1=phlébite | n2=en:porphyria | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:postoperative thrombosis n1=phlébite | n2=en:postoperative thrombosis | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:premature occlusive vascular disease n1=phlébite | n2=en:premature occlusive vascular disease | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:pressure disorder n1=phlébite | n2=en:pressure disorder | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:procedure categorized by action status n1=phlébite | n2=en:procedure categorized by action status | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:prolonged bleeding due to a qualitative defect in the vwf protein n1=phlébite | n2=en:prolonged bleeding due to a qualitative defect in the vwf protein | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:prominent superficial veins n1=phlébite | n2=en:prominent superficial veins | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:pulmonary artery dilation, mild (in one patient) n1=phlébite | n2=en:pulmonary artery dilation, mild (in one patient) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:pulmonary artery vasoconstriction n1=phlébite | n2=en:pulmonary artery vasoconstriction | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:pulmonary stenosis (in some patients) n1=phlébite | n2=en:pulmonary stenosis (in some patients) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:rectal laxatives a-z n1=phlébite | n2=en:rectal laxatives a-z | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:red cell anisopoikilocytosis (in some patients) n1=phlébite | n2=en:red cell anisopoikilocytosis (in some patients) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:reduced or absent erythroid precursors in bone marrow n1=phlébite | n2=en:reduced or absent erythroid precursors in bone marrow | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:response to immunization and/or skin test n1=phlébite | n2=en:response to immunization and/or skin test | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:retinal vascular disorder n1=phlébite | n2=en:retinal vascular disorder | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:salmonella group d2 phase 1 f-r n1=phlébite | n2=en:salmonella group d2 phase 1 f-r | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:salmonella group f phase 1 f-r n1=phlébite | n2=en:salmonella group f phase 1 f-r | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:set of choroid blood vessels n1=phlébite | n2=en:set of choroid blood vessels | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:severe bleeding after biopsies (uncommon) n1=phlébite | n2=en:severe bleeding after biopsies (uncommon) | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:shift displacement n1=phlébite | n2=en:shift displacement | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:small and large vessel vasculitis n1=phlébite | n2=en:small and large vessel vasculitis | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:small vessel retinal infarcts and aneurysms n1=phlébite | n2=en:small vessel retinal infarcts and aneurysms | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:spherocytosis n1=phlébite | n2=en:spherocytosis | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:stomatocytosis result n1=phlébite | n2=en:stomatocytosis result | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:suicide and self inflicted injury by phenobarbital n1=phlébite | n2=en:suicide and self inflicted injury by phenobarbital | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:suicide or self injury by electric current n1=phlébite | n2=en:suicide or self injury by electric current | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:suicide or selfinflicted injury by hunting rifle n1=phlébite | n2=en:suicide or selfinflicted injury by hunting rifle | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:syncope adverse event n1=phlébite | n2=en:syncope adverse event | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:systemic mastocytosis n1=phlébite | n2=en:systemic mastocytosis | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:thrombophlebitis migrans n1=phlébite | n2=en:thrombophlebitis migrans | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:thrombotic stroke n1=phlébite | n2=en:thrombotic stroke | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:tortuosity of conjunctival vessels n1=phlébite | n2=en:tortuosity of conjunctival vessels | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:transfusion medicine n1=phlébite | n2=en:transfusion medicine | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:tumor of mesothelial and soft tissue n1=phlébite | n2=en:tumor of mesothelial and soft tissue | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:tumor-like lesion of brain n1=phlébite | n2=en:tumor-like lesion of brain | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:types of drugs h-m n1=phlébite | n2=en:types of drugs h-m | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:urogenital protozoan n1=phlébite | n2=en:urogenital protozoan | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:vacuolization of marrow precursors n1=phlébite | n2=en:vacuolization of marrow precursors | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:variable bleeding episodes n1=phlébite | n2=en:variable bleeding episodes | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:vascular calcification n1=phlébite | n2=en:vascular calcification | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:vasculopathy of the small arteries penetrating the white matter n1=phlébite | n2=en:vasculopathy of the small arteries penetrating the white matter | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:vena caval embolism and thrombosis n1=phlébite | n2=en:vena caval embolism and thrombosis | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:vertebral hemangiomas n1=phlébite | n2=en:vertebral hemangiomas | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> en:zoonotic bacteria n1=phlébite | n2=en:zoonotic bacteria | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> flux sanguin n1=phlébite | n2=flux sanguin | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> thrombokinase n1=phlébite | n2=thrombokinase | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 63 / 0.263 -> thrombose veineuse portale n1=phlébite | n2=thrombose veineuse portale | rel=r_associated | relid=0 | w=63 phlébite -- r_associated #0: 62 / 0.258 -> caillot n1=phlébite | n2=caillot | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> embolie n1=phlébite | n2=embolie | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:abnormal microbiology finding n1=phlébite | n2=en:abnormal microbiology finding | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:abnormal platelet maturation n1=phlébite | n2=en:abnormal platelet maturation | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:absence of lutheran antigen on red blood cells n1=phlébite | n2=en:absence of lutheran antigen on red blood cells | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:accidental cut, puncture, perforation or hemorrhage during injection n1=phlébite | n2=en:accidental cut, puncture, perforation or hemorrhage during injection | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:accidental cut, puncture, perforation or hemorrhage during vaccination n1=phlébite | n2=en:accidental cut, puncture, perforation or hemorrhage during vaccination | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:alternative medicine agent n1=phlébite | n2=en:alternative medicine agent | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:alveolar capillary dysplasia (rare) n1=phlébite | n2=en:alveolar capillary dysplasia (rare) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:amegakaryocytic thrombocytopenia n1=phlébite | n2=en:amegakaryocytic thrombocytopenia | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:anemia may be exacerbated during infection or pregnancy n1=phlébite | n2=en:anemia may be exacerbated during infection or pregnancy | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:animal transmitted infectious disease n1=phlébite | n2=en:animal transmitted infectious disease | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:anisocytosis n1=phlébite | n2=en:anisocytosis | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:antineoplastic/immunosuppressant/immunostimulant poisoning n1=phlébite | n2=en:antineoplastic/immunosuppressant/immunostimulant poisoning | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:aortic coarctation (1 patient) n1=phlébite | n2=en:aortic coarctation (1 patient) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:aortic segment n1=phlébite | n2=en:aortic segment | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:application site thrombosis n1=phlébite | n2=en:application site thrombosis | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:arbovirus n1=phlébite | n2=en:arbovirus | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:arterial graft thrombosis n1=phlébite | n2=en:arterial graft thrombosis | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:arterial segment n1=phlébite | n2=en:arterial segment | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:arteriovenous hemangioma n1=phlébite | n2=en:arteriovenous hemangioma | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:arthropod-borne organism n1=phlébite | n2=en:arthropod-borne organism | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:barrier preparation allergy n1=phlébite | n2=en:barrier preparation allergy | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:benign tumor of oral cavity, lips, salivary glands n1=phlébite | n2=en:benign tumor of oral cavity, lips, salivary glands | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:bleeding tendency, mild, mucocutaneous n1=phlébite | n2=en:bleeding tendency, mild, mucocutaneous | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:blood vessel of peritoneal cavity n1=phlébite | n2=en:blood vessel of peritoneal cavity | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:bone marrow aspirate shows normal cellularity and reticular fibrosis n1=phlébite | n2=en:bone marrow aspirate shows normal cellularity and reticular fibrosis | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:bone marrow failure n1=phlébite | n2=en:bone marrow failure | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:bone marrow hypocellularity n1=phlébite | n2=en:bone marrow hypocellularity | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:burr cell n1=phlébite | n2=en:burr cell | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:calcium/bismuth antacids a-z n1=phlébite | n2=en:calcium/bismuth antacids a-z | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:cardiovascular abnormality due to anomalous origin of arterial duct n1=phlébite | n2=en:cardiovascular abnormality due to anomalous origin of arterial duct | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:cardiovascular abnormality due to anomalous origin of coronary artery from pulmonary artery n1=phlébite | n2=en:cardiovascular abnormality due to anomalous origin of coronary artery from pulmonary artery | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:cardiovascular abnormality due to infective myocarditis n1=phlébite | n2=en:cardiovascular abnormality due to infective myocarditis | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:cerebellar artery thrombosis n1=phlébite | n2=en:cerebellar artery thrombosis | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:cerebral aneurysm (uncommon) n1=phlébite | n2=en:cerebral aneurysm (uncommon) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:congenital cardiovascular disorder n1=phlébite | n2=en:congenital cardiovascular disorder | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:coronary artery dissection (in some patients) n1=phlébite | n2=en:coronary artery dissection (in some patients) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:coronary heart disease, susceptibility to, 5 n1=phlébite | n2=en:coronary heart disease, susceptibility to, 5 | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:defective platelet aggregation in response to arachidonic acid n1=phlébite | n2=en:defective platelet aggregation in response to arachidonic acid | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:disorder of body wall and cavities n1=phlébite | n2=en:disorder of body wall and cavities | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:disorder of pericardium n1=phlébite | n2=en:disorder of pericardium | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:dissection, descending aorta (in some patients) n1=phlébite | n2=en:dissection, descending aorta (in some patients) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:drug and poison level measurement n1=phlébite | n2=en:drug and poison level measurement | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:drug groups primarily used obs, gyn.+ urinary tract dis adverse reaction n1=phlébite | n2=en:drug groups primarily used obs, gyn.+ urinary tract dis adverse reaction | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:duct changes n1=phlébite | n2=en:duct changes | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:dysfibrinogenemia causing recurrent thrombosis n1=phlébite | n2=en:dysfibrinogenemia causing recurrent thrombosis | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:elevated mean arterial pressure n1=phlébite | n2=en:elevated mean arterial pressure | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:elevated systolic blood pressure n1=phlébite | n2=en:elevated systolic blood pressure | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:elliptocytosis (in some patients, segregated independently) n1=phlébite | n2=en:elliptocytosis (in some patients, segregated independently) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:engraftment syndrome n1=phlébite | n2=en:engraftment syndrome | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:fistula n1=phlébite | n2=en:fistula | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:fluid disturbance n1=phlébite | n2=en:fluid disturbance | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:focus of ectopic electrical activity in the vein of marshall n1=phlébite | n2=en:focus of ectopic electrical activity in the vein of marshall | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:h/o: thrombosis n1=phlébite | n2=en:h/o: thrombosis | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:hematocrit increased n1=phlébite | n2=en:hematocrit increased | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:hematology finding abnormal n1=phlébite | n2=en:hematology finding abnormal | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:hematomas after trauma or injury n1=phlébite | n2=en:hematomas after trauma or injury | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:hemoconcentration n1=phlébite | n2=en:hemoconcentration | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:hemodilution n1=phlébite | n2=en:hemodilution | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:hemorrhagic episodes n1=phlébite | n2=en:hemorrhagic episodes | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:hereditary elliptocytosis n1=phlébite | n2=en:hereditary elliptocytosis | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:high blood oxygen saturation of hemoglobin (10% higher mean than the lowest values of population studied) n1=phlébite | n2=en:high blood oxygen saturation of hemoglobin (10% higher mean than the lowest values of population studied) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:histology laboratory test n1=phlébite | n2=en:histology laboratory test | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:home care and/or social service n1=phlébite | n2=en:home care and/or social service | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:hypercellular bone marrow with erythroid hyperplasia n1=phlébite | n2=en:hypercellular bone marrow with erythroid hyperplasia | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:hypermature neutrophils have condensed nuclei connected by long, stringy filaments and vacuolated cytoplasm n1=phlébite | n2=en:hypermature neutrophils have condensed nuclei connected by long, stringy filaments and vacuolated cytoplasm | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:hypersegmented neutrophils (1 patient) n1=phlébite | n2=en:hypersegmented neutrophils (1 patient) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:hypertension due to renal disease n1=phlébite | n2=en:hypertension due to renal disease | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:ileal gangrene n1=phlébite | n2=en:ileal gangrene | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:iliac, femoral, tibial, and popliteal artery calcification n1=phlébite | n2=en:iliac, femoral, tibial, and popliteal artery calcification | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:increased bleeding tendency (in 1 patient) n1=phlébite | n2=en:increased bleeding tendency (in 1 patient) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:increased muscularization of arterioles n1=phlébite | n2=en:increased muscularization of arterioles | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:increased myeloid to erythroid ratio (m:e ratio) 10:1-200:1 n1=phlébite | n2=en:increased myeloid to erythroid ratio (m:e ratio) 10:1-200:1 | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:increased pulmonary artery pressure (mean greater than 25 mm hg at rest and 30 mm hg during exercise) n1=phlébite | n2=en:increased pulmonary artery pressure (mean greater than 25 mm hg at rest and 30 mm hg during exercise) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:infective thrombosis n1=phlébite | n2=en:infective thrombosis | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:inflammatory disorder of the cardiovascular system n1=phlébite | n2=en:inflammatory disorder of the cardiovascular system | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:injury due to unintentional cut, puncture, perforation or haemorrhage during endoscopic examination n1=phlébite | n2=en:injury due to unintentional cut, puncture, perforation or haemorrhage during endoscopic examination | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:instability cardiovascular n1=phlébite | n2=en:instability cardiovascular | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:intentional alternative medicine overdose n1=phlébite | n2=en:intentional alternative medicine overdose | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:intracardiac thrombosis, not elsewhere classified n1=phlébite | n2=en:intracardiac thrombosis, not elsewhere classified | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:intracellular parasite n1=phlébite | n2=en:intracellular parasite | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:intussusception n1=phlébite | n2=en:intussusception | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:iron-deficiency anemia (in some patients) n1=phlébite | n2=en:iron-deficiency anemia (in some patients) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:large cutaneous hemangiomata, capillary and cavernous n1=phlébite | n2=en:large cutaneous hemangiomata, capillary and cavernous | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:louse-borne infectious disease n1=phlébite | n2=en:louse-borne infectious disease | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:low resting blood pressure n1=phlébite | n2=en:low resting blood pressure | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:low-to-normal platelet count (45 x 10(9)/l) n1=phlébite | n2=en:low-to-normal platelet count (45 x 10(9)/l) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:lowered biochemistry finding n1=phlébite | n2=en:lowered biochemistry finding | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:lumen of blood vessel n1=phlébite | n2=en:lumen of blood vessel | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:macrocytic anemia n1=phlébite | n2=en:macrocytic anemia | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:malformation or hamartoma of apocrine sweat gland apparatus n1=phlébite | n2=en:malformation or hamartoma of apocrine sweat gland apparatus | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:mean corpuscular volume may mildly increased or normal n1=phlébite | n2=en:mean corpuscular volume may mildly increased or normal | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:mesenteric thrombosis n1=phlébite | n2=en:mesenteric thrombosis | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:microbiology test categorized by action status n1=phlébite | n2=en:microbiology test categorized by action status | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:microvessels n1=phlébite | n2=en:microvessels | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:mosquito-borne bwamba group virus fever n1=phlébite | n2=en:mosquito-borne bwamba group virus fever | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:moya-moya phenomenon n1=phlébite | n2=en:moya-moya phenomenon | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:multinuclear erythroblasts n1=phlébite | n2=en:multinuclear erythroblasts | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:myelosuppression develops on standard doses of thiopurine drugs n1=phlébite | n2=en:myelosuppression develops on standard doses of thiopurine drugs | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:myh9-positive inclusions on immunohistochemical staining n1=phlébite | n2=en:myh9-positive inclusions on immunohistochemical staining | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:no hypertension n1=phlébite | n2=en:no hypertension | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:no increased bleeding tendency n1=phlébite | n2=en:no increased bleeding tendency | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:nucleated peripheral red cells n1=phlébite | n2=en:nucleated peripheral red cells | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:obstructive thrombosis n1=phlébite | n2=en:obstructive thrombosis | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:orthostatic hypotension due to autonomic dysfunction n1=phlébite | n2=en:orthostatic hypotension due to autonomic dysfunction | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:other cardiovascular diseases of mother complicating pregnancy, childbirth, or the puerperium, unspe n1=phlébite | n2=en:other cardiovascular diseases of mother complicating pregnancy, childbirth, or the puerperium, unspe | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:outer leaf hole n1=phlébite | n2=en:outer leaf hole | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:pappenheimer body (morphologic abnormality) n1=phlébite | n2=en:pappenheimer body (morphologic abnormality) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:parasitic nematode n1=phlébite | n2=en:parasitic nematode | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:peripheral embolism and thrombosis n1=phlébite | n2=en:peripheral embolism and thrombosis | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:peripheral vascular insufficiency n1=phlébite | n2=en:peripheral vascular insufficiency | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:perispinal vascular malformations, high-flow (in some patients) n1=phlébite | n2=en:perispinal vascular malformations, high-flow (in some patients) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:perivascular space n1=phlébite | n2=en:perivascular space | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:pernicious anemia, not influenced by intrinsic factor n1=phlébite | n2=en:pernicious anemia, not influenced by intrinsic factor | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:polycythemia vera n1=phlébite | n2=en:polycythemia vera | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:positive laboratory finding n1=phlébite | n2=en:positive laboratory finding | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:post-transfusion thrombocytopenia n1=phlébite | n2=en:post-transfusion thrombocytopenia | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:procedure by transcervical approach - neck n1=phlébite | n2=en:procedure by transcervical approach - neck | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:prominent venous pattern n1=phlébite | n2=en:prominent venous pattern | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:proprietary cough compounds m-z n1=phlébite | n2=en:proprietary cough compounds m-z | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:protein c deficiency disease n1=phlébite | n2=en:protein c deficiency disease | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:proteins a - r n1=phlébite | n2=en:proteins a - r | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:pulmonary artery aneurysm n1=phlébite | n2=en:pulmonary artery aneurysm | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:pulmonary artery vascular wall remodeling n1=phlébite | n2=en:pulmonary artery vascular wall remodeling | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:pulmonary hypertension (1/4 patients) n1=phlébite | n2=en:pulmonary hypertension (1/4 patients) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:pulmonary hypertension (rare) n1=phlébite | n2=en:pulmonary hypertension (rare) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:pulmonary valve atresia n1=phlébite | n2=en:pulmonary valve atresia | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:pulmonic stenosis, mild (in some patients) n1=phlébite | n2=en:pulmonic stenosis, mild (in some patients) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:recurrent cerebral and cerebellar hemorrhage n1=phlébite | n2=en:recurrent cerebral and cerebellar hemorrhage | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:recurrent deep vein thrombosis n1=phlébite | n2=en:recurrent deep vein thrombosis | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:recurrent strokes n1=phlébite | n2=en:recurrent strokes | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:red blood cell count raised n1=phlébite | n2=en:red blood cell count raised | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:reticulocytosis (in some) n1=phlébite | n2=en:reticulocytosis (in some) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:retinal artery occlusion n1=phlébite | n2=en:retinal artery occlusion | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:rotation disorder n1=phlébite | n2=en:rotation disorder | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:salmonella group d2 phase 1 y-z n1=phlébite | n2=en:salmonella group d2 phase 1 y-z | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:salmonella group e1 phase 1 a-e n1=phlébite | n2=en:salmonella group e1 phase 1 a-e | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:salmonella group e4 phase 1 f-r n1=phlébite | n2=en:salmonella group e4 phase 1 f-r | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:salmonella group f phase 1 a-e n1=phlébite | n2=en:salmonella group f phase 1 a-e | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:small cerebral arteries show fibrous intimal proliferation n1=phlébite | n2=en:small cerebral arteries show fibrous intimal proliferation | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:splitting of the intima and/or internal elastic membrane n1=phlébite | n2=en:splitting of the intima and/or internal elastic membrane | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:sublingual administration of treatment n1=phlébite | n2=en:sublingual administration of treatment | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:suicide and self inflicted injury by barbitone n1=phlébite | n2=en:suicide and self inflicted injury by barbitone | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:suicide and selfinflicted injury by drowning n1=phlébite | n2=en:suicide and selfinflicted injury by drowning | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:suicide and selfinflicted injury by jumping from natural sites n1=phlébite | n2=en:suicide and selfinflicted injury by jumping from natural sites | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:suicide or self injury by scalding n1=phlébite | n2=en:suicide or self injury by scalding | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:tetralogy of fallot (rare) n1=phlébite | n2=en:tetralogy of fallot (rare) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:thrombocytopenia (mean 42.7 x 10(9)/l) n1=phlébite | n2=en:thrombocytopenia (mean 42.7 x 10(9)/l) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:thrombocytopenia post hemolytic anemia n1=phlébite | n2=en:thrombocytopenia post hemolytic anemia | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:tumor-like lesion of esophagus, stomach and duodenum n1=phlébite | n2=en:tumor-like lesion of esophagus, stomach and duodenum | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:type attribute t - z n1=phlébite | n2=en:type attribute t - z | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:type of vessel n1=phlébite | n2=en:type of vessel | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:types of drugs n-s n1=phlébite | n2=en:types of drugs n-s | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:unstable hemoglobin (e.g. hb contaldo 141800.0022) n1=phlébite | n2=en:unstable hemoglobin (e.g. hb contaldo 141800.0022) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:vaccination site thrombosis n1=phlébite | n2=en:vaccination site thrombosis | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:vacuolated lymphocytes (type ii) n1=phlébite | n2=en:vacuolated lymphocytes (type ii) | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:vacuolated monocytes n1=phlébite | n2=en:vacuolated monocytes | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:variable red blood cell size n1=phlébite | n2=en:variable red blood cell size | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:vascular (arteriovenous) malformation, progressive, with cutaneous involvement n1=phlébite | n2=en:vascular (arteriovenous) malformation, progressive, with cutaneous involvement | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:vascular lesions n1=phlébite | n2=en:vascular lesions | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:vasculitis, particularly of the capillaries n1=phlébite | n2=en:vasculitis, particularly of the capillaries | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:vasovagal syncope n1=phlébite | n2=en:vasovagal syncope | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 62 / 0.258 -> en:zoonotic pathogen n1=phlébite | n2=en:zoonotic pathogen | rel=r_associated | relid=0 | w=62 phlébite -- r_associated #0: 61 / 0.254 -> en:abnormal cardiac laboratory result n1=phlébite | n2=en:abnormal cardiac laboratory result | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:abnormality of red blood cells n1=phlébite | n2=en:abnormality of red blood cells | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:accidental alternative medicine poisoning n1=phlébite | n2=en:accidental alternative medicine poisoning | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:accidental cut, puncture, perforation or hemorrhage during abdominal paracentesis n1=phlébite | n2=en:accidental cut, puncture, perforation or hemorrhage during abdominal paracentesis | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:accidental cut, puncture, perforation or hemorrhage during infusion n1=phlébite | n2=en:accidental cut, puncture, perforation or hemorrhage during infusion | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:acquired complement deficiency disease n1=phlébite | n2=en:acquired complement deficiency disease | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:administration site thrombosis n1=phlébite | n2=en:administration site thrombosis | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:administrative / management procedure n1=phlébite | n2=en:administrative / management procedure | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:adverse reaction to mixed viral-rickettsial and bacterial vaccines except combinations with a pertussis component n1=phlébite | n2=en:adverse reaction to mixed viral-rickettsial and bacterial vaccines except combinations with a pertussis component | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:alternative medicine poisoning of undetermined intent n1=phlébite | n2=en:alternative medicine poisoning of undetermined intent | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:anemia, corticosteroid-sensitive n1=phlébite | n2=en:anemia, corticosteroid-sensitive | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:anesthesia type n1=phlébite | n2=en:anesthesia type | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:aneurysm n1=phlébite | n2=en:aneurysm | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:ankylosis or instability of cervical, thoracic or lumbar spine n1=phlébite | n2=en:ankylosis or instability of cervical, thoracic or lumbar spine | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:anthroposophical medicine allergy n1=phlébite | n2=en:anthroposophical medicine allergy | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:antineoplastic/immunosuppressant/immunostim adverse reaction n1=phlébite | n2=en:antineoplastic/immunosuppressant/immunostim adverse reaction | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:antiphospholipid syndrome hemolytic anemia n1=phlébite | n2=en:antiphospholipid syndrome hemolytic anemia | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:aortic dissection n1=phlébite | n2=en:aortic dissection | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:arterial disorder n1=phlébite | n2=en:arterial disorder | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:arterial occlusion rare n1=phlébite | n2=en:arterial occlusion rare | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:arterial steal syndrome n1=phlébite | n2=en:arterial steal syndrome | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:arterial vascular wall remodeling n1=phlébite | n2=en:arterial vascular wall remodeling | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:arteries show intimal fibrosis n1=phlébite | n2=en:arteries show intimal fibrosis | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:arteriomegaly, diffuse, secondary to femoropopliteal occlusion n1=phlébite | n2=en:arteriomegaly, diffuse, secondary to femoropopliteal occlusion | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:assessment scales ja-me n1=phlébite | n2=en:assessment scales ja-me | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:bleeding due to vitamin k deficiency (1 patient) n1=phlébite | n2=en:bleeding due to vitamin k deficiency (1 patient) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:bleeding episodes (epistaxis, menorrhagia, ecchymosis) n1=phlébite | n2=en:bleeding episodes (epistaxis, menorrhagia, ecchymosis) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:bone marrow granulomas n1=phlébite | n2=en:bone marrow granulomas | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:carcinoma in situ of breast and genitourinary system n1=phlébite | n2=en:carcinoma in situ of breast and genitourinary system | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:cerebrovascular ischemia n1=phlébite | n2=en:cerebrovascular ischemia | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:complex procedure n1=phlébite | n2=en:complex procedure | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:congenital or acquired anatomic abnormality n1=phlébite | n2=en:congenital or acquired anatomic abnormality | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:cooper's ligament changes n1=phlébite | n2=en:cooper's ligament changes | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:decreased beta-thromboglobulin n1=phlébite | n2=en:decreased beta-thromboglobulin | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:decreased beta-tubulin in platelets n1=phlébite | n2=en:decreased beta-tubulin in platelets | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:decreased f2 activity n1=phlébite | n2=en:decreased f2 activity | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:decreased f2 antigen levels (in some patients) n1=phlébite | n2=en:decreased f2 antigen levels (in some patients) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:decreased levels of erythrocyte cytochrome b5 n1=phlébite | n2=en:decreased levels of erythrocyte cytochrome b5 | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:decreased serum thromboxane b2 n1=phlébite | n2=en:decreased serum thromboxane b2 | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:dilatation of pulmonary artery, unspecified n1=phlébite | n2=en:dilatation of pulmonary artery, unspecified | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:dilation of dermal capillaries n1=phlébite | n2=en:dilation of dermal capillaries | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:disorder of portal venous system n1=phlébite | n2=en:disorder of portal venous system | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:dysplastic changes in all cell lineages in the bone marrow n1=phlébite | n2=en:dysplastic changes in all cell lineages in the bone marrow | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:echinocytosis n1=phlébite | n2=en:echinocytosis | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:elevated fetal hemoglobin (hbf) n1=phlébite | n2=en:elevated fetal hemoglobin (hbf) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:elevated serum thrombopoietin (tpo) n1=phlébite | n2=en:elevated serum thrombopoietin (tpo) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:episodic hemolytic anemia n1=phlébite | n2=en:episodic hemolytic anemia | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:erythrocyte macrocytosis n1=phlébite | n2=en:erythrocyte macrocytosis | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:fragmented red cells n1=phlébite | n2=en:fragmented red cells | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:gastrointestinal embolism and thrombosis n1=phlébite | n2=en:gastrointestinal embolism and thrombosis | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:giant inclusion bodies present in most granulated cells n1=phlébite | n2=en:giant inclusion bodies present in most granulated cells | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:heart: myocardium/pericardium n1=phlébite | n2=en:heart: myocardium/pericardium | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:hemangioma n1=phlébite | n2=en:hemangioma | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:hemangiomas and lymphangiomas of any site n1=phlébite | n2=en:hemangiomas and lymphangiomas of any site | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:hematology finding negative n1=phlébite | n2=en:hematology finding negative | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:hematomas, recurrent large subcutaneous n1=phlébite | n2=en:hematomas, recurrent large subcutaneous | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:hemoglobin increased n1=phlébite | n2=en:hemoglobin increased | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:hemoglobinopathy n1=phlébite | n2=en:hemoglobinopathy | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:hemorrhagic disorders n1=phlébite | n2=en:hemorrhagic disorders | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:hepatic infarction n1=phlébite | n2=en:hepatic infarction | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:hormones and their metabolites and precursors t - z n1=phlébite | n2=en:hormones and their metabolites and precursors t - z | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:hyaline thickening of cerebral arteries n1=phlébite | n2=en:hyaline thickening of cerebral arteries | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:hypersensitivity of erythroid colony-forming units to erythropoietin (epo, 133170) n1=phlébite | n2=en:hypersensitivity of erythroid colony-forming units to erythropoietin (epo, 133170) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:hypolipidemia n1=phlébite | n2=en:hypolipidemia | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:hypolobulated megakaryocytes in the bone marrow n1=phlébite | n2=en:hypolobulated megakaryocytes in the bone marrow | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:idiopathic thrombocytopenic purpura n1=phlébite | n2=en:idiopathic thrombocytopenic purpura | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:impaired coagulation due to malnutrition n1=phlébite | n2=en:impaired coagulation due to malnutrition | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:increase in blood monocytes (2-3 times normal) n1=phlébite | n2=en:increase in blood monocytes (2-3 times normal) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:increased absolute neutrophil count (anc) within 0.0-0.2 x 10(9)/l n1=phlébite | n2=en:increased absolute neutrophil count (anc) within 0.0-0.2 x 10(9)/l | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:increased red cell osmotic fragility n1=phlébite | n2=en:increased red cell osmotic fragility | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:infectious disorder n1=phlébite | n2=en:infectious disorder | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:insect-transmitted infectious disease n1=phlébite | n2=en:insect-transmitted infectious disease | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:instillation site thrombosis n1=phlébite | n2=en:instillation site thrombosis | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:intestinal ciliate n1=phlébite | n2=en:intestinal ciliate | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:intestinal trematode n1=phlébite | n2=en:intestinal trematode | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:ischemic stroke (in some patients) n1=phlébite | n2=en:ischemic stroke (in some patients) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:karyozoic parasite n1=phlébite | n2=en:karyozoic parasite | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:lab result outside established criteria n1=phlébite | n2=en:lab result outside established criteria | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:laboratory test result borderline n1=phlébite | n2=en:laboratory test result borderline | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:large agranular platelets n1=phlébite | n2=en:large agranular platelets | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:leukemoid reaction n1=phlébite | n2=en:leukemoid reaction | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:lowered hematology finding n1=phlébite | n2=en:lowered hematology finding | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:lymphedema n1=phlébite | n2=en:lymphedema | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:macrocytosis n1=phlébite | n2=en:macrocytosis | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:medullary arteries of the brain n1=phlébite | n2=en:medullary arteries of the brain | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:megaloblastic anemia, chronic, relapsing n1=phlébite | n2=en:megaloblastic anemia, chronic, relapsing | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:metazoonosis n1=phlébite | n2=en:metazoonosis | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:mild form of hemoglobin h (hb h) disease n1=phlébite | n2=en:mild form of hemoglobin h (hb h) disease | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:moderate-severe bleeding tendencies (epistaxis, menorrhagia, hemarthrosis, easy bruisability) n1=phlébite | n2=en:moderate-severe bleeding tendencies (epistaxis, menorrhagia, hemarthrosis, easy bruisability) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:myelofibrosis n1=phlébite | n2=en:myelofibrosis | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:neoplasm of mesothelial tissue of site other than pleura and pericardium n1=phlébite | n2=en:neoplasm of mesothelial tissue of site other than pleura and pericardium | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:neoplasm of uncertain behavior of pleura, thymus and mediastinum n1=phlébite | n2=en:neoplasm of uncertain behavior of pleura, thymus and mediastinum | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:no bone marrow abnormalities n1=phlébite | n2=en:no bone marrow abnormalities | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:normal blood pressure n1=phlébite | n2=en:normal blood pressure | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:normal laboratory finding n1=phlébite | n2=en:normal laboratory finding | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:obstetrics and gynecology sample n1=phlébite | n2=en:obstetrics and gynecology sample | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:other cardiovascular diseases complicating pregnancy, childbirth, or the puerperium n1=phlébite | n2=en:other cardiovascular diseases complicating pregnancy, childbirth, or the puerperium | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:other cardiovascular diseases of mother, antepartum condition or complication n1=phlébite | n2=en:other cardiovascular diseases of mother, antepartum condition or complication | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:patent ductus arteriosus n1=phlébite | n2=en:patent ductus arteriosus | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:patients with type 2b develop thrombocytopenia n1=phlébite | n2=en:patients with type 2b develop thrombocytopenia | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:philadelphia chromosome-positive acute lymphoblastic leukemia n1=phlébite | n2=en:philadelphia chromosome-positive acute lymphoblastic leukemia | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:physical examination completion status n1=phlébite | n2=en:physical examination completion status | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:placental transfusion syndromes n1=phlébite | n2=en:placental transfusion syndromes | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:platelets show normal adp-induced shape change n1=phlébite | n2=en:platelets show normal adp-induced shape change | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:poisoning / injury n1=phlébite | n2=en:poisoning / injury | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:polycythemia n1=phlébite | n2=en:polycythemia | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:postsurgical bleeding n1=phlébite | n2=en:postsurgical bleeding | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:procedure by abdominal approach n1=phlébite | n2=en:procedure by abdominal approach | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:prolonged bleeding n1=phlébite | n2=en:prolonged bleeding | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:proteins s - z n1=phlébite | n2=en:proteins s - z | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:pulmonary artery hypertension (in some patients) n1=phlébite | n2=en:pulmonary artery hypertension (in some patients) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:pulmonary artery hypoplasia (in some patients) n1=phlébite | n2=en:pulmonary artery hypoplasia (in some patients) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:pulmonary hypertension (secondary to scoliosis, in some patients) n1=phlébite | n2=en:pulmonary hypertension (secondary to scoliosis, in some patients) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:pulmonary stenosis n1=phlébite | n2=en:pulmonary stenosis | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:raised biochemistry finding n1=phlébite | n2=en:raised biochemistry finding | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:raised hematology finding n1=phlébite | n2=en:raised hematology finding | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:raynaud phenomenon (in some patients) n1=phlébite | n2=en:raynaud phenomenon (in some patients) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:renal function test n1=phlébite | n2=en:renal function test | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:resistance to moderate and severe diastolic hypertension n1=phlébite | n2=en:resistance to moderate and severe diastolic hypertension | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:respiratory tract and mouth n1=phlébite | n2=en:respiratory tract and mouth | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:salmonella group c2 and c3 phase 1 y-z n1=phlébite | n2=en:salmonella group c2 and c3 phase 1 y-z | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:salmonella group m phase 1 a-e n1=phlébite | n2=en:salmonella group m phase 1 a-e | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:salmonella group r phase 1 y-z n1=phlébite | n2=en:salmonella group r phase 1 y-z | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:severe autoimmune cytopenia n1=phlébite | n2=en:severe autoimmune cytopenia | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:severity of anemia can range from mild to life-threatening n1=phlébite | n2=en:severity of anemia can range from mild to life-threatening | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:solvent d - f n1=phlébite | n2=en:solvent d - f | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:spatial displacement n1=phlébite | n2=en:spatial displacement | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:stenosis of the intracranial arteries n1=phlébite | n2=en:stenosis of the intracranial arteries | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:suicide and self inflicted injury by butabarbitone n1=phlébite | n2=en:suicide and self inflicted injury by butabarbitone | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:suicide and selfinflicted injury by jumping or lying before moving object n1=phlébite | n2=en:suicide and selfinflicted injury by jumping or lying before moving object | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:suicide and selfinflicted injury by lying before moving object n1=phlébite | n2=en:suicide and selfinflicted injury by lying before moving object | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:suicide and selfinflicted injury by suffocation by plastic bag n1=phlébite | n2=en:suicide and selfinflicted injury by suffocation by plastic bag | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:suicide or attempted suicide by drowning n1=phlébite | n2=en:suicide or attempted suicide by drowning | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:suicide or selfinflicted injury by crashing of aircraft n1=phlébite | n2=en:suicide or selfinflicted injury by crashing of aircraft | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:suicide or selfinflicted injury by cutting and stabbing n1=phlébite | n2=en:suicide or selfinflicted injury by cutting and stabbing | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:template entry - ehr category n1=phlébite | n2=en:template entry - ehr category | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:thoracic aortic dissection (rare) n1=phlébite | n2=en:thoracic aortic dissection (rare) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:thrombocytopenia (hellp syndrome) n1=phlébite | n2=en:thrombocytopenia (hellp syndrome) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:thrombocytopenia, late-onset (1 patient) n1=phlébite | n2=en:thrombocytopenia, late-onset (1 patient) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:thrombosis of vein of upper limb n1=phlébite | n2=en:thrombosis of vein of upper limb | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:thrombotic episodes n1=phlébite | n2=en:thrombotic episodes | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:total white blood cell count less than 25,000/cubic mm with 30-70% eosinophils n1=phlébite | n2=en:total white blood cell count less than 25,000/cubic mm with 30-70% eosinophils | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:toxic effect of benzene and/or homologue n1=phlébite | n2=en:toxic effect of benzene and/or homologue | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:toxic effect of nonpetroleum-based solvent n1=phlébite | n2=en:toxic effect of nonpetroleum-based solvent | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:tranexamic acid n1=phlébite | n2=en:tranexamic acid | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:tumor of lymphoid, hemopoietic and related tissue n1=phlébite | n2=en:tumor of lymphoid, hemopoietic and related tissue | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:vascular malformations n1=phlébite | n2=en:vascular malformations | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:venous intravasation n1=phlébite | n2=en:venous intravasation | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> en:vibrio species a-m n1=phlébite | n2=en:vibrio species a-m | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> Médecine n1=phlébite | n2=Médecine | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> médecine (science) n1=phlébite | n2=médecine (science) | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> thrombophlébite cérébrale n1=phlébite | n2=thrombophlébite cérébrale | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> thrombosé n1=phlébite | n2=thrombosé | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> thrombose artérielle aigüe n1=phlébite | n2=thrombose artérielle aigüe | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> thrombose de la veine porte n1=phlébite | n2=thrombose de la veine porte | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> thrombose des sinus veineux cérébraux n1=phlébite | n2=thrombose des sinus veineux cérébraux | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> thrombose porte n1=phlébite | n2=thrombose porte | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> thrombose veineuse cérébrale n1=phlébite | n2=thrombose veineuse cérébrale | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 61 / 0.254 -> thrombus n1=phlébite | n2=thrombus | rel=r_associated | relid=0 | w=61 phlébite -- r_associated #0: 56 / 0.233 -> en:arterial intramural haematoma n1=phlébite | n2=en:arterial intramural haematoma | rel=r_associated | relid=0 | w=56 phlébite -- r_associated #0: 56 / 0.233 -> en:arterial restenosis n1=phlébite | n2=en:arterial restenosis | rel=r_associated | relid=0 | w=56 phlébite -- r_associated #0: 56 / 0.233 -> en:arteritis n1=phlébite | n2=en:arteritis | rel=r_associated | relid=0 | w=56 phlébite -- r_associated #0: 56 / 0.233 -> en:inflammatory arteriopathy n1=phlébite | n2=en:inflammatory arteriopathy | rel=r_associated | relid=0 | w=56 phlébite -- r_associated #0: 56 / 0.233 -> en:mechanical phlebitis n1=phlébite | n2=en:mechanical phlebitis | rel=r_associated | relid=0 | w=56 phlébite -- r_associated #0: 56 / 0.233 -> en:other phlebitis and thrombosis complicating pregnancy and the puerperium, unspecified as to episode of care or not applicable n1=phlébite | n2=en:other phlebitis and thrombosis complicating pregnancy and the puerperium, unspecified as to episode of care or not applicable | rel=r_associated | relid=0 | w=56 phlébite -- r_associated #0: 56 / 0.233 -> en:phlebitis and thrombophlebitis of lower extremities, unspecified n1=phlébite | n2=en:phlebitis and thrombophlebitis of lower extremities, unspecified | rel=r_associated | relid=0 | w=56 phlébite -- r_associated #0: 56 / 0.233 -> en:phlebitis deep n1=phlébite | n2=en:phlebitis deep | rel=r_associated | relid=0 | w=56 phlébite -- r_associated #0: 56 / 0.233 -> en:pulmonary infarction n1=phlébite | n2=en:pulmonary infarction | rel=r_associated | relid=0 | w=56 phlébite -- r_associated #0: 56 / 0.233 -> en:secondary raynaud phenomenon n1=phlébite | n2=en:secondary raynaud phenomenon | rel=r_associated | relid=0 | w=56 phlébite -- r_associated #0: 51 / 0.213 -> embolie pulmonaire n1=phlébite | n2=embolie pulmonaire | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:administration site phlebitis n1=phlébite | n2=en:administration site phlebitis | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:antemortem thrombus n1=phlébite | n2=en:antemortem thrombus | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:aortic perforation n1=phlébite | n2=en:aortic perforation | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:av graft thrombosis n1=phlébite | n2=en:av graft thrombosis | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:cardiac and vascular procedural complications n1=phlébite | n2=en:cardiac and vascular procedural complications | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:chemical phlebitis n1=phlébite | n2=en:chemical phlebitis | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:chemically induced n1=phlébite | n2=en:chemically induced | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:metabolic aspects n1=phlébite | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:post-phlebitic dermatosis of lower leg n1=phlébite | n2=en:post-phlebitic dermatosis of lower leg | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:postphlebitic limb n1=phlébite | n2=en:postphlebitic limb | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:postphlebitic syndrome n1=phlébite | n2=en:postphlebitic syndrome | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:roentgenographic n1=phlébite | n2=en:roentgenographic | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:rupture of superficial cerebral vein n1=phlébite | n2=en:rupture of superficial cerebral vein | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:splanchnic vein thrombosis n1=phlébite | n2=en:splanchnic vein thrombosis | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:thrombophlebitis of superficial veins of lower extremity n1=phlébite | n2=en:thrombophlebitis of superficial veins of lower extremity | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:thrombosis of retinal vein n1=phlébite | n2=en:thrombosis of retinal vein | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:venous thrombosis related to vascular access complication n1=phlébite | n2=en:venous thrombosis related to vascular access complication | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:venous thrombosis, phlebitis and thrombophlebitis n1=phlébite | n2=en:venous thrombosis, phlebitis and thrombophlebitis | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 51 / 0.213 -> en:veterinary aspects n1=phlébite | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=51 phlébite -- r_associated #0: 50 / 0.208 -> vaisseau sanguin n1=phlébite | n2=vaisseau sanguin | rel=r_associated | relid=0 | w=50 phlébite -- r_associated #0: 49 / 0.204 -> en:thrombose n1=phlébite | n2=en:thrombose | rel=r_associated | relid=0 | w=49 phlébite -- r_associated #0: 48 / 0.2 -> en:phlebitis n1=phlébite | n2=en:phlebitis | rel=r_associated | relid=0 | w=48 phlébite -- r_associated #0: 48 / 0.2 -> phlébitique n1=phlébite | n2=phlébitique | rel=r_associated | relid=0 | w=48 phlébite -- r_associated #0: 47 / 0.196 -> en:periphlebitides n1=phlébite | n2=en:periphlebitides | rel=r_associated | relid=0 | w=47 phlébite -- r_associated #0: 47 / 0.196 -> gonflement n1=phlébite | n2=gonflement | rel=r_associated | relid=0 | w=47 phlébite -- r_associated #0: 46 / 0.192 -> 351 thrombi n1=phlébite | n2=351 thrombi | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:abnormality of systemic vein n1=phlébite | n2=en:abnormality of systemic vein | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:acquired abnormality of jugular vein n1=phlébite | n2=en:acquired abnormality of jugular vein | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:acute deep venous thrombosis of internal jugular vein n1=phlébite | n2=en:acute deep venous thrombosis of internal jugular vein | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:acute hemorrhagic edema of infancy n1=phlébite | n2=en:acute hemorrhagic edema of infancy | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:aneurysm recanalisation n1=phlébite | n2=en:aneurysm recanalisation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:aortic restenosis n1=phlébite | n2=en:aortic restenosis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:aortitis n1=phlébite | n2=en:aortitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:aortitis salmonella n1=phlébite | n2=en:aortitis salmonella | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:application site vasculitis n1=phlébite | n2=en:application site vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:arterial bypass stenosis n1=phlébite | n2=en:arterial bypass stenosis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:arterial perforation n1=phlébite | n2=en:arterial perforation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:arterioenteric fistula n1=phlébite | n2=en:arterioenteric fistula | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:arteriovenous fistula occlusion n1=phlébite | n2=en:arteriovenous fistula occlusion | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:arteriovenous fistula site complication n1=phlébite | n2=en:arteriovenous fistula site complication | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:arteriovenous fistula site haemorrhage n1=phlébite | n2=en:arteriovenous fistula site haemorrhage | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:arteriovenous graft site abscess n1=phlébite | n2=en:arteriovenous graft site abscess | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:arteriovenous graft site infection n1=phlébite | n2=en:arteriovenous graft site infection | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:autoimmune vasculitis n1=phlébite | n2=en:autoimmune vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:av fistula aneurysm n1=phlébite | n2=en:av fistula aneurysm | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:av fistula maturation failure n1=phlébite | n2=en:av fistula maturation failure | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:av graft aneurysm n1=phlébite | n2=en:av graft aneurysm | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:blood vessel perforation n1=phlébite | n2=en:blood vessel perforation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:brachiocephalic vein occlusion n1=phlébite | n2=en:brachiocephalic vein occlusion | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:brachiocephalic vein stenosis n1=phlébite | n2=en:brachiocephalic vein stenosis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:capillaritis n1=phlébite | n2=en:capillaritis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:cardiac complication of procedure n1=phlébite | n2=en:cardiac complication of procedure | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:cardiac perforation n1=phlébite | n2=en:cardiac perforation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:cardiac septal defect residual shunt n1=phlébite | n2=en:cardiac septal defect residual shunt | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:cardiac transplant rejection n1=phlébite | n2=en:cardiac transplant rejection | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:cardiac valve replacement complication n1=phlébite | n2=en:cardiac valve replacement complication | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:cardiac vein perforation n1=phlébite | n2=en:cardiac vein perforation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:cardiac ventricular scarring n1=phlébite | n2=en:cardiac ventricular scarring | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:carotid artery perforation n1=phlébite | n2=en:carotid artery perforation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:catheter site phlebitis n1=phlébite | n2=en:catheter site phlebitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:catheter site vasculitis n1=phlébite | n2=en:catheter site vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:central nervous system vasculitis n1=phlébite | n2=en:central nervous system vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:cerebral aneurysm perforation n1=phlébite | n2=en:cerebral aneurysm perforation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:cerebral hypoperfusion n1=phlébite | n2=en:cerebral hypoperfusion | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:cerebral vein occlusion n1=phlébite | n2=en:cerebral vein occlusion | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:congenital anomaly of peripheral blood vessel n1=phlébite | n2=en:congenital anomaly of peripheral blood vessel | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:coronary artery perforation n1=phlébite | n2=en:coronary artery perforation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:coronary vascular graft occlusion n1=phlébite | n2=en:coronary vascular graft occlusion | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:coronary venous dissection n1=phlébite | n2=en:coronary venous dissection | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:cutaneous vasculitis n1=phlébite | n2=en:cutaneous vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:deep thrombophlebitis n1=phlébite | n2=en:deep thrombophlebitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:deep vein phlebitis and thrombophlebitis of the leg n1=phlébite | n2=en:deep vein phlebitis and thrombophlebitis of the leg | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:digital vasculitis n1=phlébite | n2=en:digital vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:dirofilarial vena caval syndrome n1=phlébite | n2=en:dirofilarial vena caval syndrome | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:disorder of hepatic portal vein n1=phlébite | n2=en:disorder of hepatic portal vein | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:disorder of vein of lower extremity n1=phlébite | n2=en:disorder of vein of lower extremity | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:disorder of vena cava umbrella n1=phlébite | n2=en:disorder of vena cava umbrella | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:distended umbilical veins n1=phlébite | n2=en:distended umbilical veins | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:ectactic vein n1=phlébite | n2=en:ectactic vein | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:erythrocyanosis n1=phlébite | n2=en:erythrocyanosis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:erythromelalgia n1=phlébite | n2=en:erythromelalgia | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:femoral vein perforation n1=phlébite | n2=en:femoral vein perforation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:fetal chorionic vasculitis n1=phlébite | n2=en:fetal chorionic vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:focal vasculitis n1=phlébite | n2=en:focal vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:gonadal thrombosis n1=phlébite | n2=en:gonadal thrombosis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:graft occlusion, vascular n1=phlébite | n2=en:graft occlusion, vascular | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:granulomatous vasculitis n1=phlébite | n2=en:granulomatous vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:hemorrhagic vasculitis n1=phlébite | n2=en:hemorrhagic vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:henoch-schönlein purpura n1=phlébite | n2=en:henoch-schönlein purpura | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:henoch-schönlein purpura nephritis n1=phlébite | n2=en:henoch-schönlein purpura nephritis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:immunology aspects n1=phlébite | n2=en:immunology aspects | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:implant site phlebitis n1=phlébite | n2=en:implant site phlebitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:increased venous pressure n1=phlébite | n2=en:increased venous pressure | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:infective phlebitis n1=phlébite | n2=en:infective phlebitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:inferior vena cava perforation n1=phlébite | n2=en:inferior vena cava perforation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:inflammation n1=phlébite | n2=en:inflammation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:infusion site vasculitis n1=phlébite | n2=en:infusion site vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:injection site vasculitis n1=phlébite | n2=en:injection site vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:intrapericardial thrombosis n1=phlébite | n2=en:intrapericardial thrombosis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:ischaemic contracture of the left ventricle n1=phlébite | n2=en:ischaemic contracture of the left ventricle | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:isolated primary raynaud's phenomenon n1=phlébite | n2=en:isolated primary raynaud's phenomenon | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:junctional ectopic tachycardia n1=phlébite | n2=en:junctional ectopic tachycardia | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:large vessel vasculitis n1=phlébite | n2=en:large vessel vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:late congenital neurovascular syphilis n1=phlébite | n2=en:late congenital neurovascular syphilis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:leukocytoclastic vasculitis n1=phlébite | n2=en:leukocytoclastic vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:lymph fistula n1=phlébite | n2=en:lymph fistula | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:lymphatic duct injury n1=phlébite | n2=en:lymphatic duct injury | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:malignant atrophic papulosis n1=phlébite | n2=en:malignant atrophic papulosis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:medical device site phlebitis n1=phlébite | n2=en:medical device site phlebitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:medical device site vasculitis n1=phlébite | n2=en:medical device site vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:mesenteric-portal fistula n1=phlébite | n2=en:mesenteric-portal fistula | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:methysergide maleate 2mg tablet n1=phlébite | n2=en:methysergide maleate 2mg tablet | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:microscopic polyarteritis n1=phlébite | n2=en:microscopic polyarteritis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:mitral perforation n1=phlébite | n2=en:mitral perforation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:myocardial reperfusion injury n1=phlébite | n2=en:myocardial reperfusion injury | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:necrotizing vasculitis n1=phlébite | n2=en:necrotizing vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:nodular inflammatory vasculitis n1=phlébite | n2=en:nodular inflammatory vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:nodular vasculitis n1=phlébite | n2=en:nodular vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:occlusion mesenteric vein n1=phlébite | n2=en:occlusion mesenteric vein | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:other peripheral vascular disease n1=phlébite | n2=en:other peripheral vascular disease | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:other phlebitis and thrombosis complicating pregnancy and the puerperium, antepartum condition or complication n1=phlébite | n2=en:other phlebitis and thrombosis complicating pregnancy and the puerperium, antepartum condition or complication | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:other phlebitis and thrombosis complicating pregnancy and the puerperium, delivered, with mention of postpartum complication n1=phlébite | n2=en:other phlebitis and thrombosis complicating pregnancy and the puerperium, delivered, with mention of postpartum complication | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:other phlebitis and thrombosis in pregnancy and the puerperium n1=phlébite | n2=en:other phlebitis and thrombosis in pregnancy and the puerperium | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:other venous complications in pregnancy n1=phlébite | n2=en:other venous complications in pregnancy | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:other venous complications in pregnancy and the puerperium n1=phlébite | n2=en:other venous complications in pregnancy and the puerperium | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:other venous complications in the puerperium n1=phlébite | n2=en:other venous complications in the puerperium | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:other venous complications of pregnancy and the puerperium, unspecified as to episode of care or not applicable n1=phlébite | n2=en:other venous complications of pregnancy and the puerperium, unspecified as to episode of care or not applicable | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:panagiitis n1=phlébite | n2=en:panagiitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:paravalvular aortic regurgitation n1=phlébite | n2=en:paravalvular aortic regurgitation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:patient problem n1=phlébite | n2=en:patient problem | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:perforation of femoral artery n1=phlébite | n2=en:perforation of femoral artery | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:perinatal rupture of superficial cerebral vein n1=phlébite | n2=en:perinatal rupture of superficial cerebral vein | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:peripheral angiopathy in diseases classified elsewhere n1=phlébite | n2=en:peripheral angiopathy in diseases classified elsewhere | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:peripheral arterial disorder n1=phlébite | n2=en:peripheral arterial disorder | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:peripheral arterial reocclusion n1=phlébite | n2=en:peripheral arterial reocclusion | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:peripheral vascular complication n1=phlébite | n2=en:peripheral vascular complication | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:peripheral vascular complication of procedure n1=phlébite | n2=en:peripheral vascular complication of procedure | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:peripheral vascular disease associated with another disorder n1=phlébite | n2=en:peripheral vascular disease associated with another disorder | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:peripheral venous malformation n1=phlébite | n2=en:peripheral venous malformation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:phlebitis and thrombophlebitis n1=phlébite | n2=en:phlebitis and thrombophlebitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:phlebitis and thrombophlebitis of intracranial sinuses n1=phlébite | n2=en:phlebitis and thrombophlebitis of intracranial sinuses | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:phlebitis and thrombophlebitis of other deep vessels of lower extremities n1=phlébite | n2=en:phlebitis and thrombophlebitis of other deep vessels of lower extremities | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:phlebitis and thrombophlebitis of other sites n1=phlébite | n2=en:phlebitis and thrombophlebitis of other sites | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:phlebitis and thrombophlebitis of upper extremities, unspecified n1=phlébite | n2=en:phlebitis and thrombophlebitis of upper extremities, unspecified | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:phlebitis arm n1=phlébite | n2=en:phlebitis arm | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:phlebitis of lower limb vein n1=phlébite | n2=en:phlebitis of lower limb vein | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:phlebolithiasis n1=phlébite | n2=en:phlebolithiasis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:phlebosclerosis n1=phlébite | n2=en:phlebosclerosis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:physiopathological n1=phlébite | n2=en:physiopathological | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:plaque shift n1=phlébite | n2=en:plaque shift | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:poor peripheral circulation n1=phlébite | n2=en:poor peripheral circulation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:portal pyemia n1=phlébite | n2=en:portal pyemia | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:portocaval shunt malfunction n1=phlébite | n2=en:portocaval shunt malfunction | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:positive vessel remodelling n1=phlébite | n2=en:positive vessel remodelling | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:post-pericardiotomy syndrome n1=phlébite | n2=en:post-pericardiotomy syndrome | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:post-phlebitic lipodermatosclerosis n1=phlébite | n2=en:post-phlebitic lipodermatosclerosis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:postoperative deep vein thrombosis n1=phlébite | n2=en:postoperative deep vein thrombosis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:postprocedural inferior vena cava complication n1=phlébite | n2=en:postprocedural inferior vena cava complication | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:procedural pneumothorax n1=phlébite | n2=en:procedural pneumothorax | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:pseudovasculitis n1=phlébite | n2=en:pseudovasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:pulmonary embolism n1=phlébite | n2=en:pulmonary embolism | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:pulmonary vein dilatation n1=phlébite | n2=en:pulmonary vein dilatation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:renal vasculitis n1=phlébite | n2=en:renal vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:retinal vasculitis n1=phlébite | n2=en:retinal vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:retinal vein occlusion n1=phlébite | n2=en:retinal vein occlusion | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:segmental hyalinizing vasculitis n1=phlébite | n2=en:segmental hyalinizing vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:sequela of phlebitis n1=phlébite | n2=en:sequela of phlebitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:shunt blood flow excessive n1=phlébite | n2=en:shunt blood flow excessive | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:shwartzman phenomenon n1=phlébite | n2=en:shwartzman phenomenon | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:sinus pericranii n1=phlébite | n2=en:sinus pericranii | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:splenic artery perforation n1=phlébite | n2=en:splenic artery perforation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:stoma site vasculitis n1=phlébite | n2=en:stoma site vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:structural valve deterioration n1=phlébite | n2=en:structural valve deterioration | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:subclavian artery perforation n1=phlébite | n2=en:subclavian artery perforation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:superior vena cava perforation n1=phlébite | n2=en:superior vena cava perforation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:surgical aspects n1=phlébite | n2=en:surgical aspects | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:surgical occlusion of intracranial artery n1=phlébite | n2=en:surgical occlusion of intracranial artery | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:thrombosis complicating pregnancy and/or puerperium n1=phlébite | n2=en:thrombosis complicating pregnancy and/or puerperium | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:thrombosis of subclavian vein n1=phlébite | n2=en:thrombosis of subclavian vein | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:thrombosis of vein of lower limb n1=phlébite | n2=en:thrombosis of vein of lower limb | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:thrombosis of vein of trunk n1=phlébite | n2=en:thrombosis of vein of trunk | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:truncal arteriovenous fistula n1=phlébite | n2=en:truncal arteriovenous fistula | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:unspecified venous complication of pregnancy and the puerperium, delivered, with or without mention of antepartum condition n1=phlébite | n2=en:unspecified venous complication of pregnancy and the puerperium, delivered, with or without mention of antepartum condition | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vaccination site vasculitis n1=phlébite | n2=en:vaccination site vasculitis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular access complication n1=phlébite | n2=en:vascular access complication | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular access malfunction n1=phlébite | n2=en:vascular access malfunction | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular access site bruising n1=phlébite | n2=en:vascular access site bruising | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular access site complication n1=phlébite | n2=en:vascular access site complication | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular access site dissection n1=phlébite | n2=en:vascular access site dissection | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular access site haemorrhage n1=phlébite | n2=en:vascular access site haemorrhage | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular access site infection n1=phlébite | n2=en:vascular access site infection | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular access site inflammation n1=phlébite | n2=en:vascular access site inflammation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular access site occlusion n1=phlébite | n2=en:vascular access site occlusion | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular access site pain n1=phlébite | n2=en:vascular access site pain | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular access site pseudoaneurysm n1=phlébite | n2=en:vascular access site pseudoaneurysm | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular access site rupture n1=phlébite | n2=en:vascular access site rupture | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular bypass dysfunction n1=phlébite | n2=en:vascular bypass dysfunction | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular disorder of extremity n1=phlébite | n2=en:vascular disorder of extremity | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular graft complication n1=phlébite | n2=en:vascular graft complication | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular graft hemorrhage n1=phlébite | n2=en:vascular graft hemorrhage | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular hemostatic disorders n1=phlébite | n2=en:vascular hemostatic disorders | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular procedure complication n1=phlébite | n2=en:vascular procedure complication | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vascular pseudoaneurysm ruptured n1=phlébite | n2=en:vascular pseudoaneurysm ruptured | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vasculitic ulcer n1=phlébite | n2=en:vasculitic ulcer | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vasculitis aggravated n1=phlébite | n2=en:vasculitis aggravated | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vasculitis diffuse n1=phlébite | n2=en:vasculitis diffuse | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vasculitis gastrointestinal n1=phlébite | n2=en:vasculitis gastrointestinal | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vasculitis legs n1=phlébite | n2=en:vasculitis legs | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vein collapse n1=phlébite | n2=en:vein collapse | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:venospasm n1=phlébite | n2=en:venospasm | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:venous and venular disorders n1=phlébite | n2=en:venous and venular disorders | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:venous collateral circulation, any site n1=phlébite | n2=en:venous collateral circulation, any site | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:venous complication in pregnancy, unspecified n1=phlébite | n2=en:venous complication in pregnancy, unspecified | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:venous complication in the puerperium n1=phlébite | n2=en:venous complication in the puerperium | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:venous embolism n1=phlébite | n2=en:venous embolism | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:venous hemorrhage n1=phlébite | n2=en:venous hemorrhage | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:venous injury n1=phlébite | n2=en:venous injury | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:venous obstruction n1=phlébite | n2=en:venous obstruction | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:vertebral artery perforation n1=phlébite | n2=en:vertebral artery perforation | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:viruses n1=phlébite | n2=en:viruses | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> en:wegener granulomatosis n1=phlébite | n2=en:wegener granulomatosis | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 46 / 0.192 -> inflammation de paroi veineuse n1=phlébite | n2=inflammation de paroi veineuse | rel=r_associated | relid=0 | w=46 phlébite -- r_associated #0: 45 / 0.188 -> veinite n1=phlébite | n2=veinite | rel=r_associated | relid=0 | w=45 phlébite -- r_associated #0: 43 / 0.179 -> Phillips (bougie, sonde de) n1=phlébite | n2=Phillips (bougie, sonde de) | rel=r_associated | relid=0 | w=43 phlébite -- r_associated #0: 42 / 0.175 -> en:thrombosis n1=phlébite | n2=en:thrombosis | rel=r_associated | relid=0 | w=42 phlébite -- r_associated #0: 41 / 0.171 -> en:acquired abnormality of pulmonary venous structure n1=phlébite | n2=en:acquired abnormality of pulmonary venous structure | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:administration site vasculitis n1=phlébite | n2=en:administration site vasculitis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:aneurysm perforation n1=phlébite | n2=en:aneurysm perforation | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:anti-neutrophil cytoplasmic antibody positive vasculitis n1=phlébite | n2=en:anti-neutrophil cytoplasmic antibody positive vasculitis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:application site phlebitis n1=phlébite | n2=en:application site phlebitis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:arterial bypass occlusion n1=phlébite | n2=en:arterial bypass occlusion | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:arteriovenous graft site haematoma n1=phlébite | n2=en:arteriovenous graft site haematoma | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:arteriovenous graft site haemorrhage n1=phlébite | n2=en:arteriovenous graft site haemorrhage | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:basilar artery perforation n1=phlébite | n2=en:basilar artery perforation | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:behcet syndrome n1=phlébite | n2=en:behcet syndrome | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:cardiac function disturbance postoperative n1=phlébite | n2=en:cardiac function disturbance postoperative | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:cardiac valve rupture n1=phlébite | n2=en:cardiac valve rupture | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:cardiac vein dissection n1=phlébite | n2=en:cardiac vein dissection | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:chronic deep venous thrombosis of internal jugular vein n1=phlébite | n2=en:chronic deep venous thrombosis of internal jugular vein | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:chronic peripheral venous hypertension n1=phlébite | n2=en:chronic peripheral venous hypertension | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:compression of vein n1=phlébite | n2=en:compression of vein | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:congenital peripheral aneurysm n1=phlébite | n2=en:congenital peripheral aneurysm | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:coronary artery reocclusion n1=phlébite | n2=en:coronary artery reocclusion | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:coronary bypass stenosis n1=phlébite | n2=en:coronary bypass stenosis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:coronary bypass thrombosis n1=phlébite | n2=en:coronary bypass thrombosis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:disease of non-coronary systemic artery n1=phlébite | n2=en:disease of non-coronary systemic artery | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:disorder of intracranial venous sinus n1=phlébite | n2=en:disorder of intracranial venous sinus | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:event description.adverse event:find:pt:^patient:nom:observed.mersth n1=phlébite | n2=en:event description.adverse event:find:pt:^patient:nom:observed.mersth | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:h/o: phlebitis n1=phlébite | n2=en:h/o: phlebitis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:iliac vein perforation n1=phlébite | n2=en:iliac vein perforation | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:induration of venous wall n1=phlébite | n2=en:induration of venous wall | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:infusion site phlebitis n1=phlébite | n2=en:infusion site phlebitis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:injury of vein of head and neck n1=phlébite | n2=en:injury of vein of head and neck | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:internal jugular phlebectasia n1=phlébite | n2=en:internal jugular phlebectasia | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:intracranial venous septic embolism n1=phlébite | n2=en:intracranial venous septic embolism | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:livedo reticularis n1=phlébite | n2=en:livedo reticularis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:lower limb artery perforation n1=phlébite | n2=en:lower limb artery perforation | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:methysergide maleate n1=phlébite | n2=en:methysergide maleate | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:mouth and genital ulcers with inflamed cartilage syndrome n1=phlébite | n2=en:mouth and genital ulcers with inflamed cartilage syndrome | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:ocular vasculitis n1=phlébite | n2=en:ocular vasculitis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:oculovestibuloauditory syndrome n1=phlébite | n2=en:oculovestibuloauditory syndrome | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:orbital thrombophlebitis n1=phlébite | n2=en:orbital thrombophlebitis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:other specified peripheral vascular diseases n1=phlébite | n2=en:other specified peripheral vascular diseases | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:other venous complications of pregnancy and the puerperium, delivered, with mention of postpartum complication n1=phlébite | n2=en:other venous complications of pregnancy and the puerperium, delivered, with mention of postpartum complication | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:peripheral vascular complications of care n1=phlébite | n2=en:peripheral vascular complications of care | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:peripheral vein complication following surgery n1=phlébite | n2=en:peripheral vein complication following surgery | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:phlebitis injection site n1=phlébite | n2=en:phlebitis injection site | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:phlebitis of central nervous system venous sinuses n1=phlébite | n2=en:phlebitis of central nervous system venous sinuses | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:portal vein-hepatic artery fistula n1=phlébite | n2=en:portal vein-hepatic artery fistula | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:post angioplasty restenosis n1=phlébite | n2=en:post angioplasty restenosis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:post embolisation syndrome n1=phlébite | n2=en:post embolisation syndrome | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:pulmonary hypertensive venous disease n1=phlébite | n2=en:pulmonary hypertensive venous disease | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:renal artery perforation n1=phlébite | n2=en:renal artery perforation | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:renal vein thrombosis n1=phlébite | n2=en:renal vein thrombosis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:retinal phlebitis n1=phlébite | n2=en:retinal phlebitis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:retinociliary vein n1=phlébite | n2=en:retinociliary vein | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:sublingual varices n1=phlébite | n2=en:sublingual varices | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:systemic venovenous collateral vein n1=phlébite | n2=en:systemic venovenous collateral vein | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:takayasu arteritis n1=phlébite | n2=en:takayasu arteritis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:temporal arteritis n1=phlébite | n2=en:temporal arteritis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:thromboembolism of vein n1=phlébite | n2=en:thromboembolism of vein | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:thrombosis of jugular vein n1=phlébite | n2=en:thrombosis of jugular vein | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:umbilical vasculitis n1=phlébite | n2=en:umbilical vasculitis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:unspecified venous complication of pregnancy and the puerperium, delivered, with mention of postpartum complication n1=phlébite | n2=en:unspecified venous complication of pregnancy and the puerperium, delivered, with mention of postpartum complication | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:upper extremity deep vein thrombosis n1=phlébite | n2=en:upper extremity deep vein thrombosis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:vaccination site phlebitis n1=phlébite | n2=en:vaccination site phlebitis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:vascular access site haematoma n1=phlébite | n2=en:vascular access site haematoma | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:vascular access site oedema n1=phlébite | n2=en:vascular access site oedema | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:vascular access site rash n1=phlébite | n2=en:vascular access site rash | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:vascular access site swelling n1=phlébite | n2=en:vascular access site swelling | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:vascular access site thrombosis n1=phlébite | n2=en:vascular access site thrombosis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:vascular purpura n1=phlébite | n2=en:vascular purpura | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:vascular stent infection n1=phlébite | n2=en:vascular stent infection | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:vasculitic rash n1=phlébite | n2=en:vasculitic rash | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:vasomotor acroparesthesia n1=phlébite | n2=en:vasomotor acroparesthesia | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:vasoplegia syndrome n1=phlébite | n2=en:vasoplegia syndrome | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:venous hypertension n1=phlébite | n2=en:venous hypertension | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:venous perforation n1=phlébite | n2=en:venous perforation | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 41 / 0.171 -> en:vessel puncture site phlebitis n1=phlébite | n2=en:vessel puncture site phlebitis | rel=r_associated | relid=0 | w=41 phlébite -- r_associated #0: 40 / 0.167 -> cancer n1=phlébite | n2=cancer | rel=r_associated | relid=0 | w=40 phlébite -- r_associated #0: 40 / 0.167 -> embolie cruorique n1=phlébite | n2=embolie cruorique | rel=r_associated | relid=0 | w=40 phlébite -- r_associated #0: 40 / 0.167 -> embolie paradoxale n1=phlébite | n2=embolie paradoxale | rel=r_associated | relid=0 | w=40 phlébite -- r_associated #0: 40 / 0.167 -> obturation n1=phlébite | n2=obturation | rel=r_associated | relid=0 | w=40 phlébite -- r_associated #0: 40 / 0.167 -> vaisseau n1=phlébite | n2=vaisseau | rel=r_associated | relid=0 | w=40 phlébite -- r_associated #0: 37 / 0.154 -> fibrinogène n1=phlébite | n2=fibrinogène | rel=r_associated | relid=0 | w=37 phlébite -- r_associated #0: 37 / 0.154 -> pathologie n1=phlébite | n2=pathologie | rel=r_associated | relid=0 | w=37 phlébite -- r_associated #0: 36 / 0.15 -> en:aneurysm of vein n1=phlébite | n2=en:aneurysm of vein | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:arterial bypass thrombosis n1=phlébite | n2=en:arterial bypass thrombosis | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:arteriovenous fistula site infection n1=phlébite | n2=en:arteriovenous fistula site infection | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:atrio-oesophageal fistula n1=phlébite | n2=en:atrio-oesophageal fistula | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:blue toe syndrome n1=phlébite | n2=en:blue toe syndrome | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:buerger disease n1=phlébite | n2=en:buerger disease | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:cerebral hyperperfusion syndrome n1=phlébite | n2=en:cerebral hyperperfusion syndrome | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:congenital vena cava abnormality n1=phlébite | n2=en:congenital vena cava abnormality | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:coronary restenosis n1=phlébite | n2=en:coronary restenosis | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:coronary vascular graft stenosis n1=phlébite | n2=en:coronary vascular graft stenosis | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:ctrp terminology n1=phlébite | n2=en:ctrp terminology | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:incision site vessel occlusion n1=phlébite | n2=en:incision site vessel occlusion | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:intracranial venous thrombosis n1=phlébite | n2=en:intracranial venous thrombosis | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:kawasaki disease n1=phlébite | n2=en:kawasaki disease | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:may-thurner syndrome n1=phlébite | n2=en:may-thurner syndrome | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:methysergide n1=phlébite | n2=en:methysergide | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:other phlebitis and thrombosis complicating pregnancy and the puerperium, delivered, with or without mention of antepartum condition n1=phlébite | n2=en:other phlebitis and thrombosis complicating pregnancy and the puerperium, delivered, with or without mention of antepartum condition | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:other specified peripheral vascular disease not elsewhere classified n1=phlébite | n2=en:other specified peripheral vascular disease not elsewhere classified | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:other venous complications of pregnancy and the puerperium, delivered, with or without mention of antepartum condition n1=phlébite | n2=en:other venous complications of pregnancy and the puerperium, delivered, with or without mention of antepartum condition | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:perforation iliac artery n1=phlébite | n2=en:perforation iliac artery | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:phlebitis nec n1=phlébite | n2=en:phlebitis nec | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:post procedural myocardial infarction n1=phlébite | n2=en:post procedural myocardial infarction | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:postimplantation syndrome n1=phlébite | n2=en:postimplantation syndrome | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:primary angiitis of the central nervous system n1=phlébite | n2=en:primary angiitis of the central nervous system | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:retinal venous engorgement n1=phlébite | n2=en:retinal venous engorgement | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:rupture of vein n1=phlébite | n2=en:rupture of vein | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:septic phlebitis n1=phlébite | n2=en:septic phlebitis | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:sterile phlebitis n1=phlébite | n2=en:sterile phlebitis | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:stoma site phlebitis n1=phlébite | n2=en:stoma site phlebitis | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:subclavian vein perforation n1=phlébite | n2=en:subclavian vein perforation | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:superficial phlebitis n1=phlébite | n2=en:superficial phlebitis | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:systemic vasculitis n1=phlébite | n2=en:systemic vasculitis | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:thrombosis of internal jugular vein n1=phlébite | n2=en:thrombosis of internal jugular vein | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:thrombosis of transplanted vein n1=phlébite | n2=en:thrombosis of transplanted vein | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:vascular graft stenosis n1=phlébite | n2=en:vascular graft stenosis | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:venous complication in pregnancy and/or the puerperium n1=phlébite | n2=en:venous complication in pregnancy and/or the puerperium | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> en:venous thrombosis due to central venous access device n1=phlébite | n2=en:venous thrombosis due to central venous access device | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 36 / 0.15 -> thrombus blanc n1=phlébite | n2=thrombus blanc | rel=r_associated | relid=0 | w=36 phlébite -- r_associated #0: 35 / 0.146 -> en:abdominal aorta thrombosis n1=phlébite | n2=en:abdominal aorta thrombosis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:aberrant origin of right subclavian artery n1=phlébite | n2=en:aberrant origin of right subclavian artery | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:abnormal cerebral vessels n1=phlébite | n2=en:abnormal cerebral vessels | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:abnormal rbc morphology (anisocytosis, poikilocytes, acanthocytes) (in some patients) n1=phlébite | n2=en:abnormal rbc morphology (anisocytosis, poikilocytes, acanthocytes) (in some patients) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:absent neutrophil inclusions n1=phlébite | n2=en:absent neutrophil inclusions | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:acanthocyte n1=phlébite | n2=en:acanthocyte | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:administration, management n1=phlébite | n2=en:administration, management | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:adverse cutaneous reaction to alternative medical therapy n1=phlébite | n2=en:adverse cutaneous reaction to alternative medical therapy | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:alpha thalassemia n1=phlébite | n2=en:alpha thalassemia | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:alternative medicine overdose n1=phlébite | n2=en:alternative medicine overdose | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:alternative medicine preparation n1=phlébite | n2=en:alternative medicine preparation | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:amelioration of ss disease (e.g. hb memphis 141800.0096) n1=phlébite | n2=en:amelioration of ss disease (e.g. hb memphis 141800.0096) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:anemia (associated with mutation in the cox10 gene) n1=phlébite | n2=en:anemia (associated with mutation in the cox10 gene) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:aneurysm of right middle cerebral artery, horizontal segment n1=phlébite | n2=en:aneurysm of right middle cerebral artery, horizontal segment | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:aniso-poikilocytosis on blood smear n1=phlébite | n2=en:aniso-poikilocytosis on blood smear | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:anthroposophical medicine (product) n1=phlébite | n2=en:anthroposophical medicine (product) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:anthroposophical medicine adverse reaction n1=phlébite | n2=en:anthroposophical medicine adverse reaction | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:aortic aneurysms (ascending or aortic arch) n1=phlébite | n2=en:aortic aneurysms (ascending or aortic arch) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:aortic coarctation (in some patients) n1=phlébite | n2=en:aortic coarctation (in some patients) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:aortic valve stenosis n1=phlébite | n2=en:aortic valve stenosis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:aplastic anemia and other bone marrow failure syndromes n1=phlébite | n2=en:aplastic anemia and other bone marrow failure syndromes | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:arterial embolus n1=phlébite | n2=en:arterial embolus | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:arterial thrombosis n1=phlébite | n2=en:arterial thrombosis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:artery n1=phlébite | n2=en:artery | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:assessment scales di-ga n1=phlébite | n2=en:assessment scales di-ga | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:assessment scales ge-iz n1=phlébite | n2=en:assessment scales ge-iz | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:atherosclerotic plaque disruption with thrombosis of artery n1=phlébite | n2=en:atherosclerotic plaque disruption with thrombosis of artery | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:atypical mycobacteria species a-m n1=phlébite | n2=en:atypical mycobacteria species a-m | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:benign breast condition n1=phlébite | n2=en:benign breast condition | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:bleeding tendency, mild n1=phlébite | n2=en:bleeding tendency, mild | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:blood and tissue flagellate n1=phlébite | n2=en:blood and tissue flagellate | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:blood protein disorders n1=phlébite | n2=en:blood protein disorders | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:blood vessel part n1=phlébite | n2=en:blood vessel part | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:bone marrow biopsy shows erythrocyte hypocellularity n1=phlébite | n2=en:bone marrow biopsy shows erythrocyte hypocellularity | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:bone marrow oedema syndrome n1=phlébite | n2=en:bone marrow oedema syndrome | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:bone marrow shows abnormal development of neutrophils n1=phlébite | n2=en:bone marrow shows abnormal development of neutrophils | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:borderline histology finding n1=phlébite | n2=en:borderline histology finding | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:capillary malformations, small, multiple, diffuse n1=phlébite | n2=en:capillary malformations, small, multiple, diffuse | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:cardiological test categorized by action status n1=phlébite | n2=en:cardiological test categorized by action status | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:cardiovascular abnormality due to patent arterial duct n1=phlébite | n2=en:cardiovascular abnormality due to patent arterial duct | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:cardiovascular infections n1=phlébite | n2=en:cardiovascular infections | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:cardiovascular neoplasm n1=phlébite | n2=en:cardiovascular neoplasm | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:category b biological agent n1=phlébite | n2=en:category b biological agent | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:cerebrovascular system n1=phlébite | n2=en:cerebrovascular system | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:chronic disease of immune system n1=phlébite | n2=en:chronic disease of immune system | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:clotting and bleeding disorders n1=phlébite | n2=en:clotting and bleeding disorders | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:coarctation of the aorta (1 patient) n1=phlébite | n2=en:coarctation of the aorta (1 patient) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:congenital hypoplasia of pulmonary artery n1=phlébite | n2=en:congenital hypoplasia of pulmonary artery | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:cord sign n1=phlébite | n2=en:cord sign | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:coronary and carotid arteries spared (in most patients) n1=phlébite | n2=en:coronary and carotid arteries spared (in most patients) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:decorative products causing toxic effect n1=phlébite | n2=en:decorative products causing toxic effect | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:decreased erythropoietic response under hypoxic conditions n1=phlébite | n2=en:decreased erythropoietic response under hypoxic conditions | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:decreased level (laboratory finding) n1=phlébite | n2=en:decreased level (laboratory finding) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:decreased oxygen-binding capacity of hemoglobin n1=phlébite | n2=en:decreased oxygen-binding capacity of hemoglobin | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:defective platelet aggregation in response to adp n1=phlébite | n2=en:defective platelet aggregation in response to adp | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:defective platelet binding to collagen n1=phlébite | n2=en:defective platelet binding to collagen | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:disease of capillaries n1=phlébite | n2=en:disease of capillaries | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:disorder of system n1=phlébite | n2=en:disorder of system | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:drug groups primarily used in obstets, gyne. and urinary tract disorders poisoning n1=phlébite | n2=en:drug groups primarily used in obstets, gyne. and urinary tract disorders poisoning | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:drug monitoring procedure and/or toxicology screen n1=phlébite | n2=en:drug monitoring procedure and/or toxicology screen | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:electron microscopy shows iron-loaded mitochondria n1=phlébite | n2=en:electron microscopy shows iron-loaded mitochondria | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:elevated hbf n1=phlébite | n2=en:elevated hbf | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:embolism and thrombosis of other arteries n1=phlébite | n2=en:embolism and thrombosis of other arteries | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:embolism, cerebral n1=phlébite | n2=en:embolism, cerebral | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:enteropathogen n1=phlébite | n2=en:enteropathogen | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:enzymes a - l n1=phlébite | n2=en:enzymes a - l | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:equivocal hematology finding n1=phlébite | n2=en:equivocal hematology finding | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:folate-responsive megaloblastic anemia n1=phlébite | n2=en:folate-responsive megaloblastic anemia | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:gastric acidity increasers a-z n1=phlébite | n2=en:gastric acidity increasers a-z | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:gaucher cells in bone marrow n1=phlébite | n2=en:gaucher cells in bone marrow | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:giant platelet n1=phlébite | n2=en:giant platelet | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:head and neck arterial thrombosis n1=phlébite | n2=en:head and neck arterial thrombosis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:hematological disorders of fetus and newborn n1=phlébite | n2=en:hematological disorders of fetus and newborn | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:hematology finding absent n1=phlébite | n2=en:hematology finding absent | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:hematology finding present n1=phlébite | n2=en:hematology finding present | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:hemoglobin decreased n1=phlébite | n2=en:hemoglobin decreased | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:hemolytic anemia n1=phlébite | n2=en:hemolytic anemia | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:hemolytic anemia (in some patients) n1=phlébite | n2=en:hemolytic anemia (in some patients) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:hemophagocytosis n1=phlébite | n2=en:hemophagocytosis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:hepatic artery thrombosis n1=phlébite | n2=en:hepatic artery thrombosis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:history taking status n1=phlébite | n2=en:history taking status | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:hormones and their metabolites and precursors h - s n1=phlébite | n2=en:hormones and their metabolites and precursors h - s | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:hrg wt allele n1=phlébite | n2=en:hrg wt allele | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:hyperglobulinemia n1=phlébite | n2=en:hyperglobulinemia | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:hypertension (in all patients) n1=phlébite | n2=en:hypertension (in all patients) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:hypertension (reported in 1 patient) n1=phlébite | n2=en:hypertension (reported in 1 patient) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:hypocellular bone marrow n1=phlébite | n2=en:hypocellular bone marrow | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:inappropriately low reticulocyte counts n1=phlébite | n2=en:inappropriately low reticulocyte counts | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:increased platelet content of plau n1=phlébite | n2=en:increased platelet content of plau | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:infection of body wall and cavities n1=phlébite | n2=en:infection of body wall and cavities | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:injection of small joint n1=phlébite | n2=en:injection of small joint | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:intestinal ameba n1=phlébite | n2=en:intestinal ameba | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:intestinal protozoan n1=phlébite | n2=en:intestinal protozoan | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:intracranial aneurysm n1=phlébite | n2=en:intracranial aneurysm | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:intracranial hypertension due to multisutural cranial fusion n1=phlébite | n2=en:intracranial hypertension due to multisutural cranial fusion | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:ischemic cerebrovascular accident n1=phlébite | n2=en:ischemic cerebrovascular accident | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:leukoerythroblastosis n1=phlébite | n2=en:leukoerythroblastosis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:lipid droplets in granulocytes n1=phlébite | n2=en:lipid droplets in granulocytes | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:low peripheral neutrophil counts (absolute neutrophil count less than 500/microliter) n1=phlébite | n2=en:low peripheral neutrophil counts (absolute neutrophil count less than 500/microliter) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:lowered laboratory finding n1=phlébite | n2=en:lowered laboratory finding | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:lymphoproliferative disorder n1=phlébite | n2=en:lymphoproliferative disorder | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:macrocytic anemia (folate or rarely b12 deficiency) n1=phlébite | n2=en:macrocytic anemia (folate or rarely b12 deficiency) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:mammalian schistosome n1=phlébite | n2=en:mammalian schistosome | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:maturation arrest of neutrophil precursors seen on bone marrow biopsy n1=phlébite | n2=en:maturation arrest of neutrophil precursors seen on bone marrow biopsy | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:medical device site thrombosis n1=phlébite | n2=en:medical device site thrombosis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:melanocytic nevi of upper limb, including shoulder n1=phlébite | n2=en:melanocytic nevi of upper limb, including shoulder | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:mild anemia n1=phlébite | n2=en:mild anemia | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:mild thrombocytopenia n1=phlébite | n2=en:mild thrombocytopenia | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:mild-moderate bleeding tendencies n1=phlébite | n2=en:mild-moderate bleeding tendencies | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:minimally invasive procedure n1=phlébite | n2=en:minimally invasive procedure | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:miscellaneous topical preparations adverse reaction n1=phlébite | n2=en:miscellaneous topical preparations adverse reaction | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:mite-borne hemorrhagic fever n1=phlébite | n2=en:mite-borne hemorrhagic fever | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:mosquito-borne alphavirus encephalitis n1=phlébite | n2=en:mosquito-borne alphavirus encephalitis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:mosquito-borne california group virus fever n1=phlébite | n2=en:mosquito-borne california group virus fever | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:mosquito-borne flavivirus encephalitis n1=phlébite | n2=en:mosquito-borne flavivirus encephalitis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:mosquito-borne flavivirus hemorrhagic fever n1=phlébite | n2=en:mosquito-borne flavivirus hemorrhagic fever | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:mosquito-borne serogroup c bunyavirus fever n1=phlébite | n2=en:mosquito-borne serogroup c bunyavirus fever | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:moyamoya disease n1=phlébite | n2=en:moyamoya disease | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:multisystem disorder c-d n1=phlébite | n2=en:multisystem disorder c-d | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:multisystem disorder m-n n1=phlébite | n2=en:multisystem disorder m-n | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:multisystem disorder y-z n1=phlébite | n2=en:multisystem disorder y-z | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:negative laboratory finding n1=phlébite | n2=en:negative laboratory finding | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:negative virology finding n1=phlébite | n2=en:negative virology finding | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:neutrophil maturation in bone marrow intact n1=phlébite | n2=en:neutrophil maturation in bone marrow intact | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:nicolau syndrome n1=phlébite | n2=en:nicolau syndrome | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:no vascular tortuosity n1=phlébite | n2=en:no vascular tortuosity | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:normal mean platelet volume (mpv) n1=phlébite | n2=en:normal mean platelet volume (mpv) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:normal platelet aggregation response to ristocetin and arachidonic acid (aa) n1=phlébite | n2=en:normal platelet aggregation response to ristocetin and arachidonic acid (aa) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:nucleated red cells in peripheral blood n1=phlébite | n2=en:nucleated red cells in peripheral blood | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:nursing attributes a - l n1=phlébite | n2=en:nursing attributes a - l | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:obstruction of right atrial tunnel after prior total cavopulmonary connection procedure n1=phlébite | n2=en:obstruction of right atrial tunnel after prior total cavopulmonary connection procedure | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:occlusion mesenteric n1=phlébite | n2=en:occlusion mesenteric | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:oral administration of treatment n1=phlébite | n2=en:oral administration of treatment | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:orthostatic acrocyanosis n1=phlébite | n2=en:orthostatic acrocyanosis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:osmotic fragility (finding) n1=phlébite | n2=en:osmotic fragility (finding) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:other hematologic conditions n1=phlébite | n2=en:other hematologic conditions | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:other specified transient hematological disorders of fetus or newborn n1=phlébite | n2=en:other specified transient hematological disorders of fetus or newborn | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:papular, squamous and granulomatous eruptions of skin n1=phlébite | n2=en:papular, squamous and granulomatous eruptions of skin | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:parenteral route of administration n1=phlébite | n2=en:parenteral route of administration | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:peripheral thrombosis n1=phlébite | n2=en:peripheral thrombosis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:persistent left superior vena cava n1=phlébite | n2=en:persistent left superior vena cava | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:platelets had abnormal membrane complexes n1=phlébite | n2=en:platelets had abnormal membrane complexes | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:portal hypertension n1=phlébite | n2=en:portal hypertension | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:positive hematology finding n1=phlébite | n2=en:positive hematology finding | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:post-angioplasty coronary artery restenosis n1=phlébite | n2=en:post-angioplasty coronary artery restenosis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:premalignant hematologic condition n1=phlébite | n2=en:premalignant hematologic condition | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:procedure / intervention (navigational concept) n1=phlébite | n2=en:procedure / intervention (navigational concept) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:procedure by transsternal approach n1=phlébite | n2=en:procedure by transsternal approach | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:proprietary agent and/or biological product n1=phlébite | n2=en:proprietary agent and/or biological product | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:prostaglandin-endoperoxide synthase 1 (ptgs1, 176805) deficiency in platelets n1=phlébite | n2=en:prostaglandin-endoperoxide synthase 1 (ptgs1, 176805) deficiency in platelets | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:pulmonary artery sling n1=phlébite | n2=en:pulmonary artery sling | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:reactive laboratory finding n1=phlébite | n2=en:reactive laboratory finding | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:rectal compounds+steroids a-z n1=phlébite | n2=en:rectal compounds+steroids a-z | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:red cell adenylate kinase deficiency n1=phlébite | n2=en:red cell adenylate kinase deficiency | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:right aortic arch (rare) n1=phlébite | n2=en:right aortic arch (rare) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:ringed sideroblasts on bone marrow examination n1=phlébite | n2=en:ringed sideroblasts on bone marrow examination | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:risk factor for carotid atherosclerosis n1=phlébite | n2=en:risk factor for carotid atherosclerosis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:salmonella group c2 and c3 phase 1 f-r n1=phlébite | n2=en:salmonella group c2 and c3 phase 1 f-r | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:salmonella group d1 phase 1 f-r n1=phlébite | n2=en:salmonella group d1 phase 1 f-r | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:salmonella group e1 phase 1 f-r n1=phlébite | n2=en:salmonella group e1 phase 1 f-r | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:salmonella group f phase 1 y-z n1=phlébite | n2=en:salmonella group f phase 1 y-z | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:shock n1=phlébite | n2=en:shock | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:sickness n1=phlébite | n2=en:sickness | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:small vessel brain infarcts and aneurysms n1=phlébite | n2=en:small vessel brain infarcts and aneurysms | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:specimen related microbial interpretation n1=phlébite | n2=en:specimen related microbial interpretation | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:spider veins n1=phlébite | n2=en:spider veins | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:spontaneous closure of surgically created fenestration of atrial tunnel after prior atrial fenestration operation n1=phlébite | n2=en:spontaneous closure of surgically created fenestration of atrial tunnel after prior atrial fenestration operation | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:stomatocytes (may be few in number) n1=phlébite | n2=en:stomatocytes (may be few in number) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:sturge-weber syndrome n1=phlébite | n2=en:sturge-weber syndrome | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:subcutaneous administration of treatment n1=phlébite | n2=en:subcutaneous administration of treatment | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:subsidiary classification of laterality and operation sites n1=phlébite | n2=en:subsidiary classification of laterality and operation sites | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:suicide and selfinflicted injury by caustic substances, excluding poisoning n1=phlébite | n2=en:suicide and selfinflicted injury by caustic substances, excluding poisoning | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:suicide or self injury by jumping from high man-made structure n1=phlébite | n2=en:suicide or self injury by jumping from high man-made structure | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:supravalvular pulmonary stenosis, minimal n1=phlébite | n2=en:supravalvular pulmonary stenosis, minimal | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:thickened coronary arteries n1=phlébite | n2=en:thickened coronary arteries | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:thoracic aortic dissection n1=phlébite | n2=en:thoracic aortic dissection | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:thrombocytopenia due to immune destruction n1=phlébite | n2=en:thrombocytopenia due to immune destruction | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:thrombophilia n1=phlébite | n2=en:thrombophilia | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:thrombophlebitis of the newborn n1=phlébite | n2=en:thrombophlebitis of the newborn | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:thrombosis, susceptibility to (post-splenectomy patients) n1=phlébite | n2=en:thrombosis, susceptibility to (post-splenectomy patients) | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:tick-borne orthobunyavirus fever n1=phlébite | n2=en:tick-borne orthobunyavirus fever | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:tortuous cerebral arteries n1=phlébite | n2=en:tortuous cerebral arteries | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:transdermal administration of treatment n1=phlébite | n2=en:transdermal administration of treatment | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:transient ischemic attack n1=phlébite | n2=en:transient ischemic attack | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:tumor embolism n1=phlébite | n2=en:tumor embolism | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:tumor of oral cavity, lips, and salivary glands n1=phlébite | n2=en:tumor of oral cavity, lips, and salivary glands | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:tumour thrombosis n1=phlébite | n2=en:tumour thrombosis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:types of drugs a-g n1=phlébite | n2=en:types of drugs a-g | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:unilateral vertebral artery hypoplasia n1=phlébite | n2=en:unilateral vertebral artery hypoplasia | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:vacuolated lymphocytes n1=phlébite | n2=en:vacuolated lymphocytes | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:vascular abnormalities restricted to skin n1=phlébite | n2=en:vascular abnormalities restricted to skin | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:vascular disorders, general and nec n1=phlébite | n2=en:vascular disorders, general and nec | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:vascular ectasia n1=phlébite | n2=en:vascular ectasia | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:vascular malformation n1=phlébite | n2=en:vascular malformation | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:vascular shunt thrombosis n1=phlébite | n2=en:vascular shunt thrombosis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:vascular structure of organs n1=phlébite | n2=en:vascular structure of organs | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:vector-transmitted infectious disease n1=phlébite | n2=en:vector-transmitted infectious disease | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:venous thrombosis neonatal n1=phlébite | n2=en:venous thrombosis neonatal | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 35 / 0.146 -> en:vessel puncture site thrombosis n1=phlébite | n2=en:vessel puncture site thrombosis | rel=r_associated | relid=0 | w=35 phlébite -- r_associated #0: 33 / 0.138 -> embolie artérielle périphérique n1=phlébite | n2=embolie artérielle périphérique | rel=r_associated | relid=0 | w=33 phlébite -- r_associated #0: 31 / 0.129 -> en:arteriovenous fistula site haematoma n1=phlébite | n2=en:arteriovenous fistula site haematoma | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 31 / 0.129 -> en:brachiocephalic vein thrombosis n1=phlébite | n2=en:brachiocephalic vein thrombosis | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 31 / 0.129 -> en:cerebral artery perforation n1=phlébite | n2=en:cerebral artery perforation | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 31 / 0.129 -> en:churg-strauss syndrome n1=phlébite | n2=en:churg-strauss syndrome | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 31 / 0.129 -> en:extravasation following blood transfusion n1=phlébite | n2=en:extravasation following blood transfusion | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 31 / 0.129 -> en:internal jugular vein stenosis n1=phlébite | n2=en:internal jugular vein stenosis | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 31 / 0.129 -> en:myocardial oedema n1=phlébite | n2=en:myocardial oedema | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 31 / 0.129 -> en:pulmonary vasculitis n1=phlébite | n2=en:pulmonary vasculitis | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 31 / 0.129 -> en:reperfusion injury n1=phlébite | n2=en:reperfusion injury | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 31 / 0.129 -> en:skin vascular disorder n1=phlébite | n2=en:skin vascular disorder | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 31 / 0.129 -> en:small vessel vasculitis n1=phlébite | n2=en:small vessel vasculitis | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 31 / 0.129 -> en:thrombophlebitis of central nervous system venous sinuses n1=phlébite | n2=en:thrombophlebitis of central nervous system venous sinuses | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 31 / 0.129 -> en:thrombophlebitis of deep femoral vein n1=phlébite | n2=en:thrombophlebitis of deep femoral vein | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 31 / 0.129 -> en:vein of galen aneurysm n1=phlébite | n2=en:vein of galen aneurysm | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 31 / 0.129 -> en:venous insufficiency n1=phlébite | n2=en:venous insufficiency | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 31 / 0.129 -> orteil bleu (syndrome de l') n1=phlébite | n2=orteil bleu (syndrome de l') | rel=r_associated | relid=0 | w=31 phlébite -- r_associated #0: 30 / 0.125 -> congestion n1=phlébite | n2=congestion | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:abdominal aorta, calcification of n1=phlébite | n2=en:abdominal aorta, calcification of | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:abnormal cytological finding in specimen from respiratory organ and thorax n1=phlébite | n2=en:abnormal cytological finding in specimen from respiratory organ and thorax | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:abnormal histological finding in specimen from respiratory organ and thorax n1=phlébite | n2=en:abnormal histological finding in specimen from respiratory organ and thorax | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:abnormal microbiological finding in specimen from digestive organ and abdominal cavity n1=phlébite | n2=en:abnormal microbiological finding in specimen from digestive organ and abdominal cavity | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:accidental cut, puncture, perforation or hemorrhage during infusion or transfusion n1=phlébite | n2=en:accidental cut, puncture, perforation or hemorrhage during infusion or transfusion | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:accidental cut, puncture, perforation or hemorrhage during lumbar puncture n1=phlébite | n2=en:accidental cut, puncture, perforation or hemorrhage during lumbar puncture | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:accidental wound during transfusion n1=phlébite | n2=en:accidental wound during transfusion | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:acquired hemolytic anemia n1=phlébite | n2=en:acquired hemolytic anemia | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:adverse reaction to bases and inactive substances n1=phlébite | n2=en:adverse reaction to bases and inactive substances | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:adverse reaction to emollients, demulcents and protectants n1=phlébite | n2=en:adverse reaction to emollients, demulcents and protectants | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:air embolism n1=phlébite | n2=en:air embolism | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:anemia requiring transfusions n1=phlébite | n2=en:anemia requiring transfusions | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:anemia, hemolytic, congenital nonspherocytic n1=phlébite | n2=en:anemia, hemolytic, congenital nonspherocytic | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:anemia, mild (in some patients) n1=phlébite | n2=en:anemia, mild (in some patients) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:aneurysm, descending aorta (in some patients) n1=phlébite | n2=en:aneurysm, descending aorta (in some patients) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:antineoplastic/immunosuppressant/immunostimulant allergy n1=phlébite | n2=en:antineoplastic/immunosuppressant/immunostimulant allergy | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:aorta n1=phlébite | n2=en:aorta | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:aortic arch syndrome n1=phlébite | n2=en:aortic arch syndrome | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:aortic coarctation n1=phlébite | n2=en:aortic coarctation | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:aplastic anemia n1=phlébite | n2=en:aplastic anemia | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:arterial occlusion n1=phlébite | n2=en:arterial occlusion | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:arterial stenoses, multiple n1=phlébite | n2=en:arterial stenoses, multiple | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:arteriospasm n1=phlébite | n2=en:arteriospasm | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:bleeding defect due to decreased plasminogen activator inhibitor-1 n1=phlébite | n2=en:bleeding defect due to decreased plasminogen activator inhibitor-1 | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:bleeding episodes n1=phlébite | n2=en:bleeding episodes | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:blood coagulation n1=phlébite | n2=en:blood coagulation | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:blood group incompatibility n1=phlébite | n2=en:blood group incompatibility | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:bone marrow contains lipid-laden macrophages n1=phlébite | n2=en:bone marrow contains lipid-laden macrophages | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:bone marrow failure (1 patient) n1=phlébite | n2=en:bone marrow failure (1 patient) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:bone marrow necrosis n1=phlébite | n2=en:bone marrow necrosis | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:bone marrow shows increased numbers of abnormal megakaryocytes n1=phlébite | n2=en:bone marrow shows increased numbers of abnormal megakaryocytes | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:borderline hematology finding n1=phlébite | n2=en:borderline hematology finding | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:carotid aneurysm, intracranial (in some patients) n1=phlébite | n2=en:carotid aneurysm, intracranial (in some patients) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:cerebral amyloid angiopathy n1=phlébite | n2=en:cerebral amyloid angiopathy | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:cerebral arterial thrombosis n1=phlébite | n2=en:cerebral arterial thrombosis | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:chlorhexidine i-z n1=phlébite | n2=en:chlorhexidine i-z | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:circulatory topical preparations a-z n1=phlébite | n2=en:circulatory topical preparations a-z | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:clotting decreased n1=phlébite | n2=en:clotting decreased | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:coagulopathy due to liver dysfunction n1=phlébite | n2=en:coagulopathy due to liver dysfunction | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:complement deficiency n1=phlébite | n2=en:complement deficiency | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:compound bronchodilators a-z n1=phlébite | n2=en:compound bronchodilators a-z | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:congenital bleeding diathesis n1=phlébite | n2=en:congenital bleeding diathesis | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:congenital blood disorder n1=phlébite | n2=en:congenital blood disorder | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:congenital disorder of glycosylation type 1b n1=phlébite | n2=en:congenital disorder of glycosylation type 1b | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:congenital methemoglobinemia n1=phlébite | n2=en:congenital methemoglobinemia | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:congestion of lower extremities n1=phlébite | n2=en:congestion of lower extremities | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:coronary occlusion/thrombosis n1=phlébite | n2=en:coronary occlusion/thrombosis | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:decreased euglobin lysis time n1=phlébite | n2=en:decreased euglobin lysis time | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:decreased multimerin n1=phlébite | n2=en:decreased multimerin | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:deep venous thrombosis n1=phlébite | n2=en:deep venous thrombosis | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:deficient capillarization of airspace walls n1=phlébite | n2=en:deficient capillarization of airspace walls | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:definite thrombus n1=phlébite | n2=en:definite thrombus | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:dilation of the thoracic aorta n1=phlébite | n2=en:dilation of the thoracic aorta | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:diminished or absent peripheral pulses n1=phlébite | n2=en:diminished or absent peripheral pulses | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:disseminated intravascular coagulation n1=phlébite | n2=en:disseminated intravascular coagulation | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:distal tapering of the carotid, cerebellar, and meningeal arteries n1=phlébite | n2=en:distal tapering of the carotid, cerebellar, and meningeal arteries | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:dyserythropoiesis in bone marrow (1 patient) n1=phlébite | n2=en:dyserythropoiesis in bone marrow (1 patient) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:eclampsia in pregnancy n1=phlébite | n2=en:eclampsia in pregnancy | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:embolism and thrombosis of other specified veins n1=phlébite | n2=en:embolism and thrombosis of other specified veins | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:endocrine, nutritional, metabolic and immunity disorders n1=phlébite | n2=en:endocrine, nutritional, metabolic and immunity disorders | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:erythrosis n1=phlébite | n2=en:erythrosis | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:extramedullary hematopoiesis n1=phlébite | n2=en:extramedullary hematopoiesis | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:flow disorder n1=phlébite | n2=en:flow disorder | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:function and/or dysfunction of axon n1=phlébite | n2=en:function and/or dysfunction of axon | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:functional blood flow disorder n1=phlébite | n2=en:functional blood flow disorder | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:genitalia, sexual function and urinary tract observations n1=phlébite | n2=en:genitalia, sexual function and urinary tract observations | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:genitourinary test categorized by action status n1=phlébite | n2=en:genitourinary test categorized by action status | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:granulocyte hypocellularity (in some patients) n1=phlébite | n2=en:granulocyte hypocellularity (in some patients) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:hematological sample n1=phlébite | n2=en:hematological sample | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:hemolysis (e.g. hb koelliker 141800.0083) n1=phlébite | n2=en:hemolysis (e.g. hb koelliker 141800.0083) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:hemolytic anemia (variable) n1=phlébite | n2=en:hemolytic anemia (variable) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:hemophilia b n1=phlébite | n2=en:hemophilia b | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:hemorrhagic cerebrovascular accident n1=phlébite | n2=en:hemorrhagic cerebrovascular accident | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:hereditary factor v deficiency n1=phlébite | n2=en:hereditary factor v deficiency | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:hereditary factor xi deficiency disease n1=phlébite | n2=en:hereditary factor xi deficiency disease | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:hypertension (especially in atypical hemolytic-uremic syndrome (ahus)) n1=phlébite | n2=en:hypertension (especially in atypical hemolytic-uremic syndrome (ahus)) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:hypertension (suppressible by glucocorticoid treatment) n1=phlébite | n2=en:hypertension (suppressible by glucocorticoid treatment) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:hypochromic anemia n1=phlébite | n2=en:hypochromic anemia | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:hypoglycosylation of red blood cell membranes n1=phlébite | n2=en:hypoglycosylation of red blood cell membranes | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:hypoplastic anemia n1=phlébite | n2=en:hypoplastic anemia | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:hypotension n1=phlébite | n2=en:hypotension | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:immune system disorder n1=phlébite | n2=en:immune system disorder | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:immunohematology n1=phlébite | n2=en:immunohematology | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:immunology finding n1=phlébite | n2=en:immunology finding | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:increased bleeding tendency due to platelet dysfunction n1=phlébite | n2=en:increased bleeding tendency due to platelet dysfunction | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:increased bleeding tendency, moderate to severe n1=phlébite | n2=en:increased bleeding tendency, moderate to severe | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:increased fibrinolysis (finding) n1=phlébite | n2=en:increased fibrinolysis (finding) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:increased myeloid precursor cells n1=phlébite | n2=en:increased myeloid precursor cells | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:increased number of platelets n1=phlébite | n2=en:increased number of platelets | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:increased promyelocytes n1=phlébite | n2=en:increased promyelocytes | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:increased serum ferritin n1=phlébite | n2=en:increased serum ferritin | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:infiltration n1=phlébite | n2=en:infiltration | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:intracranial thrombosis (2 of 7 patients) n1=phlébite | n2=en:intracranial thrombosis (2 of 7 patients) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:intracytoplasmic vacuoles in eosinophils, neutrophils and lymphocytes n1=phlébite | n2=en:intracytoplasmic vacuoles in eosinophils, neutrophils and lymphocytes | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:iron deficiency (in some patients) n1=phlébite | n2=en:iron deficiency (in some patients) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:jejunal gangrene n1=phlébite | n2=en:jejunal gangrene | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:lack of dense granules in platelets n1=phlébite | n2=en:lack of dense granules in platelets | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:large platelets (in some patients) n1=phlébite | n2=en:large platelets (in some patients) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:large, spherical platelets n1=phlébite | n2=en:large, spherical platelets | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:leukocytosis (before age 50) n1=phlébite | n2=en:leukocytosis (before age 50) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:locomotor test categorized by action status n1=phlébite | n2=en:locomotor test categorized by action status | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:long perforating arteries of the brain are affected n1=phlébite | n2=en:long perforating arteries of the brain are affected | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:low-normal platelet count in carrier females n1=phlébite | n2=en:low-normal platelet count in carrier females | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:mahler sign n1=phlébite | n2=en:mahler sign | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:megakaryocytes are abnormally stretched along bone marrow sinuses n1=phlébite | n2=en:megakaryocytes are abnormally stretched along bone marrow sinuses | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:methemoglobinuria n1=phlébite | n2=en:methemoglobinuria | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:microcytic hypochromic anemia (disorder) n1=phlébite | n2=en:microcytic hypochromic anemia (disorder) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:mild alpha-granule deficiency n1=phlébite | n2=en:mild alpha-granule deficiency | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:mild-moderate prolonged bleeding time n1=phlébite | n2=en:mild-moderate prolonged bleeding time | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:mixed vaccine poisoning, excluding pertussis n1=phlébite | n2=en:mixed vaccine poisoning, excluding pertussis | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:mosquito-borne alphavirus hemorrhagic fever n1=phlébite | n2=en:mosquito-borne alphavirus hemorrhagic fever | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:mucocutaneous bleeding n1=phlébite | n2=en:mucocutaneous bleeding | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:neonatal circulatory failure n1=phlébite | n2=en:neonatal circulatory failure | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:neonatal hemolytic anemia (harderoporphyria) n1=phlébite | n2=en:neonatal hemolytic anemia (harderoporphyria) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:neoplasm of uncertain behavior of stomach, intestines and rectum n1=phlébite | n2=en:neoplasm of uncertain behavior of stomach, intestines and rectum | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:neurological sample n1=phlébite | n2=en:neurological sample | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:neutropenia n1=phlébite | n2=en:neutropenia | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:neutrophil membranes show absence of sialyl-lewis-x n1=phlébite | n2=en:neutrophil membranes show absence of sialyl-lewis-x | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:no leukocyte inclusions on giemsa staining n1=phlébite | n2=en:no leukocyte inclusions on giemsa staining | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:normal beta-thromboglobulin n1=phlébite | n2=en:normal beta-thromboglobulin | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:normal hematologic parameters (both patients) n1=phlébite | n2=en:normal hematologic parameters (both patients) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:normal heterochromatin in erythroblasts n1=phlébite | n2=en:normal heterochromatin in erythroblasts | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:normal platelet aggregation studies n1=phlébite | n2=en:normal platelet aggregation studies | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:normochromic anemia n1=phlébite | n2=en:normochromic anemia | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:organic compounds d-h n1=phlébite | n2=en:organic compounds d-h | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:other and unspecified disorders of the circulatory system n1=phlébite | n2=en:other and unspecified disorders of the circulatory system | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:other symptoms involving cardiovascular system n1=phlébite | n2=en:other symptoms involving cardiovascular system | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:pancytopenia n1=phlébite | n2=en:pancytopenia | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:pathogen n1=phlébite | n2=en:pathogen | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:perfusion disorder n1=phlébite | n2=en:perfusion disorder | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:peripheral pulmonary stenosis (in some patients) n1=phlébite | n2=en:peripheral pulmonary stenosis (in some patients) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:peripheral vascular occlusive disease (in some patients) n1=phlébite | n2=en:peripheral vascular occlusive disease (in some patients) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:persistent or intermittent neutropenia n1=phlébite | n2=en:persistent or intermittent neutropenia | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:platelets show decreased gpib n1=phlébite | n2=en:platelets show decreased gpib | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:platelets show impaired aggregation in response to adp n1=phlébite | n2=en:platelets show impaired aggregation in response to adp | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:polycythemia (e.g. hb chesapeake 141800.0018) n1=phlébite | n2=en:polycythemia (e.g. hb chesapeake 141800.0018) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:polycythemia neonatorum n1=phlébite | n2=en:polycythemia neonatorum | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:positive biochemistry finding n1=phlébite | n2=en:positive biochemistry finding | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:procedure by transluminal approach n1=phlébite | n2=en:procedure by transluminal approach | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:prolonged partial thromboplastin time n1=phlébite | n2=en:prolonged partial thromboplastin time | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:protein s decreased n1=phlébite | n2=en:protein s decreased | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:pulmonary artery stenosis (1 patient) n1=phlébite | n2=en:pulmonary artery stenosis (1 patient) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:pulmonary hypertension n1=phlébite | n2=en:pulmonary hypertension | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:pulmonary hypertension, mild n1=phlébite | n2=en:pulmonary hypertension, mild | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:pulmonary trunk n1=phlébite | n2=en:pulmonary trunk | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:pulmonary vascular disorder n1=phlébite | n2=en:pulmonary vascular disorder | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:pulmonic stenosis, supravalvular n1=phlébite | n2=en:pulmonic stenosis, supravalvular | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:quaternary ammonium derivative poisoning n1=phlébite | n2=en:quaternary ammonium derivative poisoning | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:rbc count low n1=phlébite | n2=en:rbc count low | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:reduced hemopoiesis n1=phlébite | n2=en:reduced hemopoiesis | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:reduced platelet aggregation response to adenosine 5'-diphosphate (adp) n1=phlébite | n2=en:reduced platelet aggregation response to adenosine 5'-diphosphate (adp) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:renal embolism and thrombosis n1=phlébite | n2=en:renal embolism and thrombosis | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:respiratory viruses n1=phlébite | n2=en:respiratory viruses | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:retinal embolism and thrombosis n1=phlébite | n2=en:retinal embolism and thrombosis | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:ringed sideroblasts on bone marrow aspirate n1=phlébite | n2=en:ringed sideroblasts on bone marrow aspirate | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:ringed sideroblasts on peripheral smear and bone marrow n1=phlébite | n2=en:ringed sideroblasts on peripheral smear and bone marrow | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:salmonella group d1 phase 1 y-z n1=phlébite | n2=en:salmonella group d1 phase 1 y-z | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:salmonella group e1 phase 1 y-z n1=phlébite | n2=en:salmonella group e1 phase 1 y-z | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:salmonella group r phase 1 f-r n1=phlébite | n2=en:salmonella group r phase 1 f-r | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:segmented neutrophils or band cells greater than 70% n1=phlébite | n2=en:segmented neutrophils or band cells greater than 70% | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:severe hyalinosis n1=phlébite | n2=en:severe hyalinosis | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:small and medium-sized leptomeningeal arteries show luminal narrowing or obliteration n1=phlébite | n2=en:small and medium-sized leptomeningeal arteries show luminal narrowing or obliteration | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:small vessel microangiopathy n1=phlébite | n2=en:small vessel microangiopathy | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:solvent m - o n1=phlébite | n2=en:solvent m - o | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:substances, materials and objects n1=phlébite | n2=en:substances, materials and objects | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:suicide and selfinflicted poisoning by solid and liquid substances n1=phlébite | n2=en:suicide and selfinflicted poisoning by solid and liquid substances | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:suicide or self injury by jumping from high natural feature n1=phlébite | n2=en:suicide or self injury by jumping from high natural feature | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:suicide or self injury by jumping off cliff n1=phlébite | n2=en:suicide or self injury by jumping off cliff | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:suicide or selfinflicted injury by explosives n1=phlébite | n2=en:suicide or selfinflicted injury by explosives | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:suicide or selfinflicted injury by handgun n1=phlébite | n2=en:suicide or selfinflicted injury by handgun | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:suicide or selfinflicted injury by stabbing n1=phlébite | n2=en:suicide or selfinflicted injury by stabbing | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:thoracic aorta calcification n1=phlébite | n2=en:thoracic aorta calcification | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:thromboarteritis n1=phlébite | n2=en:thromboarteritis | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:thrombocytopenia n1=phlébite | n2=en:thrombocytopenia | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:thrombocytopenia (in some patients) n1=phlébite | n2=en:thrombocytopenia (in some patients) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:thrombocytopenia (onset birth-neonate, may be precipitated by cow's milk allergy) n1=phlébite | n2=en:thrombocytopenia (onset birth-neonate, may be precipitated by cow's milk allergy) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:thrombosis and thrombophlebitis of unspecified site n1=phlébite | n2=en:thrombosis and thrombophlebitis of unspecified site | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:thrombosis in device n1=phlébite | n2=en:thrombosis in device | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:thrombosis leg n1=phlébite | n2=en:thrombosis leg | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:tortuosity of thoracic aorta (in some patients) n1=phlébite | n2=en:tortuosity of thoracic aorta (in some patients) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:toxic effect of chemical n1=phlébite | n2=en:toxic effect of chemical | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:toxic effect of chiefly nonmedicinal substance n1=phlébite | n2=en:toxic effect of chiefly nonmedicinal substance | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:tranexamic acid 500mg tablet n1=phlébite | n2=en:tranexamic acid 500mg tablet | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:transfusion reaction n1=phlébite | n2=en:transfusion reaction | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:treatment administration via gastrostomy n1=phlébite | n2=en:treatment administration via gastrostomy | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:truncus arteriosus n1=phlébite | n2=en:truncus arteriosus | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:type attribute a - c n1=phlébite | n2=en:type attribute a - c | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:urethral administration of treatment n1=phlébite | n2=en:urethral administration of treatment | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:variable bleeding tendencies n1=phlébite | n2=en:variable bleeding tendencies | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:varicose veins (reported in 1 family) n1=phlébite | n2=en:varicose veins (reported in 1 family) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:vascular fragility n1=phlébite | n2=en:vascular fragility | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:vascular ischemia n1=phlébite | n2=en:vascular ischemia | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:vascular malformations (in some patients) n1=phlébite | n2=en:vascular malformations (in some patients) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:vascular ring n1=phlébite | n2=en:vascular ring | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:vascular thrombosis n1=phlébite | n2=en:vascular thrombosis | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:vein disorder n1=phlébite | n2=en:vein disorder | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> en:wedge osteotomy of thorax, ribs or sternum n1=phlébite | n2=en:wedge osteotomy of thorax, ribs or sternum | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> fibrinogène marqué (test au) n1=phlébite | n2=fibrinogène marqué (test au) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> Mondor (phlébite superficielle de) n1=phlébite | n2=Mondor (phlébite superficielle de) | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> phlébite de la veine fémorale profonde n1=phlébite | n2=phlébite de la veine fémorale profonde | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 30 / 0.125 -> phlébite en cordon de Mondor n1=phlébite | n2=phlébite en cordon de Mondor | rel=r_associated | relid=0 | w=30 phlébite -- r_associated #0: 29 / 0.121 -> phlébite bleue de Grégoire n1=phlébite | n2=phlébite bleue de Grégoire | rel=r_associated | relid=0 | w=29 phlébite -- r_associated #0: 28 / 0.117 -> métrophlébite n1=phlébite | n2=métrophlébite | rel=r_associated | relid=0 | w=28 phlébite -- r_associated #0: 28 / 0.117 -> omphalo-phlébite n1=phlébite | n2=omphalo-phlébite | rel=r_associated | relid=0 | w=28 phlébite -- r_associated #0: 28 / 0.117 -> phlébite au site d'injection n1=phlébite | n2=phlébite au site d'injection | rel=r_associated | relid=0 | w=28 phlébite -- r_associated #0: 27 / 0.113 -> chaleur n1=phlébite | n2=chaleur | rel=r_associated | relid=0 | w=27 phlébite -- r_associated #0: 27 / 0.113 -> douleur n1=phlébite | n2=douleur | rel=r_associated | relid=0 | w=27 phlébite -- r_associated #0: 27 / 0.113 -> fibrinolyse n1=phlébite | n2=fibrinolyse | rel=r_associated | relid=0 | w=27 phlébite -- r_associated #0: 27 / 0.113 -> rougeur n1=phlébite | n2=rougeur | rel=r_associated | relid=0 | w=27 phlébite -- r_associated #0: 26 / 0.108 -> circulation du sang n1=phlébite | n2=circulation du sang | rel=r_associated | relid=0 | w=26 phlébite -- r_associated #0: 26 / 0.108 -> jambes n1=phlébite | n2=jambes | rel=r_associated | relid=0 | w=26 phlébite -- r_associated #0: 26 / 0.108 -> phlébite au point d'injection n1=phlébite | n2=phlébite au point d'injection | rel=r_associated | relid=0 | w=26 phlébite -- r_associated #0: 26 / 0.108 -> phlébite d'un sinus veineux latéral n1=phlébite | n2=phlébite d'un sinus veineux latéral | rel=r_associated | relid=0 | w=26 phlébite -- r_associated #0: 26 / 0.108 -> thrombus veineux n1=phlébite | n2=thrombus veineux | rel=r_associated | relid=0 | w=26 phlébite -- r_associated #0: 26 / 0.108 -> veines n1=phlébite | n2=veines | rel=r_associated | relid=0 | w=26 phlébite -- r_associated #0: 25 / 0.104 -> collants de contention n1=phlébite | n2=collants de contention | rel=r_associated | relid=0 | w=25 phlébite -- r_associated #0: 25 / 0.104 -> Coumadine n1=phlébite | n2=Coumadine | rel=r_associated | relid=0 | w=25 phlébite -- r_associated #0: 25 / 0.104 -> thrombose artérielle n1=phlébite | n2=thrombose artérielle | rel=r_associated | relid=0 | w=25 phlébite -- r_associated #0: 23 / 0.096 -> acide acétylsalicylique [+] anticoagulant oral n1=phlébite | n2=acide acétylsalicylique [+] anticoagulant oral | rel=r_associated | relid=0 | w=23 phlébite -- r_associated #0: 23 / 0.096 -> phlébolithe n1=phlébite | n2=phlébolithe | rel=r_associated | relid=0 | w=23 phlébite -- r_associated #0: 21 / 0.088 -> bas de contention n1=phlébite | n2=bas de contention | rel=r_associated | relid=0 | w=21 phlébite -- r_associated #0: 21 / 0.088 -> circulation sanguine n1=phlébite | n2=circulation sanguine | rel=r_associated | relid=0 | w=21 phlébite -- r_associated #0: 21 / 0.088 -> échocardiographie de contraste n1=phlébite | n2=échocardiographie de contraste | rel=r_associated | relid=0 | w=21 phlébite -- r_associated #0: 21 / 0.088 -> en:phlegmasia alba dolens n1=phlébite | n2=en:phlegmasia alba dolens | rel=r_associated | relid=0 | w=21 phlébite -- r_associated #0: 21 / 0.088 -> phlébothromboses n1=phlébite | n2=phlébothromboses | rel=r_associated | relid=0 | w=21 phlébite -- r_associated #0: 21 / 0.088 -> phlegmatia alba dolens n1=phlébite | n2=phlegmatia alba dolens | rel=r_associated | relid=0 | w=21 phlébite -- r_associated #0: 21 / 0.088 -> thrombophilie n1=phlébite | n2=thrombophilie | rel=r_associated | relid=0 | w=21 phlébite -- r_associated #0: 20 / 0.083 -> 392-395 débits vasculaires n1=phlébite | n2=392-395 débits vasculaires | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> artérite, granulomatose familiale et polyarthrite juvénile n1=phlébite | n2=artérite, granulomatose familiale et polyarthrite juvénile | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> bas à varices n1=phlébite | n2=bas à varices | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> calcul veineux n1=phlébite | n2=calcul veineux | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> Circulation sanguine n1=phlébite | n2=Circulation sanguine | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> circulation sanguine dans les veines ulnaires n1=phlébite | n2=circulation sanguine dans les veines ulnaires | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> embole pulmonaire n1=phlébite | n2=embole pulmonaire | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> embolie croisée n1=phlébite | n2=embolie croisée | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> embolie du poumon n1=phlébite | n2=embolie du poumon | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> Embolie pulmonaire n1=phlébite | n2=Embolie pulmonaire | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:angeiitis n1=phlébite | n2=en:angeiitis | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:angioleucitis n1=phlébite | n2=en:angioleucitis | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:angioleukitis n1=phlébite | n2=en:angioleukitis | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:blood circulation n1=phlébite | n2=en:blood circulation | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:blood current n1=phlébite | n2=en:blood current | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:blood stream n1=phlébite | n2=en:blood stream | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:compression stockings n1=phlébite | n2=en:compression stockings | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:contrast echocardiography n1=phlébite | n2=en:contrast echocardiography | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:edema n1=phlébite | n2=en:edema | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:elastic hosiery n1=phlébite | n2=en:elastic hosiery | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:hypercoagulable state n1=phlébite | n2=en:hypercoagulable state | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:lymphangeitis n1=phlébite | n2=en:lymphangeitis | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:lymphangioitis n1=phlébite | n2=en:lymphangioitis | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:lymphangitis n1=phlébite | n2=en:lymphangitis | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:lymphatitis n1=phlébite | n2=en:lymphatitis | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:Mondor's disease n1=phlébite | n2=en:Mondor's disease | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:oedema n1=phlébite | n2=en:oedema | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:oncosis n1=phlébite | n2=en:oncosis | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:paradoxical embolism n1=phlébite | n2=en:paradoxical embolism | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:pelvic thrombophlebitis n1=phlébite | n2=en:pelvic thrombophlebitis | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:periphlebitis n1=phlébite | n2=en:periphlebitis | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:phlebitic n1=phlébite | n2=en:phlebitic | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:phlebitis - postpartum n1=phlébite | n2=en:phlebitis - postpartum | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:phlebitis of deep femoral vein n1=phlébite | n2=en:phlebitis of deep femoral vein | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:phlebitis of femoropopliteal vein n1=phlébite | n2=en:phlebitis of femoropopliteal vein | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:phlebitis of lateral venous sinus n1=phlébite | n2=en:phlebitis of lateral venous sinus | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:phlebolith n1=phlébite | n2=en:phlebolith | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:phlegmatia alba dolens n1=phlébite | n2=en:phlegmatia alba dolens | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:poor circulation n1=phlébite | n2=en:poor circulation | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:puerpueral see-saw thrombophlebitis n1=phlébite | n2=en:puerpueral see-saw thrombophlebitis | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:pulmonary embolism without mention of acute cor pulmonale n1=phlébite | n2=en:pulmonary embolism without mention of acute cor pulmonale | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:pulmonary thromboembolism n1=phlébite | n2=en:pulmonary thromboembolism | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:superficial vein thrombosis n1=phlébite | n2=en:superficial vein thrombosis | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:support stocking n1=phlébite | n2=en:support stocking | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:support stockings n1=phlébite | n2=en:support stockings | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:sural vein thrombosis n1=phlébite | n2=en:sural vein thrombosis | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:swelling n1=phlébite | n2=en:swelling | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:thrombembolia n1=phlébite | n2=en:thrombembolia | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:thromboembolic disease n1=phlébite | n2=en:thromboembolic disease | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:thrombophlebitis of pregnancy n1=phlébite | n2=en:thrombophlebitis of pregnancy | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:tumefied n1=phlébite | n2=en:tumefied | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:vein thrombosis n1=phlébite | n2=en:vein thrombosis | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:ven wall inflammation n1=phlébite | n2=en:ven wall inflammation | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:venous return n1=phlébite | n2=en:venous return | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> en:whiteleg n1=phlébite | n2=en:whiteleg | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> enflé n1=phlébite | n2=enflé | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> état d'hypercoagulabilité n1=phlébite | n2=état d'hypercoagulabilité | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> état hypercoagulable n1=phlébite | n2=état hypercoagulable | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> favoriser le retour veineux n1=phlébite | n2=favoriser le retour veineux | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> hypercoagulabilité n1=phlébite | n2=hypercoagulabilité | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> hypercoagulabilité sanguine n1=phlébite | n2=hypercoagulabilité sanguine | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> infection staphylococcique n1=phlébite | n2=infection staphylococcique | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> intumescence n1=phlébite | n2=intumescence | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> Maladie thromboembolique n1=phlébite | n2=Maladie thromboembolique | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> Maladies n1=phlébite | n2=Maladies | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> mauvaise circulation n1=phlébite | n2=mauvaise circulation | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> médecine vasculaire n1=phlébite | n2=médecine vasculaire | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> Oedème n1=phlébite | n2=Oedème | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> oedèmes n1=phlébite | n2=oedèmes | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> phlébite au site du cathéter n1=phlébite | n2=phlébite au site du cathéter | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> phlébite bleue de grégoire n1=phlébite | n2=phlébite bleue de grégoire | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> phlébite circulaire du prépuce n1=phlébite | n2=phlébite circulaire du prépuce | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> phlébite de la veine fémoro-poplitée n1=phlébite | n2=phlébite de la veine fémoro-poplitée | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> phlébite en cordon de la paroi thoracique n1=phlébite | n2=phlébite en cordon de la paroi thoracique | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> phlébite post-partum n1=phlébite | n2=phlébite post-partum | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> phlébite récidivante migratrice n1=phlébite | n2=phlébite récidivante migratrice | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> phlébite septique (ou suppurée) n1=phlébite | n2=phlébite septique (ou suppurée) | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> phlébite superficielle de la paroi thoraciqu n1=phlébite | n2=phlébite superficielle de la paroi thoraciqu | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> phlébite superficielle de la paroi thoracique n1=phlébite | n2=phlébite superficielle de la paroi thoracique | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> phlébite utéropelvienne suppurée du postpartum n1=phlébite | n2=phlébite utéropelvienne suppurée du postpartum | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> retour veineux n1=phlébite | n2=retour veineux | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> statines n1=phlébite | n2=statines | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> thromboembolique (maladie) n1=phlébite | n2=thromboembolique (maladie) | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> thromboembolisme pulmonaire n1=phlébite | n2=thromboembolisme pulmonaire | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> thrombophlébite de la grossesse n1=phlébite | n2=thrombophlébite de la grossesse | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> tuméfié n1=phlébite | n2=tuméfié | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 20 / 0.083 -> tumescence n1=phlébite | n2=tumescence | rel=r_associated | relid=0 | w=20 phlébite -- r_associated #0: 15 / 0.063 -> en:medicine n1=phlébite | n2=en:medicine | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> phlébite de la grossesse n1=phlébite | n2=phlébite de la grossesse | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> phlébite pelvienne n1=phlébite | n2=phlébite pelvienne | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> phlébite puerpérale à bascule n1=phlébite | n2=phlébite puerpérale à bascule | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> phlébite superficielle de Mondor n1=phlébite | n2=phlébite superficielle de Mondor | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> phlébite surale n1=phlébite | n2=phlébite surale | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose aérienne n1=phlébite | n2=thrombose aérienne | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose cérébrale n1=phlébite | n2=thrombose cérébrale | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose d'origine congénitale n1=phlébite | n2=thrombose d'origine congénitale | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose de l'oreillette gauche n1=phlébite | n2=thrombose de l'oreillette gauche | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose de la veine jugulaire n1=phlébite | n2=thrombose de la veine jugulaire | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose de la veine ovarienne droite n1=phlébite | n2=thrombose de la veine ovarienne droite | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose de la veine portale n1=phlébite | n2=thrombose de la veine portale | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose de la veine rénale n1=phlébite | n2=thrombose de la veine rénale | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose de la veine sous clavière n1=phlébite | n2=thrombose de la veine sous clavière | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose de la veine splénique n1=phlébite | n2=thrombose de la veine splénique | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose de pontage aorto-coronarien n1=phlébite | n2=thrombose de pontage aorto-coronarien | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose des sinus veineux cérébral n1=phlébite | n2=thrombose des sinus veineux cérébral | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose du sinus dural n1=phlébite | n2=thrombose du sinus dural | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose intervilleuse n1=phlébite | n2=thrombose intervilleuse | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose portale n1=phlébite | n2=thrombose portale | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose sous-choriale n1=phlébite | n2=thrombose sous-choriale | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose vasculaire n1=phlébite | n2=thrombose vasculaire | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose veineuse musculaire n1=phlébite | n2=thrombose veineuse musculaire | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose veineuse profonde distale n1=phlébite | n2=thrombose veineuse profonde distale | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 15 / 0.063 -> thrombose veineuse profonde proximale n1=phlébite | n2=thrombose veineuse profonde proximale | rel=r_associated | relid=0 | w=15 phlébite -- r_associated #0: 12 / 0.05 -> produit final n1=phlébite | n2=produit final | rel=r_associated | relid=0 | w=12 phlébite -- r_associated #0: 11 / 0.046 -> phlébectomie n1=phlébite | n2=phlébectomie | rel=r_associated | relid=0 | w=11 phlébite -- r_associated #0: 10 / 0.042 -> bougie n1=phlébite | n2=bougie | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 10 / 0.042 -> en:follower n1=phlébite | n2=en:follower | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 10 / 0.042 -> formation n1=phlébite | n2=formation | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 10 / 0.042 -> formation d'un caillot sanguin n1=phlébite | n2=formation d'un caillot sanguin | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 10 / 0.042 -> Phillips n1=phlébite | n2=Phillips | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 10 / 0.042 -> philobate n1=phlébite | n2=philobate | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 10 / 0.042 -> philtrum n1=phlébite | n2=philtrum | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 10 / 0.042 -> phimosis n1=phlébite | n2=phimosis | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 10 / 0.042 -> phlébalgie n1=phlébite | n2=phlébalgie | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 10 / 0.042 -> phlébangiome n1=phlébite | n2=phlébangiome | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 10 / 0.042 -> phlébartérie n1=phlébite | n2=phlébartérie | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 10 / 0.042 -> phlébartériectasie n1=phlébite | n2=phlébartériectasie | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 10 / 0.042 -> phlébectasie n1=phlébite | n2=phlébectasie | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 10 / 0.042 -> phlébectasie de la veine jugulaire interne n1=phlébite | n2=phlébectasie de la veine jugulaire interne | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 10 / 0.042 -> phlébectomie ambulatoire n1=phlébite | n2=phlébectomie ambulatoire | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 10 / 0.042 -> sonde n1=phlébite | n2=sonde | rel=r_associated | relid=0 | w=10 phlébite -- r_associated #0: 5 / 0.021 -> en:phimosis n1=phlébite | n2=en:phimosis | rel=r_associated | relid=0 | w=5 phlébite -- r_associated #0: 3 / 0.013 -> phlébite ombilicale n1=phlébite | n2=phlébite ombilicale | rel=r_associated | relid=0 | w=3 phlébite -- r_associated #0: 2 / 0.008 -> angiopathie veineuse n1=phlébite | n2=angiopathie veineuse | rel=r_associated | relid=0 | w=2 phlébite -- r_associated #0: 2 / 0.008 -> processus n1=phlébite | n2=processus | rel=r_associated | relid=0 | w=2

≈ 3231 relations entrantes en:phlebitis of lateral venous sinus --- r_associated #0: 272 --> phlébite n1=en:phlebitis of lateral venous sinus | n2=phlébite | rel=r_associated | relid=0 | w=272 phlébite d'un sinus veineux latéral --- r_associated #0: 270 --> phlébite n1=phlébite d'un sinus veineux latéral | n2=phlébite | rel=r_associated | relid=0 | w=270 en:phlebitis of deep femoral vein --- r_associated #0: 265 --> phlébite n1=en:phlebitis of deep femoral vein | n2=phlébite | rel=r_associated | relid=0 | w=265 phlébite de la veine fémorale profonde --- r_associated #0: 261 --> phlébite n1=phlébite de la veine fémorale profonde | n2=phlébite | rel=r_associated | relid=0 | w=261 oedème --- r_associated #0: 232 --> phlébite n1=oedème | n2=phlébite | rel=r_associated | relid=0 | w=232 en:edema --- r_associated #0: 230 --> phlébite n1=en:edema | n2=phlébite | rel=r_associated | relid=0 | w=230 médecine --- r_associated #0: 192 --> phlébite n1=médecine | n2=phlébite | rel=r_associated | relid=0 | w=192 thrombose veineuse profonde --- r_associated #0: 161 --> phlébite n1=thrombose veineuse profonde | n2=phlébite | rel=r_associated | relid=0 | w=161 en:deep vein thrombosis --- r_associated #0: 160 --> phlébite n1=en:deep vein thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=160 phlébite superficielle --- r_associated #0: 147 --> phlébite n1=phlébite superficielle | n2=phlébite | rel=r_associated | relid=0 | w=147 Oedème --- r_associated #0: 136 --> phlébite n1=Oedème | n2=phlébite | rel=r_associated | relid=0 | w=136 en:deep venous thrombosis --- r_associated #0: 120 --> phlébite n1=en:deep venous thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=120 thrombophlébite --- r_associated #0: 111 --> phlébite n1=thrombophlébite | n2=phlébite | rel=r_associated | relid=0 | w=111 œdème --- r_associated #0: 110 --> phlébite n1=œdème | n2=phlébite | rel=r_associated | relid=0 | w=110 en:thrombophlebitis --- r_associated #0: 110 --> phlébite n1=en:thrombophlebitis | n2=phlébite | rel=r_associated | relid=0 | w=110 thrombo-phlébite --- r_associated #0: 110 --> phlébite n1=thrombo-phlébite | n2=phlébite | rel=r_associated | relid=0 | w=110 omphalo-phlébite --- r_associated #0: 109 --> phlébite n1=omphalo-phlébite | n2=phlébite | rel=r_associated | relid=0 | w=109 phlébite ombilicale --- r_associated #0: 107 --> phlébite n1=phlébite ombilicale | n2=phlébite | rel=r_associated | relid=0 | w=107 œdème --- r_associated #0: 106 --> phlébite n1=œdème | n2=phlébite | rel=r_associated | relid=0 | w=106 phlébite profonde --- r_associated #0: 100 --> phlébite n1=phlébite profonde | n2=phlébite | rel=r_associated | relid=0 | w=100 état hypercoagulable --- r_associated #0: 92 --> phlébite n1=état hypercoagulable | n2=phlébite | rel=r_associated | relid=0 | w=92 en:thrombophilia --- r_associated #0: 91 --> phlébite n1=en:thrombophilia | n2=phlébite | rel=r_associated | relid=0 | w=91 en:pulmonary embolism without mention of acute cor pulmonale --- r_associated #0: 89 --> phlébite n1=en:pulmonary embolism without mention of acute cor pulmonale | n2=phlébite | rel=r_associated | relid=0 | w=89 hypercoagulabilité sanguine --- r_associated #0: 88 --> phlébite n1=hypercoagulabilité sanguine | n2=phlébite | rel=r_associated | relid=0 | w=88 état d'hypercoagulabilité --- r_associated #0: 87 --> phlébite n1=état d'hypercoagulabilité | n2=phlébite | rel=r_associated | relid=0 | w=87 en:pulmonary thromboembolism --- r_associated #0: 86 --> phlébite n1=en:pulmonary thromboembolism | n2=phlébite | rel=r_associated | relid=0 | w=86 thromboembolisme pulmonaire --- r_associated #0: 86 --> phlébite n1=thromboembolisme pulmonaire | n2=phlébite | rel=r_associated | relid=0 | w=86 embole pulmonaire --- r_associated #0: 85 --> phlébite n1=embole pulmonaire | n2=phlébite | rel=r_associated | relid=0 | w=85 embolie du poumon --- r_associated #0: 85 --> phlébite n1=embolie du poumon | n2=phlébite | rel=r_associated | relid=0 | w=85 embolie pulmonaire --- r_associated #0: 85 --> phlébite n1=embolie pulmonaire | n2=phlébite | rel=r_associated | relid=0 | w=85 en:pulmonary embolism --- r_associated #0: 85 --> phlébite n1=en:pulmonary embolism | n2=phlébite | rel=r_associated | relid=0 | w=85 phlébite au point d'injection --- r_associated #0: 82 --> phlébite n1=phlébite au point d'injection | n2=phlébite | rel=r_associated | relid=0 | w=82 thrombophilie --- r_associated #0: 82 --> phlébite n1=thrombophilie | n2=phlébite | rel=r_associated | relid=0 | w=82 en:phlebitis injection site --- r_associated #0: 81 --> phlébite n1=en:phlebitis injection site | n2=phlébite | rel=r_associated | relid=0 | w=81 hypercoagulabilité --- r_associated #0: 81 --> phlébite n1=hypercoagulabilité | n2=phlébite | rel=r_associated | relid=0 | w=81 phlébite au site d'injection --- r_associated #0: 76 --> phlébite n1=phlébite au site d'injection | n2=phlébite | rel=r_associated | relid=0 | w=76 phlébite septique (ou suppurée) --- r_associated #0: 75 --> phlébite n1=phlébite septique (ou suppurée) | n2=phlébite | rel=r_associated | relid=0 | w=75 phlébite surale --- r_associated #0: 72 --> phlébite n1=phlébite surale | n2=phlébite | rel=r_associated | relid=0 | w=72 bas de contention --- r_associated #0: 71 --> phlébite n1=bas de contention | n2=phlébite | rel=r_associated | relid=0 | w=71 calcul veineux --- r_associated #0: 69 --> phlébite n1=calcul veineux | n2=phlébite | rel=r_associated | relid=0 | w=69 retour veineux --- r_associated #0: 67 --> phlébite n1=retour veineux | n2=phlébite | rel=r_associated | relid=0 | w=67 en:phlebolithiasis --- r_associated #0: 66 --> phlébite n1=en:phlebolithiasis | n2=phlébite | rel=r_associated | relid=0 | w=66 phlébite utéropelvienne suppurée du postpartum --- r_associated #0: 65 --> phlébite n1=phlébite utéropelvienne suppurée du postpartum | n2=phlébite | rel=r_associated | relid=0 | w=65 en:venous return --- r_associated #0: 64 --> phlébite n1=en:venous return | n2=phlébite | rel=r_associated | relid=0 | w=64 phlébite superficielle de Mondor --- r_associated #0: 64 --> phlébite n1=phlébite superficielle de Mondor | n2=phlébite | rel=r_associated | relid=0 | w=64 en:phlebitis - postpartum --- r_associated #0: 62 --> phlébite n1=en:phlebitis - postpartum | n2=phlébite | rel=r_associated | relid=0 | w=62 phlébite puerpérale à bascule --- r_associated #0: 62 --> phlébite n1=phlébite puerpérale à bascule | n2=phlébite | rel=r_associated | relid=0 | w=62 phlébite post-partum --- r_associated #0: 61 --> phlébite n1=phlébite post-partum | n2=phlébite | rel=r_associated | relid=0 | w=61 Mondor (phlébite superficielle de) --- r_associated #0: 60 --> phlébite n1=Mondor (phlébite superficielle de) | n2=phlébite | rel=r_associated | relid=0 | w=60 thrombose --- r_associated #0: 60 --> phlébite n1=thrombose | n2=phlébite | rel=r_associated | relid=0 | w=60 thrombosé --- r_associated #0: 60 --> phlébite n1=thrombosé | n2=phlébite | rel=r_associated | relid=0 | w=60 acide acétylsalicylique [+] anticoagulant oral --- r_associated #0: 59 --> phlébite n1=acide acétylsalicylique [+] anticoagulant oral | n2=phlébite | rel=r_associated | relid=0 | w=59 phlébite circulaire du prépuce --- r_associated #0: 59 --> phlébite n1=phlébite circulaire du prépuce | n2=phlébite | rel=r_associated | relid=0 | w=59 phlébolithe --- r_associated #0: 59 --> phlébite n1=phlébolithe | n2=phlébite | rel=r_associated | relid=0 | w=59 phlébite de la grossesse --- r_associated #0: 58 --> phlébite n1=phlébite de la grossesse | n2=phlébite | rel=r_associated | relid=0 | w=58 phlébite superficielle de la paroi thoracique --- r_associated #0: 58 --> phlébite n1=phlébite superficielle de la paroi thoracique | n2=phlébite | rel=r_associated | relid=0 | w=58 collants de contention --- r_associated #0: 57 --> phlébite n1=collants de contention | n2=phlébite | rel=r_associated | relid=0 | w=57 en:phlebitis of femoropopliteal vein --- r_associated #0: 57 --> phlébite n1=en:phlebitis of femoropopliteal vein | n2=phlébite | rel=r_associated | relid=0 | w=57 en:thrombosis --- r_associated #0: 57 --> phlébite n1=en:thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=57 phlébite de la veine fémoro-poplitée --- r_associated #0: 56 --> phlébite n1=phlébite de la veine fémoro-poplitée | n2=phlébite | rel=r_associated | relid=0 | w=56 phlébite récidivante migratrice --- r_associated #0: 56 --> phlébite n1=phlébite récidivante migratrice | n2=phlébite | rel=r_associated | relid=0 | w=56 Coumadine --- r_associated #0: 55 --> phlébite n1=Coumadine | n2=phlébite | rel=r_associated | relid=0 | w=55 Maladie thromboembolique --- r_associated #0: 55 --> phlébite n1=Maladie thromboembolique | n2=phlébite | rel=r_associated | relid=0 | w=55 circulation du sang --- r_associated #0: 55 --> phlébite n1=circulation du sang | n2=phlébite | rel=r_associated | relid=0 | w=55 en:support stocking --- r_associated #0: 55 --> phlébite n1=en:support stocking | n2=phlébite | rel=r_associated | relid=0 | w=55 enflé --- r_associated #0: 55 --> phlébite n1=enflé | n2=phlébite | rel=r_associated | relid=0 | w=55 tuméfié --- r_associated #0: 55 --> phlébite n1=tuméfié | n2=phlébite | rel=r_associated | relid=0 | w=55 maladie thrombo-embolique --- r_associated #0: 54 --> phlébite n1=maladie thrombo-embolique | n2=phlébite | rel=r_associated | relid=0 | w=54 maladie thromboembolique --- r_associated #0: 54 --> phlébite n1=maladie thromboembolique | n2=phlébite | rel=r_associated | relid=0 | w=54 phlébite pelvienne --- r_associated #0: 54 --> phlébite n1=phlébite pelvienne | n2=phlébite | rel=r_associated | relid=0 | w=54 phlébite superficielle de la paroi thoraciqu --- r_associated #0: 53 --> phlébite n1=phlébite superficielle de la paroi thoraciqu | n2=phlébite | rel=r_associated | relid=0 | w=53 en:catheter site phlebitis --- r_associated #0: 52 --> phlébite n1=en:catheter site phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=52 gonflement --- r_associated #0: 52 --> phlébite n1=gonflement | n2=phlébite | rel=r_associated | relid=0 | w=52 thrombus veineux --- r_associated #0: 52 --> phlébite n1=thrombus veineux | n2=phlébite | rel=r_associated | relid=0 | w=52 favoriser le retour veineux --- r_associated #0: 51 --> phlébite n1=favoriser le retour veineux | n2=phlébite | rel=r_associated | relid=0 | w=51 maladie (médecine) --- r_associated #0: 51 --> phlébite n1=maladie (médecine) | n2=phlébite | rel=r_associated | relid=0 | w=51 phlébite au site du cathéter --- r_associated #0: 51 --> phlébite n1=phlébite au site du cathéter | n2=phlébite | rel=r_associated | relid=0 | w=51 phlébite en cordon de la paroi thoracique --- r_associated #0: 51 --> phlébite n1=phlébite en cordon de la paroi thoracique | n2=phlébite | rel=r_associated | relid=0 | w=51 en:oedema --- r_associated #0: 49 --> phlébite n1=en:oedema | n2=phlébite | rel=r_associated | relid=0 | w=49 tuméfaction --- r_associated #0: 47 --> phlébite n1=tuméfaction | n2=phlébite | rel=r_associated | relid=0 | w=47 en:swelling --- r_associated #0: 45 --> phlébite n1=en:swelling | n2=phlébite | rel=r_associated | relid=0 | w=45 thrombose veineuse --- r_associated #0: 45 --> phlébite n1=thrombose veineuse | n2=phlébite | rel=r_associated | relid=0 | w=45 veinite --- r_associated #0: 45 --> phlébite n1=veinite | n2=phlébite | rel=r_associated | relid=0 | w=45 artérite --- r_associated #0: 44 --> phlébite n1=artérite | n2=phlébite | rel=r_associated | relid=0 | w=44 en:ven wall inflammation --- r_associated #0: 44 --> phlébite n1=en:ven wall inflammation | n2=phlébite | rel=r_associated | relid=0 | w=44 embolie cruorique --- r_associated #0: 43 --> phlébite n1=embolie cruorique | n2=phlébite | rel=r_associated | relid=0 | w=43 en:thrombophlebitis of pregnancy --- r_associated #0: 42 --> phlébite n1=en:thrombophlebitis of pregnancy | n2=phlébite | rel=r_associated | relid=0 | w=42 phlegmatia alba dolens --- r_associated #0: 42 --> phlébite n1=phlegmatia alba dolens | n2=phlébite | rel=r_associated | relid=0 | w=42 phlébite en cordon de Mondor --- r_associated #0: 42 --> phlébite n1=phlébite en cordon de Mondor | n2=phlébite | rel=r_associated | relid=0 | w=42 en:venous thrombosis --- r_associated #0: 41 --> phlébite n1=en:venous thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=41 bas à varices --- r_associated #0: 40 --> phlébite n1=bas à varices | n2=phlébite | rel=r_associated | relid=0 | w=40 embolie paradoxale --- r_associated #0: 40 --> phlébite n1=embolie paradoxale | n2=phlébite | rel=r_associated | relid=0 | w=40 en:arteritis --- r_associated #0: 40 --> phlébite n1=en:arteritis | n2=phlébite | rel=r_associated | relid=0 | w=40 en:blood circulation --- r_associated #0: 40 --> phlébite n1=en:blood circulation | n2=phlébite | rel=r_associated | relid=0 | w=40 en:support stockings --- r_associated #0: 40 --> phlébite n1=en:support stockings | n2=phlébite | rel=r_associated | relid=0 | w=40 en:thromboembolic disease --- r_associated #0: 40 --> phlébite n1=en:thromboembolic disease | n2=phlébite | rel=r_associated | relid=0 | w=40 en:thrombose --- r_associated #0: 40 --> phlébite n1=en:thrombose | n2=phlébite | rel=r_associated | relid=0 | w=40 en:thrombus --- r_associated #0: 40 --> phlébite n1=en:thrombus | n2=phlébite | rel=r_associated | relid=0 | w=40 en:vein thrombosis --- r_associated #0: 40 --> phlébite n1=en:vein thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=40 en:whiteleg --- r_associated #0: 40 --> phlébite n1=en:whiteleg | n2=phlébite | rel=r_associated | relid=0 | w=40 maladie cardiaque non précisée --- r_associated #0: 40 --> phlébite n1=maladie cardiaque non précisée | n2=phlébite | rel=r_associated | relid=0 | w=40 maladie du coeur --- r_associated #0: 40 --> phlébite n1=maladie du coeur | n2=phlébite | rel=r_associated | relid=0 | w=40 section 3-1 maladies cardiaques --- r_associated #0: 40 --> phlébite n1=section 3-1 maladies cardiaques | n2=phlébite | rel=r_associated | relid=0 | w=40 en:compression stockings --- r_associated #0: 39 --> phlébite n1=en:compression stockings | n2=phlébite | rel=r_associated | relid=0 | w=39 en:phlegmatia alba dolens --- r_associated #0: 39 --> phlébite n1=en:phlegmatia alba dolens | n2=phlébite | rel=r_associated | relid=0 | w=39 phlébitique --- r_associated #0: 39 --> phlébite n1=phlébitique | n2=phlébite | rel=r_associated | relid=0 | w=39 Circulation sanguine --- r_associated #0: 38 --> phlébite n1=Circulation sanguine | n2=phlébite | rel=r_associated | relid=0 | w=38 lymphangite --- r_associated #0: 38 --> phlébite n1=lymphangite | n2=phlébite | rel=r_associated | relid=0 | w=38 en:phlebitic --- r_associated #0: 37 --> phlébite n1=en:phlebitic | n2=phlébite | rel=r_associated | relid=0 | w=37 en:sural vein thrombosis --- r_associated #0: 37 --> phlébite n1=en:sural vein thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=37 en:pelvic thrombophlebitis --- r_associated #0: 36 --> phlébite n1=en:pelvic thrombophlebitis | n2=phlébite | rel=r_associated | relid=0 | w=36 thrombus --- r_associated #0: 36 --> phlébite n1=thrombus | n2=phlébite | rel=r_associated | relid=0 | w=36 tumescence --- r_associated #0: 36 --> phlébite n1=tumescence | n2=phlébite | rel=r_associated | relid=0 | w=36 œdèmes --- r_associated #0: 35 --> phlébite n1=œdèmes | n2=phlébite | rel=r_associated | relid=0 | w=35 circulation sanguine --- r_associated #0: 35 --> phlébite n1=circulation sanguine | n2=phlébite | rel=r_associated | relid=0 | w=35 en:blood clot --- r_associated #0: 35 --> phlébite n1=en:blood clot | n2=phlébite | rel=r_associated | relid=0 | w=35 en:contrast echocardiography --- r_associated #0: 35 --> phlébite n1=en:contrast echocardiography | n2=phlébite | rel=r_associated | relid=0 | w=35 en:phlegmasia alba dolens --- r_associated #0: 35 --> phlébite n1=en:phlegmasia alba dolens | n2=phlébite | rel=r_associated | relid=0 | w=35 maladies cardiaques --- r_associated #0: 35 --> phlébite n1=maladies cardiaques | n2=phlébite | rel=r_associated | relid=0 | w=35 maladies du coeur --- r_associated #0: 35 --> phlébite n1=maladies du coeur | n2=phlébite | rel=r_associated | relid=0 | w=35 périphlébite --- r_associated #0: 35 --> phlébite n1=périphlébite | n2=phlébite | rel=r_associated | relid=0 | w=35 échocardiographie de contraste --- r_associated #0: 35 --> phlébite n1=échocardiographie de contraste | n2=phlébite | rel=r_associated | relid=0 | w=35 en:lymphangitis --- r_associated #0: 34 --> phlébite n1=en:lymphangitis | n2=phlébite | rel=r_associated | relid=0 | w=34 inflammation d'une veine --- r_associated #0: 34 --> phlébite n1=inflammation d'une veine | n2=phlébite | rel=r_associated | relid=0 | w=34 mauvaise circulation --- r_associated #0: 34 --> phlébite n1=mauvaise circulation | n2=phlébite | rel=r_associated | relid=0 | w=34 en:hypercoagulable state --- r_associated #0: 33 --> phlébite n1=en:hypercoagulable state | n2=phlébite | rel=r_associated | relid=0 | w=33 en:periphlebitis --- r_associated #0: 33 --> phlébite n1=en:periphlebitis | n2=phlébite | rel=r_associated | relid=0 | w=33 en:puerpueral see-saw thrombophlebitis --- r_associated #0: 33 --> phlébite n1=en:puerpueral see-saw thrombophlebitis | n2=phlébite | rel=r_associated | relid=0 | w=33 en:superficial vein thrombosis --- r_associated #0: 33 --> phlébite n1=en:superficial vein thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=33 Embolie pulmonaire --- r_associated #0: 32 --> phlébite n1=Embolie pulmonaire | n2=phlébite | rel=r_associated | relid=0 | w=32 en:periphlebitides --- r_associated #0: 32 --> phlébite n1=en:periphlebitides | n2=phlébite | rel=r_associated | relid=0 | w=32 en:phlebitis --- r_associated #0: 32 --> phlébite n1=en:phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=32 en:phlebolith --- r_associated #0: 32 --> phlébite n1=en:phlebolith | n2=phlébite | rel=r_associated | relid=0 | w=32 oedèmes --- r_associated #0: 32 --> phlébite n1=oedèmes | n2=phlébite | rel=r_associated | relid=0 | w=32 phlébite bleue de Grégoire --- r_associated #0: 32 --> phlébite n1=phlébite bleue de Grégoire | n2=phlébite | rel=r_associated | relid=0 | w=32 phlébite bleue de grégoire --- r_associated #0: 32 --> phlébite n1=phlébite bleue de grégoire | n2=phlébite | rel=r_associated | relid=0 | w=32 phlébothromboses --- r_associated #0: 32 --> phlébite n1=phlébothromboses | n2=phlébite | rel=r_associated | relid=0 | w=32 en:Mondor's disease --- r_associated #0: 31 --> phlébite n1=en:Mondor's disease | n2=phlébite | rel=r_associated | relid=0 | w=31 en:paradoxical embolism --- r_associated #0: 31 --> phlébite n1=en:paradoxical embolism | n2=phlébite | rel=r_associated | relid=0 | w=31 inflammation (médecine) --- r_associated #0: 31 --> phlébite n1=inflammation (médecine) | n2=phlébite | rel=r_associated | relid=0 | w=31 maladie --- r_associated #0: 31 --> phlébite n1=maladie | n2=phlébite | rel=r_associated | relid=0 | w=31 392-395 débits vasculaires --- r_associated #0: 30 --> phlébite n1=392-395 débits vasculaires | n2=phlébite | rel=r_associated | relid=0 | w=30 Maladies --- r_associated #0: 30 --> phlébite n1=Maladies | n2=phlébite | rel=r_associated | relid=0 | w=30 anti-vitamine K --- r_associated #0: 30 --> phlébite n1=anti-vitamine K | n2=phlébite | rel=r_associated | relid=0 | w=30 cardiopathies --- r_associated #0: 30 --> phlébite n1=cardiopathies | n2=phlébite | rel=r_associated | relid=0 | w=30 en:blood current --- r_associated #0: 30 --> phlébite n1=en:blood current | n2=phlébite | rel=r_associated | relid=0 | w=30 en:lymphangeitis --- r_associated #0: 30 --> phlébite n1=en:lymphangeitis | n2=phlébite | rel=r_associated | relid=0 | w=30 en:thrombembolia --- r_associated #0: 30 --> phlébite n1=en:thrombembolia | n2=phlébite | rel=r_associated | relid=0 | w=30 en:thrombophlebitis migrans --- r_associated #0: 30 --> phlébite n1=en:thrombophlebitis migrans | n2=phlébite | rel=r_associated | relid=0 | w=30 en:vasculitis --- r_associated #0: 30 --> phlébite n1=en:vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=30 fibrinogène marqué (test au) --- r_associated #0: 30 --> phlébite n1=fibrinogène marqué (test au) | n2=phlébite | rel=r_associated | relid=0 | w=30 infection staphylococcique --- r_associated #0: 30 --> phlébite n1=infection staphylococcique | n2=phlébite | rel=r_associated | relid=0 | w=30 inflammation --- r_associated #0: 30 --> phlébite n1=inflammation | n2=phlébite | rel=r_associated | relid=0 | w=30 intumescence --- r_associated #0: 30 --> phlébite n1=intumescence | n2=phlébite | rel=r_associated | relid=0 | w=30 maladie thromboembolique veineuse --- r_associated #0: 30 --> phlébite n1=maladie thromboembolique veineuse | n2=phlébite | rel=r_associated | relid=0 | w=30 en:poor circulation --- r_associated #0: 29 --> phlébite n1=en:poor circulation | n2=phlébite | rel=r_associated | relid=0 | w=29 médecine vasculaire --- r_associated #0: 29 --> phlébite n1=médecine vasculaire | n2=phlébite | rel=r_associated | relid=0 | w=29 angéite --- r_associated #0: 28 --> phlébite n1=angéite | n2=phlébite | rel=r_associated | relid=0 | w=28 artérite, granulomatose familiale et polyarthrite juvénile --- r_associated #0: 28 --> phlébite n1=artérite, granulomatose familiale et polyarthrite juvénile | n2=phlébite | rel=r_associated | relid=0 | w=28 en:angeiitis --- r_associated #0: 28 --> phlébite n1=en:angeiitis | n2=phlébite | rel=r_associated | relid=0 | w=28 en:angioleucitis --- r_associated #0: 28 --> phlébite n1=en:angioleucitis | n2=phlébite | rel=r_associated | relid=0 | w=28 en:angioleukitis --- r_associated #0: 28 --> phlébite n1=en:angioleukitis | n2=phlébite | rel=r_associated | relid=0 | w=28 métrophlébite --- r_associated #0: 28 --> phlébite n1=métrophlébite | n2=phlébite | rel=r_associated | relid=0 | w=28 pathologie neurovasculaire --- r_associated #0: 28 --> phlébite n1=pathologie neurovasculaire | n2=phlébite | rel=r_associated | relid=0 | w=28 phlébite seule --- r_associated #0: 28 --> phlébite n1=phlébite seule | n2=phlébite | rel=r_associated | relid=0 | w=28 phlébites --- r_associated #0: 28 --> phlébite n1=phlébites | n2=phlébite | rel=r_associated | relid=0 | w=28 statines --- r_associated #0: 28 --> phlébite n1=statines | n2=phlébite | rel=r_associated | relid=0 | w=28 thromboembolique (maladie) --- r_associated #0: 28 --> phlébite n1=thromboembolique (maladie) | n2=phlébite | rel=r_associated | relid=0 | w=28 TVP --- r_associated #0: 27 --> phlébite n1=TVP | n2=phlébite | rel=r_associated | relid=0 | w=27 anticoagulant --- r_associated #0: 27 --> phlébite n1=anticoagulant | n2=phlébite | rel=r_associated | relid=0 | w=27 en:tumefied --- r_associated #0: 27 --> phlébite n1=en:tumefied | n2=phlébite | rel=r_associated | relid=0 | w=27 orteil bleu (syndrome de l') --- r_associated #0: 27 --> phlébite n1=orteil bleu (syndrome de l') | n2=phlébite | rel=r_associated | relid=0 | w=27 Phillips (bougie, sonde de) --- r_associated #0: 26 --> phlébite n1=Phillips (bougie, sonde de) | n2=phlébite | rel=r_associated | relid=0 | w=26 circulation sanguine dans les veines ulnaires --- r_associated #0: 26 --> phlébite n1=circulation sanguine dans les veines ulnaires | n2=phlébite | rel=r_associated | relid=0 | w=26 embolie croisée --- r_associated #0: 26 --> phlébite n1=embolie croisée | n2=phlébite | rel=r_associated | relid=0 | w=26 en:blood stream --- r_associated #0: 26 --> phlébite n1=en:blood stream | n2=phlébite | rel=r_associated | relid=0 | w=26 en:elastic hosiery --- r_associated #0: 26 --> phlébite n1=en:elastic hosiery | n2=phlébite | rel=r_associated | relid=0 | w=26 en:lymphangioitis --- r_associated #0: 26 --> phlébite n1=en:lymphangioitis | n2=phlébite | rel=r_associated | relid=0 | w=26 en:lymphatitis --- r_associated #0: 26 --> phlébite n1=en:lymphatitis | n2=phlébite | rel=r_associated | relid=0 | w=26 en:oncosis --- r_associated #0: 26 --> phlébite n1=en:oncosis | n2=phlébite | rel=r_associated | relid=0 | w=26 en:phlebitis (following medical procedure) --- r_associated #0: 26 --> phlébite n1=en:phlebitis (following medical procedure) | n2=phlébite | rel=r_associated | relid=0 | w=26 en:thromboembolism --- r_associated #0: 26 --> phlébite n1=en:thromboembolism | n2=phlébite | rel=r_associated | relid=0 | w=26 enflure --- r_associated #0: 26 --> phlébite n1=enflure | n2=phlébite | rel=r_associated | relid=0 | w=26 thrombophlébite de la grossesse --- r_associated #0: 26 --> phlébite n1=thrombophlébite de la grossesse | n2=phlébite | rel=r_associated | relid=0 | w=26 affection vasculaire --- r_associated #0: 25 --> phlébite n1=affection vasculaire | n2=phlébite | rel=r_associated | relid=0 | w=25 en:PE --- r_associated #0: 25 --> phlébite n1=en:PE | n2=phlébite | rel=r_associated | relid=0 | w=25 en:crossed embolism --- r_associated #0: 25 --> phlébite n1=en:crossed embolism | n2=phlébite | rel=r_associated | relid=0 | w=25 en:infarct --- r_associated #0: 25 --> phlébite n1=en:infarct | n2=phlébite | rel=r_associated | relid=0 | w=25 en:oncoma --- r_associated #0: 25 --> phlébite n1=en:oncoma | n2=phlébite | rel=r_associated | relid=0 | w=25 en:post-partum suppurated utero-pelvic thrombophlebitis --- r_associated #0: 25 --> phlébite n1=en:post-partum suppurated utero-pelvic thrombophlebitis | n2=phlébite | rel=r_associated | relid=0 | w=25 en:thrombotic --- r_associated #0: 25 --> phlébite n1=en:thrombotic | n2=phlébite | rel=r_associated | relid=0 | w=25 en:vein stone --- r_associated #0: 25 --> phlébite n1=en:vein stone | n2=phlébite | rel=r_associated | relid=0 | w=25 maladie des vaisseaux --- r_associated #0: 25 --> phlébite n1=maladie des vaisseaux | n2=phlébite | rel=r_associated | relid=0 | w=25 trouble vasculaire --- r_associated #0: 25 --> phlébite n1=trouble vasculaire | n2=phlébite | rel=r_associated | relid=0 | w=25 veine --- r_associated #0: 25 --> phlébite n1=veine | n2=phlébite | rel=r_associated | relid=0 | w=25 TULV --- r_associated #0: 24 --> phlébite n1=TULV | n2=phlébite | rel=r_associated | relid=0 | w=24 en:angileucitis --- r_associated #0: 24 --> phlébite n1=en:angileucitis | n2=phlébite | rel=r_associated | relid=0 | w=24 en:lymphangiitis --- r_associated #0: 24 --> phlébite n1=en:lymphangiitis | n2=phlébite | rel=r_associated | relid=0 | w=24 en:white leg --- r_associated #0: 24 --> phlébite n1=en:white leg | n2=phlébite | rel=r_associated | relid=0 | w=24 maladies --- r_associated #0: 24 --> phlébite n1=maladies | n2=phlébite | rel=r_associated | relid=0 | w=24 processus pathologique --- r_associated #0: 24 --> phlébite n1=processus pathologique | n2=phlébite | rel=r_associated | relid=0 | w=24 en:angiolymphitis --- r_associated #0: 23 --> phlébite n1=en:angiolymphitis | n2=phlébite | rel=r_associated | relid=0 | w=23 en:septic phlebitis --- r_associated #0: 23 --> phlébite n1=en:septic phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=23 en:vascular plug --- r_associated #0: 23 --> phlébite n1=en:vascular plug | n2=phlébite | rel=r_associated | relid=0 | w=23 thrombolytique (traitement) --- r_associated #0: 23 --> phlébite n1=thrombolytique (traitement) | n2=phlébite | rel=r_associated | relid=0 | w=23 en:clot embolism --- r_associated #0: 22 --> phlébite n1=en:clot embolism | n2=phlébite | rel=r_associated | relid=0 | w=22 en:infectious vein thrombosis --- r_associated #0: 22 --> phlébite n1=en:infectious vein thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=22 en:omphalophlebitis --- r_associated #0: 22 --> phlébite n1=en:omphalophlebitis | n2=phlébite | rel=r_associated | relid=0 | w=22 en:post-partum suppurated utero-pelvic thrombo phlebitis --- r_associated #0: 22 --> phlébite n1=en:post-partum suppurated utero-pelvic thrombo phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=22 en:water thesaurismosis --- r_associated #0: 22 --> phlébite n1=en:water thesaurismosis | n2=phlébite | rel=r_associated | relid=0 | w=22 thrombotique --- r_associated #0: 22 --> phlébite n1=thrombotique | n2=phlébite | rel=r_associated | relid=0 | w=22 vaisseau sanguin --- r_associated #0: 22 --> phlébite n1=vaisseau sanguin | n2=phlébite | rel=r_associated | relid=0 | w=22 vascularite --- r_associated #0: 22 --> phlébite n1=vascularite | n2=phlébite | rel=r_associated | relid=0 | w=22 veines --- r_associated #0: 22 --> phlébite n1=veines | n2=phlébite | rel=r_associated | relid=0 | w=22 Thrombophilie --- r_associated #0: 21 --> phlébite n1=Thrombophilie | n2=phlébite | rel=r_associated | relid=0 | w=21 Thrombose --- r_associated #0: 21 --> phlébite n1=Thrombose | n2=phlébite | rel=r_associated | relid=0 | w=21 en:cruoric embolism --- r_associated #0: 21 --> phlébite n1=en:cruoric embolism | n2=phlébite | rel=r_associated | relid=0 | w=21 en:milk leg --- r_associated #0: 21 --> phlébite n1=en:milk leg | n2=phlébite | rel=r_associated | relid=0 | w=21 en:recurrent idiopathic thrombophlebitis --- r_associated #0: 21 --> phlébite n1=en:recurrent idiopathic thrombophlebitis | n2=phlébite | rel=r_associated | relid=0 | w=21 en:superficial phlebitis --- r_associated #0: 21 --> phlébite n1=en:superficial phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=21 en:tumentia --- r_associated #0: 21 --> phlébite n1=en:tumentia | n2=phlébite | rel=r_associated | relid=0 | w=21 infarctus --- r_associated #0: 21 --> phlébite n1=infarctus | n2=phlébite | rel=r_associated | relid=0 | w=21 maladie vasculaire --- r_associated #0: 21 --> phlébite n1=maladie vasculaire | n2=phlébite | rel=r_associated | relid=0 | w=21 omphalophlébite --- r_associated #0: 21 --> phlébite n1=omphalophlébite | n2=phlébite | rel=r_associated | relid=0 | w=21 pénicillines --- r_associated #0: 21 --> phlébite n1=pénicillines | n2=phlébite | rel=r_associated | relid=0 | w=21 rougeur --- r_associated #0: 21 --> phlébite n1=rougeur | n2=phlébite | rel=r_associated | relid=0 | w=21 thrombo-embolie --- r_associated #0: 21 --> phlébite n1=thrombo-embolie | n2=phlébite | rel=r_associated | relid=0 | w=21 thromboembolie --- r_associated #0: 21 --> phlébite n1=thromboembolie | n2=phlébite | rel=r_associated | relid=0 | w=21 thrombophlébite puerpérale à bascule --- r_associated #0: 21 --> phlébite n1=thrombophlébite puerpérale à bascule | n2=phlébite | rel=r_associated | relid=0 | w=21 thromboser --- r_associated #0: 21 --> phlébite n1=thromboser | n2=phlébite | rel=r_associated | relid=0 | w=21 varice --- r_associated #0: 21 --> phlébite n1=varice | n2=phlébite | rel=r_associated | relid=0 | w=21 351 thrombi --- r_associated #0: 20 --> phlébite n1=351 thrombi | n2=phlébite | rel=r_associated | relid=0 | w=20 Médecine --- r_associated #0: 20 --> phlébite n1=Médecine | n2=phlébite | rel=r_associated | relid=0 | w=20 Thrombus --- r_associated #0: 20 --> phlébite n1=Thrombus | n2=phlébite | rel=r_associated | relid=0 | w=20 affection cardiaque --- r_associated #0: 20 --> phlébite n1=affection cardiaque | n2=phlébite | rel=r_associated | relid=0 | w=20 affections cardiaques --- r_associated #0: 20 --> phlébite n1=affections cardiaques | n2=phlébite | rel=r_associated | relid=0 | w=20 altitude --- r_associated #0: 20 --> phlébite n1=altitude | n2=phlébite | rel=r_associated | relid=0 | w=20 anomalie cardiaque --- r_associated #0: 20 --> phlébite n1=anomalie cardiaque | n2=phlébite | rel=r_associated | relid=0 | w=20 cancer --- r_associated #0: 20 --> phlébite n1=cancer | n2=phlébite | rel=r_associated | relid=0 | w=20 card --- r_associated #0: 20 --> phlébite n1=card | n2=phlébite | rel=r_associated | relid=0 | w=20 cardiopathie --- r_associated #0: 20 --> phlébite n1=cardiopathie | n2=phlébite | rel=r_associated | relid=0 | w=20 chaleur --- r_associated #0: 20 --> phlébite n1=chaleur | n2=phlébite | rel=r_associated | relid=0 | w=20 congestion --- r_associated #0: 20 --> phlébite n1=congestion | n2=phlébite | rel=r_associated | relid=0 | w=20 douleur --- r_associated #0: 20 --> phlébite n1=douleur | n2=phlébite | rel=r_associated | relid=0 | w=20 embolie artérielle périphérique --- r_associated #0: 20 --> phlébite n1=embolie artérielle périphérique | n2=phlébite | rel=r_associated | relid=0 | w=20 en:'leukemoid' granulocytosis --- r_associated #0: 20 --> phlébite n1=en:'leukemoid' granulocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abdominal aorta thrombosis --- r_associated #0: 20 --> phlébite n1=en:abdominal aorta thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abdominal aorta, calcification of --- r_associated #0: 20 --> phlébite n1=en:abdominal aorta, calcification of | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abdominal aortic aneurysm (in some patients) --- r_associated #0: 20 --> phlébite n1=en:abdominal aortic aneurysm (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aberrant left subclavian --- r_associated #0: 20 --> phlébite n1=en:aberrant left subclavian | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aberrant origin of right subclavian artery --- r_associated #0: 20 --> phlébite n1=en:aberrant origin of right subclavian artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aberrant origin vertebral artery --- r_associated #0: 20 --> phlébite n1=en:aberrant origin vertebral artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aberrant subclavian artery --- r_associated #0: 20 --> phlébite n1=en:aberrant subclavian artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal biochemistry finding --- r_associated #0: 20 --> phlébite n1=en:abnormal biochemistry finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal blood coagulation studies (prolonged pt and ptt) --- r_associated #0: 20 --> phlébite n1=en:abnormal blood coagulation studies (prolonged pt and ptt) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal cardiac laboratory result --- r_associated #0: 20 --> phlébite n1=en:abnormal cardiac laboratory result | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal cerebral vessels --- r_associated #0: 20 --> phlébite n1=en:abnormal cerebral vessels | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal cytologic finding in specimen from digestive organ and abdominal cavity --- r_associated #0: 20 --> phlébite n1=en:abnormal cytologic finding in specimen from digestive organ and abdominal cavity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal cytological finding in specimen from respiratory organ and thorax --- r_associated #0: 20 --> phlébite n1=en:abnormal cytological finding in specimen from respiratory organ and thorax | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal finding on cytological and histological examination of urine --- r_associated #0: 20 --> phlébite n1=en:abnormal finding on cytological and histological examination of urine | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal histological finding in specimen from digestive organ and abdominal cavity --- r_associated #0: 20 --> phlébite n1=en:abnormal histological finding in specimen from digestive organ and abdominal cavity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal histological finding in specimen from respiratory organ and thorax --- r_associated #0: 20 --> phlébite n1=en:abnormal histological finding in specimen from respiratory organ and thorax | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal immunological finding in specimen from digestive organ and abdominal cavity --- r_associated #0: 20 --> phlébite n1=en:abnormal immunological finding in specimen from digestive organ and abdominal cavity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal immunological finding in specimen from respiratory organ and thorax --- r_associated #0: 20 --> phlébite n1=en:abnormal immunological finding in specimen from respiratory organ and thorax | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal immunology finding --- r_associated #0: 20 --> phlébite n1=en:abnormal immunology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal laboratory test result --- r_associated #0: 20 --> phlébite n1=en:abnormal laboratory test result | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal microbiological finding in specimen from digestive organ and abdominal cavity --- r_associated #0: 20 --> phlébite n1=en:abnormal microbiological finding in specimen from digestive organ and abdominal cavity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal microbiological finding in specimen from respiratory organ and thorax --- r_associated #0: 20 --> phlébite n1=en:abnormal microbiological finding in specimen from respiratory organ and thorax | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal microbiology finding --- r_associated #0: 20 --> phlébite n1=en:abnormal microbiology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal platelet --- r_associated #0: 20 --> phlébite n1=en:abnormal platelet | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal platelet maturation --- r_associated #0: 20 --> phlébite n1=en:abnormal platelet maturation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal platelet morphology with paucity of granules (in some patients) --- r_associated #0: 20 --> phlébite n1=en:abnormal platelet morphology with paucity of granules (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal platelets with giant morphology --- r_associated #0: 20 --> phlébite n1=en:abnormal platelets with giant morphology | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal pulmonary venous return to right atria (in some patients) --- r_associated #0: 20 --> phlébite n1=en:abnormal pulmonary venous return to right atria (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal rbc morphology (anisocytosis, poikilocytes, acanthocytes) (in some patients) --- r_associated #0: 20 --> phlébite n1=en:abnormal rbc morphology (anisocytosis, poikilocytes, acanthocytes) (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormal retraction --- r_associated #0: 20 --> phlébite n1=en:abnormal retraction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormality of coagulation --- r_associated #0: 20 --> phlébite n1=en:abnormality of coagulation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormality of internal carotid artery --- r_associated #0: 20 --> phlébite n1=en:abnormality of internal carotid artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormality of red blood cells --- r_associated #0: 20 --> phlébite n1=en:abnormality of red blood cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormality of systemic vein --- r_associated #0: 20 --> phlébite n1=en:abnormality of systemic vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:abnormality of the vasculature --- r_associated #0: 20 --> phlébite n1=en:abnormality of the vasculature | n2=phlébite | rel=r_associated | relid=0 | w=20 en:absence (morphologic abnormality) --- r_associated #0: 20 --> phlébite n1=en:absence (morphologic abnormality) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:absence of hb h inclusions in red blood cells --- r_associated #0: 20 --> phlébite n1=en:absence of hb h inclusions in red blood cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:absence of lutheran antigen on red blood cells --- r_associated #0: 20 --> phlébite n1=en:absence of lutheran antigen on red blood cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:absence of platelet dense bodies --- r_associated #0: 20 --> phlébite n1=en:absence of platelet dense bodies | n2=phlébite | rel=r_associated | relid=0 | w=20 en:absent bone marrow myeloid elements --- r_associated #0: 20 --> phlébite n1=en:absent bone marrow myeloid elements | n2=phlébite | rel=r_associated | relid=0 | w=20 en:absent dense bodies in platelets --- r_associated #0: 20 --> phlébite n1=en:absent dense bodies in platelets | n2=phlébite | rel=r_associated | relid=0 | w=20 en:absent neutrophil inclusions --- r_associated #0: 20 --> phlébite n1=en:absent neutrophil inclusions | n2=phlébite | rel=r_associated | relid=0 | w=20 en:absent or hypoplastic megakaryocytes --- r_associated #0: 20 --> phlébite n1=en:absent or hypoplastic megakaryocytes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:absent platelet aggregation response to epinephrine --- r_associated #0: 20 --> phlébite n1=en:absent platelet aggregation response to epinephrine | n2=phlébite | rel=r_associated | relid=0 | w=20 en:absent platelet delta granules --- r_associated #0: 20 --> phlébite n1=en:absent platelet delta granules | n2=phlébite | rel=r_associated | relid=0 | w=20 en:acanthocyte --- r_associated #0: 20 --> phlébite n1=en:acanthocyte | n2=phlébite | rel=r_associated | relid=0 | w=20 en:acanthocytosis --- r_associated #0: 20 --> phlébite n1=en:acanthocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accelerated atherosclerosis --- r_associated #0: 20 --> phlébite n1=en:accelerated atherosclerosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accidental alternative medicine overdose --- r_associated #0: 20 --> phlébite n1=en:accidental alternative medicine overdose | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accidental alternative medicine poisoning --- r_associated #0: 20 --> phlébite n1=en:accidental alternative medicine poisoning | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accidental cut, puncture, perforation or hemorrhage during abdominal paracentesis --- r_associated #0: 20 --> phlébite n1=en:accidental cut, puncture, perforation or hemorrhage during abdominal paracentesis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accidental cut, puncture, perforation or hemorrhage during administration of enema --- r_associated #0: 20 --> phlébite n1=en:accidental cut, puncture, perforation or hemorrhage during administration of enema | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accidental cut, puncture, perforation or hemorrhage during aspirating needle biopsy --- r_associated #0: 20 --> phlébite n1=en:accidental cut, puncture, perforation or hemorrhage during aspirating needle biopsy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accidental cut, puncture, perforation or hemorrhage during blood sampling --- r_associated #0: 20 --> phlébite n1=en:accidental cut, puncture, perforation or hemorrhage during blood sampling | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accidental cut, puncture, perforation or hemorrhage during infusion --- r_associated #0: 20 --> phlébite n1=en:accidental cut, puncture, perforation or hemorrhage during infusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accidental cut, puncture, perforation or hemorrhage during infusion or transfusion --- r_associated #0: 20 --> phlébite n1=en:accidental cut, puncture, perforation or hemorrhage during infusion or transfusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accidental cut, puncture, perforation or hemorrhage during injection --- r_associated #0: 20 --> phlébite n1=en:accidental cut, puncture, perforation or hemorrhage during injection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accidental cut, puncture, perforation or hemorrhage during lumbar puncture --- r_associated #0: 20 --> phlébite n1=en:accidental cut, puncture, perforation or hemorrhage during lumbar puncture | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accidental cut, puncture, perforation or hemorrhage during medical care --- r_associated #0: 20 --> phlébite n1=en:accidental cut, puncture, perforation or hemorrhage during medical care | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accidental cut, puncture, perforation or hemorrhage during thoracentesis --- r_associated #0: 20 --> phlébite n1=en:accidental cut, puncture, perforation or hemorrhage during thoracentesis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accidental cut, puncture, perforation or hemorrhage during transfusion --- r_associated #0: 20 --> phlébite n1=en:accidental cut, puncture, perforation or hemorrhage during transfusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accidental cut, puncture, perforation or hemorrhage during vaccination --- r_associated #0: 20 --> phlébite n1=en:accidental cut, puncture, perforation or hemorrhage during vaccination | n2=phlébite | rel=r_associated | relid=0 | w=20 en:accidental wound during transfusion --- r_associated #0: 20 --> phlébite n1=en:accidental wound during transfusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:acquired --- r_associated #0: 20 --> phlébite n1=en:acquired | n2=phlébite | rel=r_associated | relid=0 | w=20 en:acquired abnormality of jugular vein --- r_associated #0: 20 --> phlébite n1=en:acquired abnormality of jugular vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:acquired abnormality of pulmonary venous structure --- r_associated #0: 20 --> phlébite n1=en:acquired abnormality of pulmonary venous structure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:acquired cardiovascular abnormality associated with atrioventricular septal defect --- r_associated #0: 20 --> phlébite n1=en:acquired cardiovascular abnormality associated with atrioventricular septal defect | n2=phlébite | rel=r_associated | relid=0 | w=20 en:acquired complement deficiency disease --- r_associated #0: 20 --> phlébite n1=en:acquired complement deficiency disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:acquired hemolytic anemia --- r_associated #0: 20 --> phlébite n1=en:acquired hemolytic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:acquired phlebectasia --- r_associated #0: 20 --> phlébite n1=en:acquired phlebectasia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:activities, functions and processes --- r_associated #0: 20 --> phlébite n1=en:activities, functions and processes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:acute deep venous thrombosis of internal jugular vein --- r_associated #0: 20 --> phlébite n1=en:acute deep venous thrombosis of internal jugular vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:acute disease of cardiovascular system --- r_associated #0: 20 --> phlébite n1=en:acute disease of cardiovascular system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:acute disease of hematopoietic system --- r_associated #0: 20 --> phlébite n1=en:acute disease of hematopoietic system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:acute hemolytic transfusion reaction when transfused with vel-positive blood --- r_associated #0: 20 --> phlébite n1=en:acute hemolytic transfusion reaction when transfused with vel-positive blood | n2=phlébite | rel=r_associated | relid=0 | w=20 en:acute hemorrhagic edema of infancy --- r_associated #0: 20 --> phlébite n1=en:acute hemorrhagic edema of infancy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:additional pain and sensation observations --- r_associated #0: 20 --> phlébite n1=en:additional pain and sensation observations | n2=phlébite | rel=r_associated | relid=0 | w=20 en:administration of treatment via specific route --- r_associated #0: 20 --> phlébite n1=en:administration of treatment via specific route | n2=phlébite | rel=r_associated | relid=0 | w=20 en:administration site phlebitis --- r_associated #0: 20 --> phlébite n1=en:administration site phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:administration site thrombosis --- r_associated #0: 20 --> phlébite n1=en:administration site thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:administration site vasculitis --- r_associated #0: 20 --> phlébite n1=en:administration site vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:administration, management --- r_associated #0: 20 --> phlébite n1=en:administration, management | n2=phlébite | rel=r_associated | relid=0 | w=20 en:administration, topical --- r_associated #0: 20 --> phlébite n1=en:administration, topical | n2=phlébite | rel=r_associated | relid=0 | w=20 en:administrative / management procedure --- r_associated #0: 20 --> phlébite n1=en:administrative / management procedure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:adrenal gland myelolipoma --- r_associated #0: 20 --> phlébite n1=en:adrenal gland myelolipoma | n2=phlébite | rel=r_associated | relid=0 | w=20 en:adverse cutaneous reaction to alternative medical therapy --- r_associated #0: 20 --> phlébite n1=en:adverse cutaneous reaction to alternative medical therapy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:adverse reaction to bases and inactive substances --- r_associated #0: 20 --> phlébite n1=en:adverse reaction to bases and inactive substances | n2=phlébite | rel=r_associated | relid=0 | w=20 en:adverse reaction to emollients, demulcents and protectants --- r_associated #0: 20 --> phlébite n1=en:adverse reaction to emollients, demulcents and protectants | n2=phlébite | rel=r_associated | relid=0 | w=20 en:adverse reaction to local astringents and local detergents --- r_associated #0: 20 --> phlébite n1=en:adverse reaction to local astringents and local detergents | n2=phlébite | rel=r_associated | relid=0 | w=20 en:adverse reaction to mixed bacterial vaccines, excluding combinations with a pertussis component --- r_associated #0: 20 --> phlébite n1=en:adverse reaction to mixed bacterial vaccines, excluding combinations with a pertussis component | n2=phlébite | rel=r_associated | relid=0 | w=20 en:adverse reaction to mixed viral-rickettsial and bacterial vaccines except combinations with a pertussis component --- r_associated #0: 20 --> phlébite n1=en:adverse reaction to mixed viral-rickettsial and bacterial vaccines except combinations with a pertussis component | n2=phlébite | rel=r_associated | relid=0 | w=20 en:adverse reaction to premedication --- r_associated #0: 20 --> phlébite n1=en:adverse reaction to premedication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:affected arteries have electron-dense granular material close to vascular smooth muscle cell membranes --- r_associated #0: 20 --> phlébite n1=en:affected arteries have electron-dense granular material close to vascular smooth muscle cell membranes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:affected arteries show loss of smooth muscle cells --- r_associated #0: 20 --> phlébite n1=en:affected arteries show loss of smooth muscle cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:agenesis of pulmonary artery --- r_associated #0: 20 --> phlébite n1=en:agenesis of pulmonary artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:agenesis of pulmonary vessels --- r_associated #0: 20 --> phlébite n1=en:agenesis of pulmonary vessels | n2=phlébite | rel=r_associated | relid=0 | w=20 en:air embolism --- r_associated #0: 20 --> phlébite n1=en:air embolism | n2=phlébite | rel=r_associated | relid=0 | w=20 en:allergy to bases and inactive substances --- r_associated #0: 20 --> phlébite n1=en:allergy to bases and inactive substances | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alpha polypeptide hemoglobin chain --- r_associated #0: 20 --> phlébite n1=en:alpha polypeptide hemoglobin chain | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alpha thalassemia --- r_associated #0: 20 --> phlébite n1=en:alpha thalassemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alpha-thalassemia silent carrier (3 normal genes) --- r_associated #0: 20 --> phlébite n1=en:alpha-thalassemia silent carrier (3 normal genes) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alpha-thalassemia with fatal hb bart's hydrops fetalis (no normal gene) --- r_associated #0: 20 --> phlébite n1=en:alpha-thalassemia with fatal hb bart's hydrops fetalis (no normal gene) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alpha-thalassemia with microcytosis (2 normal genes) --- r_associated #0: 20 --> phlébite n1=en:alpha-thalassemia with microcytosis (2 normal genes) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alpha-thalassemia with microcytosis and hemolysis, hb h disease (1 normal gene) --- r_associated #0: 20 --> phlébite n1=en:alpha-thalassemia with microcytosis and hemolysis, hb h disease (1 normal gene) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alternative arterial hierarchy --- r_associated #0: 20 --> phlébite n1=en:alternative arterial hierarchy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alternative medicine agent --- r_associated #0: 20 --> phlébite n1=en:alternative medicine agent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alternative medicine overdose --- r_associated #0: 20 --> phlébite n1=en:alternative medicine overdose | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alternative medicine overdose of undetermined intent --- r_associated #0: 20 --> phlébite n1=en:alternative medicine overdose of undetermined intent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alternative medicine poisoning --- r_associated #0: 20 --> phlébite n1=en:alternative medicine poisoning | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alternative medicine poisoning of undetermined intent --- r_associated #0: 20 --> phlébite n1=en:alternative medicine poisoning of undetermined intent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alternative medicine preparation --- r_associated #0: 20 --> phlébite n1=en:alternative medicine preparation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alternative medicines adverse reaction --- r_associated #0: 20 --> phlébite n1=en:alternative medicines adverse reaction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alternative medicines allergy --- r_associated #0: 20 --> phlébite n1=en:alternative medicines allergy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alveolar capillary dysplasia (acd) --- r_associated #0: 20 --> phlébite n1=en:alveolar capillary dysplasia (acd) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:alveolar capillary dysplasia (rare) --- r_associated #0: 20 --> phlébite n1=en:alveolar capillary dysplasia (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:amegakaryocytic thrombocytopenia --- r_associated #0: 20 --> phlébite n1=en:amegakaryocytic thrombocytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:amelioration of ss disease (e.g. hb memphis 141800.0096) --- r_associated #0: 20 --> phlébite n1=en:amelioration of ss disease (e.g. hb memphis 141800.0096) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:amemia --- r_associated #0: 20 --> phlébite n1=en:amemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:amphixenosis --- r_associated #0: 20 --> phlébite n1=en:amphixenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:analgesics and non-steroidal anti-inflammatory drug allergy --- r_associated #0: 20 --> phlébite n1=en:analgesics and non-steroidal anti-inflammatory drug allergy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia --- r_associated #0: 20 --> phlébite n1=en:anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia (associated with mutation in the cox10 gene) --- r_associated #0: 20 --> phlébite n1=en:anemia (associated with mutation in the cox10 gene) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia (in some patients) --- r_associated #0: 20 --> phlébite n1=en:anemia (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia (in some) --- r_associated #0: 20 --> phlébite n1=en:anemia (in some) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia (less common) --- r_associated #0: 20 --> phlébite n1=en:anemia (less common) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia (not responsive to pyridoxine supplementation) --- r_associated #0: 20 --> phlébite n1=en:anemia (not responsive to pyridoxine supplementation) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia (rare) --- r_associated #0: 20 --> phlébite n1=en:anemia (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia (with bone marrow involvement) --- r_associated #0: 20 --> phlébite n1=en:anemia (with bone marrow involvement) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia due to poor nutrition --- r_associated #0: 20 --> phlébite n1=en:anemia due to poor nutrition | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia may be exacerbated during infection or pregnancy --- r_associated #0: 20 --> phlébite n1=en:anemia may be exacerbated during infection or pregnancy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia requiring transfusions --- r_associated #0: 20 --> phlébite n1=en:anemia requiring transfusions | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia, congenital hypoplastic, moderate-severe (normochromic, macrocytic) --- r_associated #0: 20 --> phlébite n1=en:anemia, congenital hypoplastic, moderate-severe (normochromic, macrocytic) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia, corticosteroid-sensitive --- r_associated #0: 20 --> phlébite n1=en:anemia, corticosteroid-sensitive | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia, dyserythropoietic (in some patients) --- r_associated #0: 20 --> phlébite n1=en:anemia, dyserythropoietic (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia, hemolytic, congenital nonspherocytic --- r_associated #0: 20 --> phlébite n1=en:anemia, hemolytic, congenital nonspherocytic | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia, mild (in some patients) --- r_associated #0: 20 --> phlébite n1=en:anemia, mild (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia, severe --- r_associated #0: 20 --> phlébite n1=en:anemia, severe | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anemia, unresponsive to oral iron and only partially responsive to parenteral iron --- r_associated #0: 20 --> phlébite n1=en:anemia, unresponsive to oral iron and only partially responsive to parenteral iron | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anesthesia type --- r_associated #0: 20 --> phlébite n1=en:anesthesia type | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aneurysm --- r_associated #0: 20 --> phlébite n1=en:aneurysm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aneurysm of aortic root --- r_associated #0: 20 --> phlébite n1=en:aneurysm of aortic root | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aneurysm of ascending aorta --- r_associated #0: 20 --> phlébite n1=en:aneurysm of ascending aorta | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aneurysm of other aortic segments rare --- r_associated #0: 20 --> phlébite n1=en:aneurysm of other aortic segments rare | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aneurysm of popliteal artery --- r_associated #0: 20 --> phlébite n1=en:aneurysm of popliteal artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aneurysm of right middle cerebral artery, horizontal segment --- r_associated #0: 20 --> phlébite n1=en:aneurysm of right middle cerebral artery, horizontal segment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aneurysm of vein --- r_associated #0: 20 --> phlébite n1=en:aneurysm of vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aneurysm perforation --- r_associated #0: 20 --> phlébite n1=en:aneurysm perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aneurysm recanalisation --- r_associated #0: 20 --> phlébite n1=en:aneurysm recanalisation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aneurysm, descending aorta (in some patients) --- r_associated #0: 20 --> phlébite n1=en:aneurysm, descending aorta (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aneurysms (internal carotid artery, cerebral artery, subclavian) --- r_associated #0: 20 --> phlébite n1=en:aneurysms (internal carotid artery, cerebral artery, subclavian) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aneurysms of right internal carotid artery, intracranial segment --- r_associated #0: 20 --> phlébite n1=en:aneurysms of right internal carotid artery, intracranial segment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:angiitis, cerebral --- r_associated #0: 20 --> phlébite n1=en:angiitis, cerebral | n2=phlébite | rel=r_associated | relid=0 | w=20 en:angina --- r_associated #0: 20 --> phlébite n1=en:angina | n2=phlébite | rel=r_associated | relid=0 | w=20 en:angitis kidney --- r_associated #0: 20 --> phlébite n1=en:angitis kidney | n2=phlébite | rel=r_associated | relid=0 | w=20 en:animal transmitted infectious disease --- r_associated #0: 20 --> phlébite n1=en:animal transmitted infectious disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aniso-poikilocytosis on blood smear --- r_associated #0: 20 --> phlébite n1=en:aniso-poikilocytosis on blood smear | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anisocytosis --- r_associated #0: 20 --> phlébite n1=en:anisocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anisopoikilocytosis --- r_associated #0: 20 --> phlébite n1=en:anisopoikilocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ankylosis or instability of cervical, thoracic or lumbar spine --- r_associated #0: 20 --> phlébite n1=en:ankylosis or instability of cervical, thoracic or lumbar spine | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anomalous branches of internal carotid artery --- r_associated #0: 20 --> phlébite n1=en:anomalous branches of internal carotid artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anomalous pulmonary drainage --- r_associated #0: 20 --> phlébite n1=en:anomalous pulmonary drainage | n2=phlébite | rel=r_associated | relid=0 | w=20 en:antemortem thrombus --- r_associated #0: 20 --> phlébite n1=en:antemortem thrombus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:antenatal blood group screening status --- r_associated #0: 20 --> phlébite n1=en:antenatal blood group screening status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:antenatal sickle cell screening categorized by action status --- r_associated #0: 20 --> phlébite n1=en:antenatal sickle cell screening categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:antenatal syphilis screening categorized by action status --- r_associated #0: 20 --> phlébite n1=en:antenatal syphilis screening categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anterior spinal artery thrombosis --- r_associated #0: 20 --> phlébite n1=en:anterior spinal artery thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anteversion --- r_associated #0: 20 --> phlébite n1=en:anteversion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anthroposophical agent --- r_associated #0: 20 --> phlébite n1=en:anthroposophical agent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anthroposophical medicine (product) --- r_associated #0: 20 --> phlébite n1=en:anthroposophical medicine (product) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anthroposophical medicine (regime/therapy) --- r_associated #0: 20 --> phlébite n1=en:anthroposophical medicine (regime/therapy) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anthroposophical medicine adverse reaction --- r_associated #0: 20 --> phlébite n1=en:anthroposophical medicine adverse reaction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anthroposophical medicine allergy --- r_associated #0: 20 --> phlébite n1=en:anthroposophical medicine allergy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anthropozoonosis --- r_associated #0: 20 --> phlébite n1=en:anthropozoonosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:anti-neutrophil cytoplasmic antibody positive vasculitis --- r_associated #0: 20 --> phlébite n1=en:anti-neutrophil cytoplasmic antibody positive vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:antineoplastic/immunosuppressant/immunostim adverse reaction --- r_associated #0: 20 --> phlébite n1=en:antineoplastic/immunosuppressant/immunostim adverse reaction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:antineoplastic/immunosuppressant/immunostimulant allergy --- r_associated #0: 20 --> phlébite n1=en:antineoplastic/immunosuppressant/immunostimulant allergy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:antineoplastic/immunosuppressant/immunostimulant overdose --- r_associated #0: 20 --> phlébite n1=en:antineoplastic/immunosuppressant/immunostimulant overdose | n2=phlébite | rel=r_associated | relid=0 | w=20 en:antineoplastic/immunosuppressant/immunostimulant poisoning --- r_associated #0: 20 --> phlébite n1=en:antineoplastic/immunosuppressant/immunostimulant poisoning | n2=phlébite | rel=r_associated | relid=0 | w=20 en:antiphospholipid syndrome --- r_associated #0: 20 --> phlébite n1=en:antiphospholipid syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:antiphospholipid syndrome hemolytic anemia --- r_associated #0: 20 --> phlébite n1=en:antiphospholipid syndrome hemolytic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:antithrombin iii decreased --- r_associated #0: 20 --> phlébite n1=en:antithrombin iii decreased | n2=phlébite | rel=r_associated | relid=0 | w=20 en:antithrombin iii deficiency --- r_associated #0: 20 --> phlébite n1=en:antithrombin iii deficiency | n2=phlébite | rel=r_associated | relid=0 | w=20 en:antithrombin iii deficiency (in 1 patient) --- r_associated #0: 20 --> phlébite n1=en:antithrombin iii deficiency (in 1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aorta --- r_associated #0: 20 --> phlébite n1=en:aorta | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aorta arises from right ventricle --- r_associated #0: 20 --> phlébite n1=en:aorta arises from right ventricle | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic aneurysm --- r_associated #0: 20 --> phlébite n1=en:aortic aneurysm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic aneurysms (ascending or aortic arch) --- r_associated #0: 20 --> phlébite n1=en:aortic aneurysms (ascending or aortic arch) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic arch calcification --- r_associated #0: 20 --> phlébite n1=en:aortic arch calcification | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic arch syndrome --- r_associated #0: 20 --> phlébite n1=en:aortic arch syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic coarctation --- r_associated #0: 20 --> phlébite n1=en:aortic coarctation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic coarctation (1 patient) --- r_associated #0: 20 --> phlébite n1=en:aortic coarctation (1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic coarctation (in some patients) --- r_associated #0: 20 --> phlébite n1=en:aortic coarctation (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic coarctation (rare) --- r_associated #0: 20 --> phlébite n1=en:aortic coarctation (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic dilatation (1 family) --- r_associated #0: 20 --> phlébite n1=en:aortic dilatation (1 family) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic dissection --- r_associated #0: 20 --> phlébite n1=en:aortic dissection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic embolism and thrombosis --- r_associated #0: 20 --> phlébite n1=en:aortic embolism and thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic isthmus stenosis (in some patients) --- r_associated #0: 20 --> phlébite n1=en:aortic isthmus stenosis (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic perforation --- r_associated #0: 20 --> phlébite n1=en:aortic perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic restenosis --- r_associated #0: 20 --> phlébite n1=en:aortic restenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic root dilatation --- r_associated #0: 20 --> phlébite n1=en:aortic root dilatation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic root dilation --- r_associated #0: 20 --> phlébite n1=en:aortic root dilation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic rupture (rare) --- r_associated #0: 20 --> phlébite n1=en:aortic rupture (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic segment --- r_associated #0: 20 --> phlébite n1=en:aortic segment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortic valve stenosis --- r_associated #0: 20 --> phlébite n1=en:aortic valve stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortitis --- r_associated #0: 20 --> phlébite n1=en:aortitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aortitis salmonella --- r_associated #0: 20 --> phlébite n1=en:aortitis salmonella | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aplastic anemia --- r_associated #0: 20 --> phlébite n1=en:aplastic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aplastic anemia (in some patients) --- r_associated #0: 20 --> phlébite n1=en:aplastic anemia (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aplastic anemia and other bone marrow failure syndromes --- r_associated #0: 20 --> phlébite n1=en:aplastic anemia and other bone marrow failure syndromes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:application site phlebitis --- r_associated #0: 20 --> phlébite n1=en:application site phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:application site thrombosis --- r_associated #0: 20 --> phlébite n1=en:application site thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:application site vasculitis --- r_associated #0: 20 --> phlébite n1=en:application site vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arbovirus --- r_associated #0: 20 --> phlébite n1=en:arbovirus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:architectural distortion --- r_associated #0: 20 --> phlébite n1=en:architectural distortion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arrhythmia --- r_associated #0: 20 --> phlébite n1=en:arrhythmia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial aneurysm --- r_associated #0: 20 --> phlébite n1=en:arterial aneurysm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial aneurysm of celiac and mesenteric vessels --- r_associated #0: 20 --> phlébite n1=en:arterial aneurysm of celiac and mesenteric vessels | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial aneurysms, multiple --- r_associated #0: 20 --> phlébite n1=en:arterial aneurysms, multiple | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial bypass occlusion --- r_associated #0: 20 --> phlébite n1=en:arterial bypass occlusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial bypass stenosis --- r_associated #0: 20 --> phlébite n1=en:arterial bypass stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial bypass thrombosis --- r_associated #0: 20 --> phlébite n1=en:arterial bypass thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial disorder --- r_associated #0: 20 --> phlébite n1=en:arterial disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial embolus --- r_associated #0: 20 --> phlébite n1=en:arterial embolus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial embolus and thrombosis --- r_associated #0: 20 --> phlébite n1=en:arterial embolus and thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial graft thrombosis --- r_associated #0: 20 --> phlébite n1=en:arterial graft thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial hypertension (in 1 patient) --- r_associated #0: 20 --> phlébite n1=en:arterial hypertension (in 1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial intramural haematoma --- r_associated #0: 20 --> phlébite n1=en:arterial intramural haematoma | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial occlusion --- r_associated #0: 20 --> phlébite n1=en:arterial occlusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial occlusion rare --- r_associated #0: 20 --> phlébite n1=en:arterial occlusion rare | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial perforation --- r_associated #0: 20 --> phlébite n1=en:arterial perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial restenosis --- r_associated #0: 20 --> phlébite n1=en:arterial restenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial segment --- r_associated #0: 20 --> phlébite n1=en:arterial segment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial steal syndrome --- r_associated #0: 20 --> phlébite n1=en:arterial steal syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial stenoses, multiple --- r_associated #0: 20 --> phlébite n1=en:arterial stenoses, multiple | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial stenosis due to myointimal proliferation --- r_associated #0: 20 --> phlébite n1=en:arterial stenosis due to myointimal proliferation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial thrombosis --- r_associated #0: 20 --> phlébite n1=en:arterial thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial thrombosis of spinal cord --- r_associated #0: 20 --> phlébite n1=en:arterial thrombosis of spinal cord | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial thrombosis related to vascular access complication --- r_associated #0: 20 --> phlébite n1=en:arterial thrombosis related to vascular access complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial tortuosity --- r_associated #0: 20 --> phlébite n1=en:arterial tortuosity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial tortuosity (large and medium-sized arteries including aorta) --- r_associated #0: 20 --> phlébite n1=en:arterial tortuosity (large and medium-sized arteries including aorta) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial tortuosity, generalized --- r_associated #0: 20 --> phlébite n1=en:arterial tortuosity, generalized | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial vascular wall remodeling --- r_associated #0: 20 --> phlébite n1=en:arterial vascular wall remodeling | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial vessel disorders --- r_associated #0: 20 --> phlébite n1=en:arterial vessel disorders | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial vessels show disruption of the elastic fibers of the tunica media --- r_associated #0: 20 --> phlébite n1=en:arterial vessels show disruption of the elastic fibers of the tunica media | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterial vessels show fragmentation of the internal elastic membrane --- r_associated #0: 20 --> phlébite n1=en:arterial vessels show fragmentation of the internal elastic membrane | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteries show intimal fibrosis --- r_associated #0: 20 --> phlébite n1=en:arteries show intimal fibrosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteries show medial hypertrophy --- r_associated #0: 20 --> phlébite n1=en:arteries show medial hypertrophy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arterioenteric fistula --- r_associated #0: 20 --> phlébite n1=en:arterioenteric fistula | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriole --- r_associated #0: 20 --> phlébite n1=en:arteriole | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriomegaly, diffuse, secondary to femoropopliteal occlusion --- r_associated #0: 20 --> phlébite n1=en:arteriomegaly, diffuse, secondary to femoropopliteal occlusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriosclerosis --- r_associated #0: 20 --> phlébite n1=en:arteriosclerosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriospasm --- r_associated #0: 20 --> phlébite n1=en:arteriospasm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriovenous fistula --- r_associated #0: 20 --> phlébite n1=en:arteriovenous fistula | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriovenous fistula occlusion --- r_associated #0: 20 --> phlébite n1=en:arteriovenous fistula occlusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriovenous fistula site complication --- r_associated #0: 20 --> phlébite n1=en:arteriovenous fistula site complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriovenous fistula site haematoma --- r_associated #0: 20 --> phlébite n1=en:arteriovenous fistula site haematoma | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriovenous fistula site haemorrhage --- r_associated #0: 20 --> phlébite n1=en:arteriovenous fistula site haemorrhage | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriovenous fistula site infection --- r_associated #0: 20 --> phlébite n1=en:arteriovenous fistula site infection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriovenous fistulas of celiac and mesenteric vessels --- r_associated #0: 20 --> phlébite n1=en:arteriovenous fistulas of celiac and mesenteric vessels | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriovenous graft site abscess --- r_associated #0: 20 --> phlébite n1=en:arteriovenous graft site abscess | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriovenous graft site haematoma --- r_associated #0: 20 --> phlébite n1=en:arteriovenous graft site haematoma | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriovenous graft site haemorrhage --- r_associated #0: 20 --> phlébite n1=en:arteriovenous graft site haemorrhage | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriovenous graft site infection --- r_associated #0: 20 --> phlébite n1=en:arteriovenous graft site infection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriovenous hemangioma --- r_associated #0: 20 --> phlébite n1=en:arteriovenous hemangioma | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriovenous malformation (cerebral, spinal, pulmonary, liver) --- r_associated #0: 20 --> phlébite n1=en:arteriovenous malformation (cerebral, spinal, pulmonary, liver) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arteriovenous shunt --- r_associated #0: 20 --> phlébite n1=en:arteriovenous shunt | n2=phlébite | rel=r_associated | relid=0 | w=20 en:artery --- r_associated #0: 20 --> phlébite n1=en:artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arthrocentesis and injection of intermediate joint --- r_associated #0: 20 --> phlébite n1=en:arthrocentesis and injection of intermediate joint | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arthrocentesis of intermediate joint --- r_associated #0: 20 --> phlébite n1=en:arthrocentesis of intermediate joint | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arthropathies and related disorders --- r_associated #0: 20 --> phlébite n1=en:arthropathies and related disorders | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arthropod-borne infectious disease --- r_associated #0: 20 --> phlébite n1=en:arthropod-borne infectious disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:arthropod-borne organism --- r_associated #0: 20 --> phlébite n1=en:arthropod-borne organism | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ascending aorta dilatation --- r_associated #0: 20 --> phlébite n1=en:ascending aorta dilatation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ascending aortic dissection --- r_associated #0: 20 --> phlébite n1=en:ascending aortic dissection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aspects of mortality statistics --- r_associated #0: 20 --> phlébite n1=en:aspects of mortality statistics | n2=phlébite | rel=r_associated | relid=0 | w=20 en:aspects of radionuclide imaging --- r_associated #0: 20 --> phlébite n1=en:aspects of radionuclide imaging | n2=phlébite | rel=r_associated | relid=0 | w=20 en:assessment scales aa-az --- r_associated #0: 20 --> phlébite n1=en:assessment scales aa-az | n2=phlébite | rel=r_associated | relid=0 | w=20 en:assessment scales ba-bz --- r_associated #0: 20 --> phlébite n1=en:assessment scales ba-bz | n2=phlébite | rel=r_associated | relid=0 | w=20 en:assessment scales ca-de --- r_associated #0: 20 --> phlébite n1=en:assessment scales ca-de | n2=phlébite | rel=r_associated | relid=0 | w=20 en:assessment scales di-ga --- r_associated #0: 20 --> phlébite n1=en:assessment scales di-ga | n2=phlébite | rel=r_associated | relid=0 | w=20 en:assessment scales ge-iz --- r_associated #0: 20 --> phlébite n1=en:assessment scales ge-iz | n2=phlébite | rel=r_associated | relid=0 | w=20 en:assessment scales ja-me --- r_associated #0: 20 --> phlébite n1=en:assessment scales ja-me | n2=phlébite | rel=r_associated | relid=0 | w=20 en:assessment scales mi-oz --- r_associated #0: 20 --> phlébite n1=en:assessment scales mi-oz | n2=phlébite | rel=r_associated | relid=0 | w=20 en:assessment scales pa-ra --- r_associated #0: 20 --> phlébite n1=en:assessment scales pa-ra | n2=phlébite | rel=r_associated | relid=0 | w=20 en:assessment scales re-sc --- r_associated #0: 20 --> phlébite n1=en:assessment scales re-sc | n2=phlébite | rel=r_associated | relid=0 | w=20 en:assessment scales se-su --- r_associated #0: 20 --> phlébite n1=en:assessment scales se-su | n2=phlébite | rel=r_associated | relid=0 | w=20 en:assessment scales sw-va --- r_associated #0: 20 --> phlébite n1=en:assessment scales sw-va | n2=phlébite | rel=r_associated | relid=0 | w=20 en:assessment scales ve-zu --- r_associated #0: 20 --> phlébite n1=en:assessment scales ve-zu | n2=phlébite | rel=r_associated | relid=0 | w=20 en:associated with iron deficiency anemia --- r_associated #0: 20 --> phlébite n1=en:associated with iron deficiency anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:asymptomatic (easy bruisability, postoperative hemorrhage) --- r_associated #0: 20 --> phlébite n1=en:asymptomatic (easy bruisability, postoperative hemorrhage) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:asymptomatic bleeding tendencies (petechiae, epistaxis, mucosal bleeding) --- r_associated #0: 20 --> phlébite n1=en:asymptomatic bleeding tendencies (petechiae, epistaxis, mucosal bleeding) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:asymptomatic to mild bleeding episodes (epistaxis, postoperative hemorrhage) --- r_associated #0: 20 --> phlébite n1=en:asymptomatic to mild bleeding episodes (epistaxis, postoperative hemorrhage) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:atherosclerosis --- r_associated #0: 20 --> phlébite n1=en:atherosclerosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:atherosclerotic plaque disruption with thrombosis of artery --- r_associated #0: 20 --> phlébite n1=en:atherosclerotic plaque disruption with thrombosis of artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:atherothrombosis --- r_associated #0: 20 --> phlébite n1=en:atherothrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:atrio-oesophageal fistula --- r_associated #0: 20 --> phlébite n1=en:atrio-oesophageal fistula | n2=phlébite | rel=r_associated | relid=0 | w=20 en:atypical lymphocytosis --- r_associated #0: 20 --> phlébite n1=en:atypical lymphocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:atypical mycobacteria species a-m --- r_associated #0: 20 --> phlébite n1=en:atypical mycobacteria species a-m | n2=phlébite | rel=r_associated | relid=0 | w=20 en:atypical mycobacteria species n-z --- r_associated #0: 20 --> phlébite n1=en:atypical mycobacteria species n-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:autoimmune cytopenia --- r_associated #0: 20 --> phlébite n1=en:autoimmune cytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:autoimmune hemolytic anemia --- r_associated #0: 20 --> phlébite n1=en:autoimmune hemolytic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:autoimmune hemolytic anemia (in some patients) --- r_associated #0: 20 --> phlébite n1=en:autoimmune hemolytic anemia (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:autoimmune neutropenia --- r_associated #0: 20 --> phlébite n1=en:autoimmune neutropenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:autoimmune vasculitis --- r_associated #0: 20 --> phlébite n1=en:autoimmune vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:av fistula aneurysm --- r_associated #0: 20 --> phlébite n1=en:av fistula aneurysm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:av fistula maturation failure --- r_associated #0: 20 --> phlébite n1=en:av fistula maturation failure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:av fistula stenosis --- r_associated #0: 20 --> phlébite n1=en:av fistula stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:av fistula thrombosis --- r_associated #0: 20 --> phlébite n1=en:av fistula thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:av graft aneurysm --- r_associated #0: 20 --> phlébite n1=en:av graft aneurysm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:av graft stenosis --- r_associated #0: 20 --> phlébite n1=en:av graft stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:av graft thrombosis --- r_associated #0: 20 --> phlébite n1=en:av graft thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:avian schistosome --- r_associated #0: 20 --> phlébite n1=en:avian schistosome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:azygous connection --- r_associated #0: 20 --> phlébite n1=en:azygous connection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:barrier preparation adverse reaction --- r_associated #0: 20 --> phlébite n1=en:barrier preparation adverse reaction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:barrier preparation allergy --- r_associated #0: 20 --> phlébite n1=en:barrier preparation allergy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:basilar artery perforation --- r_associated #0: 20 --> phlébite n1=en:basilar artery perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:basophilic stippling --- r_associated #0: 20 --> phlébite n1=en:basophilic stippling | n2=phlébite | rel=r_associated | relid=0 | w=20 en:behcet syndrome --- r_associated #0: 20 --> phlébite n1=en:behcet syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:benign breast condition --- r_associated #0: 20 --> phlébite n1=en:benign breast condition | n2=phlébite | rel=r_associated | relid=0 | w=20 en:benign neutropenia --- r_associated #0: 20 --> phlébite n1=en:benign neutropenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:benign tumor of mesothelial and soft tissue --- r_associated #0: 20 --> phlébite n1=en:benign tumor of mesothelial and soft tissue | n2=phlébite | rel=r_associated | relid=0 | w=20 en:benign tumor of oral cavity, lips, salivary glands --- r_associated #0: 20 --> phlébite n1=en:benign tumor of oral cavity, lips, salivary glands | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bilateral stenoses of the terminal internal carotid artery --- r_associated #0: 20 --> phlébite n1=en:bilateral stenoses of the terminal internal carotid artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:biochemical finding --- r_associated #0: 20 --> phlébite n1=en:biochemical finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:biochemistry interpretation --- r_associated #0: 20 --> phlébite n1=en:biochemistry interpretation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:birth trauma, asphyxia and hypoxia --- r_associated #0: 20 --> phlébite n1=en:birth trauma, asphyxia and hypoxia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bleeding associated with peptic ulcer disease --- r_associated #0: 20 --> phlébite n1=en:bleeding associated with peptic ulcer disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bleeding defect due to decreased plasminogen activator inhibitor-1 --- r_associated #0: 20 --> phlébite n1=en:bleeding defect due to decreased plasminogen activator inhibitor-1 | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bleeding diathesis --- r_associated #0: 20 --> phlébite n1=en:bleeding diathesis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bleeding due to vitamin k deficiency (1 patient) --- r_associated #0: 20 --> phlébite n1=en:bleeding due to vitamin k deficiency (1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bleeding episodes --- r_associated #0: 20 --> phlébite n1=en:bleeding episodes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bleeding episodes (epistaxis, menorrhagia, ecchymosis) --- r_associated #0: 20 --> phlébite n1=en:bleeding episodes (epistaxis, menorrhagia, ecchymosis) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bleeding tendency (e.g., epistaxis) --- r_associated #0: 20 --> phlébite n1=en:bleeding tendency (e.g., epistaxis) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bleeding tendency due to defect in prothrombin and inability to form fibrin clot --- r_associated #0: 20 --> phlébite n1=en:bleeding tendency due to defect in prothrombin and inability to form fibrin clot | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bleeding tendency due to platelet defect --- r_associated #0: 20 --> phlébite n1=en:bleeding tendency due to platelet defect | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bleeding tendency, mild --- r_associated #0: 20 --> phlébite n1=en:bleeding tendency, mild | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bleeding tendency, mild, mucocutaneous --- r_associated #0: 20 --> phlébite n1=en:bleeding tendency, mild, mucocutaneous | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bleeding time normal to mildly prolonged --- r_associated #0: 20 --> phlébite n1=en:bleeding time normal to mildly prolonged | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bleeding, mild --- r_associated #0: 20 --> phlébite n1=en:bleeding, mild | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood and tissue coccidia --- r_associated #0: 20 --> phlébite n1=en:blood and tissue coccidia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood and tissue flagellate --- r_associated #0: 20 --> phlébite n1=en:blood and tissue flagellate | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood and tissue microsporidian --- r_associated #0: 20 --> phlébite n1=en:blood and tissue microsporidian | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood and tissue protozoan --- r_associated #0: 20 --> phlébite n1=en:blood and tissue protozoan | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood capillary --- r_associated #0: 20 --> phlébite n1=en:blood capillary | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood coagulation --- r_associated #0: 20 --> phlébite n1=en:blood coagulation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood group incompatibility --- r_associated #0: 20 --> phlébite n1=en:blood group incompatibility | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood platelet disorders --- r_associated #0: 20 --> phlébite n1=en:blood platelet disorders | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood procedure and/or transfusion --- r_associated #0: 20 --> phlébite n1=en:blood procedure and/or transfusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood product reservation, release, transfusion or disposition --- r_associated #0: 20 --> phlébite n1=en:blood product reservation, release, transfusion or disposition | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood protein disorders --- r_associated #0: 20 --> phlébite n1=en:blood protein disorders | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood sporozoan --- r_associated #0: 20 --> phlébite n1=en:blood sporozoan | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood vessel --- r_associated #0: 20 --> phlébite n1=en:blood vessel | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood vessel occlusion --- r_associated #0: 20 --> phlébite n1=en:blood vessel occlusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood vessel of peritoneal cavity --- r_associated #0: 20 --> phlébite n1=en:blood vessel of peritoneal cavity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood vessel part --- r_associated #0: 20 --> phlébite n1=en:blood vessel part | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood vessel perforation --- r_associated #0: 20 --> phlébite n1=en:blood vessel perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood vessel structure of skin --- r_associated #0: 20 --> phlébite n1=en:blood vessel structure of skin | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood vessel viewed microscopically --- r_associated #0: 20 --> phlébite n1=en:blood vessel viewed microscopically | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blood/lymphatic neoplasm --- r_associated #0: 20 --> phlébite n1=en:blood/lymphatic neoplasm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:blue toe syndrome --- r_associated #0: 20 --> phlébite n1=en:blue toe syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bombay (hh) blood phenotype --- r_associated #0: 20 --> phlébite n1=en:bombay (hh) blood phenotype | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow aspirate shows normal cellularity and reticular fibrosis --- r_associated #0: 20 --> phlébite n1=en:bone marrow aspirate shows normal cellularity and reticular fibrosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow biopsy shows erythrocyte hypocellularity --- r_associated #0: 20 --> phlébite n1=en:bone marrow biopsy shows erythrocyte hypocellularity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow biopsy shows erythroid hyperplasia --- r_associated #0: 20 --> phlébite n1=en:bone marrow biopsy shows erythroid hyperplasia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow biopsy shows increased eosinophils without myeloblasts --- r_associated #0: 20 --> phlébite n1=en:bone marrow biopsy shows increased eosinophils without myeloblasts | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow biopsy shows increased numbers of normal to small megakaryocytes --- r_associated #0: 20 --> phlébite n1=en:bone marrow biopsy shows increased numbers of normal to small megakaryocytes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow biopsy shows megaloblastic erythroblasts --- r_associated #0: 20 --> phlébite n1=en:bone marrow biopsy shows megaloblastic erythroblasts | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow biopsy shows megaloblastic erythroid hyperplasia --- r_associated #0: 20 --> phlébite n1=en:bone marrow biopsy shows megaloblastic erythroid hyperplasia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow contains lipid-laden macrophages --- r_associated #0: 20 --> phlébite n1=en:bone marrow contains lipid-laden macrophages | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow disorder --- r_associated #0: 20 --> phlébite n1=en:bone marrow disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow failure --- r_associated #0: 20 --> phlébite n1=en:bone marrow failure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow failure (1 patient) --- r_associated #0: 20 --> phlébite n1=en:bone marrow failure (1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow failure (classic feature, nola3 patient) --- r_associated #0: 20 --> phlébite n1=en:bone marrow failure (classic feature, nola3 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow failure (in some patients) --- r_associated #0: 20 --> phlébite n1=en:bone marrow failure (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow fibrosis --- r_associated #0: 20 --> phlébite n1=en:bone marrow fibrosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow foam cells (type ii) --- r_associated #0: 20 --> phlébite n1=en:bone marrow foam cells (type ii) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow granulomas --- r_associated #0: 20 --> phlébite n1=en:bone marrow granulomas | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow haemorrhage --- r_associated #0: 20 --> phlébite n1=en:bone marrow haemorrhage | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow hypercellularity --- r_associated #0: 20 --> phlébite n1=en:bone marrow hypercellularity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow hypocellularity --- r_associated #0: 20 --> phlébite n1=en:bone marrow hypocellularity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow infiltration --- r_associated #0: 20 --> phlébite n1=en:bone marrow infiltration | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow involvement may cause pancytopenia --- r_associated #0: 20 --> phlébite n1=en:bone marrow involvement may cause pancytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow ischemia --- r_associated #0: 20 --> phlébite n1=en:bone marrow ischemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow may show hemophagocytosis --- r_associated #0: 20 --> phlébite n1=en:bone marrow may show hemophagocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow megaloblastic (finding) --- r_associated #0: 20 --> phlébite n1=en:bone marrow megaloblastic (finding) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow necrosis --- r_associated #0: 20 --> phlébite n1=en:bone marrow necrosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow oedema --- r_associated #0: 20 --> phlébite n1=en:bone marrow oedema | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow oedema syndrome --- r_associated #0: 20 --> phlébite n1=en:bone marrow oedema syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow shows abnormal development of neutrophils --- r_associated #0: 20 --> phlébite n1=en:bone marrow shows abnormal development of neutrophils | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow shows gaucher cells --- r_associated #0: 20 --> phlébite n1=en:bone marrow shows gaucher cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow shows increased numbers of abnormal megakaryocytes --- r_associated #0: 20 --> phlébite n1=en:bone marrow shows increased numbers of abnormal megakaryocytes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow smear shows erythroid hyperplasia --- r_associated #0: 20 --> phlébite n1=en:bone marrow smear shows erythroid hyperplasia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone marrow transplant rejection --- r_associated #0: 20 --> phlébite n1=en:bone marrow transplant rejection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:bone-marrow foam cells --- r_associated #0: 20 --> phlébite n1=en:bone-marrow foam cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:borderline biochemistry finding --- r_associated #0: 20 --> phlébite n1=en:borderline biochemistry finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:borderline hematology finding --- r_associated #0: 20 --> phlébite n1=en:borderline hematology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:borderline histology finding --- r_associated #0: 20 --> phlébite n1=en:borderline histology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:borderline laboratory finding --- r_associated #0: 20 --> phlébite n1=en:borderline laboratory finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:borderline microbiology finding --- r_associated #0: 20 --> phlébite n1=en:borderline microbiology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:brachiocephalic vein occlusion --- r_associated #0: 20 --> phlébite n1=en:brachiocephalic vein occlusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:brachiocephalic vein stenosis --- r_associated #0: 20 --> phlébite n1=en:brachiocephalic vein stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:brachiocephalic vein thrombosis --- r_associated #0: 20 --> phlébite n1=en:brachiocephalic vein thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:buccal administration of treatment --- r_associated #0: 20 --> phlébite n1=en:buccal administration of treatment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:budd-chiari syndrome --- r_associated #0: 20 --> phlébite n1=en:budd-chiari syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:buerger disease --- r_associated #0: 20 --> phlébite n1=en:buerger disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:burr cell --- r_associated #0: 20 --> phlébite n1=en:burr cell | n2=phlébite | rel=r_associated | relid=0 | w=20 en:calcification of the aorta --- r_associated #0: 20 --> phlébite n1=en:calcification of the aorta | n2=phlébite | rel=r_associated | relid=0 | w=20 en:calcium embolism --- r_associated #0: 20 --> phlébite n1=en:calcium embolism | n2=phlébite | rel=r_associated | relid=0 | w=20 en:calcium/bismuth antacids a-z --- r_associated #0: 20 --> phlébite n1=en:calcium/bismuth antacids a-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:camouflaging preparations a-z --- r_associated #0: 20 --> phlébite n1=en:camouflaging preparations a-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:capillaritis --- r_associated #0: 20 --> phlébite n1=en:capillaritis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:capillary hemangioma on face --- r_associated #0: 20 --> phlébite n1=en:capillary hemangioma on face | n2=phlébite | rel=r_associated | relid=0 | w=20 en:capillary malformation (disorder) --- r_associated #0: 20 --> phlébite n1=en:capillary malformation (disorder) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:capillary malformations, small, multiple, diffuse --- r_associated #0: 20 --> phlébite n1=en:capillary malformations, small, multiple, diffuse | n2=phlébite | rel=r_associated | relid=0 | w=20 en:carboxyhemoglobinemia --- r_associated #0: 20 --> phlébite n1=en:carboxyhemoglobinemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:carcinoma in situ of breast and genitourinary system --- r_associated #0: 20 --> phlébite n1=en:carcinoma in situ of breast and genitourinary system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiac and vascular procedural complications --- r_associated #0: 20 --> phlébite n1=en:cardiac and vascular procedural complications | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiac complication of procedure --- r_associated #0: 20 --> phlébite n1=en:cardiac complication of procedure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiac function disturbance postoperative --- r_associated #0: 20 --> phlébite n1=en:cardiac function disturbance postoperative | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiac perforation --- r_associated #0: 20 --> phlébite n1=en:cardiac perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiac septal defect residual shunt --- r_associated #0: 20 --> phlébite n1=en:cardiac septal defect residual shunt | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiac transplant rejection --- r_associated #0: 20 --> phlébite n1=en:cardiac transplant rejection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiac valve replacement complication --- r_associated #0: 20 --> phlébite n1=en:cardiac valve replacement complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiac valve rupture --- r_associated #0: 20 --> phlébite n1=en:cardiac valve rupture | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiac vein dissection --- r_associated #0: 20 --> phlébite n1=en:cardiac vein dissection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiac vein perforation --- r_associated #0: 20 --> phlébite n1=en:cardiac vein perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiac ventricular scarring --- r_associated #0: 20 --> phlébite n1=en:cardiac ventricular scarring | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiogenic shock --- r_associated #0: 20 --> phlébite n1=en:cardiogenic shock | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiological test categorized by action status --- r_associated #0: 20 --> phlébite n1=en:cardiological test categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiovascular abnormalities --- r_associated #0: 20 --> phlébite n1=en:cardiovascular abnormalities | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiovascular abnormality due to anomalous origin of arterial duct --- r_associated #0: 20 --> phlébite n1=en:cardiovascular abnormality due to anomalous origin of arterial duct | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiovascular abnormality due to anomalous origin of coronary artery from pulmonary artery --- r_associated #0: 20 --> phlébite n1=en:cardiovascular abnormality due to anomalous origin of coronary artery from pulmonary artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiovascular abnormality due to anomalous origin of coronary artery orifice --- r_associated #0: 20 --> phlébite n1=en:cardiovascular abnormality due to anomalous origin of coronary artery orifice | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiovascular abnormality due to bilateral arterial ducts --- r_associated #0: 20 --> phlébite n1=en:cardiovascular abnormality due to bilateral arterial ducts | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiovascular abnormality due to infective myocarditis --- r_associated #0: 20 --> phlébite n1=en:cardiovascular abnormality due to infective myocarditis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiovascular abnormality due to patent arterial duct --- r_associated #0: 20 --> phlébite n1=en:cardiovascular abnormality due to patent arterial duct | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiovascular disorder --- r_associated #0: 20 --> phlébite n1=en:cardiovascular disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiovascular fistula due to endocarditis --- r_associated #0: 20 --> phlébite n1=en:cardiovascular fistula due to endocarditis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiovascular infections --- r_associated #0: 20 --> phlébite n1=en:cardiovascular infections | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiovascular injury --- r_associated #0: 20 --> phlébite n1=en:cardiovascular injury | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiovascular neoplasm --- r_associated #0: 20 --> phlébite n1=en:cardiovascular neoplasm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiovascular occlusion --- r_associated #0: 20 --> phlébite n1=en:cardiovascular occlusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiovascular system complication of procedure --- r_associated #0: 20 --> phlébite n1=en:cardiovascular system complication of procedure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cardiovascular system hereditary disorder --- r_associated #0: 20 --> phlébite n1=en:cardiovascular system hereditary disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:carotid aneurysm, intracranial (in some patients) --- r_associated #0: 20 --> phlébite n1=en:carotid aneurysm, intracranial (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:carotid artery embolism --- r_associated #0: 20 --> phlébite n1=en:carotid artery embolism | n2=phlébite | rel=r_associated | relid=0 | w=20 en:carotid artery obstruction --- r_associated #0: 20 --> phlébite n1=en:carotid artery obstruction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:carotid artery perforation --- r_associated #0: 20 --> phlébite n1=en:carotid artery perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:carotid artery thrombosis --- r_associated #0: 20 --> phlébite n1=en:carotid artery thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:carotid string sign --- r_associated #0: 20 --> phlébite n1=en:carotid string sign | n2=phlébite | rel=r_associated | relid=0 | w=20 en:category a biological agent --- r_associated #0: 20 --> phlébite n1=en:category a biological agent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:category b biological agent --- r_associated #0: 20 --> phlébite n1=en:category b biological agent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:category c biological agent --- r_associated #0: 20 --> phlébite n1=en:category c biological agent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:catheter site vasculitis --- r_associated #0: 20 --> phlébite n1=en:catheter site vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:causes of injury and poisoning --- r_associated #0: 20 --> phlébite n1=en:causes of injury and poisoning | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cd43 (sialophorin) defectively expressed on surface of blood cells --- r_associated #0: 20 --> phlébite n1=en:cd43 (sialophorin) defectively expressed on surface of blood cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:celiac artery thrombosis --- r_associated #0: 20 --> phlébite n1=en:celiac artery thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:central nervous system vasculitis --- r_associated #0: 20 --> phlébite n1=en:central nervous system vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebellar artery thrombosis --- r_associated #0: 20 --> phlébite n1=en:cerebellar artery thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebral amyloid angiopathy --- r_associated #0: 20 --> phlébite n1=en:cerebral amyloid angiopathy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebral aneurysm --- r_associated #0: 20 --> phlébite n1=en:cerebral aneurysm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebral aneurysm (uncommon) --- r_associated #0: 20 --> phlébite n1=en:cerebral aneurysm (uncommon) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebral aneurysm perforation --- r_associated #0: 20 --> phlébite n1=en:cerebral aneurysm perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebral arterial aneurysm --- r_associated #0: 20 --> phlébite n1=en:cerebral arterial aneurysm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebral artery amyloidosis (amyloid deposition in cerebral arteries) --- r_associated #0: 20 --> phlébite n1=en:cerebral artery amyloidosis (amyloid deposition in cerebral arteries) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebral artery perforation --- r_associated #0: 20 --> phlébite n1=en:cerebral artery perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebral degenerations usually manifest in childhood --- r_associated #0: 20 --> phlébite n1=en:cerebral degenerations usually manifest in childhood | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebral hyperperfusion syndrome --- r_associated #0: 20 --> phlébite n1=en:cerebral hyperperfusion syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebral hypoperfusion --- r_associated #0: 20 --> phlébite n1=en:cerebral hypoperfusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebral infarction --- r_associated #0: 20 --> phlébite n1=en:cerebral infarction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebral thrombosis --- r_associated #0: 20 --> phlébite n1=en:cerebral thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebral thrombosis (rare) --- r_associated #0: 20 --> phlébite n1=en:cerebral thrombosis (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebral vein occlusion --- r_associated #0: 20 --> phlébite n1=en:cerebral vein occlusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebrovascular accident --- r_associated #0: 20 --> phlébite n1=en:cerebrovascular accident | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebrovascular aneurysm (in some patients) --- r_associated #0: 20 --> phlébite n1=en:cerebrovascular aneurysm (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebrovascular disorder --- r_associated #0: 20 --> phlébite n1=en:cerebrovascular disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebrovascular embolism and thrombosis --- r_associated #0: 20 --> phlébite n1=en:cerebrovascular embolism and thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebrovascular hemorrhagic attacks --- r_associated #0: 20 --> phlébite n1=en:cerebrovascular hemorrhagic attacks | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebrovascular ischemia --- r_associated #0: 20 --> phlébite n1=en:cerebrovascular ischemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebrovascular ischemic attacks --- r_associated #0: 20 --> phlébite n1=en:cerebrovascular ischemic attacks | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebrovascular occlusions --- r_associated #0: 20 --> phlébite n1=en:cerebrovascular occlusions | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cerebrovascular system --- r_associated #0: 20 --> phlébite n1=en:cerebrovascular system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chemical pathology test categorized by action status --- r_associated #0: 20 --> phlébite n1=en:chemical pathology test categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chemical phlebitis --- r_associated #0: 20 --> phlébite n1=en:chemical phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chemically induced --- r_associated #0: 20 --> phlébite n1=en:chemically induced | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chest tube entrapment --- r_associated #0: 20 --> phlébite n1=en:chest tube entrapment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chlorhexidine a-h --- r_associated #0: 20 --> phlébite n1=en:chlorhexidine a-h | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chlorhexidine i-z --- r_associated #0: 20 --> phlébite n1=en:chlorhexidine i-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chronic anemia (in 1 patient) --- r_associated #0: 20 --> phlébite n1=en:chronic anemia (in 1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chronic deep venous thrombosis of internal jugular vein --- r_associated #0: 20 --> phlébite n1=en:chronic deep venous thrombosis of internal jugular vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chronic disease of cardiovascular system --- r_associated #0: 20 --> phlébite n1=en:chronic disease of cardiovascular system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chronic disease of hematopoietic system --- r_associated #0: 20 --> phlébite n1=en:chronic disease of hematopoietic system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chronic disease of immune system --- r_associated #0: 20 --> phlébite n1=en:chronic disease of immune system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chronic disseminated intravascular coagulation --- r_associated #0: 20 --> phlébite n1=en:chronic disseminated intravascular coagulation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chronic hemolytic anemia --- r_associated #0: 20 --> phlébite n1=en:chronic hemolytic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chronic lymphocytic leukemia --- r_associated #0: 20 --> phlébite n1=en:chronic lymphocytic leukemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chronic myelogenous leukemia, bcr-abl1 positive --- r_associated #0: 20 --> phlébite n1=en:chronic myelogenous leukemia, bcr-abl1 positive | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chronic peripheral venous hypertension --- r_associated #0: 20 --> phlébite n1=en:chronic peripheral venous hypertension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:chronic total occlusion vessel --- r_associated #0: 20 --> phlébite n1=en:chronic total occlusion vessel | n2=phlébite | rel=r_associated | relid=0 | w=20 en:churg-strauss syndrome --- r_associated #0: 20 --> phlébite n1=en:churg-strauss syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:circulating orthochromatic erythroblasts --- r_associated #0: 20 --> phlébite n1=en:circulating orthochromatic erythroblasts | n2=phlébite | rel=r_associated | relid=0 | w=20 en:circulatory topical preparations a-z --- r_associated #0: 20 --> phlébite n1=en:circulatory topical preparations a-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:claudication --- r_associated #0: 20 --> phlébite n1=en:claudication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:clinical test result --- r_associated #0: 20 --> phlébite n1=en:clinical test result | n2=phlébite | rel=r_associated | relid=0 | w=20 en:clostridium species a-f --- r_associated #0: 20 --> phlébite n1=en:clostridium species a-f | n2=phlébite | rel=r_associated | relid=0 | w=20 en:clostridium species g-p --- r_associated #0: 20 --> phlébite n1=en:clostridium species g-p | n2=phlébite | rel=r_associated | relid=0 | w=20 en:clostridium species q-z --- r_associated #0: 20 --> phlébite n1=en:clostridium species q-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:clotting and bleeding disorders --- r_associated #0: 20 --> phlébite n1=en:clotting and bleeding disorders | n2=phlébite | rel=r_associated | relid=0 | w=20 en:clotting decreased --- r_associated #0: 20 --> phlébite n1=en:clotting decreased | n2=phlébite | rel=r_associated | relid=0 | w=20 en:clotting increased --- r_associated #0: 20 --> phlébite n1=en:clotting increased | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coagulation and hemorrhagic disorders --- r_associated #0: 20 --> phlébite n1=en:coagulation and hemorrhagic disorders | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coagulation defect due to decreased liver function --- r_associated #0: 20 --> phlébite n1=en:coagulation defect due to decreased liver function | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coagulation defects (1 patient) --- r_associated #0: 20 --> phlébite n1=en:coagulation defects (1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coagulation disorder --- r_associated #0: 20 --> phlébite n1=en:coagulation disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coagulation factor deficiency --- r_associated #0: 20 --> phlébite n1=en:coagulation factor deficiency | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coagulation process --- r_associated #0: 20 --> phlébite n1=en:coagulation process | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coagulopathy due to hepatic failure --- r_associated #0: 20 --> phlébite n1=en:coagulopathy due to hepatic failure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coagulopathy due to liver dysfunction --- r_associated #0: 20 --> phlébite n1=en:coagulopathy due to liver dysfunction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coagulopathy in those with liver failure --- r_associated #0: 20 --> phlébite n1=en:coagulopathy in those with liver failure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coagulopathy secondary to liver disease --- r_associated #0: 20 --> phlébite n1=en:coagulopathy secondary to liver disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coagulopathy secondary to liver failure --- r_associated #0: 20 --> phlébite n1=en:coagulopathy secondary to liver failure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coarctation of aorta (rare) --- r_associated #0: 20 --> phlébite n1=en:coarctation of aorta (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coarctation of the aorta (1 patient) --- r_associated #0: 20 --> phlébite n1=en:coarctation of the aorta (1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coarse granulocyte chromatin --- r_associated #0: 20 --> phlébite n1=en:coarse granulocyte chromatin | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coccidian parasite --- r_associated #0: 20 --> phlébite n1=en:coccidian parasite | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coelozoic parasite --- r_associated #0: 20 --> phlébite n1=en:coelozoic parasite | n2=phlébite | rel=r_associated | relid=0 | w=20 en:commensal parasite --- r_associated #0: 20 --> phlébite n1=en:commensal parasite | n2=phlébite | rel=r_associated | relid=0 | w=20 en:common eye and/or eyelid symptom --- r_associated #0: 20 --> phlébite n1=en:common eye and/or eyelid symptom | n2=phlébite | rel=r_associated | relid=0 | w=20 en:complement deficiency --- r_associated #0: 20 --> phlébite n1=en:complement deficiency | n2=phlébite | rel=r_associated | relid=0 | w=20 en:complex procedure --- r_associated #0: 20 --> phlébite n1=en:complex procedure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:complication aspects --- r_associated #0: 20 --> phlébite n1=en:complication aspects | n2=phlébite | rel=r_associated | relid=0 | w=20 en:complication for medication therapy --- r_associated #0: 20 --> phlébite n1=en:complication for medication therapy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:compound analgesics a-l --- r_associated #0: 20 --> phlébite n1=en:compound analgesics a-l | n2=phlébite | rel=r_associated | relid=0 | w=20 en:compound analgesics m-z --- r_associated #0: 20 --> phlébite n1=en:compound analgesics m-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:compound antidepressants a-z --- r_associated #0: 20 --> phlébite n1=en:compound antidepressants a-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:compound antispasmodics a-z --- r_associated #0: 20 --> phlébite n1=en:compound antispasmodics a-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:compound bronchodilators a-z --- r_associated #0: 20 --> phlébite n1=en:compound bronchodilators a-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:compound proprietary antacids a-c --- r_associated #0: 20 --> phlébite n1=en:compound proprietary antacids a-c | n2=phlébite | rel=r_associated | relid=0 | w=20 en:compound proprietary antacids d-l --- r_associated #0: 20 --> phlébite n1=en:compound proprietary antacids d-l | n2=phlébite | rel=r_associated | relid=0 | w=20 en:compound proprietary antacids m-z --- r_associated #0: 20 --> phlébite n1=en:compound proprietary antacids m-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:compression of vein --- r_associated #0: 20 --> phlébite n1=en:compression of vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital anomaly - oral/respiratory --- r_associated #0: 20 --> phlébite n1=en:congenital anomaly - oral/respiratory | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital anomaly of aortic arch --- r_associated #0: 20 --> phlébite n1=en:congenital anomaly of aortic arch | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital anomaly of peripheral blood vessel --- r_associated #0: 20 --> phlébite n1=en:congenital anomaly of peripheral blood vessel | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital atresia of pulmonary artery --- r_associated #0: 20 --> phlébite n1=en:congenital atresia of pulmonary artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital bleeding diathesis --- r_associated #0: 20 --> phlébite n1=en:congenital bleeding diathesis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital blood disorder --- r_associated #0: 20 --> phlébite n1=en:congenital blood disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital cardiovascular abnormality --- r_associated #0: 20 --> phlébite n1=en:congenital cardiovascular abnormality | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital cardiovascular disorder --- r_associated #0: 20 --> phlébite n1=en:congenital cardiovascular disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital disorder of glycosylation type 1b --- r_associated #0: 20 --> phlébite n1=en:congenital disorder of glycosylation type 1b | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital heinz body anemia (e.g. hb toyama 141800.0152) --- r_associated #0: 20 --> phlébite n1=en:congenital heinz body anemia (e.g. hb toyama 141800.0152) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital hematological disorder --- r_associated #0: 20 --> phlébite n1=en:congenital hematological disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital hypoplasia of pulmonary artery --- r_associated #0: 20 --> phlébite n1=en:congenital hypoplasia of pulmonary artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital hypoplastic anemia --- r_associated #0: 20 --> phlébite n1=en:congenital hypoplastic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital leptomeningeal angiomatosis --- r_associated #0: 20 --> phlébite n1=en:congenital leptomeningeal angiomatosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital mesh qualifier --- r_associated #0: 20 --> phlébite n1=en:congenital mesh qualifier | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital methemoglobinemia --- r_associated #0: 20 --> phlébite n1=en:congenital methemoglobinemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital neutropenia --- r_associated #0: 20 --> phlébite n1=en:congenital neutropenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital or acquired anatomic abnormality --- r_associated #0: 20 --> phlébite n1=en:congenital or acquired anatomic abnormality | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital peripheral aneurysm --- r_associated #0: 20 --> phlébite n1=en:congenital peripheral aneurysm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital thrombocytopenia --- r_associated #0: 20 --> phlébite n1=en:congenital thrombocytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital vascular anomaly --- r_associated #0: 20 --> phlébite n1=en:congenital vascular anomaly | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congenital vena cava abnormality --- r_associated #0: 20 --> phlébite n1=en:congenital vena cava abnormality | n2=phlébite | rel=r_associated | relid=0 | w=20 en:congestion of lower extremities --- r_associated #0: 20 --> phlébite n1=en:congestion of lower extremities | n2=phlébite | rel=r_associated | relid=0 | w=20 en:consolidation --- r_associated #0: 20 --> phlébite n1=en:consolidation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cooper's ligament changes --- r_associated #0: 20 --> phlébite n1=en:cooper's ligament changes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cord sign --- r_associated #0: 20 --> phlébite n1=en:cord sign | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary and carotid arteries spared (in most patients) --- r_associated #0: 20 --> phlébite n1=en:coronary and carotid arteries spared (in most patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary artery aneurysm (in some patients) --- r_associated #0: 20 --> phlébite n1=en:coronary artery aneurysm (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary artery disease --- r_associated #0: 20 --> phlébite n1=en:coronary artery disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary artery disease (in some patients) --- r_associated #0: 20 --> phlébite n1=en:coronary artery disease (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary artery dissection (in some patients) --- r_associated #0: 20 --> phlébite n1=en:coronary artery dissection (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary artery perforation --- r_associated #0: 20 --> phlébite n1=en:coronary artery perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary artery reocclusion --- r_associated #0: 20 --> phlébite n1=en:coronary artery reocclusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary artery stenosis --- r_associated #0: 20 --> phlébite n1=en:coronary artery stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary atherosclerosis --- r_associated #0: 20 --> phlébite n1=en:coronary atherosclerosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary bypass stenosis --- r_associated #0: 20 --> phlébite n1=en:coronary bypass stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary bypass thrombosis --- r_associated #0: 20 --> phlébite n1=en:coronary bypass thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary heart disease, susceptibility to, 5 --- r_associated #0: 20 --> phlébite n1=en:coronary heart disease, susceptibility to, 5 | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary occlusion/thrombosis --- r_associated #0: 20 --> phlébite n1=en:coronary occlusion/thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary restenosis --- r_associated #0: 20 --> phlébite n1=en:coronary restenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary vascular graft occlusion --- r_associated #0: 20 --> phlébite n1=en:coronary vascular graft occlusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary vascular graft stenosis --- r_associated #0: 20 --> phlébite n1=en:coronary vascular graft stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:coronary venous dissection --- r_associated #0: 20 --> phlébite n1=en:coronary venous dissection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ctrp terminology --- r_associated #0: 20 --> phlébite n1=en:ctrp terminology | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cutaneous extramedullary haemopoiesis --- r_associated #0: 20 --> phlébite n1=en:cutaneous extramedullary haemopoiesis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cutaneous t-cell dyscrasia --- r_associated #0: 20 --> phlébite n1=en:cutaneous t-cell dyscrasia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cutaneous vasculitis --- r_associated #0: 20 --> phlébite n1=en:cutaneous vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cyclozoonosis --- r_associated #0: 20 --> phlébite n1=en:cyclozoonosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:cystourethroscopy with ureteroscopy and pyeloscopy --- r_associated #0: 20 --> phlébite n1=en:cystourethroscopy with ureteroscopy and pyeloscopy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decorative products causing toxic effect --- r_associated #0: 20 --> phlébite n1=en:decorative products causing toxic effect | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased beta-thromboglobulin --- r_associated #0: 20 --> phlébite n1=en:decreased beta-thromboglobulin | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased beta-tubulin in platelets --- r_associated #0: 20 --> phlébite n1=en:decreased beta-tubulin in platelets | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased coagulation factors ix, xi, xii --- r_associated #0: 20 --> phlébite n1=en:decreased coagulation factors ix, xi, xii | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased erythropoietic response under hypoxic conditions --- r_associated #0: 20 --> phlébite n1=en:decreased erythropoietic response under hypoxic conditions | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased euglobin lysis time --- r_associated #0: 20 --> phlébite n1=en:decreased euglobin lysis time | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased expression of cd44 and aqp1 on red cells --- r_associated #0: 20 --> phlébite n1=en:decreased expression of cd44 and aqp1 on red cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased f2 activity --- r_associated #0: 20 --> phlébite n1=en:decreased f2 activity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased f2 antigen levels (in some patients) --- r_associated #0: 20 --> phlébite n1=en:decreased f2 antigen levels (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased hemoglobin oxygen saturation --- r_associated #0: 20 --> phlébite n1=en:decreased hemoglobin oxygen saturation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased level (laboratory finding) --- r_associated #0: 20 --> phlébite n1=en:decreased level (laboratory finding) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased levels of erythrocyte cytochrome b5 --- r_associated #0: 20 --> phlébite n1=en:decreased levels of erythrocyte cytochrome b5 | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased mean platelet volume (mpv) --- r_associated #0: 20 --> phlébite n1=en:decreased mean platelet volume (mpv) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased multimerin --- r_associated #0: 20 --> phlébite n1=en:decreased multimerin | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased myeloperoxidase activity in neutrophils and monocytes --- r_associated #0: 20 --> phlébite n1=en:decreased myeloperoxidase activity in neutrophils and monocytes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased number of small megakaryocytes (1 patient) --- r_associated #0: 20 --> phlébite n1=en:decreased number of small megakaryocytes (1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased oxygen-binding capacity of hemoglobin --- r_associated #0: 20 --> phlébite n1=en:decreased oxygen-binding capacity of hemoglobin | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased platelet count --- r_associated #0: 20 --> phlébite n1=en:decreased platelet count | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased platelet expression of gp6 --- r_associated #0: 20 --> phlébite n1=en:decreased platelet expression of gp6 | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased platelet function --- r_associated #0: 20 --> phlébite n1=en:decreased platelet function | n2=phlébite | rel=r_associated | relid=0 | w=20 en:decreased serum thromboxane b2 --- r_associated #0: 20 --> phlébite n1=en:decreased serum thromboxane b2 | n2=phlébite | rel=r_associated | relid=0 | w=20 en:deep thrombophlebitis --- r_associated #0: 20 --> phlébite n1=en:deep thrombophlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:deep vein phlebitis and thrombophlebitis of the leg --- r_associated #0: 20 --> phlébite n1=en:deep vein phlebitis and thrombophlebitis of the leg | n2=phlébite | rel=r_associated | relid=0 | w=20 en:deep vein thromoboses --- r_associated #0: 20 --> phlébite n1=en:deep vein thromoboses | n2=phlébite | rel=r_associated | relid=0 | w=20 en:defective nk cell activity --- r_associated #0: 20 --> phlébite n1=en:defective nk cell activity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:defective nk cell degranulation --- r_associated #0: 20 --> phlébite n1=en:defective nk cell degranulation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:defective platelet activation and aggregation in response to collagen --- r_associated #0: 20 --> phlébite n1=en:defective platelet activation and aggregation in response to collagen | n2=phlébite | rel=r_associated | relid=0 | w=20 en:defective platelet adhesion with normal platelet count --- r_associated #0: 20 --> phlébite n1=en:defective platelet adhesion with normal platelet count | n2=phlébite | rel=r_associated | relid=0 | w=20 en:defective platelet aggregation in response to adp --- r_associated #0: 20 --> phlébite n1=en:defective platelet aggregation in response to adp | n2=phlébite | rel=r_associated | relid=0 | w=20 en:defective platelet aggregation in response to arachidonic acid --- r_associated #0: 20 --> phlébite n1=en:defective platelet aggregation in response to arachidonic acid | n2=phlébite | rel=r_associated | relid=0 | w=20 en:defective platelet binding to collagen --- r_associated #0: 20 --> phlébite n1=en:defective platelet binding to collagen | n2=phlébite | rel=r_associated | relid=0 | w=20 en:defective platelet calcium mobilization --- r_associated #0: 20 --> phlébite n1=en:defective platelet calcium mobilization | n2=phlébite | rel=r_associated | relid=0 | w=20 en:deficient capillarization of airspace walls --- r_associated #0: 20 --> phlébite n1=en:deficient capillarization of airspace walls | n2=phlébite | rel=r_associated | relid=0 | w=20 en:definite thrombus --- r_associated #0: 20 --> phlébite n1=en:definite thrombus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:degraded platelet alpha-granule proteins --- r_associated #0: 20 --> phlébite n1=en:degraded platelet alpha-granule proteins | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dermal neoplasm --- r_associated #0: 20 --> phlébite n1=en:dermal neoplasm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:descending aortic aneurysm (uncommon) --- r_associated #0: 20 --> phlébite n1=en:descending aortic aneurysm (uncommon) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:device embolization --- r_associated #0: 20 --> phlébite n1=en:device embolization | n2=phlébite | rel=r_associated | relid=0 | w=20 en:device related thrombosis --- r_associated #0: 20 --> phlébite n1=en:device related thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:diabetic vascular disorder --- r_associated #0: 20 --> phlébite n1=en:diabetic vascular disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:diagnosis aspect --- r_associated #0: 20 --> phlébite n1=en:diagnosis aspect | n2=phlébite | rel=r_associated | relid=0 | w=20 en:diagnostic imaging and nuclear medicine procedures --- r_associated #0: 20 --> phlébite n1=en:diagnostic imaging and nuclear medicine procedures | n2=phlébite | rel=r_associated | relid=0 | w=20 en:digestive tract and abdominal organs --- r_associated #0: 20 --> phlébite n1=en:digestive tract and abdominal organs | n2=phlébite | rel=r_associated | relid=0 | w=20 en:digital vasculitis --- r_associated #0: 20 --> phlébite n1=en:digital vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dilatation of pulmonary artery, unspecified --- r_associated #0: 20 --> phlébite n1=en:dilatation of pulmonary artery, unspecified | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dilatation of the aortic arch --- r_associated #0: 20 --> phlébite n1=en:dilatation of the aortic arch | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dilated aortic root --- r_associated #0: 20 --> phlébite n1=en:dilated aortic root | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dilated pulmonary arteries --- r_associated #0: 20 --> phlébite n1=en:dilated pulmonary arteries | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dilation of dermal capillaries --- r_associated #0: 20 --> phlébite n1=en:dilation of dermal capillaries | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dilation of the sinuses of valsalva --- r_associated #0: 20 --> phlébite n1=en:dilation of the sinuses of valsalva | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dilation of the thoracic aorta --- r_associated #0: 20 --> phlébite n1=en:dilation of the thoracic aorta | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dilation of vein of galen (rare) --- r_associated #0: 20 --> phlébite n1=en:dilation of vein of galen (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:diminished or absent peripheral pulses --- r_associated #0: 20 --> phlébite n1=en:diminished or absent peripheral pulses | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dirofilarial vena caval syndrome --- r_associated #0: 20 --> phlébite n1=en:dirofilarial vena caval syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disease of capillaries --- r_associated #0: 20 --> phlébite n1=en:disease of capillaries | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disease of non-coronary systemic artery --- r_associated #0: 20 --> phlébite n1=en:disease of non-coronary systemic artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disorder of blood / lymphatics / immune system --- r_associated #0: 20 --> phlébite n1=en:disorder of blood / lymphatics / immune system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disorder of body wall and cavities --- r_associated #0: 20 --> phlébite n1=en:disorder of body wall and cavities | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disorder of hepatic portal vein --- r_associated #0: 20 --> phlébite n1=en:disorder of hepatic portal vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disorder of intracranial venous sinus --- r_associated #0: 20 --> phlébite n1=en:disorder of intracranial venous sinus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disorder of pericardium --- r_associated #0: 20 --> phlébite n1=en:disorder of pericardium | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disorder of portal venous system --- r_associated #0: 20 --> phlébite n1=en:disorder of portal venous system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disorder of pregnancy / labor / delivery / puerperium --- r_associated #0: 20 --> phlébite n1=en:disorder of pregnancy / labor / delivery / puerperium | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disorder of system --- r_associated #0: 20 --> phlébite n1=en:disorder of system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disorder of the circulatory system --- r_associated #0: 20 --> phlébite n1=en:disorder of the circulatory system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disorder of the third, fourth and sixth nerves and of eye movements --- r_associated #0: 20 --> phlébite n1=en:disorder of the third, fourth and sixth nerves and of eye movements | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disorder of vein of lower extremity --- r_associated #0: 20 --> phlébite n1=en:disorder of vein of lower extremity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disorder of vena cava umbrella --- r_associated #0: 20 --> phlébite n1=en:disorder of vena cava umbrella | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dissection, ascending aorta (in some patients) --- r_associated #0: 20 --> phlébite n1=en:dissection, ascending aorta (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dissection, descending aorta (in some patients) --- r_associated #0: 20 --> phlébite n1=en:dissection, descending aorta (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disseminated intravascular coagulation --- r_associated #0: 20 --> phlébite n1=en:disseminated intravascular coagulation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disseminated intravascular coagulation in newborn --- r_associated #0: 20 --> phlébite n1=en:disseminated intravascular coagulation in newborn | n2=phlébite | rel=r_associated | relid=0 | w=20 en:disseminated intravascular coagulation, episodic --- r_associated #0: 20 --> phlébite n1=en:disseminated intravascular coagulation, episodic | n2=phlébite | rel=r_associated | relid=0 | w=20 en:distal tapering of the carotid, cerebellar, and meningeal arteries --- r_associated #0: 20 --> phlébite n1=en:distal tapering of the carotid, cerebellar, and meningeal arteries | n2=phlébite | rel=r_associated | relid=0 | w=20 en:distended umbilical veins --- r_associated #0: 20 --> phlébite n1=en:distended umbilical veins | n2=phlébite | rel=r_associated | relid=0 | w=20 en:diuretics+potassium supplement a-z --- r_associated #0: 20 --> phlébite n1=en:diuretics+potassium supplement a-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:diverticulum --- r_associated #0: 20 --> phlébite n1=en:diverticulum | n2=phlébite | rel=r_associated | relid=0 | w=20 en:division of bone of thorax, ribs or sternum --- r_associated #0: 20 --> phlébite n1=en:division of bone of thorax, ribs or sternum | n2=phlébite | rel=r_associated | relid=0 | w=20 en:drug and poison level measurement --- r_associated #0: 20 --> phlébite n1=en:drug and poison level measurement | n2=phlébite | rel=r_associated | relid=0 | w=20 en:drug groups primarily used in obstetrics, gynecological and urinary tract disorders overdose --- r_associated #0: 20 --> phlébite n1=en:drug groups primarily used in obstetrics, gynecological and urinary tract disorders overdose | n2=phlébite | rel=r_associated | relid=0 | w=20 en:drug groups primarily used in obstets, gyne. and urinary tract disorders poisoning --- r_associated #0: 20 --> phlébite n1=en:drug groups primarily used in obstets, gyne. and urinary tract disorders poisoning | n2=phlébite | rel=r_associated | relid=0 | w=20 en:drug groups primarily used obs, gyn.+ urinary tract dis adverse reaction --- r_associated #0: 20 --> phlébite n1=en:drug groups primarily used obs, gyn.+ urinary tract dis adverse reaction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:drug monitoring procedure and/or toxicology screen --- r_associated #0: 20 --> phlébite n1=en:drug monitoring procedure and/or toxicology screen | n2=phlébite | rel=r_associated | relid=0 | w=20 en:duct changes --- r_associated #0: 20 --> phlébite n1=en:duct changes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ductus arteriosus dependent systemic circulation --- r_associated #0: 20 --> phlébite n1=en:ductus arteriosus dependent systemic circulation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dyserythropoiesis in bone marrow (1 patient) --- r_associated #0: 20 --> phlébite n1=en:dyserythropoiesis in bone marrow (1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dyserythropoietic anemia --- r_associated #0: 20 --> phlébite n1=en:dyserythropoietic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dysfibrinogenemia causing recurrent thrombosis --- r_associated #0: 20 --> phlébite n1=en:dysfibrinogenemia causing recurrent thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dysglobulinemia --- r_associated #0: 20 --> phlébite n1=en:dysglobulinemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dysplastic changes in all cell lineages in the bone marrow --- r_associated #0: 20 --> phlébite n1=en:dysplastic changes in all cell lineages in the bone marrow | n2=phlébite | rel=r_associated | relid=0 | w=20 en:dysplastic erythroblasts with internuclear chromatin strands --- r_associated #0: 20 --> phlébite n1=en:dysplastic erythroblasts with internuclear chromatin strands | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ear, nose and throat/auditory test categorized by action status --- r_associated #0: 20 --> phlébite n1=en:ear, nose and throat/auditory test categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:easy bruising --- r_associated #0: 20 --> phlébite n1=en:easy bruising | n2=phlébite | rel=r_associated | relid=0 | w=20 en:eccentrocytes (in some patients) --- r_associated #0: 20 --> phlébite n1=en:eccentrocytes (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:echinocytosis --- r_associated #0: 20 --> phlébite n1=en:echinocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:eclampsia in pregnancy --- r_associated #0: 20 --> phlébite n1=en:eclampsia in pregnancy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ectactic vein --- r_associated #0: 20 --> phlébite n1=en:ectactic vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ectozoic parasite --- r_associated #0: 20 --> phlébite n1=en:ectozoic parasite | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ektacytometric osmotic gradient curve shifted to the left --- r_associated #0: 20 --> phlébite n1=en:ektacytometric osmotic gradient curve shifted to the left | n2=phlébite | rel=r_associated | relid=0 | w=20 en:electron microscopy shows iron-loaded mitochondria --- r_associated #0: 20 --> phlébite n1=en:electron microscopy shows iron-loaded mitochondria | n2=phlébite | rel=r_associated | relid=0 | w=20 en:elevated diastolic blood pressure --- r_associated #0: 20 --> phlébite n1=en:elevated diastolic blood pressure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:elevated fetal hemoglobin (hbf) --- r_associated #0: 20 --> phlébite n1=en:elevated fetal hemoglobin (hbf) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:elevated hba(2) --- r_associated #0: 20 --> phlébite n1=en:elevated hba(2) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:elevated hbf --- r_associated #0: 20 --> phlébite n1=en:elevated hbf | n2=phlébite | rel=r_associated | relid=0 | w=20 en:elevated mean arterial pressure --- r_associated #0: 20 --> phlébite n1=en:elevated mean arterial pressure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:elevated pulmonary artery pressure --- r_associated #0: 20 --> phlébite n1=en:elevated pulmonary artery pressure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:elevated serum thrombopoietin (tpo) --- r_associated #0: 20 --> phlébite n1=en:elevated serum thrombopoietin (tpo) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:elevated systolic blood pressure --- r_associated #0: 20 --> phlébite n1=en:elevated systolic blood pressure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:elevated thrombopoietin (tpo) --- r_associated #0: 20 --> phlébite n1=en:elevated thrombopoietin (tpo) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:elevated venous pressure --- r_associated #0: 20 --> phlébite n1=en:elevated venous pressure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:elliptocytosis (in some patients, segregated independently) --- r_associated #0: 20 --> phlébite n1=en:elliptocytosis (in some patients, segregated independently) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:elongated arteries (large and medium-sized arteries including aorta) --- r_associated #0: 20 --> phlébite n1=en:elongated arteries (large and medium-sized arteries including aorta) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:elongated, tortuous carotid arteries --- r_associated #0: 20 --> phlébite n1=en:elongated, tortuous carotid arteries | n2=phlébite | rel=r_associated | relid=0 | w=20 en:emboli, pulmonary (in some patients) --- r_associated #0: 20 --> phlébite n1=en:emboli, pulmonary (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:embolism --- r_associated #0: 20 --> phlébite n1=en:embolism | n2=phlébite | rel=r_associated | relid=0 | w=20 en:embolism and thrombosis --- r_associated #0: 20 --> phlébite n1=en:embolism and thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:embolism and thrombosis of other arteries --- r_associated #0: 20 --> phlébite n1=en:embolism and thrombosis of other arteries | n2=phlébite | rel=r_associated | relid=0 | w=20 en:embolism and thrombosis of other specified artery --- r_associated #0: 20 --> phlébite n1=en:embolism and thrombosis of other specified artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:embolism and thrombosis of other specified veins --- r_associated #0: 20 --> phlébite n1=en:embolism and thrombosis of other specified veins | n2=phlébite | rel=r_associated | relid=0 | w=20 en:embolism, cerebral --- r_associated #0: 20 --> phlébite n1=en:embolism, cerebral | n2=phlébite | rel=r_associated | relid=0 | w=20 en:embolism, paradoxical --- r_associated #0: 20 --> phlébite n1=en:embolism, paradoxical | n2=phlébite | rel=r_associated | relid=0 | w=20 en:embolus --- r_associated #0: 20 --> phlébite n1=en:embolus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:embolus arm --- r_associated #0: 20 --> phlébite n1=en:embolus arm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:embolus leg --- r_associated #0: 20 --> phlébite n1=en:embolus leg | n2=phlébite | rel=r_associated | relid=0 | w=20 en:embryologic --- r_associated #0: 20 --> phlébite n1=en:embryologic | n2=phlébite | rel=r_associated | relid=0 | w=20 en:embryonic vascular structure --- r_associated #0: 20 --> phlébite n1=en:embryonic vascular structure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:emollients/barrier creams: a-e --- r_associated #0: 20 --> phlébite n1=en:emollients/barrier creams: a-e | n2=phlébite | rel=r_associated | relid=0 | w=20 en:emollients/barrier creams: f-o --- r_associated #0: 20 --> phlébite n1=en:emollients/barrier creams: f-o | n2=phlébite | rel=r_associated | relid=0 | w=20 en:emollients/barrier creams: p-z --- r_associated #0: 20 --> phlébite n1=en:emollients/barrier creams: p-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:emperipolesis --- r_associated #0: 20 --> phlébite n1=en:emperipolesis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:empty delta sign --- r_associated #0: 20 --> phlébite n1=en:empty delta sign | n2=phlébite | rel=r_associated | relid=0 | w=20 en:encephalitis due to tick-borne encephalitis virus subgroup --- r_associated #0: 20 --> phlébite n1=en:encephalitis due to tick-borne encephalitis virus subgroup | n2=phlébite | rel=r_associated | relid=0 | w=20 en:endocrine / nutritional / metabolic disorder --- r_associated #0: 20 --> phlébite n1=en:endocrine / nutritional / metabolic disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:endocrine, breast and special senses --- r_associated #0: 20 --> phlébite n1=en:endocrine, breast and special senses | n2=phlébite | rel=r_associated | relid=0 | w=20 en:endocrine, nutritional, metabolic and immunity disorders --- r_associated #0: 20 --> phlébite n1=en:endocrine, nutritional, metabolic and immunity disorders | n2=phlébite | rel=r_associated | relid=0 | w=20 en:engraftment syndrome --- r_associated #0: 20 --> phlébite n1=en:engraftment syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:enlarged pulmonary trunk (in some patients) --- r_associated #0: 20 --> phlébite n1=en:enlarged pulmonary trunk (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ent test finding --- r_associated #0: 20 --> phlébite n1=en:ent test finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:enteropathogen --- r_associated #0: 20 --> phlébite n1=en:enteropathogen | n2=phlébite | rel=r_associated | relid=0 | w=20 en:enteropathogenic bacteria --- r_associated #0: 20 --> phlébite n1=en:enteropathogenic bacteria | n2=phlébite | rel=r_associated | relid=0 | w=20 en:enteropathogenic virus --- r_associated #0: 20 --> phlébite n1=en:enteropathogenic virus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:entire blood vessel --- r_associated #0: 20 --> phlébite n1=en:entire blood vessel | n2=phlébite | rel=r_associated | relid=0 | w=20 en:entozoic parasite --- r_associated #0: 20 --> phlébite n1=en:entozoic parasite | n2=phlébite | rel=r_associated | relid=0 | w=20 en:enzymes a - l --- r_associated #0: 20 --> phlébite n1=en:enzymes a - l | n2=phlébite | rel=r_associated | relid=0 | w=20 en:enzymes m - z --- r_associated #0: 20 --> phlébite n1=en:enzymes m - z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:enzymology --- r_associated #0: 20 --> phlébite n1=en:enzymology | n2=phlébite | rel=r_associated | relid=0 | w=20 en:eosinophilia --- r_associated #0: 20 --> phlébite n1=en:eosinophilia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:epidemic encephalitis --- r_associated #0: 20 --> phlébite n1=en:epidemic encephalitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:epidemiologic --- r_associated #0: 20 --> phlébite n1=en:epidemiologic | n2=phlébite | rel=r_associated | relid=0 | w=20 en:episodic bleeding --- r_associated #0: 20 --> phlébite n1=en:episodic bleeding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:episodic hemolytic anemia --- r_associated #0: 20 --> phlébite n1=en:episodic hemolytic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:episodic hypertension --- r_associated #0: 20 --> phlébite n1=en:episodic hypertension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:epistaxis --- r_associated #0: 20 --> phlébite n1=en:epistaxis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:equivocal biochemistry finding --- r_associated #0: 20 --> phlébite n1=en:equivocal biochemistry finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:equivocal hematology finding --- r_associated #0: 20 --> phlébite n1=en:equivocal hematology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:equivocal laboratory finding --- r_associated #0: 20 --> phlébite n1=en:equivocal laboratory finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:equivocal microbiology finding --- r_associated #0: 20 --> phlébite n1=en:equivocal microbiology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:erythroblast morphologic abnormalities --- r_associated #0: 20 --> phlébite n1=en:erythroblast morphologic abnormalities | n2=phlébite | rel=r_associated | relid=0 | w=20 en:erythroblasts show atypical cytoplasmic inclusions --- r_associated #0: 20 --> phlébite n1=en:erythroblasts show atypical cytoplasmic inclusions | n2=phlébite | rel=r_associated | relid=0 | w=20 en:erythrocyanosis --- r_associated #0: 20 --> phlébite n1=en:erythrocyanosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:erythrocyte macrocytosis --- r_associated #0: 20 --> phlébite n1=en:erythrocyte macrocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:erythrocyte morphology - elliptocytes (lab test) --- r_associated #0: 20 --> phlébite n1=en:erythrocyte morphology - elliptocytes (lab test) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:erythrocytes have defects in cation permeability --- r_associated #0: 20 --> phlébite n1=en:erythrocytes have defects in cation permeability | n2=phlébite | rel=r_associated | relid=0 | w=20 en:erythrocytosis --- r_associated #0: 20 --> phlébite n1=en:erythrocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:erythroid hyperplasia seen on bone marrow biopsy --- r_associated #0: 20 --> phlébite n1=en:erythroid hyperplasia seen on bone marrow biopsy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:erythromelalgia --- r_associated #0: 20 --> phlébite n1=en:erythromelalgia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:erythropoietic hyperplasia of bone marrow --- r_associated #0: 20 --> phlébite n1=en:erythropoietic hyperplasia of bone marrow | n2=phlébite | rel=r_associated | relid=0 | w=20 en:erythrosis --- r_associated #0: 20 --> phlébite n1=en:erythrosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:essential thrombocythemia --- r_associated #0: 20 --> phlébite n1=en:essential thrombocythemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ethnologic --- r_associated #0: 20 --> phlébite n1=en:ethnologic | n2=phlébite | rel=r_associated | relid=0 | w=20 en:etiology aspects --- r_associated #0: 20 --> phlébite n1=en:etiology aspects | n2=phlébite | rel=r_associated | relid=0 | w=20 en:evagination --- r_associated #0: 20 --> phlébite n1=en:evagination | n2=phlébite | rel=r_associated | relid=0 | w=20 en:event description.adverse event:find:pt:^patient:nom:observed.mersth --- r_associated #0: 20 --> phlébite n1=en:event description.adverse event:find:pt:^patient:nom:observed.mersth | n2=phlébite | rel=r_associated | relid=0 | w=20 en:experimental hematology --- r_associated #0: 20 --> phlébite n1=en:experimental hematology | n2=phlébite | rel=r_associated | relid=0 | w=20 en:exposure as collected domain --- r_associated #0: 20 --> phlébite n1=en:exposure as collected domain | n2=phlébite | rel=r_associated | relid=0 | w=20 en:exposure to electric current and radiation --- r_associated #0: 20 --> phlébite n1=en:exposure to electric current and radiation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:extracellular volume depletion (rare, in severe cases only) --- r_associated #0: 20 --> phlébite n1=en:extracellular volume depletion (rare, in severe cases only) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:extramedullary erythropoiesis --- r_associated #0: 20 --> phlébite n1=en:extramedullary erythropoiesis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:extramedullary hematopoiesis --- r_associated #0: 20 --> phlébite n1=en:extramedullary hematopoiesis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:extravasation following blood transfusion --- r_associated #0: 20 --> phlébite n1=en:extravasation following blood transfusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:facial capillary hemangioma --- r_associated #0: 20 --> phlébite n1=en:facial capillary hemangioma | n2=phlébite | rel=r_associated | relid=0 | w=20 en:facultative parasite --- r_associated #0: 20 --> phlébite n1=en:facultative parasite | n2=phlébite | rel=r_associated | relid=0 | w=20 en:fainting spells --- r_associated #0: 20 --> phlébite n1=en:fainting spells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:fat embolism (disorder) --- r_associated #0: 20 --> phlébite n1=en:fat embolism (disorder) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:femoral vein perforation --- r_associated #0: 20 --> phlébite n1=en:femoral vein perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:fetal / neonatal / perinatal disorder --- r_associated #0: 20 --> phlébite n1=en:fetal / neonatal / perinatal disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:fetal and newborn blood disorders --- r_associated #0: 20 --> phlébite n1=en:fetal and newborn blood disorders | n2=phlébite | rel=r_associated | relid=0 | w=20 en:fetal cardiovascular disorder --- r_associated #0: 20 --> phlébite n1=en:fetal cardiovascular disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:fetal chorionic vasculitis --- r_associated #0: 20 --> phlébite n1=en:fetal chorionic vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:fh: thrombosis --- r_associated #0: 20 --> phlébite n1=en:fh: thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:finding / observation / clinical history --- r_associated #0: 20 --> phlébite n1=en:finding / observation / clinical history | n2=phlébite | rel=r_associated | relid=0 | w=20 en:fistula --- r_associated #0: 20 --> phlébite n1=en:fistula | n2=phlébite | rel=r_associated | relid=0 | w=20 en:flea-borne infectious disease --- r_associated #0: 20 --> phlébite n1=en:flea-borne infectious disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:flow disorder --- r_associated #0: 20 --> phlébite n1=en:flow disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:fluid disturbance --- r_associated #0: 20 --> phlébite n1=en:fluid disturbance | n2=phlébite | rel=r_associated | relid=0 | w=20 en:foam cells on bone marrow biopsy --- r_associated #0: 20 --> phlébite n1=en:foam cells on bone marrow biopsy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:focal vasculitis --- r_associated #0: 20 --> phlébite n1=en:focal vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:focus of ectopic electrical activity in the vein of marshall --- r_associated #0: 20 --> phlébite n1=en:focus of ectopic electrical activity in the vein of marshall | n2=phlébite | rel=r_associated | relid=0 | w=20 en:folate-responsive megaloblastic anemia --- r_associated #0: 20 --> phlébite n1=en:folate-responsive megaloblastic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:food, vitamin, electrolyte and inorganic salt overdose --- r_associated #0: 20 --> phlébite n1=en:food, vitamin, electrolyte and inorganic salt overdose | n2=phlébite | rel=r_associated | relid=0 | w=20 en:food, vitamin, electrolyte and inorganic salt poisoning --- r_associated #0: 20 --> phlébite n1=en:food, vitamin, electrolyte and inorganic salt poisoning | n2=phlébite | rel=r_associated | relid=0 | w=20 en:foods, vitamins, electrolytes and inorganic salts allergy --- r_associated #0: 20 --> phlébite n1=en:foods, vitamins, electrolytes and inorganic salts allergy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:foods, vitamins, electrolytes inorganic salts adverse reaction --- r_associated #0: 20 --> phlébite n1=en:foods, vitamins, electrolytes inorganic salts adverse reaction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:foreign body --- r_associated #0: 20 --> phlébite n1=en:foreign body | n2=phlébite | rel=r_associated | relid=0 | w=20 en:foreign body embolism --- r_associated #0: 20 --> phlébite n1=en:foreign body embolism | n2=phlébite | rel=r_associated | relid=0 | w=20 en:foreign body of cardiovascular structure --- r_associated #0: 20 --> phlébite n1=en:foreign body of cardiovascular structure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:fragmented erythrocytes --- r_associated #0: 20 --> phlébite n1=en:fragmented erythrocytes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:fragmented red cells --- r_associated #0: 20 --> phlébite n1=en:fragmented red cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:function and/or dysfunction of axon --- r_associated #0: 20 --> phlébite n1=en:function and/or dysfunction of axon | n2=phlébite | rel=r_associated | relid=0 | w=20 en:functional blood flow disorder --- r_associated #0: 20 --> phlébite n1=en:functional blood flow disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:fusiform dilation and tortuosity of cerebrovascular arteries --- r_associated #0: 20 --> phlébite n1=en:fusiform dilation and tortuosity of cerebrovascular arteries | n2=phlébite | rel=r_associated | relid=0 | w=20 en:gangrene --- r_associated #0: 20 --> phlébite n1=en:gangrene | n2=phlébite | rel=r_associated | relid=0 | w=20 en:gastric acidity increasers a-z --- r_associated #0: 20 --> phlébite n1=en:gastric acidity increasers a-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:gastric antral vascular ectasia --- r_associated #0: 20 --> phlébite n1=en:gastric antral vascular ectasia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:gastrointestinal embolism and thrombosis --- r_associated #0: 20 --> phlébite n1=en:gastrointestinal embolism and thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:gastrointestinal tract test categorized by action status --- r_associated #0: 20 --> phlébite n1=en:gastrointestinal tract test categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:gaucher cells in bone marrow --- r_associated #0: 20 --> phlébite n1=en:gaucher cells in bone marrow | n2=phlébite | rel=r_associated | relid=0 | w=20 en:generalized bone marrow fibrosis --- r_associated #0: 20 --> phlébite n1=en:generalized bone marrow fibrosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:generalized calcification of arteries, including aorta and intraparenchymal arteries --- r_associated #0: 20 --> phlébite n1=en:generalized calcification of arteries, including aorta and intraparenchymal arteries | n2=phlébite | rel=r_associated | relid=0 | w=20 en:genetic aspects --- r_associated #0: 20 --> phlébite n1=en:genetic aspects | n2=phlébite | rel=r_associated | relid=0 | w=20 en:genetic, molecular and/or cellular finding --- r_associated #0: 20 --> phlébite n1=en:genetic, molecular and/or cellular finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:genitalia, sexual function and urinary tract observations --- r_associated #0: 20 --> phlébite n1=en:genitalia, sexual function and urinary tract observations | n2=phlébite | rel=r_associated | relid=0 | w=20 en:genitourinary test categorized by action status --- r_associated #0: 20 --> phlébite n1=en:genitourinary test categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:giant inclusion bodies present in most granulated cells --- r_associated #0: 20 --> phlébite n1=en:giant inclusion bodies present in most granulated cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:giant platelet --- r_associated #0: 20 --> phlébite n1=en:giant platelet | n2=phlébite | rel=r_associated | relid=0 | w=20 en:giant platelet alpha granules (peripheral blood) --- r_associated #0: 20 --> phlébite n1=en:giant platelet alpha granules (peripheral blood) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:gingival administration of treatment --- r_associated #0: 20 --> phlébite n1=en:gingival administration of treatment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:glanzmann thrombasthenia --- r_associated #0: 20 --> phlébite n1=en:glanzmann thrombasthenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:gonadal thrombosis --- r_associated #0: 20 --> phlébite n1=en:gonadal thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:graft occlusion, vascular --- r_associated #0: 20 --> phlébite n1=en:graft occlusion, vascular | n2=phlébite | rel=r_associated | relid=0 | w=20 en:graft thrombosis --- r_associated #0: 20 --> phlébite n1=en:graft thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:granulocyte hypocellularity (in some patients) --- r_associated #0: 20 --> phlébite n1=en:granulocyte hypocellularity (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:granulomatous vasculitis --- r_associated #0: 20 --> phlébite n1=en:granulomatous vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:gray platelets --- r_associated #0: 20 --> phlébite n1=en:gray platelets | n2=phlébite | rel=r_associated | relid=0 | w=20 en:gray polymorphonuclear neutrophils --- r_associated #0: 20 --> phlébite n1=en:gray polymorphonuclear neutrophils | n2=phlébite | rel=r_associated | relid=0 | w=20 en:gray-to-gray-blue platelet on wright-giemsa stain --- r_associated #0: 20 --> phlébite n1=en:gray-to-gray-blue platelet on wright-giemsa stain | n2=phlébite | rel=r_associated | relid=0 | w=20 en:great blood vessel --- r_associated #0: 20 --> phlébite n1=en:great blood vessel | n2=phlébite | rel=r_associated | relid=0 | w=20 en:h/o: phlebitis --- r_associated #0: 20 --> phlébite n1=en:h/o: phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:h/o: thrombosis --- r_associated #0: 20 --> phlébite n1=en:h/o: thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:haematotoxicity --- r_associated #0: 20 --> phlébite n1=en:haematotoxicity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hb h inclusions in red blood cells --- r_associated #0: 20 --> phlébite n1=en:hb h inclusions in red blood cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:head and neck arterial thrombosis --- r_associated #0: 20 --> phlébite n1=en:head and neck arterial thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:heart disorder --- r_associated #0: 20 --> phlébite n1=en:heart disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:heart: muscle/valve --- r_associated #0: 20 --> phlébite n1=en:heart: muscle/valve | n2=phlébite | rel=r_associated | relid=0 | w=20 en:heart: myocardium/pericardium --- r_associated #0: 20 --> phlébite n1=en:heart: myocardium/pericardium | n2=phlébite | rel=r_associated | relid=0 | w=20 en:heavy metal agonist poisoning --- r_associated #0: 20 --> phlébite n1=en:heavy metal agonist poisoning | n2=phlébite | rel=r_associated | relid=0 | w=20 en:helminth --- r_associated #0: 20 --> phlébite n1=en:helminth | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemangioma --- r_associated #0: 20 --> phlébite n1=en:hemangioma | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemangiomas and lymphangiomas of any site --- r_associated #0: 20 --> phlébite n1=en:hemangiomas and lymphangiomas of any site | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemangiomatosis with thrombocytopenia --- r_associated #0: 20 --> phlébite n1=en:hemangiomatosis with thrombocytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematocrit increased --- r_associated #0: 20 --> phlébite n1=en:hematocrit increased | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematologic and lymphocytic disorder --- r_associated #0: 20 --> phlébite n1=en:hematologic and lymphocytic disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematologic disorder in newborn --- r_associated #0: 20 --> phlébite n1=en:hematologic disorder in newborn | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematologic tests --- r_associated #0: 20 --> phlébite n1=en:hematologic tests | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematological disorders of fetus and newborn --- r_associated #0: 20 --> phlébite n1=en:hematological disorders of fetus and newborn | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematological sample --- r_associated #0: 20 --> phlébite n1=en:hematological sample | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematology --- r_associated #0: 20 --> phlébite n1=en:hematology | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematology finding --- r_associated #0: 20 --> phlébite n1=en:hematology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematology finding abnormal --- r_associated #0: 20 --> phlébite n1=en:hematology finding abnormal | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematology finding absent --- r_associated #0: 20 --> phlébite n1=en:hematology finding absent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematology finding negative --- r_associated #0: 20 --> phlébite n1=en:hematology finding negative | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematology finding present --- r_associated #0: 20 --> phlébite n1=en:hematology finding present | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematology test categorized by action status --- r_associated #0: 20 --> phlébite n1=en:hematology test categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematology, other --- r_associated #0: 20 --> phlébite n1=en:hematology, other | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematomas after trauma or injury --- r_associated #0: 20 --> phlébite n1=en:hematomas after trauma or injury | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematomas, recurrent large subcutaneous --- r_associated #0: 20 --> phlébite n1=en:hematomas, recurrent large subcutaneous | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematopoietic and lymphoid cell neoplasm --- r_associated #0: 20 --> phlébite n1=en:hematopoietic and lymphoid cell neoplasm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematopoietic toxicity develops on standard doses of thiopurine drugs --- r_associated #0: 20 --> phlébite n1=en:hematopoietic toxicity develops on standard doses of thiopurine drugs | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hematozoic parasite --- r_associated #0: 20 --> phlébite n1=en:hematozoic parasite | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemoconcentration --- r_associated #0: 20 --> phlébite n1=en:hemoconcentration | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemodilution --- r_associated #0: 20 --> phlébite n1=en:hemodilution | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemoglobin decreased --- r_associated #0: 20 --> phlébite n1=en:hemoglobin decreased | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemoglobin f increased --- r_associated #0: 20 --> phlébite n1=en:hemoglobin f increased | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemoglobin increased --- r_associated #0: 20 --> phlébite n1=en:hemoglobin increased | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemoglobinopathy --- r_associated #0: 20 --> phlébite n1=en:hemoglobinopathy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemolysis (e.g. hb koelliker 141800.0083) --- r_associated #0: 20 --> phlébite n1=en:hemolysis (e.g. hb koelliker 141800.0083) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemolysis biological process --- r_associated #0: 20 --> phlébite n1=en:hemolysis biological process | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemolytic anemia --- r_associated #0: 20 --> phlébite n1=en:hemolytic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemolytic anemia (in some patients) --- r_associated #0: 20 --> phlébite n1=en:hemolytic anemia (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemolytic anemia (variable) --- r_associated #0: 20 --> phlébite n1=en:hemolytic anemia (variable) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemolytic anemia in approximately 60% of patients --- r_associated #0: 20 --> phlébite n1=en:hemolytic anemia in approximately 60% of patients | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemolytic disease of the newborn --- r_associated #0: 20 --> phlébite n1=en:hemolytic disease of the newborn | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemophagocytosis --- r_associated #0: 20 --> phlébite n1=en:hemophagocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemophilia b --- r_associated #0: 20 --> phlébite n1=en:hemophilia b | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemorrhage --- r_associated #0: 20 --> phlébite n1=en:hemorrhage | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemorrhagic cerebrovascular accident --- r_associated #0: 20 --> phlébite n1=en:hemorrhagic cerebrovascular accident | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemorrhagic diathesis, mild --- r_associated #0: 20 --> phlébite n1=en:hemorrhagic diathesis, mild | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemorrhagic disorders --- r_associated #0: 20 --> phlébite n1=en:hemorrhagic disorders | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemorrhagic episodes --- r_associated #0: 20 --> phlébite n1=en:hemorrhagic episodes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hemorrhagic vasculitis --- r_associated #0: 20 --> phlébite n1=en:hemorrhagic vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:henoch-schönlein purpura --- r_associated #0: 20 --> phlébite n1=en:henoch-schönlein purpura | n2=phlébite | rel=r_associated | relid=0 | w=20 en:henoch-schönlein purpura nephritis --- r_associated #0: 20 --> phlébite n1=en:henoch-schönlein purpura nephritis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:heparin cofactor ii deficiency (disorder) --- r_associated #0: 20 --> phlébite n1=en:heparin cofactor ii deficiency (disorder) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:heparin induced thrombocytopenia --- r_associated #0: 20 --> phlébite n1=en:heparin induced thrombocytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hepatic and portal embolism and thrombosis --- r_associated #0: 20 --> phlébite n1=en:hepatic and portal embolism and thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hepatic artery thrombosis --- r_associated #0: 20 --> phlébite n1=en:hepatic artery thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hepatic infarction --- r_associated #0: 20 --> phlébite n1=en:hepatic infarction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hepatosplenomegaly, with extramedullary hematopoiesis (rare) --- r_associated #0: 20 --> phlébite n1=en:hepatosplenomegaly, with extramedullary hematopoiesis (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hereditary elliptocytosis --- r_associated #0: 20 --> phlébite n1=en:hereditary elliptocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hereditary factor v deficiency --- r_associated #0: 20 --> phlébite n1=en:hereditary factor v deficiency | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hereditary factor xi deficiency disease --- r_associated #0: 20 --> phlébite n1=en:hereditary factor xi deficiency disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hereditary factor xiii deficiency --- r_associated #0: 20 --> phlébite n1=en:hereditary factor xiii deficiency | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hereditary hemolytic anemia --- r_associated #0: 20 --> phlébite n1=en:hereditary hemolytic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hernia --- r_associated #0: 20 --> phlébite n1=en:hernia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:heterochromatin clumps with spongy, 'swiss cheese' appearance --- r_associated #0: 20 --> phlébite n1=en:heterochromatin clumps with spongy, 'swiss cheese' appearance | n2=phlébite | rel=r_associated | relid=0 | w=20 en:high blood oxygen saturation of hemoglobin (10% higher mean than the lowest values of population studied) --- r_associated #0: 20 --> phlébite n1=en:high blood oxygen saturation of hemoglobin (10% higher mean than the lowest values of population studied) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:histology laboratory test --- r_associated #0: 20 --> phlébite n1=en:histology laboratory test | n2=phlébite | rel=r_associated | relid=0 | w=20 en:histopathology test categorized by action status --- r_associated #0: 20 --> phlébite n1=en:histopathology test categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:historical aspects qualifier --- r_associated #0: 20 --> phlébite n1=en:historical aspects qualifier | n2=phlébite | rel=r_associated | relid=0 | w=20 en:history taking status --- r_associated #0: 20 --> phlébite n1=en:history taking status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:history/symptoms --- r_associated #0: 20 --> phlébite n1=en:history/symptoms | n2=phlébite | rel=r_associated | relid=0 | w=20 en:home care and/or social service --- r_associated #0: 20 --> phlébite n1=en:home care and/or social service | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hormones and their metabolites and precursors a - g --- r_associated #0: 20 --> phlébite n1=en:hormones and their metabolites and precursors a - g | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hormones and their metabolites and precursors h - s --- r_associated #0: 20 --> phlébite n1=en:hormones and their metabolites and precursors h - s | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hormones and their metabolites and precursors t - z --- r_associated #0: 20 --> phlébite n1=en:hormones and their metabolites and precursors t - z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:household product causing toxic effect --- r_associated #0: 20 --> phlébite n1=en:household product causing toxic effect | n2=phlébite | rel=r_associated | relid=0 | w=20 en:howell-jolly bodies --- r_associated #0: 20 --> phlébite n1=en:howell-jolly bodies | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hrg gene --- r_associated #0: 20 --> phlébite n1=en:hrg gene | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hrg wt allele --- r_associated #0: 20 --> phlébite n1=en:hrg wt allele | n2=phlébite | rel=r_associated | relid=0 | w=20 en:human arthropod parasite --- r_associated #0: 20 --> phlébite n1=en:human arthropod parasite | n2=phlébite | rel=r_associated | relid=0 | w=20 en:human parasite --- r_associated #0: 20 --> phlébite n1=en:human parasite | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hyaline thickening of cerebral arteries --- r_associated #0: 20 --> phlébite n1=en:hyaline thickening of cerebral arteries | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypercellular bone marrow --- r_associated #0: 20 --> phlébite n1=en:hypercellular bone marrow | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypercellular bone marrow with erythroid hyperplasia --- r_associated #0: 20 --> phlébite n1=en:hypercellular bone marrow with erythroid hyperplasia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypereosinophilia --- r_associated #0: 20 --> phlébite n1=en:hypereosinophilia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypergammaglobulinemia --- r_associated #0: 20 --> phlébite n1=en:hypergammaglobulinemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hyperglobulinemia --- r_associated #0: 20 --> phlébite n1=en:hyperglobulinemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hyperlipidemia --- r_associated #0: 20 --> phlébite n1=en:hyperlipidemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypermature neutrophils have condensed nuclei connected by long, stringy filaments and vacuolated cytoplasm --- r_associated #0: 20 --> phlébite n1=en:hypermature neutrophils have condensed nuclei connected by long, stringy filaments and vacuolated cytoplasm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypersegmented neutrophil --- r_associated #0: 20 --> phlébite n1=en:hypersegmented neutrophil | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypersegmented neutrophils (1 patient) --- r_associated #0: 20 --> phlébite n1=en:hypersegmented neutrophils (1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypersensitivity of erythroid colony-forming units to erythropoietin (epo, 133170) --- r_associated #0: 20 --> phlébite n1=en:hypersensitivity of erythroid colony-forming units to erythropoietin (epo, 133170) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypersplenism --- r_associated #0: 20 --> phlébite n1=en:hypersplenism | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension --- r_associated #0: 20 --> phlébite n1=en:hypertension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension (1 family) --- r_associated #0: 20 --> phlébite n1=en:hypertension (1 family) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension (compression of renal arteries) --- r_associated #0: 20 --> phlébite n1=en:hypertension (compression of renal arteries) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension (especially in atypical hemolytic-uremic syndrome (ahus)) --- r_associated #0: 20 --> phlébite n1=en:hypertension (especially in atypical hemolytic-uremic syndrome (ahus)) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension (hcp) --- r_associated #0: 20 --> phlébite n1=en:hypertension (hcp) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension (in all patients) --- r_associated #0: 20 --> phlébite n1=en:hypertension (in all patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension (in some patients) --- r_associated #0: 20 --> phlébite n1=en:hypertension (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension (reported in 1 patient) --- r_associated #0: 20 --> phlébite n1=en:hypertension (reported in 1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension (suppressible by glucocorticoid treatment) --- r_associated #0: 20 --> phlébite n1=en:hypertension (suppressible by glucocorticoid treatment) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension (variable) --- r_associated #0: 20 --> phlébite n1=en:hypertension (variable) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension (with pheochromocytoma) --- r_associated #0: 20 --> phlébite n1=en:hypertension (with pheochromocytoma) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension adverse event --- r_associated #0: 20 --> phlébite n1=en:hypertension adverse event | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension due to renal disease --- r_associated #0: 20 --> phlébite n1=en:hypertension due to renal disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension, mild --- r_associated #0: 20 --> phlébite n1=en:hypertension, mild | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension, moderate, secondary to renal disease --- r_associated #0: 20 --> phlébite n1=en:hypertension, moderate, secondary to renal disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertension, severe --- r_associated #0: 20 --> phlébite n1=en:hypertension, severe | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertensive episode --- r_associated #0: 20 --> phlébite n1=en:hypertensive episode | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypertrophy of branches of the hepatic artery --- r_associated #0: 20 --> phlébite n1=en:hypertrophy of branches of the hepatic artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hyperuricemia --- r_associated #0: 20 --> phlébite n1=en:hyperuricemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hyperviscosity syndrome --- r_associated #0: 20 --> phlébite n1=en:hyperviscosity syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypervolemia --- r_associated #0: 20 --> phlébite n1=en:hypervolemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypocellular bone marrow --- r_associated #0: 20 --> phlébite n1=en:hypocellular bone marrow | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypochromia --- r_associated #0: 20 --> phlébite n1=en:hypochromia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypochromic anemia --- r_associated #0: 20 --> phlébite n1=en:hypochromic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypoglobulinemia --- r_associated #0: 20 --> phlébite n1=en:hypoglobulinemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypoglycosylation of red blood cell membranes --- r_associated #0: 20 --> phlébite n1=en:hypoglycosylation of red blood cell membranes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypolipidemia --- r_associated #0: 20 --> phlébite n1=en:hypolipidemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypolobulated (bilobed or rod-like) granulocyte nuclei (heterozygote) --- r_associated #0: 20 --> phlébite n1=en:hypolobulated (bilobed or rod-like) granulocyte nuclei (heterozygote) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypolobulated megakaryocytes in the bone marrow --- r_associated #0: 20 --> phlébite n1=en:hypolobulated megakaryocytes in the bone marrow | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypolobulation of granulocyte nuclei (pelger-huet anomaly) --- r_associated #0: 20 --> phlébite n1=en:hypolobulation of granulocyte nuclei (pelger-huet anomaly) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypoplastic anemia --- r_associated #0: 20 --> phlébite n1=en:hypoplastic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypoplastic myelodysplasia --- r_associated #0: 20 --> phlébite n1=en:hypoplastic myelodysplasia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypoplastic pulmonary artery --- r_associated #0: 20 --> phlébite n1=en:hypoplastic pulmonary artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypoplastic pulmonary veins --- r_associated #0: 20 --> phlébite n1=en:hypoplastic pulmonary veins | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypotension --- r_associated #0: 20 --> phlébite n1=en:hypotension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypotension adverse event --- r_associated #0: 20 --> phlébite n1=en:hypotension adverse event | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypotension due to volume depletion --- r_associated #0: 20 --> phlébite n1=en:hypotension due to volume depletion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypotension may occur late in disease due to salt wasting --- r_associated #0: 20 --> phlébite n1=en:hypotension may occur late in disease due to salt wasting | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypotension, postural, due to autonomic dysfunction --- r_associated #0: 20 --> phlébite n1=en:hypotension, postural, due to autonomic dysfunction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypotension, severe --- r_associated #0: 20 --> phlébite n1=en:hypotension, severe | n2=phlébite | rel=r_associated | relid=0 | w=20 en:hypovolemia --- r_associated #0: 20 --> phlébite n1=en:hypovolemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:idiopathic pulmonary hypertension --- r_associated #0: 20 --> phlébite n1=en:idiopathic pulmonary hypertension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:idiopathic thrombocytopenic purpura --- r_associated #0: 20 --> phlébite n1=en:idiopathic thrombocytopenic purpura | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ileal gangrene --- r_associated #0: 20 --> phlébite n1=en:ileal gangrene | n2=phlébite | rel=r_associated | relid=0 | w=20 en:iliac vein perforation --- r_associated #0: 20 --> phlébite n1=en:iliac vein perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:iliac, femoral, tibial, and popliteal artery calcification --- r_associated #0: 20 --> phlébite n1=en:iliac, femoral, tibial, and popliteal artery calcification | n2=phlébite | rel=r_associated | relid=0 | w=20 en:imbalanced hemoglobin chain synthesis --- r_associated #0: 20 --> phlébite n1=en:imbalanced hemoglobin chain synthesis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:immune system disorder --- r_associated #0: 20 --> phlébite n1=en:immune system disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:immunohematology --- r_associated #0: 20 --> phlébite n1=en:immunohematology | n2=phlébite | rel=r_associated | relid=0 | w=20 en:immunology aspects --- r_associated #0: 20 --> phlébite n1=en:immunology aspects | n2=phlébite | rel=r_associated | relid=0 | w=20 en:immunology finding --- r_associated #0: 20 --> phlébite n1=en:immunology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:immunology finding present --- r_associated #0: 20 --> phlébite n1=en:immunology finding present | n2=phlébite | rel=r_associated | relid=0 | w=20 en:immunology test categorized by action status --- r_associated #0: 20 --> phlébite n1=en:immunology test categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:impaired coagulation due to malnutrition --- r_associated #0: 20 --> phlébite n1=en:impaired coagulation due to malnutrition | n2=phlébite | rel=r_associated | relid=0 | w=20 en:impaired platelet aggregation --- r_associated #0: 20 --> phlébite n1=en:impaired platelet aggregation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:impaired platelet aggregation (in some patients) --- r_associated #0: 20 --> phlébite n1=en:impaired platelet aggregation (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:impaired platelet aggregation and spreading --- r_associated #0: 20 --> phlébite n1=en:impaired platelet aggregation and spreading | n2=phlébite | rel=r_associated | relid=0 | w=20 en:impaired platelet function --- r_associated #0: 20 --> phlébite n1=en:impaired platelet function | n2=phlébite | rel=r_associated | relid=0 | w=20 en:impaired release of platelet adenosine diphosphate (adp) --- r_associated #0: 20 --> phlébite n1=en:impaired release of platelet adenosine diphosphate (adp) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:impingement --- r_associated #0: 20 --> phlébite n1=en:impingement | n2=phlébite | rel=r_associated | relid=0 | w=20 en:implant site phlebitis --- r_associated #0: 20 --> phlébite n1=en:implant site phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:implant site thrombosis --- r_associated #0: 20 --> phlébite n1=en:implant site thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:in blood --- r_associated #0: 20 --> phlébite n1=en:in blood | n2=phlébite | rel=r_associated | relid=0 | w=20 en:in cerebrospinal fluid --- r_associated #0: 20 --> phlébite n1=en:in cerebrospinal fluid | n2=phlébite | rel=r_associated | relid=0 | w=20 en:in urine --- r_associated #0: 20 --> phlébite n1=en:in urine | n2=phlébite | rel=r_associated | relid=0 | w=20 en:inanimate samples and substances --- r_associated #0: 20 --> phlébite n1=en:inanimate samples and substances | n2=phlébite | rel=r_associated | relid=0 | w=20 en:inappropriately low reticulocyte counts --- r_associated #0: 20 --> phlébite n1=en:inappropriately low reticulocyte counts | n2=phlébite | rel=r_associated | relid=0 | w=20 en:incision site vessel occlusion --- r_associated #0: 20 --> phlébite n1=en:incision site vessel occlusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increase in blood monocytes (2-3 times normal) --- r_associated #0: 20 --> phlébite n1=en:increase in blood monocytes (2-3 times normal) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increase in jugular venous pressure --- r_associated #0: 20 --> phlébite n1=en:increase in jugular venous pressure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased absolute neutrophil count (anc) within 0.0-0.2 x 10(9)/l --- r_associated #0: 20 --> phlébite n1=en:increased absolute neutrophil count (anc) within 0.0-0.2 x 10(9)/l | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased alpha/beta globin ratio in reticulocytes --- r_associated #0: 20 --> phlébite n1=en:increased alpha/beta globin ratio in reticulocytes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased bleeding (menorrhagia, gastrointestinal bleeding, hemarthroses) --- r_associated #0: 20 --> phlébite n1=en:increased bleeding (menorrhagia, gastrointestinal bleeding, hemarthroses) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased bleeding after trauma, surgery, or injury --- r_associated #0: 20 --> phlébite n1=en:increased bleeding after trauma, surgery, or injury | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased bleeding tendency (in 1 patient) --- r_associated #0: 20 --> phlébite n1=en:increased bleeding tendency (in 1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased bleeding tendency due to platelet dysfunction --- r_associated #0: 20 --> phlébite n1=en:increased bleeding tendency due to platelet dysfunction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased bleeding tendency, moderate to severe --- r_associated #0: 20 --> phlébite n1=en:increased bleeding tendency, moderate to severe | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased erythrocyte zinc- and metal-free protoporphyrin --- r_associated #0: 20 --> phlébite n1=en:increased erythrocyte zinc- and metal-free protoporphyrin | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased fibrinolysis (finding) --- r_associated #0: 20 --> phlébite n1=en:increased fibrinolysis (finding) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased level (laboratory finding) --- r_associated #0: 20 --> phlébite n1=en:increased level (laboratory finding) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased mean corpuscular hemoglobin concentration --- r_associated #0: 20 --> phlébite n1=en:increased mean corpuscular hemoglobin concentration | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased megakaryocyte colony forming units (cfu-mk) --- r_associated #0: 20 --> phlébite n1=en:increased megakaryocyte colony forming units (cfu-mk) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased megakaryocyte precursor cells --- r_associated #0: 20 --> phlébite n1=en:increased megakaryocyte precursor cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased micromegakaryocytes (bone marrow) --- r_associated #0: 20 --> phlébite n1=en:increased micromegakaryocytes (bone marrow) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased muscularization of arterioles --- r_associated #0: 20 --> phlébite n1=en:increased muscularization of arterioles | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased myeloid precursor cells --- r_associated #0: 20 --> phlébite n1=en:increased myeloid precursor cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased myeloid to erythroid ratio (m:e ratio) 10:1-200:1 --- r_associated #0: 20 --> phlébite n1=en:increased myeloid to erythroid ratio (m:e ratio) 10:1-200:1 | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased number of abnormal megakaryocytes seen on bone marrow biopsy --- r_associated #0: 20 --> phlébite n1=en:increased number of abnormal megakaryocytes seen on bone marrow biopsy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased number of platelets --- r_associated #0: 20 --> phlébite n1=en:increased number of platelets | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased plasma thrombopoietin (tpo) --- r_associated #0: 20 --> phlébite n1=en:increased plasma thrombopoietin (tpo) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased platelet content of plau --- r_associated #0: 20 --> phlébite n1=en:increased platelet content of plau | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased promyelocytes --- r_associated #0: 20 --> phlébite n1=en:increased promyelocytes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased pulmonary artery pressure (mean greater than 25 mm hg at rest and 30 mm hg during exercise) --- r_associated #0: 20 --> phlébite n1=en:increased pulmonary artery pressure (mean greater than 25 mm hg at rest and 30 mm hg during exercise) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased pulmonary vascular resistance --- r_associated #0: 20 --> phlébite n1=en:increased pulmonary vascular resistance | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased red blood cell mass --- r_associated #0: 20 --> phlébite n1=en:increased red blood cell mass | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased red blood cell membrane permeability to univalent cations --- r_associated #0: 20 --> phlébite n1=en:increased red blood cell membrane permeability to univalent cations | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased red cell hemolysis by shear stress --- r_associated #0: 20 --> phlébite n1=en:increased red cell hemolysis by shear stress | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased red cell osmotic fragility --- r_associated #0: 20 --> phlébite n1=en:increased red cell osmotic fragility | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased red cell osmotic resistance --- r_associated #0: 20 --> phlébite n1=en:increased red cell osmotic resistance | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased retinal vascular permeability --- r_associated #0: 20 --> phlébite n1=en:increased retinal vascular permeability | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased risk of thrombosis --- r_associated #0: 20 --> phlébite n1=en:increased risk of thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased serum ferritin --- r_associated #0: 20 --> phlébite n1=en:increased serum ferritin | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased sister chromatid exchange --- r_associated #0: 20 --> phlébite n1=en:increased sister chromatid exchange | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased total white blood count --- r_associated #0: 20 --> phlébite n1=en:increased total white blood count | n2=phlébite | rel=r_associated | relid=0 | w=20 en:increased venous pressure --- r_associated #0: 20 --> phlébite n1=en:increased venous pressure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:induration of venous wall --- r_associated #0: 20 --> phlébite n1=en:induration of venous wall | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ineffective erythropoiesis --- r_associated #0: 20 --> phlébite n1=en:ineffective erythropoiesis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:infection of body wall and cavities --- r_associated #0: 20 --> phlébite n1=en:infection of body wall and cavities | n2=phlébite | rel=r_associated | relid=0 | w=20 en:infectious agent --- r_associated #0: 20 --> phlébite n1=en:infectious agent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:infectious disorder --- r_associated #0: 20 --> phlébite n1=en:infectious disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:infective phlebitis --- r_associated #0: 20 --> phlébite n1=en:infective phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:infective thrombosis --- r_associated #0: 20 --> phlébite n1=en:infective thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:inferior vena cava interruption with azygos continuation --- r_associated #0: 20 --> phlébite n1=en:inferior vena cava interruption with azygos continuation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:inferior vena cava perforation --- r_associated #0: 20 --> phlébite n1=en:inferior vena cava perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:infiltration --- r_associated #0: 20 --> phlébite n1=en:infiltration | n2=phlébite | rel=r_associated | relid=0 | w=20 en:inflammation --- r_associated #0: 20 --> phlébite n1=en:inflammation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:inflammatory and/or infective disease of the central nervous system --- r_associated #0: 20 --> phlébite n1=en:inflammatory and/or infective disease of the central nervous system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:inflammatory arteriopathy --- r_associated #0: 20 --> phlébite n1=en:inflammatory arteriopathy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:inflammatory disorder of the cardiovascular system --- r_associated #0: 20 --> phlébite n1=en:inflammatory disorder of the cardiovascular system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:infusion site phlebitis --- r_associated #0: 20 --> phlébite n1=en:infusion site phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:infusion site thrombosis --- r_associated #0: 20 --> phlébite n1=en:infusion site thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:infusion site vasculitis --- r_associated #0: 20 --> phlébite n1=en:infusion site vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:inhalations a-z --- r_associated #0: 20 --> phlébite n1=en:inhalations a-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:injection of small joint --- r_associated #0: 20 --> phlébite n1=en:injection of small joint | n2=phlébite | rel=r_associated | relid=0 | w=20 en:injection site thrombosis --- r_associated #0: 20 --> phlébite n1=en:injection site thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:injection site vasculitis --- r_associated #0: 20 --> phlébite n1=en:injection site vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:injury due to unintentional cut, puncture, perforation or haemorrhage during aspiration, puncture and other catheterization --- r_associated #0: 20 --> phlébite n1=en:injury due to unintentional cut, puncture, perforation or haemorrhage during aspiration, puncture and other catheterization | n2=phlébite | rel=r_associated | relid=0 | w=20 en:injury due to unintentional cut, puncture, perforation or haemorrhage during endoscopic examination --- r_associated #0: 20 --> phlébite n1=en:injury due to unintentional cut, puncture, perforation or haemorrhage during endoscopic examination | n2=phlébite | rel=r_associated | relid=0 | w=20 en:injury due to unintentional cut, puncture, perforation or haemorrhage during heart catheterization --- r_associated #0: 20 --> phlébite n1=en:injury due to unintentional cut, puncture, perforation or haemorrhage during heart catheterization | n2=phlébite | rel=r_associated | relid=0 | w=20 en:injury due to unintentional cut, puncture, perforation or haemorrhage during injection or immunization --- r_associated #0: 20 --> phlébite n1=en:injury due to unintentional cut, puncture, perforation or haemorrhage during injection or immunization | n2=phlébite | rel=r_associated | relid=0 | w=20 en:injury of vein of head and neck --- r_associated #0: 20 --> phlébite n1=en:injury of vein of head and neck | n2=phlébite | rel=r_associated | relid=0 | w=20 en:inner leaf hole --- r_associated #0: 20 --> phlébite n1=en:inner leaf hole | n2=phlébite | rel=r_associated | relid=0 | w=20 en:insect-transmitted infectious disease --- r_associated #0: 20 --> phlébite n1=en:insect-transmitted infectious disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:instability --- r_associated #0: 20 --> phlébite n1=en:instability | n2=phlébite | rel=r_associated | relid=0 | w=20 en:instability cardiovascular --- r_associated #0: 20 --> phlébite n1=en:instability cardiovascular | n2=phlébite | rel=r_associated | relid=0 | w=20 en:instability vasomotor --- r_associated #0: 20 --> phlébite n1=en:instability vasomotor | n2=phlébite | rel=r_associated | relid=0 | w=20 en:instillation site thrombosis --- r_associated #0: 20 --> phlébite n1=en:instillation site thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intentional alternative medicine overdose --- r_associated #0: 20 --> phlébite n1=en:intentional alternative medicine overdose | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intentional alternative medicine poisoning --- r_associated #0: 20 --> phlébite n1=en:intentional alternative medicine poisoning | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intermittent claudication --- r_associated #0: 20 --> phlébite n1=en:intermittent claudication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intermittent claudication (30%) --- r_associated #0: 20 --> phlébite n1=en:intermittent claudication (30%) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intermittent thrombocytopenia --- r_associated #0: 20 --> phlébite n1=en:intermittent thrombocytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:internal carotid artery tortuosity (rare) --- r_associated #0: 20 --> phlébite n1=en:internal carotid artery tortuosity (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:internal jugular phlebectasia --- r_associated #0: 20 --> phlébite n1=en:internal jugular phlebectasia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:internal jugular vein stenosis --- r_associated #0: 20 --> phlébite n1=en:internal jugular vein stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:internal parasite --- r_associated #0: 20 --> phlébite n1=en:internal parasite | n2=phlébite | rel=r_associated | relid=0 | w=20 en:internuclear chromatin bridges --- r_associated #0: 20 --> phlébite n1=en:internuclear chromatin bridges | n2=phlébite | rel=r_associated | relid=0 | w=20 en:interrupted aortic arch --- r_associated #0: 20 --> phlébite n1=en:interrupted aortic arch | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intestinal ameba --- r_associated #0: 20 --> phlébite n1=en:intestinal ameba | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intestinal ciliate --- r_associated #0: 20 --> phlébite n1=en:intestinal ciliate | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intestinal coccidia --- r_associated #0: 20 --> phlébite n1=en:intestinal coccidia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intestinal flagellate --- r_associated #0: 20 --> phlébite n1=en:intestinal flagellate | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intestinal microsporidian --- r_associated #0: 20 --> phlébite n1=en:intestinal microsporidian | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intestinal nematode --- r_associated #0: 20 --> phlébite n1=en:intestinal nematode | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intestinal protozoan --- r_associated #0: 20 --> phlébite n1=en:intestinal protozoan | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intestinal trematode --- r_associated #0: 20 --> phlébite n1=en:intestinal trematode | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intimal dissection of blood vessel --- r_associated #0: 20 --> phlébite n1=en:intimal dissection of blood vessel | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intimal thickening in the coronary arteries --- r_associated #0: 20 --> phlébite n1=en:intimal thickening in the coronary arteries | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intraabdominal venous thrombosis --- r_associated #0: 20 --> phlébite n1=en:intraabdominal venous thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracardiac thrombosis, not elsewhere classified --- r_associated #0: 20 --> phlébite n1=en:intracardiac thrombosis, not elsewhere classified | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracavernous administration of treatment --- r_associated #0: 20 --> phlébite n1=en:intracavernous administration of treatment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracellular parasite --- r_associated #0: 20 --> phlébite n1=en:intracellular parasite | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracerebral hemorrhage (secondary) --- r_associated #0: 20 --> phlébite n1=en:intracerebral hemorrhage (secondary) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracranial aneurysm --- r_associated #0: 20 --> phlébite n1=en:intracranial aneurysm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracranial aneurysms (in some patients) --- r_associated #0: 20 --> phlébite n1=en:intracranial aneurysms (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracranial arterial narrowing --- r_associated #0: 20 --> phlébite n1=en:intracranial arterial narrowing | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracranial bleeding (in some patients) --- r_associated #0: 20 --> phlébite n1=en:intracranial bleeding (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracranial developmental venous anomalies --- r_associated #0: 20 --> phlébite n1=en:intracranial developmental venous anomalies | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracranial hemorrhage --- r_associated #0: 20 --> phlébite n1=en:intracranial hemorrhage | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracranial hypertension (2 of 7 patients) --- r_associated #0: 20 --> phlébite n1=en:intracranial hypertension (2 of 7 patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracranial hypertension due to multisutural cranial fusion --- r_associated #0: 20 --> phlébite n1=en:intracranial hypertension due to multisutural cranial fusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracranial thrombosis --- r_associated #0: 20 --> phlébite n1=en:intracranial thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracranial thrombosis (2 of 7 patients) --- r_associated #0: 20 --> phlébite n1=en:intracranial thrombosis (2 of 7 patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracranial venous septic embolism --- r_associated #0: 20 --> phlébite n1=en:intracranial venous septic embolism | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracranial venous thrombosis --- r_associated #0: 20 --> phlébite n1=en:intracranial venous thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intracytoplasmic vacuoles in eosinophils, neutrophils and lymphocytes --- r_associated #0: 20 --> phlébite n1=en:intracytoplasmic vacuoles in eosinophils, neutrophils and lymphocytes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intrapericardial thrombosis --- r_associated #0: 20 --> phlébite n1=en:intrapericardial thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intraspinal administration of treatment --- r_associated #0: 20 --> phlébite n1=en:intraspinal administration of treatment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intravenous administration of treatment --- r_associated #0: 20 --> phlébite n1=en:intravenous administration of treatment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intravesical administration of treatment --- r_associated #0: 20 --> phlébite n1=en:intravesical administration of treatment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:intussusception --- r_associated #0: 20 --> phlébite n1=en:intussusception | n2=phlébite | rel=r_associated | relid=0 | w=20 en:iron deficiency --- r_associated #0: 20 --> phlébite n1=en:iron deficiency | n2=phlébite | rel=r_associated | relid=0 | w=20 en:iron deficiency (in some patients) --- r_associated #0: 20 --> phlébite n1=en:iron deficiency (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:iron deficiency anemia (adults) --- r_associated #0: 20 --> phlébite n1=en:iron deficiency anemia (adults) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:iron-deficiency anemia --- r_associated #0: 20 --> phlébite n1=en:iron-deficiency anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:iron-deficiency anemia (in some patients) --- r_associated #0: 20 --> phlébite n1=en:iron-deficiency anemia (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ischaemic contracture of the left ventricle --- r_associated #0: 20 --> phlébite n1=en:ischaemic contracture of the left ventricle | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ischemic bowel disease --- r_associated #0: 20 --> phlébite n1=en:ischemic bowel disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ischemic cerebrovascular accident --- r_associated #0: 20 --> phlébite n1=en:ischemic cerebrovascular accident | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ischemic stroke (in some patients) --- r_associated #0: 20 --> phlébite n1=en:ischemic stroke (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:isolated primary raynaud's phenomenon --- r_associated #0: 20 --> phlébite n1=en:isolated primary raynaud's phenomenon | n2=phlébite | rel=r_associated | relid=0 | w=20 en:jejunal gangrene --- r_associated #0: 20 --> phlébite n1=en:jejunal gangrene | n2=phlébite | rel=r_associated | relid=0 | w=20 en:jugular hypoplasia --- r_associated #0: 20 --> phlébite n1=en:jugular hypoplasia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:junctional ectopic tachycardia --- r_associated #0: 20 --> phlébite n1=en:junctional ectopic tachycardia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:karyozoic parasite --- r_associated #0: 20 --> phlébite n1=en:karyozoic parasite | n2=phlébite | rel=r_associated | relid=0 | w=20 en:kawasaki disease --- r_associated #0: 20 --> phlébite n1=en:kawasaki disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:kinking of descending aorta --- r_associated #0: 20 --> phlébite n1=en:kinking of descending aorta | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lab result outside established criteria --- r_associated #0: 20 --> phlébite n1=en:lab result outside established criteria | n2=phlébite | rel=r_associated | relid=0 | w=20 en:labile blood pressure --- r_associated #0: 20 --> phlébite n1=en:labile blood pressure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:laboratory finding absent --- r_associated #0: 20 --> phlébite n1=en:laboratory finding absent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:laboratory finding present --- r_associated #0: 20 --> phlébite n1=en:laboratory finding present | n2=phlébite | rel=r_associated | relid=0 | w=20 en:laboratory test result --- r_associated #0: 20 --> phlébite n1=en:laboratory test result | n2=phlébite | rel=r_associated | relid=0 | w=20 en:laboratory test result borderline --- r_associated #0: 20 --> phlébite n1=en:laboratory test result borderline | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lack of dense granules in platelets --- r_associated #0: 20 --> phlébite n1=en:lack of dense granules in platelets | n2=phlébite | rel=r_associated | relid=0 | w=20 en:large agranular platelets --- r_associated #0: 20 --> phlébite n1=en:large agranular platelets | n2=phlébite | rel=r_associated | relid=0 | w=20 en:large cutaneous hemangiomata, capillary and cavernous --- r_associated #0: 20 --> phlébite n1=en:large cutaneous hemangiomata, capillary and cavernous | n2=phlébite | rel=r_associated | relid=0 | w=20 en:large platelets (in some patients) --- r_associated #0: 20 --> phlébite n1=en:large platelets (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:large vessel vasculitis --- r_associated #0: 20 --> phlébite n1=en:large vessel vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:large, spherical platelets --- r_associated #0: 20 --> phlébite n1=en:large, spherical platelets | n2=phlébite | rel=r_associated | relid=0 | w=20 en:late congenital neurovascular syphilis --- r_associated #0: 20 --> phlébite n1=en:late congenital neurovascular syphilis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lateral sinus thrombosis --- r_associated #0: 20 --> phlébite n1=en:lateral sinus thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:leukemia in remission --- r_associated #0: 20 --> phlébite n1=en:leukemia in remission | n2=phlébite | rel=r_associated | relid=0 | w=20 en:leukemoid reaction --- r_associated #0: 20 --> phlébite n1=en:leukemoid reaction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:leukocyte disorders --- r_associated #0: 20 --> phlébite n1=en:leukocyte disorders | n2=phlébite | rel=r_associated | relid=0 | w=20 en:leukocyte inclusion bodies (dohle-like bodies) --- r_associated #0: 20 --> phlébite n1=en:leukocyte inclusion bodies (dohle-like bodies) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:leukocytoclastic vasculitis --- r_associated #0: 20 --> phlébite n1=en:leukocytoclastic vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:leukocytosis --- r_associated #0: 20 --> phlébite n1=en:leukocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:leukocytosis (before age 50) --- r_associated #0: 20 --> phlébite n1=en:leukocytosis (before age 50) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:leukocytosis (mean leukocyte count 18.7 x 10(9)/l) --- r_associated #0: 20 --> phlébite n1=en:leukocytosis (mean leukocyte count 18.7 x 10(9)/l) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:leukocytosis with eosinophilia during stage 1 --- r_associated #0: 20 --> phlébite n1=en:leukocytosis with eosinophilia during stage 1 | n2=phlébite | rel=r_associated | relid=0 | w=20 en:leukocytosis with predominant granulocytosis (20,000-100,000 /mm3) common --- r_associated #0: 20 --> phlébite n1=en:leukocytosis with predominant granulocytosis (20,000-100,000 /mm3) common | n2=phlébite | rel=r_associated | relid=0 | w=20 en:leukoerythroblastosis --- r_associated #0: 20 --> phlébite n1=en:leukoerythroblastosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:leukopenia --- r_associated #0: 20 --> phlébite n1=en:leukopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:leukopenia (less common) --- r_associated #0: 20 --> phlébite n1=en:leukopenia (less common) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lewis a- and b- negative cells --- r_associated #0: 20 --> phlébite n1=en:lewis a- and b- negative cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lipid droplets in granulocytes --- r_associated #0: 20 --> phlébite n1=en:lipid droplets in granulocytes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:livedo reticularis --- r_associated #0: 20 --> phlébite n1=en:livedo reticularis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:locomotor test categorized by action status --- r_associated #0: 20 --> phlébite n1=en:locomotor test categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:long perforating arteries of the brain are affected --- r_associated #0: 20 --> phlébite n1=en:long perforating arteries of the brain are affected | n2=phlébite | rel=r_associated | relid=0 | w=20 en:louse-borne infectious disease --- r_associated #0: 20 --> phlébite n1=en:louse-borne infectious disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:low flow state --- r_associated #0: 20 --> phlébite n1=en:low flow state | n2=phlébite | rel=r_associated | relid=0 | w=20 en:low peripheral neutrophil counts (absolute neutrophil count less than 500/microliter) --- r_associated #0: 20 --> phlébite n1=en:low peripheral neutrophil counts (absolute neutrophil count less than 500/microliter) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:low resting blood pressure --- r_associated #0: 20 --> phlébite n1=en:low resting blood pressure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:low serum transferrin --- r_associated #0: 20 --> phlébite n1=en:low serum transferrin | n2=phlébite | rel=r_associated | relid=0 | w=20 en:low to low-normal platelet count --- r_associated #0: 20 --> phlébite n1=en:low to low-normal platelet count | n2=phlébite | rel=r_associated | relid=0 | w=20 en:low to normal reticulocyte count --- r_associated #0: 20 --> phlébite n1=en:low to normal reticulocyte count | n2=phlébite | rel=r_associated | relid=0 | w=20 en:low-normal platelet count in carrier females --- r_associated #0: 20 --> phlébite n1=en:low-normal platelet count in carrier females | n2=phlébite | rel=r_associated | relid=0 | w=20 en:low-to-normal blood pressure --- r_associated #0: 20 --> phlébite n1=en:low-to-normal blood pressure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:low-to-normal platelet count (45 x 10(9)/l) --- r_associated #0: 20 --> phlébite n1=en:low-to-normal platelet count (45 x 10(9)/l) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lower limb artery perforation --- r_associated #0: 20 --> phlébite n1=en:lower limb artery perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lowered biochemistry finding --- r_associated #0: 20 --> phlébite n1=en:lowered biochemistry finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lowered hematology finding --- r_associated #0: 20 --> phlébite n1=en:lowered hematology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lowered laboratory finding --- r_associated #0: 20 --> phlébite n1=en:lowered laboratory finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lowered microbiology finding --- r_associated #0: 20 --> phlébite n1=en:lowered microbiology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lumen of blood vessel --- r_associated #0: 20 --> phlébite n1=en:lumen of blood vessel | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lung trematode --- r_associated #0: 20 --> phlébite n1=en:lung trematode | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lupus anticoagulant (in some patients) --- r_associated #0: 20 --> phlébite n1=en:lupus anticoagulant (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lutheran negative phenotype --- r_associated #0: 20 --> phlébite n1=en:lutheran negative phenotype | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lymph fistula --- r_associated #0: 20 --> phlébite n1=en:lymph fistula | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lymphangioma --- r_associated #0: 20 --> phlébite n1=en:lymphangioma | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lymphatic abnormalities --- r_associated #0: 20 --> phlébite n1=en:lymphatic abnormalities | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lymphatic duct injury --- r_associated #0: 20 --> phlébite n1=en:lymphatic duct injury | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lymphatic malformation (low flow) (most cases) --- r_associated #0: 20 --> phlébite n1=en:lymphatic malformation (low flow) (most cases) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lymphedema --- r_associated #0: 20 --> phlébite n1=en:lymphedema | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lymphopenia --- r_associated #0: 20 --> phlébite n1=en:lymphopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:lymphoproliferative disorder --- r_associated #0: 20 --> phlébite n1=en:lymphoproliferative disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:macrocytic anemia --- r_associated #0: 20 --> phlébite n1=en:macrocytic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:macrocytic anemia (1 patient) --- r_associated #0: 20 --> phlébite n1=en:macrocytic anemia (1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:macrocytic anemia (folate or rarely b12 deficiency) --- r_associated #0: 20 --> phlébite n1=en:macrocytic anemia (folate or rarely b12 deficiency) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:macrocytic anemia in manifesting females --- r_associated #0: 20 --> phlébite n1=en:macrocytic anemia in manifesting females | n2=phlébite | rel=r_associated | relid=0 | w=20 en:macrocytic hemolytic anemia, appears in infancy (in 1 family) --- r_associated #0: 20 --> phlébite n1=en:macrocytic hemolytic anemia, appears in infancy (in 1 family) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:macrocytosis --- r_associated #0: 20 --> phlébite n1=en:macrocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:macrocytosis (in some patients) --- r_associated #0: 20 --> phlébite n1=en:macrocytosis (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:macrothrombocyte --- r_associated #0: 20 --> phlébite n1=en:macrothrombocyte | n2=phlébite | rel=r_associated | relid=0 | w=20 en:macrothrombocytes occasionally noted in carrier female peripheral blood smear --- r_associated #0: 20 --> phlébite n1=en:macrothrombocytes occasionally noted in carrier female peripheral blood smear | n2=phlébite | rel=r_associated | relid=0 | w=20 en:macrothrombocytopenia --- r_associated #0: 20 --> phlébite n1=en:macrothrombocytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mahler sign --- r_associated #0: 20 --> phlébite n1=en:mahler sign | n2=phlébite | rel=r_associated | relid=0 | w=20 en:malformation or hamartoma of apocrine sweat gland apparatus --- r_associated #0: 20 --> phlébite n1=en:malformation or hamartoma of apocrine sweat gland apparatus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:malformation or hamartoma of eccrine sweat gland apparatus --- r_associated #0: 20 --> phlébite n1=en:malformation or hamartoma of eccrine sweat gland apparatus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:malformation or hamartoma of pilosebaceous apparatus --- r_associated #0: 20 --> phlébite n1=en:malformation or hamartoma of pilosebaceous apparatus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:malformation or hamartoma of skin appendage --- r_associated #0: 20 --> phlébite n1=en:malformation or hamartoma of skin appendage | n2=phlébite | rel=r_associated | relid=0 | w=20 en:malignant atrophic papulosis --- r_associated #0: 20 --> phlébite n1=en:malignant atrophic papulosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:malignant melanoma of trunk, excluding scrotum --- r_associated #0: 20 --> phlébite n1=en:malignant melanoma of trunk, excluding scrotum | n2=phlébite | rel=r_associated | relid=0 | w=20 en:malignant neoplasm of digestive organs and peritoneum --- r_associated #0: 20 --> phlébite n1=en:malignant neoplasm of digestive organs and peritoneum | n2=phlébite | rel=r_associated | relid=0 | w=20 en:malignant neoplasm, overlapping lesion of connective and soft tissue --- r_associated #0: 20 --> phlébite n1=en:malignant neoplasm, overlapping lesion of connective and soft tissue | n2=phlébite | rel=r_associated | relid=0 | w=20 en:malignant tumor of mesothelial and soft tissue --- r_associated #0: 20 --> phlébite n1=en:malignant tumor of mesothelial and soft tissue | n2=phlébite | rel=r_associated | relid=0 | w=20 en:malposition of pulmonary vein branches adjacent to pulmonary artery branches (mpv) --- r_associated #0: 20 --> phlébite n1=en:malposition of pulmonary vein branches adjacent to pulmonary artery branches (mpv) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mammalian schistosome --- r_associated #0: 20 --> phlébite n1=en:mammalian schistosome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mast cell activation syndrome --- r_associated #0: 20 --> phlébite n1=en:mast cell activation syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mastocytosis --- r_associated #0: 20 --> phlébite n1=en:mastocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:maternal hypertension (after 20th week gestation, resolved postpartum) --- r_associated #0: 20 --> phlébite n1=en:maternal hypertension (after 20th week gestation, resolved postpartum) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:maternal pregnancy problem --- r_associated #0: 20 --> phlébite n1=en:maternal pregnancy problem | n2=phlébite | rel=r_associated | relid=0 | w=20 en:maturation arrest of neutrophil precursors seen on bone marrow biopsy --- r_associated #0: 20 --> phlébite n1=en:maturation arrest of neutrophil precursors seen on bone marrow biopsy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:may-thurner syndrome --- r_associated #0: 20 --> phlébite n1=en:may-thurner syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mcv - raised --- r_associated #0: 20 --> phlébite n1=en:mcv - raised | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mean corpuscular volume may mildly increased or normal --- r_associated #0: 20 --> phlébite n1=en:mean corpuscular volume may mildly increased or normal | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mechanical lesion --- r_associated #0: 20 --> phlébite n1=en:mechanical lesion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mechanical phlebitis --- r_associated #0: 20 --> phlébite n1=en:mechanical phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:medial calcification of medium-sized and major arteries --- r_associated #0: 20 --> phlébite n1=en:medial calcification of medium-sized and major arteries | n2=phlébite | rel=r_associated | relid=0 | w=20 en:median platelet volume 15.5fl --- r_associated #0: 20 --> phlébite n1=en:median platelet volume 15.5fl | n2=phlébite | rel=r_associated | relid=0 | w=20 en:medical device site phlebitis --- r_associated #0: 20 --> phlébite n1=en:medical device site phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:medical device site thrombosis --- r_associated #0: 20 --> phlébite n1=en:medical device site thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:medical device site vasculitis --- r_associated #0: 20 --> phlébite n1=en:medical device site vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:medullary arteries of the brain --- r_associated #0: 20 --> phlébite n1=en:medullary arteries of the brain | n2=phlébite | rel=r_associated | relid=0 | w=20 en:medullary blast count of less than 5% --- r_associated #0: 20 --> phlébite n1=en:medullary blast count of less than 5% | n2=phlébite | rel=r_associated | relid=0 | w=20 en:megakaryocytes are abnormally stretched along bone marrow sinuses --- r_associated #0: 20 --> phlébite n1=en:megakaryocytes are abnormally stretched along bone marrow sinuses | n2=phlébite | rel=r_associated | relid=0 | w=20 en:megakaryocytes have dysplastic features --- r_associated #0: 20 --> phlébite n1=en:megakaryocytes have dysplastic features | n2=phlébite | rel=r_associated | relid=0 | w=20 en:megakaryocytes increased in bone marrow --- r_associated #0: 20 --> phlébite n1=en:megakaryocytes increased in bone marrow | n2=phlébite | rel=r_associated | relid=0 | w=20 en:megakaryocytes show large and irregular bleb protrusions --- r_associated #0: 20 --> phlébite n1=en:megakaryocytes show large and irregular bleb protrusions | n2=phlébite | rel=r_associated | relid=0 | w=20 en:megakaryocytes show ultrastructural defects with abnormal membranes --- r_associated #0: 20 --> phlébite n1=en:megakaryocytes show ultrastructural defects with abnormal membranes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:megakaryocytes with hypolobulated nuclei or separated nuclei --- r_associated #0: 20 --> phlébite n1=en:megakaryocytes with hypolobulated nuclei or separated nuclei | n2=phlébite | rel=r_associated | relid=0 | w=20 en:megakaryocytopenia --- r_associated #0: 20 --> phlébite n1=en:megakaryocytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:megaloblastic anemia --- r_associated #0: 20 --> phlébite n1=en:megaloblastic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:megaloblastic anemia, chronic, relapsing --- r_associated #0: 20 --> phlébite n1=en:megaloblastic anemia, chronic, relapsing | n2=phlébite | rel=r_associated | relid=0 | w=20 en:megaloblastic erythropoiesis --- r_associated #0: 20 --> phlébite n1=en:megaloblastic erythropoiesis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:melanaemia --- r_associated #0: 20 --> phlébite n1=en:melanaemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:melanocytic nevi of ear and external auditory canal --- r_associated #0: 20 --> phlébite n1=en:melanocytic nevi of ear and external auditory canal | n2=phlébite | rel=r_associated | relid=0 | w=20 en:melanocytic nevi of eyelid, including canthus --- r_associated #0: 20 --> phlébite n1=en:melanocytic nevi of eyelid, including canthus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:melanocytic nevi of lower limb, including hip --- r_associated #0: 20 --> phlébite n1=en:melanocytic nevi of lower limb, including hip | n2=phlébite | rel=r_associated | relid=0 | w=20 en:melanocytic nevi of scalp and neck --- r_associated #0: 20 --> phlébite n1=en:melanocytic nevi of scalp and neck | n2=phlébite | rel=r_associated | relid=0 | w=20 en:melanocytic nevi of upper limb, including shoulder --- r_associated #0: 20 --> phlébite n1=en:melanocytic nevi of upper limb, including shoulder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:menorrhagia --- r_associated #0: 20 --> phlébite n1=en:menorrhagia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:menstrual disorder --- r_associated #0: 20 --> phlébite n1=en:menstrual disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mesenteric thrombosis --- r_associated #0: 20 --> phlébite n1=en:mesenteric thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mesenteric-portal fistula --- r_associated #0: 20 --> phlébite n1=en:mesenteric-portal fistula | n2=phlébite | rel=r_associated | relid=0 | w=20 en:metabolic aspects --- r_associated #0: 20 --> phlébite n1=en:metabolic aspects | n2=phlébite | rel=r_associated | relid=0 | w=20 en:metastatic malignant neoplasm in the bone marrow --- r_associated #0: 20 --> phlébite n1=en:metastatic malignant neoplasm in the bone marrow | n2=phlébite | rel=r_associated | relid=0 | w=20 en:metazoonosis --- r_associated #0: 20 --> phlébite n1=en:metazoonosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:methemoglobinemia --- r_associated #0: 20 --> phlébite n1=en:methemoglobinemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:methemoglobinemia (e.g. hb m boston 141800.0092) --- r_associated #0: 20 --> phlébite n1=en:methemoglobinemia (e.g. hb m boston 141800.0092) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:methemoglobinuria --- r_associated #0: 20 --> phlébite n1=en:methemoglobinuria | n2=phlébite | rel=r_associated | relid=0 | w=20 en:methods of tracheal or bronchial intubation --- r_associated #0: 20 --> phlébite n1=en:methods of tracheal or bronchial intubation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:methysergide --- r_associated #0: 20 --> phlébite n1=en:methysergide | n2=phlébite | rel=r_associated | relid=0 | w=20 en:methysergide maleate --- r_associated #0: 20 --> phlébite n1=en:methysergide maleate | n2=phlébite | rel=r_associated | relid=0 | w=20 en:methysergide maleate 2mg tablet --- r_associated #0: 20 --> phlébite n1=en:methysergide maleate 2mg tablet | n2=phlébite | rel=r_associated | relid=0 | w=20 en:microangiopathic hemolytic anemia --- r_associated #0: 20 --> phlébite n1=en:microangiopathic hemolytic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:microangiopathic hemolytic anemia (coomb negative) --- r_associated #0: 20 --> phlébite n1=en:microangiopathic hemolytic anemia (coomb negative) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:microbiological --- r_associated #0: 20 --> phlébite n1=en:microbiological | n2=phlébite | rel=r_associated | relid=0 | w=20 en:microbiology finding absent --- r_associated #0: 20 --> phlébite n1=en:microbiology finding absent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:microbiology finding present --- r_associated #0: 20 --> phlébite n1=en:microbiology finding present | n2=phlébite | rel=r_associated | relid=0 | w=20 en:microbiology test categorized by action status --- r_associated #0: 20 --> phlébite n1=en:microbiology test categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:microbleeds (less than 5 mm in diameter) occur at the gray-white matter junction in the cerebral hemispheres and cerebellum and do not occur in the thalamus, basal ganglia, or brainstem --- r_associated #0: 20 --> phlébite n1=en:microbleeds (less than 5 mm in diameter) occur at the gray-white matter junction in the cerebral hemispheres and cerebellum and do not occur in the thalamus, basal ganglia, or brainstem | n2=phlébite | rel=r_associated | relid=0 | w=20 en:microcirculatory bed --- r_associated #0: 20 --> phlébite n1=en:microcirculatory bed | n2=phlébite | rel=r_associated | relid=0 | w=20 en:microcytic anemia --- r_associated #0: 20 --> phlébite n1=en:microcytic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:microcytic hypochromic anemia (disorder) --- r_associated #0: 20 --> phlébite n1=en:microcytic hypochromic anemia (disorder) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:microcytosis --- r_associated #0: 20 --> phlébite n1=en:microcytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:microembolism --- r_associated #0: 20 --> phlébite n1=en:microembolism | n2=phlébite | rel=r_associated | relid=0 | w=20 en:micromegakaryocytes (in some patients) --- r_associated #0: 20 --> phlébite n1=en:micromegakaryocytes (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:microscopic polyarteritis --- r_associated #0: 20 --> phlébite n1=en:microscopic polyarteritis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:microvessels --- r_associated #0: 20 --> phlébite n1=en:microvessels | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mild alpha-granule deficiency --- r_associated #0: 20 --> phlébite n1=en:mild alpha-granule deficiency | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mild anemia --- r_associated #0: 20 --> phlébite n1=en:mild anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mild bleeding episodes (epistaxis, gi bleeding, menorrhagia) --- r_associated #0: 20 --> phlébite n1=en:mild bleeding episodes (epistaxis, gi bleeding, menorrhagia) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mild form of hemoglobin h (hb h) disease --- r_associated #0: 20 --> phlébite n1=en:mild form of hemoglobin h (hb h) disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mild hypochromic microcytic anemia --- r_associated #0: 20 --> phlébite n1=en:mild hypochromic microcytic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mild reticulocytosis in carrier females --- r_associated #0: 20 --> phlébite n1=en:mild reticulocytosis in carrier females | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mild thrombocytopenia --- r_associated #0: 20 --> phlébite n1=en:mild thrombocytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mild thrombocytopenia (before age 50) --- r_associated #0: 20 --> phlébite n1=en:mild thrombocytopenia (before age 50) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mild-moderate bleeding tendencies --- r_associated #0: 20 --> phlébite n1=en:mild-moderate bleeding tendencies | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mild-moderate prolonged bleeding time --- r_associated #0: 20 --> phlébite n1=en:mild-moderate prolonged bleeding time | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mild-significant bleeding episodes (epistaxis, easy bruisability, postoperative hemorrhage, menorrhagia) --- r_associated #0: 20 --> phlébite n1=en:mild-significant bleeding episodes (epistaxis, easy bruisability, postoperative hemorrhage, menorrhagia) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mildly decreased to low-normal platelet count (80-150 x 10(9)/l) --- r_associated #0: 20 --> phlébite n1=en:mildly decreased to low-normal platelet count (80-150 x 10(9)/l) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:minimally invasive procedure --- r_associated #0: 20 --> phlébite n1=en:minimally invasive procedure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:minor skin infection preparations a-z --- r_associated #0: 20 --> phlébite n1=en:minor skin infection preparations a-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:miscellaneous chemical agent --- r_associated #0: 20 --> phlébite n1=en:miscellaneous chemical agent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:miscellaneous drug --- r_associated #0: 20 --> phlébite n1=en:miscellaneous drug | n2=phlébite | rel=r_associated | relid=0 | w=20 en:miscellaneous products --- r_associated #0: 20 --> phlébite n1=en:miscellaneous products | n2=phlébite | rel=r_associated | relid=0 | w=20 en:miscellaneous topical agents --- r_associated #0: 20 --> phlébite n1=en:miscellaneous topical agents | n2=phlébite | rel=r_associated | relid=0 | w=20 en:miscellaneous topical preparations adverse reaction --- r_associated #0: 20 --> phlébite n1=en:miscellaneous topical preparations adverse reaction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:miscellaneous topical preparations allergy --- r_associated #0: 20 --> phlébite n1=en:miscellaneous topical preparations allergy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mite-borne hemorrhagic fever --- r_associated #0: 20 --> phlébite n1=en:mite-borne hemorrhagic fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mite-borne infectious disease --- r_associated #0: 20 --> phlébite n1=en:mite-borne infectious disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mitral perforation --- r_associated #0: 20 --> phlébite n1=en:mitral perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mitral valve, double orifice (rare) --- r_associated #0: 20 --> phlébite n1=en:mitral valve, double orifice (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mixed vaccine poisoning, excluding pertussis --- r_associated #0: 20 --> phlébite n1=en:mixed vaccine poisoning, excluding pertussis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:moderate-severe bleeding tendencies (epistaxis, menorrhagia, hemarthrosis, easy bruisability) --- r_associated #0: 20 --> phlébite n1=en:moderate-severe bleeding tendencies (epistaxis, menorrhagia, hemarthrosis, easy bruisability) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:monocytosis --- r_associated #0: 20 --> phlébite n1=en:monocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:monosomy 7 of bone marrow --- r_associated #0: 20 --> phlébite n1=en:monosomy 7 of bone marrow | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne alphavirus encephalitis --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne alphavirus encephalitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne alphavirus fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne alphavirus fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne alphavirus hemorrhagic fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne alphavirus hemorrhagic fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne arboviral fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne arboviral fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne bunyamwera group virus fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne bunyamwera group virus fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne bunyavirus hemorrhagic fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne bunyavirus hemorrhagic fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne bwamba group virus fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne bwamba group virus fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne california group virus fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne california group virus fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne flavivirus encephalitis --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne flavivirus encephalitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne flavivirus fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne flavivirus fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne flavivirus hemorrhagic fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne flavivirus hemorrhagic fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne guama group virus fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne guama group virus fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne hemorrhagic fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne hemorrhagic fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne infectious disease --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne infectious disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne orbivirus fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne orbivirus fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne orthobunyavirus encephalitis --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne orthobunyavirus encephalitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne orthobunyavirus fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne orthobunyavirus fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne rhabdovirus fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne rhabdovirus fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne serogroup c bunyavirus fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne serogroup c bunyavirus fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne simbu group virus fever --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne simbu group virus fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mosquito-borne viral encephalitis --- r_associated #0: 20 --> phlébite n1=en:mosquito-borne viral encephalitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mouth and genital ulcers with inflamed cartilage syndrome --- r_associated #0: 20 --> phlébite n1=en:mouth and genital ulcers with inflamed cartilage syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mouth, abdomen and bowel observations --- r_associated #0: 20 --> phlébite n1=en:mouth, abdomen and bowel observations | n2=phlébite | rel=r_associated | relid=0 | w=20 en:moya-moya phenomenon --- r_associated #0: 20 --> phlébite n1=en:moya-moya phenomenon | n2=phlébite | rel=r_associated | relid=0 | w=20 en:moyamoya disease --- r_associated #0: 20 --> phlébite n1=en:moyamoya disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mucocutaneous bleeding --- r_associated #0: 20 --> phlébite n1=en:mucocutaneous bleeding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:mucocutaneous bleeding due to platelet dysfunction --- r_associated #0: 20 --> phlébite n1=en:mucocutaneous bleeding due to platelet dysfunction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:multinuclear erythroblasts --- r_associated #0: 20 --> phlébite n1=en:multinuclear erythroblasts | n2=phlébite | rel=r_associated | relid=0 | w=20 en:multinucleated erythroblasts --- r_associated #0: 20 --> phlébite n1=en:multinucleated erythroblasts | n2=phlébite | rel=r_associated | relid=0 | w=20 en:multisystem disorder a-b --- r_associated #0: 20 --> phlébite n1=en:multisystem disorder a-b | n2=phlébite | rel=r_associated | relid=0 | w=20 en:multisystem disorder c-d --- r_associated #0: 20 --> phlébite n1=en:multisystem disorder c-d | n2=phlébite | rel=r_associated | relid=0 | w=20 en:multisystem disorder e-f --- r_associated #0: 20 --> phlébite n1=en:multisystem disorder e-f | n2=phlébite | rel=r_associated | relid=0 | w=20 en:multisystem disorder g-h --- r_associated #0: 20 --> phlébite n1=en:multisystem disorder g-h | n2=phlébite | rel=r_associated | relid=0 | w=20 en:multisystem disorder i-j --- r_associated #0: 20 --> phlébite n1=en:multisystem disorder i-j | n2=phlébite | rel=r_associated | relid=0 | w=20 en:multisystem disorder k-l --- r_associated #0: 20 --> phlébite n1=en:multisystem disorder k-l | n2=phlébite | rel=r_associated | relid=0 | w=20 en:multisystem disorder m-n --- r_associated #0: 20 --> phlébite n1=en:multisystem disorder m-n | n2=phlébite | rel=r_associated | relid=0 | w=20 en:multisystem disorder o-p --- r_associated #0: 20 --> phlébite n1=en:multisystem disorder o-p | n2=phlébite | rel=r_associated | relid=0 | w=20 en:multisystem disorder q-r --- r_associated #0: 20 --> phlébite n1=en:multisystem disorder q-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:multisystem disorder s-t --- r_associated #0: 20 --> phlébite n1=en:multisystem disorder s-t | n2=phlébite | rel=r_associated | relid=0 | w=20 en:multisystem disorder u-v --- r_associated #0: 20 --> phlébite n1=en:multisystem disorder u-v | n2=phlébite | rel=r_associated | relid=0 | w=20 en:multisystem disorder w-x --- r_associated #0: 20 --> phlébite n1=en:multisystem disorder w-x | n2=phlébite | rel=r_associated | relid=0 | w=20 en:multisystem disorder y-z --- r_associated #0: 20 --> phlébite n1=en:multisystem disorder y-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:muscle spasm --- r_associated #0: 20 --> phlébite n1=en:muscle spasm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:muscle, smooth, vascular --- r_associated #0: 20 --> phlébite n1=en:muscle, smooth, vascular | n2=phlébite | rel=r_associated | relid=0 | w=20 en:musculoskeletal functions and activities --- r_associated #0: 20 --> phlébite n1=en:musculoskeletal functions and activities | n2=phlébite | rel=r_associated | relid=0 | w=20 en:myelodysplastic syndrome --- r_associated #0: 20 --> phlébite n1=en:myelodysplastic syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:myelofibrosis --- r_associated #0: 20 --> phlébite n1=en:myelofibrosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:myelokathexis (retention of neutrophils in the bone marrow) --- r_associated #0: 20 --> phlébite n1=en:myelokathexis (retention of neutrophils in the bone marrow) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:myeloproliferative disease --- r_associated #0: 20 --> phlébite n1=en:myeloproliferative disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:myelosuppression develops on standard doses of thiopurine drugs --- r_associated #0: 20 --> phlébite n1=en:myelosuppression develops on standard doses of thiopurine drugs | n2=phlébite | rel=r_associated | relid=0 | w=20 en:myh9-positive inclusions on immunohistochemical staining --- r_associated #0: 20 --> phlébite n1=en:myh9-positive inclusions on immunohistochemical staining | n2=phlébite | rel=r_associated | relid=0 | w=20 en:myocardial bridging --- r_associated #0: 20 --> phlébite n1=en:myocardial bridging | n2=phlébite | rel=r_associated | relid=0 | w=20 en:myocardial oedema --- r_associated #0: 20 --> phlébite n1=en:myocardial oedema | n2=phlébite | rel=r_associated | relid=0 | w=20 en:myocardial reperfusion injury --- r_associated #0: 20 --> phlébite n1=en:myocardial reperfusion injury | n2=phlébite | rel=r_associated | relid=0 | w=20 en:nasogastric administration of treatment --- r_associated #0: 20 --> phlébite n1=en:nasogastric administration of treatment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:necrotizing vasculitis --- r_associated #0: 20 --> phlébite n1=en:necrotizing vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:negative biochemistry finding --- r_associated #0: 20 --> phlébite n1=en:negative biochemistry finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:negative immunology finding --- r_associated #0: 20 --> phlébite n1=en:negative immunology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:negative laboratory finding --- r_associated #0: 20 --> phlébite n1=en:negative laboratory finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:negative microbiology finding --- r_associated #0: 20 --> phlébite n1=en:negative microbiology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:negative virology finding --- r_associated #0: 20 --> phlébite n1=en:negative virology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neonatal alloimmune thrombocytopenia (nait) --- r_associated #0: 20 --> phlébite n1=en:neonatal alloimmune thrombocytopenia (nait) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neonatal cardiovascular disorder --- r_associated #0: 20 --> phlébite n1=en:neonatal cardiovascular disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neonatal circulatory failure --- r_associated #0: 20 --> phlébite n1=en:neonatal circulatory failure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neonatal hemolytic anemia (harderoporphyria) --- r_associated #0: 20 --> phlébite n1=en:neonatal hemolytic anemia (harderoporphyria) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neonatal hypertension --- r_associated #0: 20 --> phlébite n1=en:neonatal hypertension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neonatal pulmonary hypertension --- r_associated #0: 20 --> phlébite n1=en:neonatal pulmonary hypertension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neonatal research network terminology --- r_associated #0: 20 --> phlébite n1=en:neonatal research network terminology | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neoplasm of heart and/or pericardium --- r_associated #0: 20 --> phlébite n1=en:neoplasm of heart and/or pericardium | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neoplasm of mesothelial tissue of site other than pleura and pericardium --- r_associated #0: 20 --> phlébite n1=en:neoplasm of mesothelial tissue of site other than pleura and pericardium | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neoplasm of uncertain behavior of histiocytic and mast cells --- r_associated #0: 20 --> phlébite n1=en:neoplasm of uncertain behavior of histiocytic and mast cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neoplasm of uncertain behavior of pleura, thymus and mediastinum --- r_associated #0: 20 --> phlébite n1=en:neoplasm of uncertain behavior of pleura, thymus and mediastinum | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neoplasm of uncertain behavior of stomach, intestines and rectum --- r_associated #0: 20 --> phlébite n1=en:neoplasm of uncertain behavior of stomach, intestines and rectum | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neoplasm of uncertain behavior of trachea, bronchus and lung --- r_associated #0: 20 --> phlébite n1=en:neoplasm of uncertain behavior of trachea, bronchus and lung | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neurological sample --- r_associated #0: 20 --> phlébite n1=en:neurological sample | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neurological test categorized by action status --- r_associated #0: 20 --> phlébite n1=en:neurological test categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neutropenia --- r_associated #0: 20 --> phlébite n1=en:neutropenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neutropenia (in some patients) --- r_associated #0: 20 --> phlébite n1=en:neutropenia (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neutropenia, chronic or cyclic --- r_associated #0: 20 --> phlébite n1=en:neutropenia, chronic or cyclic | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neutropenia, mild --- r_associated #0: 20 --> phlébite n1=en:neutropenia, mild | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neutropenia, variable --- r_associated #0: 20 --> phlébite n1=en:neutropenia, variable | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neutrophil maturation in bone marrow intact --- r_associated #0: 20 --> phlébite n1=en:neutrophil maturation in bone marrow intact | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neutrophil membranes show absence of sialyl-lewis-x --- r_associated #0: 20 --> phlébite n1=en:neutrophil membranes show absence of sialyl-lewis-x | n2=phlébite | rel=r_associated | relid=0 | w=20 en:neutrophilia --- r_associated #0: 20 --> phlébite n1=en:neutrophilia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:nevus araneus --- r_associated #0: 20 --> phlébite n1=en:nevus araneus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:nicolau syndrome --- r_associated #0: 20 --> phlébite n1=en:nicolau syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no 'swiss cheese' abnormality --- r_associated #0: 20 --> phlébite n1=en:no 'swiss cheese' abnormality | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no abnormal biochemistry finding detected --- r_associated #0: 20 --> phlébite n1=en:no abnormal biochemistry finding detected | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no abnormal laboratory finding detected --- r_associated #0: 20 --> phlébite n1=en:no abnormal laboratory finding detected | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no abnormal microbiology finding detected --- r_associated #0: 20 --> phlébite n1=en:no abnormal microbiology finding detected | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no abnormality --- r_associated #0: 20 --> phlébite n1=en:no abnormality | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no bone marrow abnormalities --- r_associated #0: 20 --> phlébite n1=en:no bone marrow abnormalities | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no childhood hypertension --- r_associated #0: 20 --> phlébite n1=en:no childhood hypertension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no hemolysis --- r_associated #0: 20 --> phlébite n1=en:no hemolysis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no hemophagocytosis --- r_associated #0: 20 --> phlébite n1=en:no hemophagocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no hypertension --- r_associated #0: 20 --> phlébite n1=en:no hypertension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no increased bleeding tendency --- r_associated #0: 20 --> phlébite n1=en:no increased bleeding tendency | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no increased risk of thrombotic vascular events --- r_associated #0: 20 --> phlébite n1=en:no increased risk of thrombotic vascular events | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no leukocyte inclusion bodies on giemsa staining --- r_associated #0: 20 --> phlébite n1=en:no leukocyte inclusion bodies on giemsa staining | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no leukocyte inclusions on giemsa staining --- r_associated #0: 20 --> phlébite n1=en:no leukocyte inclusions on giemsa staining | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no neutrophil inclusions --- r_associated #0: 20 --> phlébite n1=en:no neutrophil inclusions | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no raynaud phenomenon --- r_associated #0: 20 --> phlébite n1=en:no raynaud phenomenon | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no thrombus --- r_associated #0: 20 --> phlébite n1=en:no thrombus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:no vascular tortuosity --- r_associated #0: 20 --> phlébite n1=en:no vascular tortuosity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:nodular inflammatory vasculitis --- r_associated #0: 20 --> phlébite n1=en:nodular inflammatory vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:nodular vasculitis --- r_associated #0: 20 --> phlébite n1=en:nodular vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:non-medicinal substance --- r_associated #0: 20 --> phlébite n1=en:non-medicinal substance | n2=phlébite | rel=r_associated | relid=0 | w=20 en:non-neoplastic cardiovascular disorder --- r_associated #0: 20 --> phlébite n1=en:non-neoplastic cardiovascular disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:non-neoplastic hematologic and lymphocytic disorder --- r_associated #0: 20 --> phlébite n1=en:non-neoplastic hematologic and lymphocytic disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:non-site specific embolism and thrombosis --- r_associated #0: 20 --> phlébite n1=en:non-site specific embolism and thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:nonclonal myeloproliferation --- r_associated #0: 20 --> phlébite n1=en:nonclonal myeloproliferation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:noninfectious, erythematous, papular and/or squamous disease --- r_associated #0: 20 --> phlébite n1=en:noninfectious, erythematous, papular and/or squamous disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:noninfectious, vesicular and/or bullous disease --- r_associated #0: 20 --> phlébite n1=en:noninfectious, vesicular and/or bullous disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal beta-thromboglobulin --- r_associated #0: 20 --> phlébite n1=en:normal beta-thromboglobulin | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal biochemistry finding --- r_associated #0: 20 --> phlébite n1=en:normal biochemistry finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal blood pressure --- r_associated #0: 20 --> phlébite n1=en:normal blood pressure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal hematologic parameters (both patients) --- r_associated #0: 20 --> phlébite n1=en:normal hematologic parameters (both patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal hematology finding --- r_associated #0: 20 --> phlébite n1=en:normal hematology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal heterochromatin in erythroblasts --- r_associated #0: 20 --> phlébite n1=en:normal heterochromatin in erythroblasts | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal immunology finding --- r_associated #0: 20 --> phlébite n1=en:normal immunology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal laboratory finding --- r_associated #0: 20 --> phlébite n1=en:normal laboratory finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal levels of known coagulation factors --- r_associated #0: 20 --> phlébite n1=en:normal levels of known coagulation factors | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal mean platelet volume (mpv) --- r_associated #0: 20 --> phlébite n1=en:normal mean platelet volume (mpv) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal microbiology finding --- r_associated #0: 20 --> phlébite n1=en:normal microbiology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal or increased platelet count --- r_associated #0: 20 --> phlébite n1=en:normal or increased platelet count | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal oxygen affinity of hemoglobin --- r_associated #0: 20 --> phlébite n1=en:normal oxygen affinity of hemoglobin | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal peripheral red blood cell survival time --- r_associated #0: 20 --> phlébite n1=en:normal peripheral red blood cell survival time | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal platelet aggregation response to ristocetin and arachidonic acid (aa) --- r_associated #0: 20 --> phlébite n1=en:normal platelet aggregation response to ristocetin and arachidonic acid (aa) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal platelet aggregation studies --- r_associated #0: 20 --> phlébite n1=en:normal platelet aggregation studies | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal platelet fibrinogen --- r_associated #0: 20 --> phlébite n1=en:normal platelet fibrinogen | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal platelet size --- r_associated #0: 20 --> phlébite n1=en:normal platelet size | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal platelet size (normal mpv) --- r_associated #0: 20 --> phlébite n1=en:normal platelet size (normal mpv) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal platelet size and morphology --- r_associated #0: 20 --> phlébite n1=en:normal platelet size and morphology | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal prothrombin and partial chromoplastin times --- r_associated #0: 20 --> phlébite n1=en:normal prothrombin and partial chromoplastin times | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal pulmonary vein pressures --- r_associated #0: 20 --> phlébite n1=en:normal pulmonary vein pressures | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal red cell osmotic fragility --- r_associated #0: 20 --> phlébite n1=en:normal red cell osmotic fragility | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal serum thromboxane b2 --- r_associated #0: 20 --> phlébite n1=en:normal serum thromboxane b2 | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal thrombospondin --- r_associated #0: 20 --> phlébite n1=en:normal thrombospondin | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normal von willebrand factor --- r_associated #0: 20 --> phlébite n1=en:normal von willebrand factor | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normochromic anemia --- r_associated #0: 20 --> phlébite n1=en:normochromic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normocytic anemia --- r_associated #0: 20 --> phlébite n1=en:normocytic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normocytic hypoplastic anemia --- r_associated #0: 20 --> phlébite n1=en:normocytic hypoplastic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:normocytic pancytopenia following sulfa use --- r_associated #0: 20 --> phlébite n1=en:normocytic pancytopenia following sulfa use | n2=phlébite | rel=r_associated | relid=0 | w=20 en:nucleated peripheral red cells --- r_associated #0: 20 --> phlébite n1=en:nucleated peripheral red cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:nucleated red cells in peripheral blood --- r_associated #0: 20 --> phlébite n1=en:nucleated red cells in peripheral blood | n2=phlébite | rel=r_associated | relid=0 | w=20 en:nursing attributes a - l --- r_associated #0: 20 --> phlébite n1=en:nursing attributes a - l | n2=phlébite | rel=r_associated | relid=0 | w=20 en:nursing attributes m - s --- r_associated #0: 20 --> phlébite n1=en:nursing attributes m - s | n2=phlébite | rel=r_associated | relid=0 | w=20 en:nursing attributes t - z --- r_associated #0: 20 --> phlébite n1=en:nursing attributes t - z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:nursing therapy --- r_associated #0: 20 --> phlébite n1=en:nursing therapy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:nutritional management --- r_associated #0: 20 --> phlébite n1=en:nutritional management | n2=phlébite | rel=r_associated | relid=0 | w=20 en:obligate parasite --- r_associated #0: 20 --> phlébite n1=en:obligate parasite | n2=phlébite | rel=r_associated | relid=0 | w=20 en:obstetrics and gynecology sample --- r_associated #0: 20 --> phlébite n1=en:obstetrics and gynecology sample | n2=phlébite | rel=r_associated | relid=0 | w=20 en:obstruction of right atrial conduit after prior total cavopulmonary connection procedure --- r_associated #0: 20 --> phlébite n1=en:obstruction of right atrial conduit after prior total cavopulmonary connection procedure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:obstruction of right atrial tunnel after prior total cavopulmonary connection procedure --- r_associated #0: 20 --> phlébite n1=en:obstruction of right atrial tunnel after prior total cavopulmonary connection procedure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:obstructive morphology --- r_associated #0: 20 --> phlébite n1=en:obstructive morphology | n2=phlébite | rel=r_associated | relid=0 | w=20 en:obstructive thrombosis --- r_associated #0: 20 --> phlébite n1=en:obstructive thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:occlusion --- r_associated #0: 20 --> phlébite n1=en:occlusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:occlusion mesenteric --- r_associated #0: 20 --> phlébite n1=en:occlusion mesenteric | n2=phlébite | rel=r_associated | relid=0 | w=20 en:occlusion mesenteric vein --- r_associated #0: 20 --> phlébite n1=en:occlusion mesenteric vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ocular vasculitis --- r_associated #0: 20 --> phlébite n1=en:ocular vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:oculovestibuloauditory syndrome --- r_associated #0: 20 --> phlébite n1=en:oculovestibuloauditory syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:oral administration of treatment --- r_associated #0: 20 --> phlébite n1=en:oral administration of treatment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:oral cavity, salivary glands and jaw diseases --- r_associated #0: 20 --> phlébite n1=en:oral cavity, salivary glands and jaw diseases | n2=phlébite | rel=r_associated | relid=0 | w=20 en:oral dermatological agent allergy --- r_associated #0: 20 --> phlébite n1=en:oral dermatological agent allergy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:orbital thrombophlebitis --- r_associated #0: 20 --> phlébite n1=en:orbital thrombophlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:organ or tissue harvesting and transplantation procedures --- r_associated #0: 20 --> phlébite n1=en:organ or tissue harvesting and transplantation procedures | n2=phlébite | rel=r_associated | relid=0 | w=20 en:organic blood flow disorder --- r_associated #0: 20 --> phlébite n1=en:organic blood flow disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:organic compounds a-c --- r_associated #0: 20 --> phlébite n1=en:organic compounds a-c | n2=phlébite | rel=r_associated | relid=0 | w=20 en:organic compounds d-h --- r_associated #0: 20 --> phlébite n1=en:organic compounds d-h | n2=phlébite | rel=r_associated | relid=0 | w=20 en:organic compounds i-r --- r_associated #0: 20 --> phlébite n1=en:organic compounds i-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:organic compounds s-z --- r_associated #0: 20 --> phlébite n1=en:organic compounds s-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:orthostatic acrocyanosis --- r_associated #0: 20 --> phlébite n1=en:orthostatic acrocyanosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:orthostatic hypotension --- r_associated #0: 20 --> phlébite n1=en:orthostatic hypotension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:orthostatic hypotension due to autonomic dysfunction --- r_associated #0: 20 --> phlébite n1=en:orthostatic hypotension due to autonomic dysfunction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:orthostatic hypotension, severe, recurrent --- r_associated #0: 20 --> phlébite n1=en:orthostatic hypotension, severe, recurrent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:osmotic fragility (finding) --- r_associated #0: 20 --> phlébite n1=en:osmotic fragility (finding) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:osteitis deformans and osteopathies associated with other diseases --- r_associated #0: 20 --> phlébite n1=en:osteitis deformans and osteopathies associated with other diseases | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other anaemias --- r_associated #0: 20 --> phlébite n1=en:other anaemias | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other and unspecified disorders of the circulatory system --- r_associated #0: 20 --> phlébite n1=en:other and unspecified disorders of the circulatory system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other cardiovascular diseases complicating pregnancy, childbirth, or the puerperium --- r_associated #0: 20 --> phlébite n1=en:other cardiovascular diseases complicating pregnancy, childbirth, or the puerperium | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other cardiovascular diseases of mother complicating pregnancy, childbirth, or the puerperium, unspe --- r_associated #0: 20 --> phlébite n1=en:other cardiovascular diseases of mother complicating pregnancy, childbirth, or the puerperium, unspe | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other cardiovascular diseases of mother, antepartum condition or complication --- r_associated #0: 20 --> phlébite n1=en:other cardiovascular diseases of mother, antepartum condition or complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other cardiovascular diseases of mother, delivered, with mention of postpartum complication --- r_associated #0: 20 --> phlébite n1=en:other cardiovascular diseases of mother, delivered, with mention of postpartum complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other cardiovascular diseases of mother, delivered, with or without mention of antepartum condition --- r_associated #0: 20 --> phlébite n1=en:other cardiovascular diseases of mother, delivered, with or without mention of antepartum condition | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other cardiovascular diseases of mother, postpartum condition or complication --- r_associated #0: 20 --> phlébite n1=en:other cardiovascular diseases of mother, postpartum condition or complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other deficiency anemias --- r_associated #0: 20 --> phlébite n1=en:other deficiency anemias | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other diseases of blood and blood-forming organs --- r_associated #0: 20 --> phlébite n1=en:other diseases of blood and blood-forming organs | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other hematologic conditions --- r_associated #0: 20 --> phlébite n1=en:other hematologic conditions | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other peripheral vascular disease --- r_associated #0: 20 --> phlébite n1=en:other peripheral vascular disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other phlebitis and thrombosis complicating pregnancy and the puerperium, antepartum condition or complication --- r_associated #0: 20 --> phlébite n1=en:other phlebitis and thrombosis complicating pregnancy and the puerperium, antepartum condition or complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other phlebitis and thrombosis complicating pregnancy and the puerperium, delivered, with mention of postpartum complication --- r_associated #0: 20 --> phlébite n1=en:other phlebitis and thrombosis complicating pregnancy and the puerperium, delivered, with mention of postpartum complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other phlebitis and thrombosis complicating pregnancy and the puerperium, delivered, with or without mention of antepartum condition --- r_associated #0: 20 --> phlébite n1=en:other phlebitis and thrombosis complicating pregnancy and the puerperium, delivered, with or without mention of antepartum condition | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other phlebitis and thrombosis complicating pregnancy and the puerperium, unspecified as to episode of care or not applicable --- r_associated #0: 20 --> phlébite n1=en:other phlebitis and thrombosis complicating pregnancy and the puerperium, unspecified as to episode of care or not applicable | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other phlebitis and thrombosis in pregnancy and the puerperium --- r_associated #0: 20 --> phlébite n1=en:other phlebitis and thrombosis in pregnancy and the puerperium | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other specified diseases of blood and blood-forming organs --- r_associated #0: 20 --> phlébite n1=en:other specified diseases of blood and blood-forming organs | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other specified disorders of circulatory system --- r_associated #0: 20 --> phlébite n1=en:other specified disorders of circulatory system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other specified peripheral vascular disease not elsewhere classified --- r_associated #0: 20 --> phlébite n1=en:other specified peripheral vascular disease not elsewhere classified | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other specified peripheral vascular diseases --- r_associated #0: 20 --> phlébite n1=en:other specified peripheral vascular diseases | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other specified transient hematological disorders of fetus or newborn --- r_associated #0: 20 --> phlébite n1=en:other specified transient hematological disorders of fetus or newborn | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other symptoms involving cardiovascular system --- r_associated #0: 20 --> phlébite n1=en:other symptoms involving cardiovascular system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other venous complications in pregnancy --- r_associated #0: 20 --> phlébite n1=en:other venous complications in pregnancy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other venous complications in pregnancy and the puerperium --- r_associated #0: 20 --> phlébite n1=en:other venous complications in pregnancy and the puerperium | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other venous complications in the puerperium --- r_associated #0: 20 --> phlébite n1=en:other venous complications in the puerperium | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other venous complications of pregnancy and the puerperium, delivered, with mention of postpartum complication --- r_associated #0: 20 --> phlébite n1=en:other venous complications of pregnancy and the puerperium, delivered, with mention of postpartum complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other venous complications of pregnancy and the puerperium, delivered, with or without mention of antepartum condition --- r_associated #0: 20 --> phlébite n1=en:other venous complications of pregnancy and the puerperium, delivered, with or without mention of antepartum condition | n2=phlébite | rel=r_associated | relid=0 | w=20 en:other venous complications of pregnancy and the puerperium, unspecified as to episode of care or not applicable --- r_associated #0: 20 --> phlébite n1=en:other venous complications of pregnancy and the puerperium, unspecified as to episode of care or not applicable | n2=phlébite | rel=r_associated | relid=0 | w=20 en:outcome --- r_associated #0: 20 --> phlébite n1=en:outcome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:outer leaf hole --- r_associated #0: 20 --> phlébite n1=en:outer leaf hole | n2=phlébite | rel=r_associated | relid=0 | w=20 en:oval macrocyte --- r_associated #0: 20 --> phlébite n1=en:oval macrocyte | n2=phlébite | rel=r_associated | relid=0 | w=20 en:overriding aorta --- r_associated #0: 20 --> phlébite n1=en:overriding aorta | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ovoid granulocyte nuclei (homozygote) --- r_associated #0: 20 --> phlébite n1=en:ovoid granulocyte nuclei (homozygote) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:panagiitis --- r_associated #0: 20 --> phlébite n1=en:panagiitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:panarteritis (rare) --- r_associated #0: 20 --> phlébite n1=en:panarteritis (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pancytopenia --- r_associated #0: 20 --> phlébite n1=en:pancytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pancytopenia (4 patients) --- r_associated #0: 20 --> phlébite n1=en:pancytopenia (4 patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pancytopenia (childhood) --- r_associated #0: 20 --> phlébite n1=en:pancytopenia (childhood) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pancytopenia (in 2 of 3 siblings) --- r_associated #0: 20 --> phlébite n1=en:pancytopenia (in 2 of 3 siblings) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pancytopenia (in 50% of patients) --- r_associated #0: 20 --> phlébite n1=en:pancytopenia (in 50% of patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pancytopenia (in some patients) --- r_associated #0: 20 --> phlébite n1=en:pancytopenia (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pancytopenia, episodic --- r_associated #0: 20 --> phlébite n1=en:pancytopenia, episodic | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pappenheimer body (morphologic abnormality) --- r_associated #0: 20 --> phlébite n1=en:pappenheimer body (morphologic abnormality) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:papular, squamous and granulomatous eruptions of skin --- r_associated #0: 20 --> phlébite n1=en:papular, squamous and granulomatous eruptions of skin | n2=phlébite | rel=r_associated | relid=0 | w=20 en:parasite --- r_associated #0: 20 --> phlébite n1=en:parasite | n2=phlébite | rel=r_associated | relid=0 | w=20 en:parasitic fluke --- r_associated #0: 20 --> phlébite n1=en:parasitic fluke | n2=phlébite | rel=r_associated | relid=0 | w=20 en:parasitic nematode --- r_associated #0: 20 --> phlébite n1=en:parasitic nematode | n2=phlébite | rel=r_associated | relid=0 | w=20 en:parasitology --- r_associated #0: 20 --> phlébite n1=en:parasitology | n2=phlébite | rel=r_associated | relid=0 | w=20 en:paravalvular aortic regurgitation --- r_associated #0: 20 --> phlébite n1=en:paravalvular aortic regurgitation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:parenteral route of administration --- r_associated #0: 20 --> phlébite n1=en:parenteral route of administration | n2=phlébite | rel=r_associated | relid=0 | w=20 en:paroxysmal nocturnal hemoglobinuria --- r_associated #0: 20 --> phlébite n1=en:paroxysmal nocturnal hemoglobinuria | n2=phlébite | rel=r_associated | relid=0 | w=20 en:patent ductus arteriosus --- r_associated #0: 20 --> phlébite n1=en:patent ductus arteriosus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:patent ductus arteriosus (2 patients) --- r_associated #0: 20 --> phlébite n1=en:patent ductus arteriosus (2 patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:patent ductus arteriosus (in 1 reported case) --- r_associated #0: 20 --> phlébite n1=en:patent ductus arteriosus (in 1 reported case) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:patent ductus arteriosus (in some patients) --- r_associated #0: 20 --> phlébite n1=en:patent ductus arteriosus (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:patent ductus arteriosus (less common) --- r_associated #0: 20 --> phlébite n1=en:patent ductus arteriosus (less common) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:patent ductus arteriosus (rare) --- r_associated #0: 20 --> phlébite n1=en:patent ductus arteriosus (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pathogen --- r_associated #0: 20 --> phlébite n1=en:pathogen | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pathologic hemolysis --- r_associated #0: 20 --> phlébite n1=en:pathologic hemolysis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pathologic perinuclear mitochondrial iron deposits in erythrocyte precursors --- r_associated #0: 20 --> phlébite n1=en:pathologic perinuclear mitochondrial iron deposits in erythrocyte precursors | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pathological aspects --- r_associated #0: 20 --> phlébite n1=en:pathological aspects | n2=phlébite | rel=r_associated | relid=0 | w=20 en:patient problem --- r_associated #0: 20 --> phlébite n1=en:patient problem | n2=phlébite | rel=r_associated | relid=0 | w=20 en:patient problem codes fda cdrh --- r_associated #0: 20 --> phlébite n1=en:patient problem codes fda cdrh | n2=phlébite | rel=r_associated | relid=0 | w=20 en:patients with type 2b develop thrombocytopenia --- r_associated #0: 20 --> phlébite n1=en:patients with type 2b develop thrombocytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pediatric adverse events terminology --- r_associated #0: 20 --> phlébite n1=en:pediatric adverse events terminology | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pediatric terminology --- r_associated #0: 20 --> phlébite n1=en:pediatric terminology | n2=phlébite | rel=r_associated | relid=0 | w=20 en:perforation --- r_associated #0: 20 --> phlébite n1=en:perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:perforation iliac artery --- r_associated #0: 20 --> phlébite n1=en:perforation iliac artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:perforation of femoral artery --- r_associated #0: 20 --> phlébite n1=en:perforation of femoral artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:perfusion disorder --- r_associated #0: 20 --> phlébite n1=en:perfusion disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:perinatal cardiovascular disorders --- r_associated #0: 20 --> phlébite n1=en:perinatal cardiovascular disorders | n2=phlébite | rel=r_associated | relid=0 | w=20 en:perinatal hematologic problems --- r_associated #0: 20 --> phlébite n1=en:perinatal hematologic problems | n2=phlébite | rel=r_associated | relid=0 | w=20 en:perinatal rupture of superficial cerebral vein --- r_associated #0: 20 --> phlébite n1=en:perinatal rupture of superficial cerebral vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral angiopathy in diseases classified elsewhere --- r_associated #0: 20 --> phlébite n1=en:peripheral angiopathy in diseases classified elsewhere | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral arterial disorder --- r_associated #0: 20 --> phlébite n1=en:peripheral arterial disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral arterial reocclusion --- r_associated #0: 20 --> phlébite n1=en:peripheral arterial reocclusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral blood smear shows abnormal red cells --- r_associated #0: 20 --> phlébite n1=en:peripheral blood smear shows abnormal red cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral blood smear shows polychromasia --- r_associated #0: 20 --> phlébite n1=en:peripheral blood smear shows polychromasia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral blood vessel --- r_associated #0: 20 --> phlébite n1=en:peripheral blood vessel | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral embolism and thrombosis --- r_associated #0: 20 --> phlébite n1=en:peripheral embolism and thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral pulmonary artery stenosis --- r_associated #0: 20 --> phlébite n1=en:peripheral pulmonary artery stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral pulmonary stenosis (in some patients) --- r_associated #0: 20 --> phlébite n1=en:peripheral pulmonary stenosis (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral pulmonary vessel aplasia --- r_associated #0: 20 --> phlébite n1=en:peripheral pulmonary vessel aplasia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral pulse absent --- r_associated #0: 20 --> phlébite n1=en:peripheral pulse absent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral thrombosis --- r_associated #0: 20 --> phlébite n1=en:peripheral thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral vascular complication --- r_associated #0: 20 --> phlébite n1=en:peripheral vascular complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral vascular complication of procedure --- r_associated #0: 20 --> phlébite n1=en:peripheral vascular complication of procedure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral vascular complications of care --- r_associated #0: 20 --> phlébite n1=en:peripheral vascular complications of care | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral vascular disease associated with another disorder --- r_associated #0: 20 --> phlébite n1=en:peripheral vascular disease associated with another disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral vascular disorder --- r_associated #0: 20 --> phlébite n1=en:peripheral vascular disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral vascular insufficiency --- r_associated #0: 20 --> phlébite n1=en:peripheral vascular insufficiency | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral vascular occlusive disease (in some patients) --- r_associated #0: 20 --> phlébite n1=en:peripheral vascular occlusive disease (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral vein complication following surgery --- r_associated #0: 20 --> phlébite n1=en:peripheral vein complication following surgery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:peripheral venous malformation --- r_associated #0: 20 --> phlébite n1=en:peripheral venous malformation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:perispinal vascular malformations, high-flow (in some patients) --- r_associated #0: 20 --> phlébite n1=en:perispinal vascular malformations, high-flow (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:perivascular space --- r_associated #0: 20 --> phlébite n1=en:perivascular space | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pernicious anemia --- r_associated #0: 20 --> phlébite n1=en:pernicious anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pernicious anemia, not influenced by intrinsic factor --- r_associated #0: 20 --> phlébite n1=en:pernicious anemia, not influenced by intrinsic factor | n2=phlébite | rel=r_associated | relid=0 | w=20 en:persistence of fetal hemoglobin --- r_associated #0: 20 --> phlébite n1=en:persistence of fetal hemoglobin | n2=phlébite | rel=r_associated | relid=0 | w=20 en:persistence of fetal hemoglobin (5-30% hbf) --- r_associated #0: 20 --> phlébite n1=en:persistence of fetal hemoglobin (5-30% hbf) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:persistent ductus arteriosus (rare) --- r_associated #0: 20 --> phlébite n1=en:persistent ductus arteriosus (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:persistent left superior vena cava --- r_associated #0: 20 --> phlébite n1=en:persistent left superior vena cava | n2=phlébite | rel=r_associated | relid=0 | w=20 en:persistent left superior vena cava (rare) --- r_associated #0: 20 --> phlébite n1=en:persistent left superior vena cava (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:persistent or intermittent neutropenia --- r_associated #0: 20 --> phlébite n1=en:persistent or intermittent neutropenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:petechia --- r_associated #0: 20 --> phlébite n1=en:petechia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pharmaceutical excipient poisoning --- r_associated #0: 20 --> phlébite n1=en:pharmaceutical excipient poisoning | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pharmacotherapeutic --- r_associated #0: 20 --> phlébite n1=en:pharmacotherapeutic | n2=phlébite | rel=r_associated | relid=0 | w=20 en:philadelphia chromosome-positive acute lymphoblastic leukemia --- r_associated #0: 20 --> phlébite n1=en:philadelphia chromosome-positive acute lymphoblastic leukemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:phlebitis and thrombophlebitis --- r_associated #0: 20 --> phlébite n1=en:phlebitis and thrombophlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:phlebitis and thrombophlebitis of intracranial sinuses --- r_associated #0: 20 --> phlébite n1=en:phlebitis and thrombophlebitis of intracranial sinuses | n2=phlébite | rel=r_associated | relid=0 | w=20 en:phlebitis and thrombophlebitis of lower extremities, unspecified --- r_associated #0: 20 --> phlébite n1=en:phlebitis and thrombophlebitis of lower extremities, unspecified | n2=phlébite | rel=r_associated | relid=0 | w=20 en:phlebitis and thrombophlebitis of other deep vessels of lower extremities --- r_associated #0: 20 --> phlébite n1=en:phlebitis and thrombophlebitis of other deep vessels of lower extremities | n2=phlébite | rel=r_associated | relid=0 | w=20 en:phlebitis and thrombophlebitis of other sites --- r_associated #0: 20 --> phlébite n1=en:phlebitis and thrombophlebitis of other sites | n2=phlébite | rel=r_associated | relid=0 | w=20 en:phlebitis and thrombophlebitis of upper extremities, unspecified --- r_associated #0: 20 --> phlébite n1=en:phlebitis and thrombophlebitis of upper extremities, unspecified | n2=phlébite | rel=r_associated | relid=0 | w=20 en:phlebitis deep --- r_associated #0: 20 --> phlébite n1=en:phlebitis deep | n2=phlébite | rel=r_associated | relid=0 | w=20 en:phlebitis nec --- r_associated #0: 20 --> phlébite n1=en:phlebitis nec | n2=phlébite | rel=r_associated | relid=0 | w=20 en:phlebitis of central nervous system venous sinuses --- r_associated #0: 20 --> phlébite n1=en:phlebitis of central nervous system venous sinuses | n2=phlébite | rel=r_associated | relid=0 | w=20 en:phlebitis of lower limb vein --- r_associated #0: 20 --> phlébite n1=en:phlebitis of lower limb vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:phlebosclerosis --- r_associated #0: 20 --> phlébite n1=en:phlebosclerosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:phlebotomy --- r_associated #0: 20 --> phlébite n1=en:phlebotomy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:physical examination completion status --- r_associated #0: 20 --> phlébite n1=en:physical examination completion status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:physiological functions and activities --- r_associated #0: 20 --> phlébite n1=en:physiological functions and activities | n2=phlébite | rel=r_associated | relid=0 | w=20 en:physiopathological --- r_associated #0: 20 --> phlébite n1=en:physiopathological | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pigmented reticuloendothelial cells --- r_associated #0: 20 --> phlébite n1=en:pigmented reticuloendothelial cells | n2=phlébite | rel=r_associated | relid=0 | w=20 en:placental transfusion syndromes --- r_associated #0: 20 --> phlébite n1=en:placental transfusion syndromes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:plaque shift --- r_associated #0: 20 --> phlébite n1=en:plaque shift | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelet aggregation abnormal --- r_associated #0: 20 --> phlébite n1=en:platelet aggregation abnormal | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelet aggregation decreased --- r_associated #0: 20 --> phlébite n1=en:platelet aggregation decreased | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelet aggregation normal --- r_associated #0: 20 --> phlébite n1=en:platelet aggregation normal | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelet anisocytosis --- r_associated #0: 20 --> phlébite n1=en:platelet anisocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelet count normal --- r_associated #0: 20 --> phlébite n1=en:platelet count normal | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelet factor 4 decreased --- r_associated #0: 20 --> phlébite n1=en:platelet factor 4 decreased | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelet function test normal --- r_associated #0: 20 --> phlébite n1=en:platelet function test normal | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelet morphology normal --- r_associated #0: 20 --> phlébite n1=en:platelet morphology normal | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets cannot synthesize thromboxane a2 from arachidonic acid --- r_associated #0: 20 --> phlébite n1=en:platelets cannot synthesize thromboxane a2 from arachidonic acid | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets fail to inhibit the rise of camp levels in response to adp --- r_associated #0: 20 --> phlébite n1=en:platelets fail to inhibit the rise of camp levels in response to adp | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets had abnormal membrane complexes --- r_associated #0: 20 --> phlébite n1=en:platelets had abnormal membrane complexes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets have decreased alpha-granules --- r_associated #0: 20 --> phlébite n1=en:platelets have decreased alpha-granules | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets have decreased expression of glycoprotein ib-alpha (cd42b) --- r_associated #0: 20 --> phlébite n1=en:platelets have decreased expression of glycoprotein ib-alpha (cd42b) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets have decreased or absent alpha-granules --- r_associated #0: 20 --> phlébite n1=en:platelets have decreased or absent alpha-granules | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets have increased expression of cd34 --- r_associated #0: 20 --> phlébite n1=en:platelets have increased expression of cd34 | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets have increased smooth endoplasmic reticulum --- r_associated #0: 20 --> phlébite n1=en:platelets have increased smooth endoplasmic reticulum | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets have paucity of granules --- r_associated #0: 20 --> phlébite n1=en:platelets have paucity of granules | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets may show reduced adp binding activity --- r_associated #0: 20 --> phlébite n1=en:platelets may show reduced adp binding activity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets show decreased gpia/gpiia surface complex --- r_associated #0: 20 --> phlébite n1=en:platelets show decreased gpia/gpiia surface complex | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets show decreased gpib --- r_associated #0: 20 --> phlébite n1=en:platelets show decreased gpib | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets show defective activation --- r_associated #0: 20 --> phlébite n1=en:platelets show defective activation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets show defective adhesion to collagen and subendothelium --- r_associated #0: 20 --> phlébite n1=en:platelets show defective adhesion to collagen and subendothelium | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets show impaired aggregation in response to adp --- r_associated #0: 20 --> phlébite n1=en:platelets show impaired aggregation in response to adp | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets show normal adp-induced shape change --- r_associated #0: 20 --> phlébite n1=en:platelets show normal adp-induced shape change | n2=phlébite | rel=r_associated | relid=0 | w=20 en:platelets.large --- r_associated #0: 20 --> phlébite n1=en:platelets.large | n2=phlébite | rel=r_associated | relid=0 | w=20 en:plexiform vascular lesions --- r_associated #0: 20 --> phlébite n1=en:plexiform vascular lesions | n2=phlébite | rel=r_associated | relid=0 | w=20 en:poikilocytosis --- r_associated #0: 20 --> phlébite n1=en:poikilocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:poisoning / injury --- r_associated #0: 20 --> phlébite n1=en:poisoning / injury | n2=phlébite | rel=r_associated | relid=0 | w=20 en:poisoning by antiallergic and antiemetic drugs --- r_associated #0: 20 --> phlébite n1=en:poisoning by antiallergic and antiemetic drugs | n2=phlébite | rel=r_associated | relid=0 | w=20 en:poisoning by dietetic drug --- r_associated #0: 20 --> phlébite n1=en:poisoning by dietetic drug | n2=phlébite | rel=r_associated | relid=0 | w=20 en:poisoning by mixed bacterial vaccine except combinations with a pertussis component --- r_associated #0: 20 --> phlébite n1=en:poisoning by mixed bacterial vaccine except combinations with a pertussis component | n2=phlébite | rel=r_associated | relid=0 | w=20 en:poisoning by uric acid metabolism drug --- r_associated #0: 20 --> phlébite n1=en:poisoning by uric acid metabolism drug | n2=phlébite | rel=r_associated | relid=0 | w=20 en:poisoning by vaccine and/or biological substance --- r_associated #0: 20 --> phlébite n1=en:poisoning by vaccine and/or biological substance | n2=phlébite | rel=r_associated | relid=0 | w=20 en:poisoning by water and/or mineral metabolism drug --- r_associated #0: 20 --> phlébite n1=en:poisoning by water and/or mineral metabolism drug | n2=phlébite | rel=r_associated | relid=0 | w=20 en:poisoning of undetermined intent by non-drug substance --- r_associated #0: 20 --> phlébite n1=en:poisoning of undetermined intent by non-drug substance | n2=phlébite | rel=r_associated | relid=0 | w=20 en:polyarteritis nodosa --- r_associated #0: 20 --> phlébite n1=en:polyarteritis nodosa | n2=phlébite | rel=r_associated | relid=0 | w=20 en:polycythemia --- r_associated #0: 20 --> phlébite n1=en:polycythemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:polycythemia (e.g. hb chesapeake 141800.0018) --- r_associated #0: 20 --> phlébite n1=en:polycythemia (e.g. hb chesapeake 141800.0018) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:polycythemia neonatorum --- r_associated #0: 20 --> phlébite n1=en:polycythemia neonatorum | n2=phlébite | rel=r_associated | relid=0 | w=20 en:polycythemia vera --- r_associated #0: 20 --> phlébite n1=en:polycythemia vera | n2=phlébite | rel=r_associated | relid=0 | w=20 en:poor peripheral circulation --- r_associated #0: 20 --> phlébite n1=en:poor peripheral circulation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:porphyria --- r_associated #0: 20 --> phlébite n1=en:porphyria | n2=phlébite | rel=r_associated | relid=0 | w=20 en:portal hypertension --- r_associated #0: 20 --> phlébite n1=en:portal hypertension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:portal pyemia --- r_associated #0: 20 --> phlébite n1=en:portal pyemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:portal vein thrombosis --- r_associated #0: 20 --> phlébite n1=en:portal vein thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:portal vein thrombosis (rare) --- r_associated #0: 20 --> phlébite n1=en:portal vein thrombosis (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:portal vein-hepatic artery fistula --- r_associated #0: 20 --> phlébite n1=en:portal vein-hepatic artery fistula | n2=phlébite | rel=r_associated | relid=0 | w=20 en:portocaval shunt malfunction --- r_associated #0: 20 --> phlébite n1=en:portocaval shunt malfunction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:positive biochemistry finding --- r_associated #0: 20 --> phlébite n1=en:positive biochemistry finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:positive hematology finding --- r_associated #0: 20 --> phlébite n1=en:positive hematology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:positive immunology finding --- r_associated #0: 20 --> phlébite n1=en:positive immunology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:positive laboratory finding --- r_associated #0: 20 --> phlébite n1=en:positive laboratory finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:positive microbiology finding --- r_associated #0: 20 --> phlébite n1=en:positive microbiology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:positive vessel remodelling --- r_associated #0: 20 --> phlébite n1=en:positive vessel remodelling | n2=phlébite | rel=r_associated | relid=0 | w=20 en:possible thrombus --- r_associated #0: 20 --> phlébite n1=en:possible thrombus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:post angioplasty restenosis --- r_associated #0: 20 --> phlébite n1=en:post angioplasty restenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:post embolisation syndrome --- r_associated #0: 20 --> phlébite n1=en:post embolisation syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:post procedural myocardial infarction --- r_associated #0: 20 --> phlébite n1=en:post procedural myocardial infarction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:post transplant distal limb syndrome --- r_associated #0: 20 --> phlébite n1=en:post transplant distal limb syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:post-angioplasty coronary artery restenosis --- r_associated #0: 20 --> phlébite n1=en:post-angioplasty coronary artery restenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:post-pericardiotomy syndrome --- r_associated #0: 20 --> phlébite n1=en:post-pericardiotomy syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:post-phlebitic dermatosis of lower leg --- r_associated #0: 20 --> phlébite n1=en:post-phlebitic dermatosis of lower leg | n2=phlébite | rel=r_associated | relid=0 | w=20 en:post-phlebitic lipodermatosclerosis --- r_associated #0: 20 --> phlébite n1=en:post-phlebitic lipodermatosclerosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:post-surgical bleeding --- r_associated #0: 20 --> phlébite n1=en:post-surgical bleeding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:post-transfusion thrombocytopenia --- r_associated #0: 20 --> phlébite n1=en:post-transfusion thrombocytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:postimplantation syndrome --- r_associated #0: 20 --> phlébite n1=en:postimplantation syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:postoperative deep vein thrombosis --- r_associated #0: 20 --> phlébite n1=en:postoperative deep vein thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:postoperative thrombosis --- r_associated #0: 20 --> phlébite n1=en:postoperative thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:postpartum thrombosis --- r_associated #0: 20 --> phlébite n1=en:postpartum thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:postpartum venous thrombosis --- r_associated #0: 20 --> phlébite n1=en:postpartum venous thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:postphlebitic limb --- r_associated #0: 20 --> phlébite n1=en:postphlebitic limb | n2=phlébite | rel=r_associated | relid=0 | w=20 en:postphlebitic syndrome --- r_associated #0: 20 --> phlébite n1=en:postphlebitic syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:postprocedural inferior vena cava complication --- r_associated #0: 20 --> phlébite n1=en:postprocedural inferior vena cava complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:postsurgical bleeding --- r_associated #0: 20 --> phlébite n1=en:postsurgical bleeding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:postthrombotic syndrome --- r_associated #0: 20 --> phlébite n1=en:postthrombotic syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:postural hypotension (in some patients) --- r_associated #0: 20 --> phlébite n1=en:postural hypotension (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:postural hypotension with compensatory tachycardia --- r_associated #0: 20 --> phlébite n1=en:postural hypotension with compensatory tachycardia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:postural hypotension without compensatory tachycardia --- r_associated #0: 20 --> phlébite n1=en:postural hypotension without compensatory tachycardia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:potassium sparing compound diuretics a-z --- r_associated #0: 20 --> phlébite n1=en:potassium sparing compound diuretics a-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pregnancy complications, cardiovascular --- r_associated #0: 20 --> phlébite n1=en:pregnancy complications, cardiovascular | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pregnancy complications, hematologic --- r_associated #0: 20 --> phlébite n1=en:pregnancy complications, hematologic | n2=phlébite | rel=r_associated | relid=0 | w=20 en:premalignant hematologic condition --- r_associated #0: 20 --> phlébite n1=en:premalignant hematologic condition | n2=phlébite | rel=r_associated | relid=0 | w=20 en:premature coronary artery disease --- r_associated #0: 20 --> phlébite n1=en:premature coronary artery disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:premature occlusive vascular disease --- r_associated #0: 20 --> phlébite n1=en:premature occlusive vascular disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:presence of i erythrocyte antigen --- r_associated #0: 20 --> phlébite n1=en:presence of i erythrocyte antigen | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pressure disorder --- r_associated #0: 20 --> phlébite n1=en:pressure disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:presyncope --- r_associated #0: 20 --> phlébite n1=en:presyncope | n2=phlébite | rel=r_associated | relid=0 | w=20 en:primary angiitis of the central nervous system --- r_associated #0: 20 --> phlébite n1=en:primary angiitis of the central nervous system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedural pneumothorax --- r_associated #0: 20 --> phlébite n1=en:procedural pneumothorax | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure / intervention (navigational concept) --- r_associated #0: 20 --> phlébite n1=en:procedure / intervention (navigational concept) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by abdominal approach --- r_associated #0: 20 --> phlébite n1=en:procedure by abdominal approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by anterior approach --- r_associated #0: 20 --> phlébite n1=en:procedure by anterior approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by colostomy approach --- r_associated #0: 20 --> phlébite n1=en:procedure by colostomy approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by extraoral approach --- r_associated #0: 20 --> phlébite n1=en:procedure by extraoral approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by intranasal approach --- r_associated #0: 20 --> phlébite n1=en:procedure by intranasal approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by intravesical approach --- r_associated #0: 20 --> phlébite n1=en:procedure by intravesical approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by perineal approach --- r_associated #0: 20 --> phlébite n1=en:procedure by perineal approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by posterior approach --- r_associated #0: 20 --> phlébite n1=en:procedure by posterior approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by sublabial approach --- r_associated #0: 20 --> phlébite n1=en:procedure by sublabial approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by suprapubic approach --- r_associated #0: 20 --> phlébite n1=en:procedure by suprapubic approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by transanal approach --- r_associated #0: 20 --> phlébite n1=en:procedure by transanal approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by transcervical approach - neck --- r_associated #0: 20 --> phlébite n1=en:procedure by transcervical approach - neck | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by transcrotal approach --- r_associated #0: 20 --> phlébite n1=en:procedure by transcrotal approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by transluminal approach --- r_associated #0: 20 --> phlébite n1=en:procedure by transluminal approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by transoral approach --- r_associated #0: 20 --> phlébite n1=en:procedure by transoral approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by transsphenoidal approach --- r_associated #0: 20 --> phlébite n1=en:procedure by transsphenoidal approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by transsternal approach --- r_associated #0: 20 --> phlébite n1=en:procedure by transsternal approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by transthoracic approach --- r_associated #0: 20 --> phlébite n1=en:procedure by transthoracic approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by transurethral approach --- r_associated #0: 20 --> phlébite n1=en:procedure by transurethral approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by transvascular approach --- r_associated #0: 20 --> phlébite n1=en:procedure by transvascular approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure by vaginal approach --- r_associated #0: 20 --> phlébite n1=en:procedure by vaginal approach | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure categorized by action status --- r_associated #0: 20 --> phlébite n1=en:procedure categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:procedure recommendation categorized by action status --- r_associated #0: 20 --> phlébite n1=en:procedure recommendation categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prolapsed arterial valve --- r_associated #0: 20 --> phlébite n1=en:prolapsed arterial valve | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prolonged activated partial thromboplastin time (aptt) --- r_associated #0: 20 --> phlébite n1=en:prolonged activated partial thromboplastin time (aptt) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prolonged appt (in 1 patient) --- r_associated #0: 20 --> phlébite n1=en:prolonged appt (in 1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prolonged bleeding --- r_associated #0: 20 --> phlébite n1=en:prolonged bleeding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prolonged bleeding after surgery or trauma --- r_associated #0: 20 --> phlébite n1=en:prolonged bleeding after surgery or trauma | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prolonged bleeding due to a qualitative defect in the vwf protein --- r_associated #0: 20 --> phlébite n1=en:prolonged bleeding due to a qualitative defect in the vwf protein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prolonged bleeding time --- r_associated #0: 20 --> phlébite n1=en:prolonged bleeding time | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prolonged bleeding time (less common) --- r_associated #0: 20 --> phlébite n1=en:prolonged bleeding time (less common) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prolonged bleeding time 15-to->30 minutes --- r_associated #0: 20 --> phlébite n1=en:prolonged bleeding time 15-to->30 minutes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prolonged bleeding time due to quantitative decrease of vwf protein --- r_associated #0: 20 --> phlébite n1=en:prolonged bleeding time due to quantitative decrease of vwf protein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prolonged partial thromboplastin time --- r_associated #0: 20 --> phlébite n1=en:prolonged partial thromboplastin time | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prominent abdominal venous pattern --- r_associated #0: 20 --> phlébite n1=en:prominent abdominal venous pattern | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prominent subcutaneous venous patterning --- r_associated #0: 20 --> phlébite n1=en:prominent subcutaneous venous patterning | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prominent superficial veins --- r_associated #0: 20 --> phlébite n1=en:prominent superficial veins | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prominent venous pattern --- r_associated #0: 20 --> phlébite n1=en:prominent venous pattern | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prominent, slightly corkscrew appearance of branches of hepatic artery on mri (in one patient) --- r_associated #0: 20 --> phlébite n1=en:prominent, slightly corkscrew appearance of branches of hepatic artery on mri (in one patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:promyelocytes have atypical nuclei and vacuolization of the cytoplasm --- r_associated #0: 20 --> phlébite n1=en:promyelocytes have atypical nuclei and vacuolization of the cytoplasm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:proprietary agent and/or biological product --- r_associated #0: 20 --> phlébite n1=en:proprietary agent and/or biological product | n2=phlébite | rel=r_associated | relid=0 | w=20 en:proprietary cough compounds a-l --- r_associated #0: 20 --> phlébite n1=en:proprietary cough compounds a-l | n2=phlébite | rel=r_associated | relid=0 | w=20 en:proprietary cough compounds m-z --- r_associated #0: 20 --> phlébite n1=en:proprietary cough compounds m-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prostaglandin-endoperoxide synthase 1 (ptgs1, 176805) deficiency in platelets --- r_associated #0: 20 --> phlébite n1=en:prostaglandin-endoperoxide synthase 1 (ptgs1, 176805) deficiency in platelets | n2=phlébite | rel=r_associated | relid=0 | w=20 en:protein c decreased --- r_associated #0: 20 --> phlébite n1=en:protein c decreased | n2=phlébite | rel=r_associated | relid=0 | w=20 en:protein c deficiency disease --- r_associated #0: 20 --> phlébite n1=en:protein c deficiency disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:protein s decreased --- r_associated #0: 20 --> phlébite n1=en:protein s decreased | n2=phlébite | rel=r_associated | relid=0 | w=20 en:protein s deficiency disease --- r_associated #0: 20 --> phlébite n1=en:protein s deficiency disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:proteins a - r --- r_associated #0: 20 --> phlébite n1=en:proteins a - r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:proteins s - z --- r_associated #0: 20 --> phlébite n1=en:proteins s - z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:prothrombin time increased --- r_associated #0: 20 --> phlébite n1=en:prothrombin time increased | n2=phlébite | rel=r_associated | relid=0 | w=20 en:protozoan parasite --- r_associated #0: 20 --> phlébite n1=en:protozoan parasite | n2=phlébite | rel=r_associated | relid=0 | w=20 en:protuberance --- r_associated #0: 20 --> phlébite n1=en:protuberance | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pseudoaneurysm --- r_associated #0: 20 --> phlébite n1=en:pseudoaneurysm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pseudomonas species a-f --- r_associated #0: 20 --> phlébite n1=en:pseudomonas species a-f | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pseudomonas species g-r --- r_associated #0: 20 --> phlébite n1=en:pseudomonas species g-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pseudomonas species s-z --- r_associated #0: 20 --> phlébite n1=en:pseudomonas species s-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pseudovasculitis --- r_associated #0: 20 --> phlébite n1=en:pseudovasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:psoriasis and similar disorders --- r_associated #0: 20 --> phlébite n1=en:psoriasis and similar disorders | n2=phlébite | rel=r_associated | relid=0 | w=20 en:psychology qualifier --- r_associated #0: 20 --> phlébite n1=en:psychology qualifier | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary arterial hypertension --- r_associated #0: 20 --> phlébite n1=en:pulmonary arterial hypertension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary arterial hypertension (in 3 patients) --- r_associated #0: 20 --> phlébite n1=en:pulmonary arterial hypertension (in 3 patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary arterial medial hypertrophy --- r_associated #0: 20 --> phlébite n1=en:pulmonary arterial medial hypertrophy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary arteries show medial hypertrophy --- r_associated #0: 20 --> phlébite n1=en:pulmonary arteries show medial hypertrophy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary artery aneurysm --- r_associated #0: 20 --> phlébite n1=en:pulmonary artery aneurysm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary artery atresia (rare) --- r_associated #0: 20 --> phlébite n1=en:pulmonary artery atresia (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary artery dilation, mild (in one patient) --- r_associated #0: 20 --> phlébite n1=en:pulmonary artery dilation, mild (in one patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary artery hypertension (in one patient) --- r_associated #0: 20 --> phlébite n1=en:pulmonary artery hypertension (in one patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary artery hypertension (in some patients) --- r_associated #0: 20 --> phlébite n1=en:pulmonary artery hypertension (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary artery hypoplasia (in some patients) --- r_associated #0: 20 --> phlébite n1=en:pulmonary artery hypoplasia (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary artery root dilation (rare) --- r_associated #0: 20 --> phlébite n1=en:pulmonary artery root dilation (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary artery sling --- r_associated #0: 20 --> phlébite n1=en:pulmonary artery sling | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary artery stenosis --- r_associated #0: 20 --> phlébite n1=en:pulmonary artery stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary artery stenosis (1 patient) --- r_associated #0: 20 --> phlébite n1=en:pulmonary artery stenosis (1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary artery stenosis (in some patients) --- r_associated #0: 20 --> phlébite n1=en:pulmonary artery stenosis (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary artery stenosis, bilateral branch --- r_associated #0: 20 --> phlébite n1=en:pulmonary artery stenosis, bilateral branch | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary artery thrombosis --- r_associated #0: 20 --> phlébite n1=en:pulmonary artery thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary artery vascular wall remodeling --- r_associated #0: 20 --> phlébite n1=en:pulmonary artery vascular wall remodeling | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary artery vasoconstriction --- r_associated #0: 20 --> phlébite n1=en:pulmonary artery vasoconstriction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary circulation obstruction --- r_associated #0: 20 --> phlébite n1=en:pulmonary circulation obstruction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary embolism and thrombosis --- r_associated #0: 20 --> phlébite n1=en:pulmonary embolism and thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary hypertension --- r_associated #0: 20 --> phlébite n1=en:pulmonary hypertension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary hypertension (1 patient) --- r_associated #0: 20 --> phlébite n1=en:pulmonary hypertension (1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary hypertension (1/4 patients) --- r_associated #0: 20 --> phlébite n1=en:pulmonary hypertension (1/4 patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary hypertension (neonatal period) --- r_associated #0: 20 --> phlébite n1=en:pulmonary hypertension (neonatal period) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary hypertension (rare) --- r_associated #0: 20 --> phlébite n1=en:pulmonary hypertension (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary hypertension (secondary to scoliosis, in some patients) --- r_associated #0: 20 --> phlébite n1=en:pulmonary hypertension (secondary to scoliosis, in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary hypertension, mild --- r_associated #0: 20 --> phlébite n1=en:pulmonary hypertension, mild | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary hypertension, severe (in end-stage disease) --- r_associated #0: 20 --> phlébite n1=en:pulmonary hypertension, severe (in end-stage disease) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary hypertensive venous disease --- r_associated #0: 20 --> phlébite n1=en:pulmonary hypertensive venous disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary infarction --- r_associated #0: 20 --> phlébite n1=en:pulmonary infarction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary stenosis --- r_associated #0: 20 --> phlébite n1=en:pulmonary stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary stenosis (in some patients) --- r_associated #0: 20 --> phlébite n1=en:pulmonary stenosis (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary thrombosis --- r_associated #0: 20 --> phlébite n1=en:pulmonary thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary trunk --- r_associated #0: 20 --> phlébite n1=en:pulmonary trunk | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary valve atresia --- r_associated #0: 20 --> phlébite n1=en:pulmonary valve atresia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary vascular disorder --- r_associated #0: 20 --> phlébite n1=en:pulmonary vascular disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary vasculitis --- r_associated #0: 20 --> phlébite n1=en:pulmonary vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonary vein dilatation --- r_associated #0: 20 --> phlébite n1=en:pulmonary vein dilatation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonic stenosis, mild (in some patients) --- r_associated #0: 20 --> phlébite n1=en:pulmonic stenosis, mild (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:pulmonic stenosis, supravalvular --- r_associated #0: 20 --> phlébite n1=en:pulmonic stenosis, supravalvular | n2=phlébite | rel=r_associated | relid=0 | w=20 en:purpura and other haemorrhagic conditions --- r_associated #0: 20 --> phlébite n1=en:purpura and other haemorrhagic conditions | n2=phlébite | rel=r_associated | relid=0 | w=20 en:quaternary ammonium derivative poisoning --- r_associated #0: 20 --> phlébite n1=en:quaternary ammonium derivative poisoning | n2=phlébite | rel=r_associated | relid=0 | w=20 en:radial pulse absent --- r_associated #0: 20 --> phlébite n1=en:radial pulse absent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:radiotherapeutic --- r_associated #0: 20 --> phlébite n1=en:radiotherapeutic | n2=phlébite | rel=r_associated | relid=0 | w=20 en:raised biochemistry finding --- r_associated #0: 20 --> phlébite n1=en:raised biochemistry finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:raised hematology finding --- r_associated #0: 20 --> phlébite n1=en:raised hematology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:raised microbiology finding --- r_associated #0: 20 --> phlébite n1=en:raised microbiology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:rare compression of inferior vena cava (secondary lower extremity edema) --- r_associated #0: 20 --> phlébite n1=en:rare compression of inferior vena cava (secondary lower extremity edema) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:raynaud phenomenon --- r_associated #0: 20 --> phlébite n1=en:raynaud phenomenon | n2=phlébite | rel=r_associated | relid=0 | w=20 en:raynaud phenomenon (in some patients) --- r_associated #0: 20 --> phlébite n1=en:raynaud phenomenon (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:rbc count low --- r_associated #0: 20 --> phlébite n1=en:rbc count low | n2=phlébite | rel=r_associated | relid=0 | w=20 en:reactive laboratory finding --- r_associated #0: 20 --> phlébite n1=en:reactive laboratory finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:reactive microbiology finding --- r_associated #0: 20 --> phlébite n1=en:reactive microbiology finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:reactive vascular proliferation --- r_associated #0: 20 --> phlébite n1=en:reactive vascular proliferation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:rectal compounds+steroids a-z --- r_associated #0: 20 --> phlébite n1=en:rectal compounds+steroids a-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:rectal laxatives a-z --- r_associated #0: 20 --> phlébite n1=en:rectal laxatives a-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:recurrent cerebral and cerebellar hemorrhage --- r_associated #0: 20 --> phlébite n1=en:recurrent cerebral and cerebellar hemorrhage | n2=phlébite | rel=r_associated | relid=0 | w=20 en:recurrent deep vein thrombosis --- r_associated #0: 20 --> phlébite n1=en:recurrent deep vein thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:recurrent hemorrhagic events --- r_associated #0: 20 --> phlébite n1=en:recurrent hemorrhagic events | n2=phlébite | rel=r_associated | relid=0 | w=20 en:recurrent strokes --- r_associated #0: 20 --> phlébite n1=en:recurrent strokes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:recurrent thrombophlebitis --- r_associated #0: 20 --> phlébite n1=en:recurrent thrombophlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:recurrent thrombophlebitis (e.g. homozygous 107300.0008 at-iii toyama) --- r_associated #0: 20 --> phlébite n1=en:recurrent thrombophlebitis (e.g. homozygous 107300.0008 at-iii toyama) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:red blood cell count raised --- r_associated #0: 20 --> phlébite n1=en:red blood cell count raised | n2=phlébite | rel=r_associated | relid=0 | w=20 en:red blood cells lack h- antigen --- r_associated #0: 20 --> phlébite n1=en:red blood cells lack h- antigen | n2=phlébite | rel=r_associated | relid=0 | w=20 en:red cell adenylate kinase deficiency --- r_associated #0: 20 --> phlébite n1=en:red cell adenylate kinase deficiency | n2=phlébite | rel=r_associated | relid=0 | w=20 en:red cell anisopoikilocytosis (in some patients) --- r_associated #0: 20 --> phlébite n1=en:red cell anisopoikilocytosis (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:reduced hemopoiesis --- r_associated #0: 20 --> phlébite n1=en:reduced hemopoiesis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:reduced leukocyte alkaline phosphatase --- r_associated #0: 20 --> phlébite n1=en:reduced leukocyte alkaline phosphatase | n2=phlébite | rel=r_associated | relid=0 | w=20 en:reduced or absent erythroid precursors in bone marrow --- r_associated #0: 20 --> phlébite n1=en:reduced or absent erythroid precursors in bone marrow | n2=phlébite | rel=r_associated | relid=0 | w=20 en:reduced platelet aggregation response to adenosine 5'-diphosphate (adp) --- r_associated #0: 20 --> phlébite n1=en:reduced platelet aggregation response to adenosine 5'-diphosphate (adp) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:refractory macrocytic anemia --- r_associated #0: 20 --> phlébite n1=en:refractory macrocytic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:regional vascular structure --- r_associated #0: 20 --> phlébite n1=en:regional vascular structure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:rehabilitation aspects --- r_associated #0: 20 --> phlébite n1=en:rehabilitation aspects | n2=phlébite | rel=r_associated | relid=0 | w=20 en:renal allograft thrombosis --- r_associated #0: 20 --> phlébite n1=en:renal allograft thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:renal artery perforation --- r_associated #0: 20 --> phlébite n1=en:renal artery perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:renal artery stenosis --- r_associated #0: 20 --> phlébite n1=en:renal artery stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:renal artery thrombosis --- r_associated #0: 20 --> phlébite n1=en:renal artery thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:renal embolism and thrombosis --- r_associated #0: 20 --> phlébite n1=en:renal embolism and thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:renal function test --- r_associated #0: 20 --> phlébite n1=en:renal function test | n2=phlébite | rel=r_associated | relid=0 | w=20 en:renal hypertension --- r_associated #0: 20 --> phlébite n1=en:renal hypertension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:renal vasculitis --- r_associated #0: 20 --> phlébite n1=en:renal vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:renal vein thrombosis --- r_associated #0: 20 --> phlébite n1=en:renal vein thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:renovascular hypertension (rare) --- r_associated #0: 20 --> phlébite n1=en:renovascular hypertension (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:reperfusion injury --- r_associated #0: 20 --> phlébite n1=en:reperfusion injury | n2=phlébite | rel=r_associated | relid=0 | w=20 en:resistance to moderate and severe diastolic hypertension --- r_associated #0: 20 --> phlébite n1=en:resistance to moderate and severe diastolic hypertension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:respiratory test categorized by action status --- r_associated #0: 20 --> phlébite n1=en:respiratory test categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:respiratory tract and mouth --- r_associated #0: 20 --> phlébite n1=en:respiratory tract and mouth | n2=phlébite | rel=r_associated | relid=0 | w=20 en:respiratory viruses --- r_associated #0: 20 --> phlébite n1=en:respiratory viruses | n2=phlébite | rel=r_associated | relid=0 | w=20 en:response to immunization and/or skin test --- r_associated #0: 20 --> phlébite n1=en:response to immunization and/or skin test | n2=phlébite | rel=r_associated | relid=0 | w=20 en:retention abnormality --- r_associated #0: 20 --> phlébite n1=en:retention abnormality | n2=phlébite | rel=r_associated | relid=0 | w=20 en:reticulin fibrosis of the bone marrow --- r_associated #0: 20 --> phlébite n1=en:reticulin fibrosis of the bone marrow | n2=phlébite | rel=r_associated | relid=0 | w=20 en:reticulocyte count increased --- r_associated #0: 20 --> phlébite n1=en:reticulocyte count increased | n2=phlébite | rel=r_associated | relid=0 | w=20 en:reticulocytopenia --- r_associated #0: 20 --> phlébite n1=en:reticulocytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:reticulocytosis --- r_associated #0: 20 --> phlébite n1=en:reticulocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:reticulocytosis (in some) --- r_associated #0: 20 --> phlébite n1=en:reticulocytosis (in some) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:retinal artery occlusion --- r_associated #0: 20 --> phlébite n1=en:retinal artery occlusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:retinal embolism and thrombosis --- r_associated #0: 20 --> phlébite n1=en:retinal embolism and thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:retinal phlebitis --- r_associated #0: 20 --> phlébite n1=en:retinal phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:retinal vascular disorder --- r_associated #0: 20 --> phlébite n1=en:retinal vascular disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:retinal vasculitis --- r_associated #0: 20 --> phlébite n1=en:retinal vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:retinal vein occlusion --- r_associated #0: 20 --> phlébite n1=en:retinal vein occlusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:retinal venous engorgement --- r_associated #0: 20 --> phlébite n1=en:retinal venous engorgement | n2=phlébite | rel=r_associated | relid=0 | w=20 en:retinociliary vein --- r_associated #0: 20 --> phlébite n1=en:retinociliary vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:retraction (finding) --- r_associated #0: 20 --> phlébite n1=en:retraction (finding) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:retrobulbar venous varix --- r_associated #0: 20 --> phlébite n1=en:retrobulbar venous varix | n2=phlébite | rel=r_associated | relid=0 | w=20 en:right aortic arch (rare) --- r_associated #0: 20 --> phlébite n1=en:right aortic arch (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:right pulmonary isomerism --- r_associated #0: 20 --> phlébite n1=en:right pulmonary isomerism | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ringed sideroblasts on bone marrow aspirate --- r_associated #0: 20 --> phlébite n1=en:ringed sideroblasts on bone marrow aspirate | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ringed sideroblasts on bone marrow examination --- r_associated #0: 20 --> phlébite n1=en:ringed sideroblasts on bone marrow examination | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ringed sideroblasts on peripheral smear and bone marrow --- r_associated #0: 20 --> phlébite n1=en:ringed sideroblasts on peripheral smear and bone marrow | n2=phlébite | rel=r_associated | relid=0 | w=20 en:risk factor for carotid atherosclerosis --- r_associated #0: 20 --> phlébite n1=en:risk factor for carotid atherosclerosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:roentgenographic --- r_associated #0: 20 --> phlébite n1=en:roentgenographic | n2=phlébite | rel=r_associated | relid=0 | w=20 en:rotation disorder --- r_associated #0: 20 --> phlébite n1=en:rotation disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:rupture of artery --- r_associated #0: 20 --> phlébite n1=en:rupture of artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:rupture of superficial cerebral vein --- r_associated #0: 20 --> phlébite n1=en:rupture of superficial cerebral vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:rupture of vein --- r_associated #0: 20 --> phlébite n1=en:rupture of vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group b phase 1 a-e --- r_associated #0: 20 --> phlébite n1=en:salmonella group b phase 1 a-e | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group b phase 1 f-r --- r_associated #0: 20 --> phlébite n1=en:salmonella group b phase 1 f-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group b phase 1 y-z --- r_associated #0: 20 --> phlébite n1=en:salmonella group b phase 1 y-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group c1 and c4 phase 1 a-e --- r_associated #0: 20 --> phlébite n1=en:salmonella group c1 and c4 phase 1 a-e | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group c1 and c4 phase 1 f-r --- r_associated #0: 20 --> phlébite n1=en:salmonella group c1 and c4 phase 1 f-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group c1 and c4 phase 1 y-z --- r_associated #0: 20 --> phlébite n1=en:salmonella group c1 and c4 phase 1 y-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group c2 and c3 phase 1 a-e --- r_associated #0: 20 --> phlébite n1=en:salmonella group c2 and c3 phase 1 a-e | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group c2 and c3 phase 1 f-r --- r_associated #0: 20 --> phlébite n1=en:salmonella group c2 and c3 phase 1 f-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group c2 and c3 phase 1 y-z --- r_associated #0: 20 --> phlébite n1=en:salmonella group c2 and c3 phase 1 y-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group d1 phase 1 a-e --- r_associated #0: 20 --> phlébite n1=en:salmonella group d1 phase 1 a-e | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group d1 phase 1 f-r --- r_associated #0: 20 --> phlébite n1=en:salmonella group d1 phase 1 f-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group d1 phase 1 y-z --- r_associated #0: 20 --> phlébite n1=en:salmonella group d1 phase 1 y-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group d2 phase 1 a-e --- r_associated #0: 20 --> phlébite n1=en:salmonella group d2 phase 1 a-e | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group d2 phase 1 f-r --- r_associated #0: 20 --> phlébite n1=en:salmonella group d2 phase 1 f-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group d2 phase 1 y-z --- r_associated #0: 20 --> phlébite n1=en:salmonella group d2 phase 1 y-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group e1 phase 1 a-e --- r_associated #0: 20 --> phlébite n1=en:salmonella group e1 phase 1 a-e | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group e1 phase 1 f-r --- r_associated #0: 20 --> phlébite n1=en:salmonella group e1 phase 1 f-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group e1 phase 1 y-z --- r_associated #0: 20 --> phlébite n1=en:salmonella group e1 phase 1 y-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group e4 phase 1 a-e --- r_associated #0: 20 --> phlébite n1=en:salmonella group e4 phase 1 a-e | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group e4 phase 1 f-r --- r_associated #0: 20 --> phlébite n1=en:salmonella group e4 phase 1 f-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group e4 phase 1 y-z --- r_associated #0: 20 --> phlébite n1=en:salmonella group e4 phase 1 y-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group f phase 1 a-e --- r_associated #0: 20 --> phlébite n1=en:salmonella group f phase 1 a-e | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group f phase 1 f-r --- r_associated #0: 20 --> phlébite n1=en:salmonella group f phase 1 f-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group f phase 1 y-z --- r_associated #0: 20 --> phlébite n1=en:salmonella group f phase 1 y-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group g1 and g2 phase 1 a-e --- r_associated #0: 20 --> phlébite n1=en:salmonella group g1 and g2 phase 1 a-e | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group g1 and g2 phase 1 f-r --- r_associated #0: 20 --> phlébite n1=en:salmonella group g1 and g2 phase 1 f-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group g1 and g2 phase 1 y-z --- r_associated #0: 20 --> phlébite n1=en:salmonella group g1 and g2 phase 1 y-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group h phase 1 a-e --- r_associated #0: 20 --> phlébite n1=en:salmonella group h phase 1 a-e | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group h phase 1 f-r --- r_associated #0: 20 --> phlébite n1=en:salmonella group h phase 1 f-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group h phase 1 y-z --- r_associated #0: 20 --> phlébite n1=en:salmonella group h phase 1 y-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group i phase 1 a-e --- r_associated #0: 20 --> phlébite n1=en:salmonella group i phase 1 a-e | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group i phase 1 f-r --- r_associated #0: 20 --> phlébite n1=en:salmonella group i phase 1 f-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group i phase 1 y-z --- r_associated #0: 20 --> phlébite n1=en:salmonella group i phase 1 y-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group m phase 1 a-e --- r_associated #0: 20 --> phlébite n1=en:salmonella group m phase 1 a-e | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group m phase 1 f-r --- r_associated #0: 20 --> phlébite n1=en:salmonella group m phase 1 f-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group m phase 1 y-z --- r_associated #0: 20 --> phlébite n1=en:salmonella group m phase 1 y-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group r phase 1 a-e --- r_associated #0: 20 --> phlébite n1=en:salmonella group r phase 1 a-e | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group r phase 1 f-r --- r_associated #0: 20 --> phlébite n1=en:salmonella group r phase 1 f-r | n2=phlébite | rel=r_associated | relid=0 | w=20 en:salmonella group r phase 1 y-z --- r_associated #0: 20 --> phlébite n1=en:salmonella group r phase 1 y-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:saprozoonosis --- r_associated #0: 20 --> phlébite n1=en:saprozoonosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:schistocyte --- r_associated #0: 20 --> phlébite n1=en:schistocyte | n2=phlébite | rel=r_associated | relid=0 | w=20 en:schistosomatidae --- r_associated #0: 20 --> phlébite n1=en:schistosomatidae | n2=phlébite | rel=r_associated | relid=0 | w=20 en:sea-blue histiocyte --- r_associated #0: 20 --> phlébite n1=en:sea-blue histiocyte | n2=phlébite | rel=r_associated | relid=0 | w=20 en:sea-blue histiocyte (bone marrow) --- r_associated #0: 20 --> phlébite n1=en:sea-blue histiocyte (bone marrow) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:secondary raynaud phenomenon --- r_associated #0: 20 --> phlébite n1=en:secondary raynaud phenomenon | n2=phlébite | rel=r_associated | relid=0 | w=20 en:secondary syphilis of viscera or bone --- r_associated #0: 20 --> phlébite n1=en:secondary syphilis of viscera or bone | n2=phlébite | rel=r_associated | relid=0 | w=20 en:segmental hyalinizing vasculitis --- r_associated #0: 20 --> phlébite n1=en:segmental hyalinizing vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:segmented neutrophils or band cells greater than 70% --- r_associated #0: 20 --> phlébite n1=en:segmented neutrophils or band cells greater than 70% | n2=phlébite | rel=r_associated | relid=0 | w=20 en:self hanging, strangulation or suffocation --- r_associated #0: 20 --> phlébite n1=en:self hanging, strangulation or suffocation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:separation (morphologic abnormality) --- r_associated #0: 20 --> phlébite n1=en:separation (morphologic abnormality) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:septic embolus --- r_associated #0: 20 --> phlébite n1=en:septic embolus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:sequela of phlebitis --- r_associated #0: 20 --> phlébite n1=en:sequela of phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:serum complement decreased --- r_associated #0: 20 --> phlébite n1=en:serum complement decreased | n2=phlébite | rel=r_associated | relid=0 | w=20 en:set of choroid blood vessels --- r_associated #0: 20 --> phlébite n1=en:set of choroid blood vessels | n2=phlébite | rel=r_associated | relid=0 | w=20 en:severe autoimmune cytopenia --- r_associated #0: 20 --> phlébite n1=en:severe autoimmune cytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:severe bleeding after biopsies (uncommon) --- r_associated #0: 20 --> phlébite n1=en:severe bleeding after biopsies (uncommon) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:severe congenital neutropenia --- r_associated #0: 20 --> phlébite n1=en:severe congenital neutropenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:severe hyalinosis --- r_associated #0: 20 --> phlébite n1=en:severe hyalinosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:severe thrombocytopenia (birth) --- r_associated #0: 20 --> phlébite n1=en:severe thrombocytopenia (birth) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:severity of anemia can range from mild to life-threatening --- r_associated #0: 20 --> phlébite n1=en:severity of anemia can range from mild to life-threatening | n2=phlébite | rel=r_associated | relid=0 | w=20 en:shift displacement --- r_associated #0: 20 --> phlébite n1=en:shift displacement | n2=phlébite | rel=r_associated | relid=0 | w=20 en:shock --- r_associated #0: 20 --> phlébite n1=en:shock | n2=phlébite | rel=r_associated | relid=0 | w=20 en:short medullary arteries of the brain --- r_associated #0: 20 --> phlébite n1=en:short medullary arteries of the brain | n2=phlébite | rel=r_associated | relid=0 | w=20 en:shunt blood flow excessive --- r_associated #0: 20 --> phlébite n1=en:shunt blood flow excessive | n2=phlébite | rel=r_associated | relid=0 | w=20 en:shwartzman phenomenon --- r_associated #0: 20 --> phlébite n1=en:shwartzman phenomenon | n2=phlébite | rel=r_associated | relid=0 | w=20 en:sickness --- r_associated #0: 20 --> phlébite n1=en:sickness | n2=phlébite | rel=r_associated | relid=0 | w=20 en:sideroblastic anemia --- r_associated #0: 20 --> phlébite n1=en:sideroblastic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:single umbilical artery --- r_associated #0: 20 --> phlébite n1=en:single umbilical artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:sinus pericranii --- r_associated #0: 20 --> phlébite n1=en:sinus pericranii | n2=phlébite | rel=r_associated | relid=0 | w=20 en:site of (a-h) --- r_associated #0: 20 --> phlébite n1=en:site of (a-h) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:site of (i-z) --- r_associated #0: 20 --> phlébite n1=en:site of (i-z) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:site specific embolism and thrombosis nec --- r_associated #0: 20 --> phlébite n1=en:site specific embolism and thrombosis nec | n2=phlébite | rel=r_associated | relid=0 | w=20 en:skin vascular disorder --- r_associated #0: 20 --> phlébite n1=en:skin vascular disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:skin, hair and nail finding --- r_associated #0: 20 --> phlébite n1=en:skin, hair and nail finding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:skull and/or spine and/or bone and/or joint operations --- r_associated #0: 20 --> phlébite n1=en:skull and/or spine and/or bone and/or joint operations | n2=phlébite | rel=r_associated | relid=0 | w=20 en:sky-blue leukocyte inclusion bodies (dohle-like bodies) that contain clusters of ribosomes oriented along parallel microfilaments --- r_associated #0: 20 --> phlébite n1=en:sky-blue leukocyte inclusion bodies (dohle-like bodies) that contain clusters of ribosomes oriented along parallel microfilaments | n2=phlébite | rel=r_associated | relid=0 | w=20 en:small and large vessel vasculitis --- r_associated #0: 20 --> phlébite n1=en:small and large vessel vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:small and medium-sized leptomeningeal arteries show luminal narrowing or obliteration --- r_associated #0: 20 --> phlébite n1=en:small and medium-sized leptomeningeal arteries show luminal narrowing or obliteration | n2=phlébite | rel=r_associated | relid=0 | w=20 en:small cerebral arteries show arteriosclerotic changes --- r_associated #0: 20 --> phlébite n1=en:small cerebral arteries show arteriosclerotic changes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:small cerebral arteries show fibrous intimal proliferation --- r_associated #0: 20 --> phlébite n1=en:small cerebral arteries show fibrous intimal proliferation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:small platelet size --- r_associated #0: 20 --> phlébite n1=en:small platelet size | n2=phlébite | rel=r_associated | relid=0 | w=20 en:small vessel brain infarcts and aneurysms --- r_associated #0: 20 --> phlébite n1=en:small vessel brain infarcts and aneurysms | n2=phlébite | rel=r_associated | relid=0 | w=20 en:small vessel cerebrovascular disease (rare) --- r_associated #0: 20 --> phlébite n1=en:small vessel cerebrovascular disease (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:small vessel microangiopathy --- r_associated #0: 20 --> phlébite n1=en:small vessel microangiopathy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:small vessel retinal infarcts and aneurysms --- r_associated #0: 20 --> phlébite n1=en:small vessel retinal infarcts and aneurysms | n2=phlébite | rel=r_associated | relid=0 | w=20 en:small vessel vasculitis --- r_associated #0: 20 --> phlébite n1=en:small vessel vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:small-vessel disease --- r_associated #0: 20 --> phlébite n1=en:small-vessel disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:smoking and/or drinking habits --- r_associated #0: 20 --> phlébite n1=en:smoking and/or drinking habits | n2=phlébite | rel=r_associated | relid=0 | w=20 en:soft tissue --- r_associated #0: 20 --> phlébite n1=en:soft tissue | n2=phlébite | rel=r_associated | relid=0 | w=20 en:solvent a - c --- r_associated #0: 20 --> phlébite n1=en:solvent a - c | n2=phlébite | rel=r_associated | relid=0 | w=20 en:solvent d - f --- r_associated #0: 20 --> phlébite n1=en:solvent d - f | n2=phlébite | rel=r_associated | relid=0 | w=20 en:solvent h - i --- r_associated #0: 20 --> phlébite n1=en:solvent h - i | n2=phlébite | rel=r_associated | relid=0 | w=20 en:solvent m - o --- r_associated #0: 20 --> phlébite n1=en:solvent m - o | n2=phlébite | rel=r_associated | relid=0 | w=20 en:solvent p --- r_associated #0: 20 --> phlébite n1=en:solvent p | n2=phlébite | rel=r_associated | relid=0 | w=20 en:solvent s - z --- r_associated #0: 20 --> phlébite n1=en:solvent s - z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:spatial displacement --- r_associated #0: 20 --> phlébite n1=en:spatial displacement | n2=phlébite | rel=r_associated | relid=0 | w=20 en:specimen related microbial interpretation --- r_associated #0: 20 --> phlébite n1=en:specimen related microbial interpretation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:spherocytosis --- r_associated #0: 20 --> phlébite n1=en:spherocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:spider veins --- r_associated #0: 20 --> phlébite n1=en:spider veins | n2=phlébite | rel=r_associated | relid=0 | w=20 en:splanchnic vein thrombosis --- r_associated #0: 20 --> phlébite n1=en:splanchnic vein thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:splenic artery perforation --- r_associated #0: 20 --> phlébite n1=en:splenic artery perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:splitting of the intima and/or internal elastic membrane --- r_associated #0: 20 --> phlébite n1=en:splitting of the intima and/or internal elastic membrane | n2=phlébite | rel=r_associated | relid=0 | w=20 en:spontaneous closure of surgically created fenestration of atrial tunnel after prior atrial fenestration operation --- r_associated #0: 20 --> phlébite n1=en:spontaneous closure of surgically created fenestration of atrial tunnel after prior atrial fenestration operation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:stenosis --- r_associated #0: 20 --> phlébite n1=en:stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:stenosis of the intracranial arteries --- r_associated #0: 20 --> phlébite n1=en:stenosis of the intracranial arteries | n2=phlébite | rel=r_associated | relid=0 | w=20 en:sterile phlebitis --- r_associated #0: 20 --> phlébite n1=en:sterile phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:stoma site phlebitis --- r_associated #0: 20 --> phlébite n1=en:stoma site phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:stoma site thrombosis --- r_associated #0: 20 --> phlébite n1=en:stoma site thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:stoma site vasculitis --- r_associated #0: 20 --> phlébite n1=en:stoma site vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:stomatocyte (cell) --- r_associated #0: 20 --> phlébite n1=en:stomatocyte (cell) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:stomatocytes (may be few in number) --- r_associated #0: 20 --> phlébite n1=en:stomatocytes (may be few in number) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:stomatocytosis result --- r_associated #0: 20 --> phlébite n1=en:stomatocytosis result | n2=phlébite | rel=r_associated | relid=0 | w=20 en:stricture of artery --- r_associated #0: 20 --> phlébite n1=en:stricture of artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:stroke (in some patients) --- r_associated #0: 20 --> phlébite n1=en:stroke (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:structural valve deterioration --- r_associated #0: 20 --> phlébite n1=en:structural valve deterioration | n2=phlébite | rel=r_associated | relid=0 | w=20 en:structure of blood vessel of retina --- r_associated #0: 20 --> phlébite n1=en:structure of blood vessel of retina | n2=phlébite | rel=r_associated | relid=0 | w=20 en:structure of small blood vessel (organ) --- r_associated #0: 20 --> phlébite n1=en:structure of small blood vessel (organ) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:structure of transplanted blood vessel --- r_associated #0: 20 --> phlébite n1=en:structure of transplanted blood vessel | n2=phlébite | rel=r_associated | relid=0 | w=20 en:structure of vitelline blood vessel of placenta --- r_associated #0: 20 --> phlébite n1=en:structure of vitelline blood vessel of placenta | n2=phlébite | rel=r_associated | relid=0 | w=20 en:sturge-weber syndrome --- r_associated #0: 20 --> phlébite n1=en:sturge-weber syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:subarachnoid hemorrhage --- r_associated #0: 20 --> phlébite n1=en:subarachnoid hemorrhage | n2=phlébite | rel=r_associated | relid=0 | w=20 en:subclavian artery perforation --- r_associated #0: 20 --> phlébite n1=en:subclavian artery perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:subclavian vein perforation --- r_associated #0: 20 --> phlébite n1=en:subclavian vein perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:subcutaneous administration of treatment --- r_associated #0: 20 --> phlébite n1=en:subcutaneous administration of treatment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:sublingual administration of treatment --- r_associated #0: 20 --> phlébite n1=en:sublingual administration of treatment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:sublingual varices --- r_associated #0: 20 --> phlébite n1=en:sublingual varices | n2=phlébite | rel=r_associated | relid=0 | w=20 en:subsidiary classification of laterality and operation sites --- r_associated #0: 20 --> phlébite n1=en:subsidiary classification of laterality and operation sites | n2=phlébite | rel=r_associated | relid=0 | w=20 en:substances, materials and objects --- r_associated #0: 20 --> phlébite n1=en:substances, materials and objects | n2=phlébite | rel=r_associated | relid=0 | w=20 en:subvalvular aortic stenosis --- r_associated #0: 20 --> phlébite n1=en:subvalvular aortic stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:subvalvular aortic stenosis (rare) --- r_associated #0: 20 --> phlébite n1=en:subvalvular aortic stenosis (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:sudden infant death syndrome --- r_associated #0: 20 --> phlébite n1=en:sudden infant death syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and self inflicted injury by amylobarbital --- r_associated #0: 20 --> phlébite n1=en:suicide and self inflicted injury by amylobarbital | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and self inflicted injury by barbitone --- r_associated #0: 20 --> phlébite n1=en:suicide and self inflicted injury by barbitone | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and self inflicted injury by barbiturates --- r_associated #0: 20 --> phlébite n1=en:suicide and self inflicted injury by barbiturates | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and self inflicted injury by butabarbitone --- r_associated #0: 20 --> phlébite n1=en:suicide and self inflicted injury by butabarbitone | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and self inflicted injury by pentabarbitone --- r_associated #0: 20 --> phlébite n1=en:suicide and self inflicted injury by pentabarbitone | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and self inflicted injury by phenobarbital --- r_associated #0: 20 --> phlébite n1=en:suicide and self inflicted injury by phenobarbital | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and self inflicted injury by quinalbarbitone --- r_associated #0: 20 --> phlébite n1=en:suicide and self inflicted injury by quinalbarbitone | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and self inflicted poisoning by barbiturates --- r_associated #0: 20 --> phlébite n1=en:suicide and self inflicted poisoning by barbiturates | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and selfinflicted injury --- r_associated #0: 20 --> phlébite n1=en:suicide and selfinflicted injury | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and selfinflicted injury by caustic substances, excluding poisoning --- r_associated #0: 20 --> phlébite n1=en:suicide and selfinflicted injury by caustic substances, excluding poisoning | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and selfinflicted injury by drowning --- r_associated #0: 20 --> phlébite n1=en:suicide and selfinflicted injury by drowning | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and selfinflicted injury by hanging, strangulation and suffocation --- r_associated #0: 20 --> phlébite n1=en:suicide and selfinflicted injury by hanging, strangulation and suffocation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and selfinflicted injury by jumping before moving object --- r_associated #0: 20 --> phlébite n1=en:suicide and selfinflicted injury by jumping before moving object | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and selfinflicted injury by jumping from natural sites --- r_associated #0: 20 --> phlébite n1=en:suicide and selfinflicted injury by jumping from natural sites | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and selfinflicted injury by jumping from residential premises --- r_associated #0: 20 --> phlébite n1=en:suicide and selfinflicted injury by jumping from residential premises | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and selfinflicted injury by jumping or lying before moving object --- r_associated #0: 20 --> phlébite n1=en:suicide and selfinflicted injury by jumping or lying before moving object | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and selfinflicted injury by lying before moving object --- r_associated #0: 20 --> phlébite n1=en:suicide and selfinflicted injury by lying before moving object | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and selfinflicted injury by suffocation by plastic bag --- r_associated #0: 20 --> phlébite n1=en:suicide and selfinflicted injury by suffocation by plastic bag | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and selfinflicted poisoning by analgesics, antipyretics and anti-rheumatics --- r_associated #0: 20 --> phlébite n1=en:suicide and selfinflicted poisoning by analgesics, antipyretics and anti-rheumatics | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide and selfinflicted poisoning by solid and liquid substances --- r_associated #0: 20 --> phlébite n1=en:suicide and selfinflicted poisoning by solid and liquid substances | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or attempted suicide by drowning --- r_associated #0: 20 --> phlébite n1=en:suicide or attempted suicide by drowning | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or attempted suicide by hanging --- r_associated #0: 20 --> phlébite n1=en:suicide or attempted suicide by hanging | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury associated with moving vehicles --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury associated with moving vehicles | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury by arson --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury by arson | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury by burning or fire --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury by burning or fire | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury by electric current --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury by electric current | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury by exposure to cold --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury by exposure to cold | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury by igniting gasoline soaked clothing --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury by igniting gasoline soaked clothing | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury by jumping from a height --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury by jumping from a height | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury by jumping from bridge --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury by jumping from bridge | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury by jumping from high building --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury by jumping from high building | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury by jumping from high man-made structure --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury by jumping from high man-made structure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury by jumping from high natural feature --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury by jumping from high natural feature | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury by jumping off cliff --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury by jumping off cliff | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury by placing self in path of moving motor vehicle --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury by placing self in path of moving motor vehicle | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury by placing self in path of moving railway vehicle --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury by placing self in path of moving railway vehicle | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury by placing self in path of moving vehicle --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury by placing self in path of moving vehicle | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or self injury by scalding --- r_associated #0: 20 --> phlébite n1=en:suicide or self injury by scalding | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or selfinflicted injury by crashing motor vehicle --- r_associated #0: 20 --> phlébite n1=en:suicide or selfinflicted injury by crashing motor vehicle | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or selfinflicted injury by crashing of aircraft --- r_associated #0: 20 --> phlébite n1=en:suicide or selfinflicted injury by crashing of aircraft | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or selfinflicted injury by cutting --- r_associated #0: 20 --> phlébite n1=en:suicide or selfinflicted injury by cutting | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or selfinflicted injury by cutting and stabbing --- r_associated #0: 20 --> phlébite n1=en:suicide or selfinflicted injury by cutting and stabbing | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or selfinflicted injury by explosives --- r_associated #0: 20 --> phlébite n1=en:suicide or selfinflicted injury by explosives | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or selfinflicted injury by firearms and explosives --- r_associated #0: 20 --> phlébite n1=en:suicide or selfinflicted injury by firearms and explosives | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or selfinflicted injury by handgun --- r_associated #0: 20 --> phlébite n1=en:suicide or selfinflicted injury by handgun | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or selfinflicted injury by hunting rifle --- r_associated #0: 20 --> phlébite n1=en:suicide or selfinflicted injury by hunting rifle | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or selfinflicted injury by military firearm --- r_associated #0: 20 --> phlébite n1=en:suicide or selfinflicted injury by military firearm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or selfinflicted injury by shotgun --- r_associated #0: 20 --> phlébite n1=en:suicide or selfinflicted injury by shotgun | n2=phlébite | rel=r_associated | relid=0 | w=20 en:suicide or selfinflicted injury by stabbing --- r_associated #0: 20 --> phlébite n1=en:suicide or selfinflicted injury by stabbing | n2=phlébite | rel=r_associated | relid=0 | w=20 en:sulfhemoglobinemia --- r_associated #0: 20 --> phlébite n1=en:sulfhemoglobinemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:sunscreening preparations a-z --- r_associated #0: 20 --> phlébite n1=en:sunscreening preparations a-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:superficial thrombophlebitis --- r_associated #0: 20 --> phlébite n1=en:superficial thrombophlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:superior vena cava left-sided, draining into left atrium --- r_associated #0: 20 --> phlébite n1=en:superior vena cava left-sided, draining into left atrium | n2=phlébite | rel=r_associated | relid=0 | w=20 en:superior vena cava perforation --- r_associated #0: 20 --> phlébite n1=en:superior vena cava perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:supravalvular pulmonary stenosis, minimal --- r_associated #0: 20 --> phlébite n1=en:supravalvular pulmonary stenosis, minimal | n2=phlébite | rel=r_associated | relid=0 | w=20 en:surgical aspects --- r_associated #0: 20 --> phlébite n1=en:surgical aspects | n2=phlébite | rel=r_associated | relid=0 | w=20 en:surgical occlusion of intracranial artery --- r_associated #0: 20 --> phlébite n1=en:surgical occlusion of intracranial artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:sustained eosinophilia (greater than 1,500/cubic mm) for greater than 6 months --- r_associated #0: 20 --> phlébite n1=en:sustained eosinophilia (greater than 1,500/cubic mm) for greater than 6 months | n2=phlébite | rel=r_associated | relid=0 | w=20 en:symptoms involving cardiovascular system --- r_associated #0: 20 --> phlébite n1=en:symptoms involving cardiovascular system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:syncope adverse event --- r_associated #0: 20 --> phlébite n1=en:syncope adverse event | n2=phlébite | rel=r_associated | relid=0 | w=20 en:systemic mastocytosis --- r_associated #0: 20 --> phlébite n1=en:systemic mastocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:systemic vascular structure --- r_associated #0: 20 --> phlébite n1=en:systemic vascular structure | n2=phlébite | rel=r_associated | relid=0 | w=20 en:systemic vasculitis --- r_associated #0: 20 --> phlébite n1=en:systemic vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:systemic venovenous collateral vein --- r_associated #0: 20 --> phlébite n1=en:systemic venovenous collateral vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:systolic hypertension, mild --- r_associated #0: 20 --> phlébite n1=en:systolic hypertension, mild | n2=phlébite | rel=r_associated | relid=0 | w=20 en:takayasu arteritis --- r_associated #0: 20 --> phlébite n1=en:takayasu arteritis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:taxonomic --- r_associated #0: 20 --> phlébite n1=en:taxonomic | n2=phlébite | rel=r_associated | relid=0 | w=20 en:techniques a-l --- r_associated #0: 20 --> phlébite n1=en:techniques a-l | n2=phlébite | rel=r_associated | relid=0 | w=20 en:techniques m-z --- r_associated #0: 20 --> phlébite n1=en:techniques m-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:template entry - ehr category --- r_associated #0: 20 --> phlébite n1=en:template entry - ehr category | n2=phlébite | rel=r_associated | relid=0 | w=20 en:temporal arteritis --- r_associated #0: 20 --> phlébite n1=en:temporal arteritis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:test categorized by action status --- r_associated #0: 20 --> phlébite n1=en:test categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tetralogy of fallot (rare) --- r_associated #0: 20 --> phlébite n1=en:tetralogy of fallot (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:therapeutic aspects --- r_associated #0: 20 --> phlébite n1=en:therapeutic aspects | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thickened coronary arteries --- r_associated #0: 20 --> phlébite n1=en:thickened coronary arteries | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thoracic aorta calcification --- r_associated #0: 20 --> phlébite n1=en:thoracic aorta calcification | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thoracic aortic aneurysm --- r_associated #0: 20 --> phlébite n1=en:thoracic aortic aneurysm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thoracic aortic dissection --- r_associated #0: 20 --> phlébite n1=en:thoracic aortic dissection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thoracic aortic dissection (rare) --- r_associated #0: 20 --> phlébite n1=en:thoracic aortic dissection (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombectomy --- r_associated #0: 20 --> phlébite n1=en:thrombectomy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thromboarteritis --- r_associated #0: 20 --> phlébite n1=en:thromboarteritis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytopenia --- r_associated #0: 20 --> phlébite n1=en:thrombocytopenia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytopenia (birth) --- r_associated #0: 20 --> phlébite n1=en:thrombocytopenia (birth) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytopenia (hellp syndrome) --- r_associated #0: 20 --> phlébite n1=en:thrombocytopenia (hellp syndrome) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytopenia (in some patients) --- r_associated #0: 20 --> phlébite n1=en:thrombocytopenia (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytopenia (less common) --- r_associated #0: 20 --> phlébite n1=en:thrombocytopenia (less common) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytopenia (mean 42.7 x 10(9)/l) --- r_associated #0: 20 --> phlébite n1=en:thrombocytopenia (mean 42.7 x 10(9)/l) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytopenia (onset birth-neonate, may be precipitated by cow's milk allergy) --- r_associated #0: 20 --> phlébite n1=en:thrombocytopenia (onset birth-neonate, may be precipitated by cow's milk allergy) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytopenia (rare) --- r_associated #0: 20 --> phlébite n1=en:thrombocytopenia (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytopenia (reported in 1 patient) --- r_associated #0: 20 --> phlébite n1=en:thrombocytopenia (reported in 1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytopenia due to immune destruction --- r_associated #0: 20 --> phlébite n1=en:thrombocytopenia due to immune destruction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytopenia post hemolytic anemia --- r_associated #0: 20 --> phlébite n1=en:thrombocytopenia post hemolytic anemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytopenia purpura (in some patients) --- r_associated #0: 20 --> phlébite n1=en:thrombocytopenia purpura (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytopenia, isolated (1 patient) --- r_associated #0: 20 --> phlébite n1=en:thrombocytopenia, isolated (1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytopenia, late-onset (1 patient) --- r_associated #0: 20 --> phlébite n1=en:thrombocytopenia, late-onset (1 patient) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytopenic purpura --- r_associated #0: 20 --> phlébite n1=en:thrombocytopenic purpura | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytosis --- r_associated #0: 20 --> phlébite n1=en:thrombocytosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombocytosis (in some patients) --- r_associated #0: 20 --> phlébite n1=en:thrombocytosis (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thromboembolism (25%) --- r_associated #0: 20 --> phlébite n1=en:thromboembolism (25%) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thromboembolism of vein --- r_associated #0: 20 --> phlébite n1=en:thromboembolism of vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombophlebitis of central nervous system venous sinuses --- r_associated #0: 20 --> phlébite n1=en:thrombophlebitis of central nervous system venous sinuses | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombophlebitis of deep femoral vein --- r_associated #0: 20 --> phlébite n1=en:thrombophlebitis of deep femoral vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombophlebitis of superficial veins of lower extremity --- r_associated #0: 20 --> phlébite n1=en:thrombophlebitis of superficial veins of lower extremity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombophlebitis of the newborn --- r_associated #0: 20 --> phlébite n1=en:thrombophlebitis of the newborn | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis and thrombophlebitis of unspecified site --- r_associated #0: 20 --> phlébite n1=en:thrombosis and thrombophlebitis of unspecified site | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis complicating pregnancy and/or puerperium --- r_associated #0: 20 --> phlébite n1=en:thrombosis complicating pregnancy and/or puerperium | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis in device --- r_associated #0: 20 --> phlébite n1=en:thrombosis in device | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis in situ --- r_associated #0: 20 --> phlébite n1=en:thrombosis in situ | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis leg --- r_associated #0: 20 --> phlébite n1=en:thrombosis leg | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis multiple --- r_associated #0: 20 --> phlébite n1=en:thrombosis multiple | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of arteries of the extremities --- r_associated #0: 20 --> phlébite n1=en:thrombosis of arteries of the extremities | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of cerebral veins --- r_associated #0: 20 --> phlébite n1=en:thrombosis of cerebral veins | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of iliac artery --- r_associated #0: 20 --> phlébite n1=en:thrombosis of iliac artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of internal jugular vein --- r_associated #0: 20 --> phlébite n1=en:thrombosis of internal jugular vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of jugular vein --- r_associated #0: 20 --> phlébite n1=en:thrombosis of jugular vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of left circumflex artery --- r_associated #0: 20 --> phlébite n1=en:thrombosis of left circumflex artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of mesenteric artery --- r_associated #0: 20 --> phlébite n1=en:thrombosis of mesenteric artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of posterior communicating artery --- r_associated #0: 20 --> phlébite n1=en:thrombosis of posterior communicating artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of retinal artery --- r_associated #0: 20 --> phlébite n1=en:thrombosis of retinal artery | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of retinal vein --- r_associated #0: 20 --> phlébite n1=en:thrombosis of retinal vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of subclavian vein --- r_associated #0: 20 --> phlébite n1=en:thrombosis of subclavian vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of thoracic aorta --- r_associated #0: 20 --> phlébite n1=en:thrombosis of thoracic aorta | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of transplanted vein --- r_associated #0: 20 --> phlébite n1=en:thrombosis of transplanted vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of vein of lower limb --- r_associated #0: 20 --> phlébite n1=en:thrombosis of vein of lower limb | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of vein of trunk --- r_associated #0: 20 --> phlébite n1=en:thrombosis of vein of trunk | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis of vein of upper limb --- r_associated #0: 20 --> phlébite n1=en:thrombosis of vein of upper limb | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombosis, susceptibility to (post-splenectomy patients) --- r_associated #0: 20 --> phlébite n1=en:thrombosis, susceptibility to (post-splenectomy patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombotic episodes --- r_associated #0: 20 --> phlébite n1=en:thrombotic episodes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombotic infarction --- r_associated #0: 20 --> phlébite n1=en:thrombotic infarction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombotic microangiopathy --- r_associated #0: 20 --> phlébite n1=en:thrombotic microangiopathy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombotic microangiopathy (hyaline thrombi of platelets and fibrin in terminal arterioles and capillaries) --- r_associated #0: 20 --> phlébite n1=en:thrombotic microangiopathy (hyaline thrombi of platelets and fibrin in terminal arterioles and capillaries) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombotic stroke --- r_associated #0: 20 --> phlébite n1=en:thrombotic stroke | n2=phlébite | rel=r_associated | relid=0 | w=20 en:thrombotic vascular disease --- r_associated #0: 20 --> phlébite n1=en:thrombotic vascular disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tick-borne bunyavirus hemorrhagic fever --- r_associated #0: 20 --> phlébite n1=en:tick-borne bunyavirus hemorrhagic fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tick-borne coltivirus encephalitis --- r_associated #0: 20 --> phlébite n1=en:tick-borne coltivirus encephalitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tick-borne diseases --- r_associated #0: 20 --> phlébite n1=en:tick-borne diseases | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tick-borne flavivirus hemorrhagic fever --- r_associated #0: 20 --> phlébite n1=en:tick-borne flavivirus hemorrhagic fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tick-borne hemorrhagic fever --- r_associated #0: 20 --> phlébite n1=en:tick-borne hemorrhagic fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tick-borne orbivirus encephalitis --- r_associated #0: 20 --> phlébite n1=en:tick-borne orbivirus encephalitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tick-borne orbivirus fever --- r_associated #0: 20 --> phlébite n1=en:tick-borne orbivirus fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tick-borne orthobunyavirus fever --- r_associated #0: 20 --> phlébite n1=en:tick-borne orthobunyavirus fever | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tick-borne rickettsiosis --- r_associated #0: 20 --> phlébite n1=en:tick-borne rickettsiosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tick-borne viral encephalitis --- r_associated #0: 20 --> phlébite n1=en:tick-borne viral encephalitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tissue ameba --- r_associated #0: 20 --> phlébite n1=en:tissue ameba | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tissue fluke --- r_associated #0: 20 --> phlébite n1=en:tissue fluke | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tissue nematode --- r_associated #0: 20 --> phlébite n1=en:tissue nematode | n2=phlébite | rel=r_associated | relid=0 | w=20 en:topical preparation --- r_associated #0: 20 --> phlébite n1=en:topical preparation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tortuosity of conjunctival vessels --- r_associated #0: 20 --> phlébite n1=en:tortuosity of conjunctival vessels | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tortuosity of thoracic aorta (in some patients) --- r_associated #0: 20 --> phlébite n1=en:tortuosity of thoracic aorta (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tortuous cerebral arteries --- r_associated #0: 20 --> phlébite n1=en:tortuous cerebral arteries | n2=phlébite | rel=r_associated | relid=0 | w=20 en:total white blood cell count less than 25,000/cubic mm with 30-70% eosinophils --- r_associated #0: 20 --> phlébite n1=en:total white blood cell count less than 25,000/cubic mm with 30-70% eosinophils | n2=phlébite | rel=r_associated | relid=0 | w=20 en:toxic effect of benzene and/or homologue --- r_associated #0: 20 --> phlébite n1=en:toxic effect of benzene and/or homologue | n2=phlébite | rel=r_associated | relid=0 | w=20 en:toxic effect of chemical --- r_associated #0: 20 --> phlébite n1=en:toxic effect of chemical | n2=phlébite | rel=r_associated | relid=0 | w=20 en:toxic effect of chiefly nonmedicinal substance --- r_associated #0: 20 --> phlébite n1=en:toxic effect of chiefly nonmedicinal substance | n2=phlébite | rel=r_associated | relid=0 | w=20 en:toxic effect of nonpetroleum-based solvent --- r_associated #0: 20 --> phlébite n1=en:toxic effect of nonpetroleum-based solvent | n2=phlébite | rel=r_associated | relid=0 | w=20 en:toxic effect of organophosphate and/or carbamate pesticide --- r_associated #0: 20 --> phlébite n1=en:toxic effect of organophosphate and/or carbamate pesticide | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tranexamic acid --- r_associated #0: 20 --> phlébite n1=en:tranexamic acid | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tranexamic acid 100mg/ml intravenous solution 10ml vial --- r_associated #0: 20 --> phlébite n1=en:tranexamic acid 100mg/ml intravenous solution 10ml vial | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tranexamic acid 500mg tablet --- r_associated #0: 20 --> phlébite n1=en:tranexamic acid 500mg tablet | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tranexamic acid 650mg tablet --- r_associated #0: 20 --> phlébite n1=en:tranexamic acid 650mg tablet | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tranexamic acid pwdr --- r_associated #0: 20 --> phlébite n1=en:tranexamic acid pwdr | n2=phlébite | rel=r_associated | relid=0 | w=20 en:transdermal administration of treatment --- r_associated #0: 20 --> phlébite n1=en:transdermal administration of treatment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:transferrin saturation increased --- r_associated #0: 20 --> phlébite n1=en:transferrin saturation increased | n2=phlébite | rel=r_associated | relid=0 | w=20 en:transfusion and related procedures --- r_associated #0: 20 --> phlébite n1=en:transfusion and related procedures | n2=phlébite | rel=r_associated | relid=0 | w=20 en:transfusion medicine --- r_associated #0: 20 --> phlébite n1=en:transfusion medicine | n2=phlébite | rel=r_associated | relid=0 | w=20 en:transfusion reaction --- r_associated #0: 20 --> phlébite n1=en:transfusion reaction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:transient ischemic attack --- r_associated #0: 20 --> phlébite n1=en:transient ischemic attack | n2=phlébite | rel=r_associated | relid=0 | w=20 en:transient neonatal hematological disorder --- r_associated #0: 20 --> phlébite n1=en:transient neonatal hematological disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:transposition of great vessels --- r_associated #0: 20 --> phlébite n1=en:transposition of great vessels | n2=phlébite | rel=r_associated | relid=0 | w=20 en:transposition of great vessels (rare) --- r_associated #0: 20 --> phlébite n1=en:transposition of great vessels (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:treatment administration via gastrostomy --- r_associated #0: 20 --> phlébite n1=en:treatment administration via gastrostomy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:treatment via bladder catheter --- r_associated #0: 20 --> phlébite n1=en:treatment via bladder catheter | n2=phlébite | rel=r_associated | relid=0 | w=20 en:trilineage dysplasia (in some patients) --- r_associated #0: 20 --> phlébite n1=en:trilineage dysplasia (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:trousseau's syndrome --- r_associated #0: 20 --> phlébite n1=en:trousseau's syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:truncal arteriovenous fistula --- r_associated #0: 20 --> phlébite n1=en:truncal arteriovenous fistula | n2=phlébite | rel=r_associated | relid=0 | w=20 en:truncus arteriosus --- r_associated #0: 20 --> phlébite n1=en:truncus arteriosus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:truncus arteriosus communis (rare) --- r_associated #0: 20 --> phlébite n1=en:truncus arteriosus communis (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tumor embolism --- r_associated #0: 20 --> phlébite n1=en:tumor embolism | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tumor of lymphoid, hemopoietic and related tissue --- r_associated #0: 20 --> phlébite n1=en:tumor of lymphoid, hemopoietic and related tissue | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tumor of mesothelial and soft tissue --- r_associated #0: 20 --> phlébite n1=en:tumor of mesothelial and soft tissue | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tumor of oral cavity, lips, and salivary glands --- r_associated #0: 20 --> phlébite n1=en:tumor of oral cavity, lips, and salivary glands | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tumor-like lesion of brain --- r_associated #0: 20 --> phlébite n1=en:tumor-like lesion of brain | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tumor-like lesion of esophagus --- r_associated #0: 20 --> phlébite n1=en:tumor-like lesion of esophagus | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tumor-like lesion of esophagus, stomach and duodenum --- r_associated #0: 20 --> phlébite n1=en:tumor-like lesion of esophagus, stomach and duodenum | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tumor-like lesion of intestine --- r_associated #0: 20 --> phlébite n1=en:tumor-like lesion of intestine | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tumor-like lesion of nervous system --- r_associated #0: 20 --> phlébite n1=en:tumor-like lesion of nervous system | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tumor-like lesion of skin --- r_associated #0: 20 --> phlébite n1=en:tumor-like lesion of skin | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tumour thrombosis --- r_associated #0: 20 --> phlébite n1=en:tumour thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tunica intima --- r_associated #0: 20 --> phlébite n1=en:tunica intima | n2=phlébite | rel=r_associated | relid=0 | w=20 en:tunica media --- r_associated #0: 20 --> phlébite n1=en:tunica media | n2=phlébite | rel=r_associated | relid=0 | w=20 en:type attribute a - c --- r_associated #0: 20 --> phlébite n1=en:type attribute a - c | n2=phlébite | rel=r_associated | relid=0 | w=20 en:type attribute d - f --- r_associated #0: 20 --> phlébite n1=en:type attribute d - f | n2=phlébite | rel=r_associated | relid=0 | w=20 en:type attribute g - l --- r_associated #0: 20 --> phlébite n1=en:type attribute g - l | n2=phlébite | rel=r_associated | relid=0 | w=20 en:type attribute m - p --- r_associated #0: 20 --> phlébite n1=en:type attribute m - p | n2=phlébite | rel=r_associated | relid=0 | w=20 en:type attribute r - s --- r_associated #0: 20 --> phlébite n1=en:type attribute r - s | n2=phlébite | rel=r_associated | relid=0 | w=20 en:type attribute t - z --- r_associated #0: 20 --> phlébite n1=en:type attribute t - z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:type i - methemoglobin concentration 10-35% --- r_associated #0: 20 --> phlébite n1=en:type i - methemoglobin concentration 10-35% | n2=phlébite | rel=r_associated | relid=0 | w=20 en:type of vessel --- r_associated #0: 20 --> phlébite n1=en:type of vessel | n2=phlébite | rel=r_associated | relid=0 | w=20 en:types of drugs a-g --- r_associated #0: 20 --> phlébite n1=en:types of drugs a-g | n2=phlébite | rel=r_associated | relid=0 | w=20 en:types of drugs h-m --- r_associated #0: 20 --> phlébite n1=en:types of drugs h-m | n2=phlébite | rel=r_associated | relid=0 | w=20 en:types of drugs n-s --- r_associated #0: 20 --> phlébite n1=en:types of drugs n-s | n2=phlébite | rel=r_associated | relid=0 | w=20 en:types of drugs t-z --- r_associated #0: 20 --> phlébite n1=en:types of drugs t-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:ulceration --- r_associated #0: 20 --> phlébite n1=en:ulceration | n2=phlébite | rel=r_associated | relid=0 | w=20 en:umbilical vasculitis --- r_associated #0: 20 --> phlébite n1=en:umbilical vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:unilateral vertebral artery hypoplasia --- r_associated #0: 20 --> phlébite n1=en:unilateral vertebral artery hypoplasia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:unintentional cut, puncture, perforation or haemorrhage during surgical and medical care --- r_associated #0: 20 --> phlébite n1=en:unintentional cut, puncture, perforation or haemorrhage during surgical and medical care | n2=phlébite | rel=r_associated | relid=0 | w=20 en:unreliable laboratory result --- r_associated #0: 20 --> phlébite n1=en:unreliable laboratory result | n2=phlébite | rel=r_associated | relid=0 | w=20 en:unspecified hematological disorder specific to newborn --- r_associated #0: 20 --> phlébite n1=en:unspecified hematological disorder specific to newborn | n2=phlébite | rel=r_associated | relid=0 | w=20 en:unspecified venous complication of pregnancy and the puerperium, delivered, with mention of postpartum complication --- r_associated #0: 20 --> phlébite n1=en:unspecified venous complication of pregnancy and the puerperium, delivered, with mention of postpartum complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:unspecified venous complication of pregnancy and the puerperium, delivered, with or without mention of antepartum condition --- r_associated #0: 20 --> phlébite n1=en:unspecified venous complication of pregnancy and the puerperium, delivered, with or without mention of antepartum condition | n2=phlébite | rel=r_associated | relid=0 | w=20 en:unstable hemoglobin (e.g. hb contaldo 141800.0022) --- r_associated #0: 20 --> phlébite n1=en:unstable hemoglobin (e.g. hb contaldo 141800.0022) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:upper extremity deep vein thrombosis --- r_associated #0: 20 --> phlébite n1=en:upper extremity deep vein thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:upper respiratory fluids and spaces --- r_associated #0: 20 --> phlébite n1=en:upper respiratory fluids and spaces | n2=phlébite | rel=r_associated | relid=0 | w=20 en:urethral administration of treatment --- r_associated #0: 20 --> phlébite n1=en:urethral administration of treatment | n2=phlébite | rel=r_associated | relid=0 | w=20 en:urogenital protozoan --- r_associated #0: 20 --> phlébite n1=en:urogenital protozoan | n2=phlébite | rel=r_associated | relid=0 | w=20 en:use of ultrasonography --- r_associated #0: 20 --> phlébite n1=en:use of ultrasonography | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vaccination site phlebitis --- r_associated #0: 20 --> phlébite n1=en:vaccination site phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vaccination site thrombosis --- r_associated #0: 20 --> phlébite n1=en:vaccination site thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vaccination site vasculitis --- r_associated #0: 20 --> phlébite n1=en:vaccination site vasculitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vaccine and biological substance --- r_associated #0: 20 --> phlébite n1=en:vaccine and biological substance | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vacuolated lymphocytes --- r_associated #0: 20 --> phlébite n1=en:vacuolated lymphocytes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vacuolated lymphocytes (type ii) --- r_associated #0: 20 --> phlébite n1=en:vacuolated lymphocytes (type ii) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vacuolated macrophages --- r_associated #0: 20 --> phlébite n1=en:vacuolated macrophages | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vacuolated monocytes --- r_associated #0: 20 --> phlébite n1=en:vacuolated monocytes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vacuolization in myeloid cell lines in the bone marrow --- r_associated #0: 20 --> phlébite n1=en:vacuolization in myeloid cell lines in the bone marrow | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vacuolization of marrow precursors --- r_associated #0: 20 --> phlébite n1=en:vacuolization of marrow precursors | n2=phlébite | rel=r_associated | relid=0 | w=20 en:variable bleeding episodes --- r_associated #0: 20 --> phlébite n1=en:variable bleeding episodes | n2=phlébite | rel=r_associated | relid=0 | w=20 en:variable bleeding episodes (menorrhagia, easy bruisability, postoperative hemorrhage) --- r_associated #0: 20 --> phlébite n1=en:variable bleeding episodes (menorrhagia, easy bruisability, postoperative hemorrhage) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:variable bleeding tendencies --- r_associated #0: 20 --> phlébite n1=en:variable bleeding tendencies | n2=phlébite | rel=r_associated | relid=0 | w=20 en:variable platelet functional defects --- r_associated #0: 20 --> phlébite n1=en:variable platelet functional defects | n2=phlébite | rel=r_associated | relid=0 | w=20 en:variable red blood cell size --- r_associated #0: 20 --> phlébite n1=en:variable red blood cell size | n2=phlébite | rel=r_associated | relid=0 | w=20 en:variable reductions in platelet aggregation --- r_associated #0: 20 --> phlébite n1=en:variable reductions in platelet aggregation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:varicose vein --- r_associated #0: 20 --> phlébite n1=en:varicose vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:varicose veins (reported in 1 family) --- r_associated #0: 20 --> phlébite n1=en:varicose veins (reported in 1 family) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasa nervorum --- r_associated #0: 20 --> phlébite n1=en:vasa nervorum | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasa vasorum --- r_associated #0: 20 --> phlébite n1=en:vasa vasorum | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular (arteriovenous) malformation, progressive, with cutaneous involvement --- r_associated #0: 20 --> phlébite n1=en:vascular (arteriovenous) malformation, progressive, with cutaneous involvement | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular abnormalities restricted to skin --- r_associated #0: 20 --> phlébite n1=en:vascular abnormalities restricted to skin | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access complication --- r_associated #0: 20 --> phlébite n1=en:vascular access complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access malfunction --- r_associated #0: 20 --> phlébite n1=en:vascular access malfunction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access site bruising --- r_associated #0: 20 --> phlébite n1=en:vascular access site bruising | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access site complication --- r_associated #0: 20 --> phlébite n1=en:vascular access site complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access site dissection --- r_associated #0: 20 --> phlébite n1=en:vascular access site dissection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access site haematoma --- r_associated #0: 20 --> phlébite n1=en:vascular access site haematoma | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access site haemorrhage --- r_associated #0: 20 --> phlébite n1=en:vascular access site haemorrhage | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access site infection --- r_associated #0: 20 --> phlébite n1=en:vascular access site infection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access site inflammation --- r_associated #0: 20 --> phlébite n1=en:vascular access site inflammation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access site occlusion --- r_associated #0: 20 --> phlébite n1=en:vascular access site occlusion | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access site oedema --- r_associated #0: 20 --> phlébite n1=en:vascular access site oedema | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access site pain --- r_associated #0: 20 --> phlébite n1=en:vascular access site pain | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access site pseudoaneurysm --- r_associated #0: 20 --> phlébite n1=en:vascular access site pseudoaneurysm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access site rash --- r_associated #0: 20 --> phlébite n1=en:vascular access site rash | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access site rupture --- r_associated #0: 20 --> phlébite n1=en:vascular access site rupture | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access site swelling --- r_associated #0: 20 --> phlébite n1=en:vascular access site swelling | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular access site thrombosis --- r_associated #0: 20 --> phlébite n1=en:vascular access site thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular anomalies (50% of patients) --- r_associated #0: 20 --> phlébite n1=en:vascular anomalies (50% of patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular bypass dysfunction --- r_associated #0: 20 --> phlébite n1=en:vascular bypass dysfunction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular calcification --- r_associated #0: 20 --> phlébite n1=en:vascular calcification | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular disorder --- r_associated #0: 20 --> phlébite n1=en:vascular disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular disorder of extremity --- r_associated #0: 20 --> phlébite n1=en:vascular disorder of extremity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular disorders, general and nec --- r_associated #0: 20 --> phlébite n1=en:vascular disorders, general and nec | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular ectasia --- r_associated #0: 20 --> phlébite n1=en:vascular ectasia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular endothelium --- r_associated #0: 20 --> phlébite n1=en:vascular endothelium | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular fragility --- r_associated #0: 20 --> phlébite n1=en:vascular fragility | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular graft complication --- r_associated #0: 20 --> phlébite n1=en:vascular graft complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular graft hemorrhage --- r_associated #0: 20 --> phlébite n1=en:vascular graft hemorrhage | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular graft stenosis --- r_associated #0: 20 --> phlébite n1=en:vascular graft stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular graft thrombosis --- r_associated #0: 20 --> phlébite n1=en:vascular graft thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular headache --- r_associated #0: 20 --> phlébite n1=en:vascular headache | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular hemorrhagic disorder --- r_associated #0: 20 --> phlébite n1=en:vascular hemorrhagic disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular hemostatic disorders --- r_associated #0: 20 --> phlébite n1=en:vascular hemostatic disorders | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular ischemia --- r_associated #0: 20 --> phlébite n1=en:vascular ischemia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular lesions --- r_associated #0: 20 --> phlébite n1=en:vascular lesions | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular malformation --- r_associated #0: 20 --> phlébite n1=en:vascular malformation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular malformations --- r_associated #0: 20 --> phlébite n1=en:vascular malformations | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular malformations (in some patients) --- r_associated #0: 20 --> phlébite n1=en:vascular malformations (in some patients) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular procedure complication --- r_associated #0: 20 --> phlébite n1=en:vascular procedure complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular pseudoaneurysm ruptured --- r_associated #0: 20 --> phlébite n1=en:vascular pseudoaneurysm ruptured | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular pseudoaneurysm thrombosis --- r_associated #0: 20 --> phlébite n1=en:vascular pseudoaneurysm thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular purpura --- r_associated #0: 20 --> phlébite n1=en:vascular purpura | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular ring --- r_associated #0: 20 --> phlébite n1=en:vascular ring | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular shunt thrombosis --- r_associated #0: 20 --> phlébite n1=en:vascular shunt thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular stasis --- r_associated #0: 20 --> phlébite n1=en:vascular stasis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular stenosis --- r_associated #0: 20 --> phlébite n1=en:vascular stenosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular stent infection --- r_associated #0: 20 --> phlébite n1=en:vascular stent infection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular structure of organs --- r_associated #0: 20 --> phlébite n1=en:vascular structure of organs | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular thrombosis --- r_associated #0: 20 --> phlébite n1=en:vascular thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascular tortuosity --- r_associated #0: 20 --> phlébite n1=en:vascular tortuosity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vascularization increased in upper dermis --- r_associated #0: 20 --> phlébite n1=en:vascularization increased in upper dermis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasculitic rash --- r_associated #0: 20 --> phlébite n1=en:vasculitic rash | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasculitic ulcer --- r_associated #0: 20 --> phlébite n1=en:vasculitic ulcer | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasculitis adverse event --- r_associated #0: 20 --> phlébite n1=en:vasculitis adverse event | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasculitis aggravated --- r_associated #0: 20 --> phlébite n1=en:vasculitis aggravated | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasculitis diffuse --- r_associated #0: 20 --> phlébite n1=en:vasculitis diffuse | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasculitis gastrointestinal --- r_associated #0: 20 --> phlébite n1=en:vasculitis gastrointestinal | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasculitis legs --- r_associated #0: 20 --> phlébite n1=en:vasculitis legs | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasculitis, particularly of the capillaries --- r_associated #0: 20 --> phlébite n1=en:vasculitis, particularly of the capillaries | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasculopathy of the small arteries penetrating the white matter --- r_associated #0: 20 --> phlébite n1=en:vasculopathy of the small arteries penetrating the white matter | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasodilation disorder --- r_associated #0: 20 --> phlébite n1=en:vasodilation disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasomotor acroparesthesia --- r_associated #0: 20 --> phlébite n1=en:vasomotor acroparesthesia | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasoplegia syndrome --- r_associated #0: 20 --> phlébite n1=en:vasoplegia syndrome | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasospasm --- r_associated #0: 20 --> phlébite n1=en:vasospasm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vasovagal syncope --- r_associated #0: 20 --> phlébite n1=en:vasovagal syncope | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vector-transmitted infectious disease --- r_associated #0: 20 --> phlébite n1=en:vector-transmitted infectious disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vein --- r_associated #0: 20 --> phlébite n1=en:vein | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vein collapse --- r_associated #0: 20 --> phlébite n1=en:vein collapse | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vein disorder --- r_associated #0: 20 --> phlébite n1=en:vein disorder | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vein of galen aneurysm --- r_associated #0: 20 --> phlébite n1=en:vein of galen aneurysm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:veins/lymphatics --- r_associated #0: 20 --> phlébite n1=en:veins/lymphatics | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vena caval embolism and thrombosis --- r_associated #0: 20 --> phlébite n1=en:vena caval embolism and thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:veno-occlusive disease --- r_associated #0: 20 --> phlébite n1=en:veno-occlusive disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venospasm --- r_associated #0: 20 --> phlébite n1=en:venospasm | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous and venular disorders --- r_associated #0: 20 --> phlébite n1=en:venous and venular disorders | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous collateral circulation, any site --- r_associated #0: 20 --> phlébite n1=en:venous collateral circulation, any site | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous complication in pregnancy and/or the puerperium --- r_associated #0: 20 --> phlébite n1=en:venous complication in pregnancy and/or the puerperium | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous complication in pregnancy, unspecified --- r_associated #0: 20 --> phlébite n1=en:venous complication in pregnancy, unspecified | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous complication in the puerperium --- r_associated #0: 20 --> phlébite n1=en:venous complication in the puerperium | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous embolism --- r_associated #0: 20 --> phlébite n1=en:venous embolism | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous hemorrhage --- r_associated #0: 20 --> phlébite n1=en:venous hemorrhage | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous hypertension --- r_associated #0: 20 --> phlébite n1=en:venous hypertension | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous injury --- r_associated #0: 20 --> phlébite n1=en:venous injury | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous insufficiency --- r_associated #0: 20 --> phlébite n1=en:venous insufficiency | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous intravasation --- r_associated #0: 20 --> phlébite n1=en:venous intravasation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous malformation --- r_associated #0: 20 --> phlébite n1=en:venous malformation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous malformation (low flow) (most cases) --- r_associated #0: 20 --> phlébite n1=en:venous malformation (low flow) (most cases) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous obstruction --- r_associated #0: 20 --> phlébite n1=en:venous obstruction | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous perforation --- r_associated #0: 20 --> phlébite n1=en:venous perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous recanalisation --- r_associated #0: 20 --> phlébite n1=en:venous recanalisation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous thrombosis due to central venous access device --- r_associated #0: 20 --> phlébite n1=en:venous thrombosis due to central venous access device | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous thrombosis in pregnancy --- r_associated #0: 20 --> phlébite n1=en:venous thrombosis in pregnancy | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous thrombosis neonatal --- r_associated #0: 20 --> phlébite n1=en:venous thrombosis neonatal | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous thrombosis related to vascular access complication --- r_associated #0: 20 --> phlébite n1=en:venous thrombosis related to vascular access complication | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous thrombosis, phlebitis and thrombophlebitis --- r_associated #0: 20 --> phlébite n1=en:venous thrombosis, phlebitis and thrombophlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous thrombosis/embolism (rare) --- r_associated #0: 20 --> phlébite n1=en:venous thrombosis/embolism (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous tortuosity --- r_associated #0: 20 --> phlébite n1=en:venous tortuosity | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venous varicosities of celiac and mesenteric vessels --- r_associated #0: 20 --> phlébite n1=en:venous varicosities of celiac and mesenteric vessels | n2=phlébite | rel=r_associated | relid=0 | w=20 en:venule --- r_associated #0: 20 --> phlébite n1=en:venule | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vertebral artery perforation --- r_associated #0: 20 --> phlébite n1=en:vertebral artery perforation | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vertebral hemangiomas --- r_associated #0: 20 --> phlébite n1=en:vertebral hemangiomas | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vertebrobasilar artery tortuosity (rare) --- r_associated #0: 20 --> phlébite n1=en:vertebrobasilar artery tortuosity (rare) | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vessel puncture site phlebitis --- r_associated #0: 20 --> phlébite n1=en:vessel puncture site phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vessel puncture site thrombosis --- r_associated #0: 20 --> phlébite n1=en:vessel puncture site thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:veterinary aspects --- r_associated #0: 20 --> phlébite n1=en:veterinary aspects | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vibrio species a-m --- r_associated #0: 20 --> phlébite n1=en:vibrio species a-m | n2=phlébite | rel=r_associated | relid=0 | w=20 en:vibrio species n-z --- r_associated #0: 20 --> phlébite n1=en:vibrio species n-z | n2=phlébite | rel=r_associated | relid=0 | w=20 en:viruses --- r_associated #0: 20 --> phlébite n1=en:viruses | n2=phlébite | rel=r_associated | relid=0 | w=20 en:visual test categorized by action status --- r_associated #0: 20 --> phlébite n1=en:visual test categorized by action status | n2=phlébite | rel=r_associated | relid=0 | w=20 en:von willebrand disease --- r_associated #0: 20 --> phlébite n1=en:von willebrand disease | n2=phlébite | rel=r_associated | relid=0 | w=20 en:wedge osteotomy of thorax, ribs or sternum --- r_associated #0: 20 --> phlébite n1=en:wedge osteotomy of thorax, ribs or sternum | n2=phlébite | rel=r_associated | relid=0 | w=20 en:wegener granulomatosis --- r_associated #0: 20 --> phlébite n1=en:wegener granulomatosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:white blood cell abnormality --- r_associated #0: 20 --> phlébite n1=en:white blood cell abnormality | n2=phlébite | rel=r_associated | relid=0 | w=20 en:zooanthroponosis --- r_associated #0: 20 --> phlébite n1=en:zooanthroponosis | n2=phlébite | rel=r_associated | relid=0 | w=20 en:zoonotic bacteria --- r_associated #0: 20 --> phlébite n1=en:zoonotic bacteria | n2=phlébite | rel=r_associated | relid=0 | w=20 en:zoonotic bacterial infection --- r_associated #0: 20 --> phlébite n1=en:zoonotic bacterial infection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:zoonotic infection --- r_associated #0: 20 --> phlébite n1=en:zoonotic infection | n2=phlébite | rel=r_associated | relid=0 | w=20 en:zoonotic pathogen --- r_associated #0: 20 --> phlébite n1=en:zoonotic pathogen | n2=phlébite | rel=r_associated | relid=0 | w=20 en:zooparasitic portal cirrhosis --- r_associated #0: 20 --> phlébite n1=en:zooparasitic portal cirrhosis | n2=phlébite | rel=r_associated | relid=0 | w=20 fibrinogène --- r_associated #0: 20 --> phlébite n1=fibrinogène | n2=phlébite | rel=r_associated | relid=0 | w=20 fibrinolyse --- r_associated #0: 20 --> phlébite n1=fibrinolyse | n2=phlébite | rel=r_associated | relid=0 | w=20 flux sanguin --- r_associated #0: 20 --> phlébite n1=flux sanguin | n2=phlébite | rel=r_associated | relid=0 | w=20 inflammation de paroi veineuse --- r_associated #0: 20 --> phlébite n1=inflammation de paroi veineuse | n2=phlébite | rel=r_associated | relid=0 | w=20 jambes --- r_associated #0: 20 --> phlébite n1=jambes | n2=phlébite | rel=r_associated | relid=0 | w=20 maladie cardiaque --- r_associated #0: 20 --> phlébite n1=maladie cardiaque | n2=phlébite | rel=r_associated | relid=0 | w=20 médecine (science) --- r_associated #0: 20 --> phlébite n1=médecine (science) | n2=phlébite | rel=r_associated | relid=0 | w=20 obstruction --- r_associated #0: 20 --> phlébite n1=obstruction | n2=phlébite | rel=r_associated | relid=0 | w=20 obturation --- r_associated #0: 20 --> phlébite n1=obturation | n2=phlébite | rel=r_associated | relid=0 | w=20 pathologie --- r_associated #0: 20 --> phlébite n1=pathologie | n2=phlébite | rel=r_associated | relid=0 | w=20 sang --- r_associated #0: 20 --> phlébite n1=sang | n2=phlébite | rel=r_associated | relid=0 | w=20 syndrome de l'orteil bleu --- r_associated #0: 20 --> phlébite n1=syndrome de l'orteil bleu | n2=phlébite | rel=r_associated | relid=0 | w=20 thrombokinase --- r_associated #0: 20 --> phlébite n1=thrombokinase | n2=phlébite | rel=r_associated | relid=0 | w=20 thrombose veineuse ovarienne --- r_associated #0: 20 --> phlébite n1=thrombose veineuse ovarienne | n2=phlébite | rel=r_associated | relid=0 | w=20 thromboses --- r_associated #0: 20 --> phlébite n1=thromboses | n2=phlébite | rel=r_associated | relid=0 | w=20 thrombus blanc --- r_associated #0: 20 --> phlébite n1=thrombus blanc | n2=phlébite | rel=r_associated | relid=0 | w=20 trouble cardiaque --- r_associated #0: 20 --> phlébite n1=trouble cardiaque | n2=phlébite | rel=r_associated | relid=0 | w=20 vaisseau --- r_associated #0: 20 --> phlébite n1=vaisseau | n2=phlébite | rel=r_associated | relid=0 | w=20 caillot --- r_associated #0: 16 --> phlébite n1=caillot | n2=phlébite | rel=r_associated | relid=0 | w=16 embolie --- r_associated #0: 16 --> phlébite n1=embolie | n2=phlébite | rel=r_associated | relid=0 | w=16 grumeau --- r_associated #0: 16 --> phlébite n1=grumeau | n2=phlébite | rel=r_associated | relid=0 | w=16 Flux sanguin --- r_associated #0: 15 --> phlébite n1=Flux sanguin | n2=phlébite | rel=r_associated | relid=0 | w=15 angiopathie --- r_associated #0: 15 --> phlébite n1=angiopathie | n2=phlébite | rel=r_associated | relid=0 | w=15 anomalie du coeur --- r_associated #0: 15 --> phlébite n1=anomalie du coeur | n2=phlébite | rel=r_associated | relid=0 | w=15 asthénie neuro-circulatoire --- r_associated #0: 15 --> phlébite n1=asthénie neuro-circulatoire | n2=phlébite | rel=r_associated | relid=0 | w=15 bas champ (magnétique) --- r_associated #0: 15 --> phlébite n1=bas champ (magnétique) | n2=phlébite | rel=r_associated | relid=0 | w=15 choc cardiogène --- r_associated #0: 15 --> phlébite n1=choc cardiogène | n2=phlébite | rel=r_associated | relid=0 | w=15 choc cardiogénique --- r_associated #0: 15 --> phlébite n1=choc cardiogénique | n2=phlébite | rel=r_associated | relid=0 | w=15 choc compliquant ou consécutif à travail et accouchement --- r_associated #0: 15 --> phlébite n1=choc compliquant ou consécutif à travail et accouchement | n2=phlébite | rel=r_associated | relid=0 | w=15 circulation cérébrale (régulation de la) --- r_associated #0: 15 --> phlébite n1=circulation cérébrale (régulation de la) | n2=phlébite | rel=r_associated | relid=0 | w=15 en:blackout - symptom --- r_associated #0: 15 --> phlébite n1=en:blackout - symptom | n2=phlébite | rel=r_associated | relid=0 | w=15 en:heart malformation --- r_associated #0: 15 --> phlébite n1=en:heart malformation | n2=phlébite | rel=r_associated | relid=0 | w=15 fibrinogénolytique --- r_associated #0: 15 --> phlébite n1=fibrinogénolytique | n2=phlébite | rel=r_associated | relid=0 | w=15 fibrinogénopénie --- r_associated #0: 15 --> phlébite n1=fibrinogénopénie | n2=phlébite | rel=r_associated | relid=0 | w=15 fibrinogénémie --- r_associated #0: 15 --> phlébite n1=fibrinogénémie | n2=phlébite | rel=r_associated | relid=0 | w=15 fibrinoïde --- r_associated #0: 15 --> phlébite n1=fibrinoïde | n2=phlébite | rel=r_associated | relid=0 | w=15 hypotension orthostatique --- r_associated #0: 15 --> phlébite n1=hypotension orthostatique | n2=phlébite | rel=r_associated | relid=0 | w=15 hypotension orthostatique neurogène --- r_associated #0: 15 --> phlébite n1=hypotension orthostatique neurogène | n2=phlébite | rel=r_associated | relid=0 | w=15 malformation cardiaque --- r_associated #0: 15 --> phlébite n1=malformation cardiaque | n2=phlébite | rel=r_associated | relid=0 | w=15 perte de connaissance --- r_associated #0: 15 --> phlébite n1=perte de connaissance | n2=phlébite | rel=r_associated | relid=0 | w=15 perte de conscience --- r_associated #0: 15 --> phlébite n1=perte de conscience | n2=phlébite | rel=r_associated | relid=0 | w=15 pouls périphériques diminués ou absents --- r_associated #0: 15 --> phlébite n1=pouls périphériques diminués ou absents | n2=phlébite | rel=r_associated | relid=0 | w=15 syncope due à la chaleur --- r_associated #0: 15 --> phlébite n1=syncope due à la chaleur | n2=phlébite | rel=r_associated | relid=0 | w=15 syncope psychogène --- r_associated #0: 15 --> phlébite n1=syncope psychogène | n2=phlébite | rel=r_associated | relid=0 | w=15 syndrome du sinus carotidien --- r_associated #0: 15 --> phlébite n1=syndrome du sinus carotidien | n2=phlébite | rel=r_associated | relid=0 | w=15 thrombus antémortem --- r_associated #0: 15 --> phlébite n1=thrombus antémortem | n2=phlébite | rel=r_associated | relid=0 | w=15 voile noir --- r_associated #0: 15 --> phlébite n1=voile noir | n2=phlébite | rel=r_associated | relid=0 | w=15 caillot de sang --- r_associated #0: 12 --> phlébite n1=caillot de sang | n2=phlébite | rel=r_associated | relid=0 | w=12 Thrombose veineuse --- r_associated #0: 11 --> phlébite n1=Thrombose veineuse | n2=phlébite | rel=r_associated | relid=0 | w=11 Thrombose veineuse profonde --- r_associated #0: 11 --> phlébite n1=Thrombose veineuse profonde | n2=phlébite | rel=r_associated | relid=0 | w=11 en:coronary --- r_associated #0: 11 --> phlébite n1=en:coronary | n2=phlébite | rel=r_associated | relid=0 | w=11 phlébectomie --- r_associated #0: 11 --> phlébite n1=phlébectomie | n2=phlébite | rel=r_associated | relid=0 | w=11 phlébographie --- r_associated #0: 11 --> phlébite n1=phlébographie | n2=phlébite | rel=r_associated | relid=0 | w=11 pyléphlébite --- r_associated #0: 11 --> phlébite n1=pyléphlébite | n2=phlébite | rel=r_associated | relid=0 | w=11 Anévrisme --- r_associated #0: 10 --> phlébite n1=Anévrisme | n2=phlébite | rel=r_associated | relid=0 | w=10 Artérite --- r_associated #0: 10 --> phlébite n1=Artérite | n2=phlébite | rel=r_associated | relid=0 | w=10 Bas à varices --- r_associated #0: 10 --> phlébite n1=Bas à varices | n2=phlébite | rel=r_associated | relid=0 | w=10 Embolie paradoxale --- r_associated #0: 10 --> phlébite n1=Embolie paradoxale | n2=phlébite | rel=r_associated | relid=0 | w=10 Fibrinogène --- r_associated #0: 10 --> phlébite n1=Fibrinogène | n2=phlébite | rel=r_associated | relid=0 | w=10 Fibrinolyse --- r_associated #0: 10 --> phlébite n1=Fibrinolyse | n2=phlébite | rel=r_associated | relid=0 | w=10 Hypercoagulabilité --- r_associated #0: 10 --> phlébite n1=Hypercoagulabilité | n2=phlébite | rel=r_associated | relid=0 | w=10 Infarctus --- r_associated #0: 10 --> phlébite n1=Infarctus | n2=phlébite | rel=r_associated | relid=0 | w=10 Oedèmes --- r_associated #0: 10 --> phlébite n1=Oedèmes | n2=phlébite | rel=r_associated | relid=0 | w=10 Pyle (maladie de) --- r_associated #0: 10 --> phlébite n1=Pyle (maladie de) | n2=phlébite | rel=r_associated | relid=0 | w=10 Retour veineux --- r_associated #0: 10 --> phlébite n1=Retour veineux | n2=phlébite | rel=r_associated | relid=0 | w=10 Schistosomatidae --- r_associated #0: 10 --> phlébite n1=Schistosomatidae | n2=phlébite | rel=r_associated | relid=0 | w=10 Thrombophlébite --- r_associated #0: 10 --> phlébite n1=Thrombophlébite | n2=phlébite | rel=r_associated | relid=0 | w=10 Tula (virus) --- r_associated #0: 10 --> phlébite n1=Tula (virus) | n2=phlébite | rel=r_associated | relid=0 | w=10 Tumarkin (vertige de) --- r_associated #0: 10 --> phlébite n1=Tumarkin (vertige de) | n2=phlébite | rel=r_associated | relid=0 | w=10 Varice --- r_associated #0: 10 --> phlébite n1=Varice | n2=phlébite | rel=r_associated | relid=0 | w=10 Zahn (crête de) --- r_associated #0: 10 --> phlébite n1=Zahn (crête de) | n2=phlébite | rel=r_associated | relid=0 | w=10 acanthocyte --- r_associated #0: 10 --> phlébite n1=acanthocyte | n2=phlébite | rel=r_associated | relid=0 | w=10 accident cérébro-vasculaire --- r_associated #0: 10 --> phlébite n1=accident cérébro-vasculaire | n2=phlébite | rel=r_associated | relid=0 | w=10 accident ischémique cérébral --- r_associated #0: 10 --> phlébite n1=accident ischémique cérébral | n2=phlébite | rel=r_associated | relid=0 | w=10 accidents vasculaires cérébraux --- r_associated #0: 10 --> phlébite n1=accidents vasculaires cérébraux | n2=phlébite | rel=r_associated | relid=0 | w=10 aggrégation plaquettaire anormale --- r_associated #0: 10 --> phlébite n1=aggrégation plaquettaire anormale | n2=phlébite | rel=r_associated | relid=0 | w=10 angiopathie amyloïde cérébrale --- r_associated #0: 10 --> phlébite n1=angiopathie amyloïde cérébrale | n2=phlébite | rel=r_associated | relid=0 | w=10 anémie --- r_associated #0: 10 --> phlébite n1=anémie | n2=phlébite | rel=r_associated | relid=0 | w=10 anémie aplasique --- r_associated #0: 10 --> phlébite n1=anémie aplasique | n2=phlébite | rel=r_associated | relid=0 | w=10 anémie aplasique non précisée --- r_associated #0: 10 --> phlébite n1=anémie aplasique non précisée | n2=phlébite | rel=r_associated | relid=0 | w=10 anémie hypoplasique --- r_associated #0: 10 --> phlébite n1=anémie hypoplasique | n2=phlébite | rel=r_associated | relid=0 | w=10 anémie hémolytique microangiopathique --- r_associated #0: 10 --> phlébite n1=anémie hémolytique microangiopathique | n2=phlébite | rel=r_associated | relid=0 | w=10 anémie pernicieuse --- r_associated #0: 10 --> phlébite n1=anémie pernicieuse | n2=phlébite | rel=r_associated | relid=0 | w=10 anévrysme --- r_associated #0: 10 --> phlébite n1=anévrysme | n2=phlébite | rel=r_associated | relid=0 | w=10 aplasie médullaire --- r_associated #0: 10 --> phlébite n1=aplasie médullaire | n2=phlébite | rel=r_associated | relid=0 | w=10 aplasie érythrocytaire --- r_associated #0: 10 --> phlébite n1=aplasie érythrocytaire | n2=phlébite | rel=r_associated | relid=0 | w=10 artère précapillaire --- r_associated #0: 10 --> phlébite n1=artère précapillaire | n2=phlébite | rel=r_associated | relid=0 | w=10 artériole --- r_associated #0: 10 --> phlébite n1=artériole | n2=phlébite | rel=r_associated | relid=0 | w=10 artériospasme --- r_associated #0: 10 --> phlébite n1=artériospasme | n2=phlébite | rel=r_associated | relid=0 | w=10 arythmie cardiaque --- r_associated #0: 10 --> phlébite n1=arythmie cardiaque | n2=phlébite | rel=r_associated | relid=0 | w=10 attaque apoplectique --- r_associated #0: 10 --> phlébite n1=attaque apoplectique | n2=phlébite | rel=r_associated | relid=0 | w=10 attaque d'apoplexie --- r_associated #0: 10 --> phlébite n1=attaque d'apoplexie | n2=phlébite | rel=r_associated | relid=0 | w=10 bas de compression --- r_associated #0: 10 --> phlébite n1=bas de compression | n2=phlébite | rel=r_associated | relid=0 | w=10 claudication intermittente --- r_associated #0: 10 --> phlébite n1=claudication intermittente | n2=phlébite | rel=r_associated | relid=0 | w=10 coccidies sanguines et tissulaires --- r_associated #0: 10 --> phlébite n1=coccidies sanguines et tissulaires | n2=phlébite | rel=r_associated | relid=0 | w=10 coronarienne --- r_associated #0: 10 --> phlébite n1=coronarienne | n2=phlébite | rel=r_associated | relid=0 | w=10 coumadine --- r_associated #0: 10 --> phlébite n1=coumadine | n2=phlébite | rel=r_associated | relid=0 | w=10 dégénérescences cérébrales se manifestant généralement pendant l'enfance --- r_associated #0: 10 --> phlébite n1=dégénérescences cérébrales se manifestant généralement pendant l'enfance | n2=phlébite | rel=r_associated | relid=0 | w=10 embolie gazeuse --- r_associated #0: 10 --> phlébite n1=embolie gazeuse | n2=phlébite | rel=r_associated | relid=0 | w=10 en:arboviruses --- r_associated #0: 10 --> phlébite n1=en:arboviruses | n2=phlébite | rel=r_associated | relid=0 | w=10 en:cardiac arrest --- r_associated #0: 10 --> phlébite n1=en:cardiac arrest | n2=phlébite | rel=r_associated | relid=0 | w=10 en:choroid blood vessels --- r_associated #0: 10 --> phlébite n1=en:choroid blood vessels | n2=phlébite | rel=r_associated | relid=0 | w=10 en:circulatory system --- r_associated #0: 10 --> phlébite n1=en:circulatory system | n2=phlébite | rel=r_associated | relid=0 | w=10 en:excision of vein --- r_associated #0: 10 --> phlébite n1=en:excision of vein | n2=phlébite | rel=r_associated | relid=0 | w=10 en:fibrinogen --- r_associated #0: 10 --> phlébite n1=en:fibrinogen | n2=phlébite | rel=r_associated | relid=0 | w=10 en:fibrinogenemia --- r_associated #0: 10 --> phlébite n1=en:fibrinogenemia | n2=phlébite | rel=r_associated | relid=0 | w=10 en:fibrinogenolytic --- r_associated #0: 10 --> phlébite n1=en:fibrinogenolytic | n2=phlébite | rel=r_associated | relid=0 | w=10 en:fibrinogenopenia --- r_associated #0: 10 --> phlébite n1=en:fibrinogenopenia | n2=phlébite | rel=r_associated | relid=0 | w=10 en:fibrinoid --- r_associated #0: 10 --> phlébite n1=en:fibrinoid | n2=phlébite | rel=r_associated | relid=0 | w=10 en:fluid overload --- r_associated #0: 10 --> phlébite n1=en:fluid overload | n2=phlébite | rel=r_associated | relid=0 | w=10 en:heart diseases --- r_associated #0: 10 --> phlébite n1=en:heart diseases | n2=phlébite | rel=r_associated | relid=0 | w=10 en:infarction --- r_associated #0: 10 --> phlébite n1=en:infarction | n2=phlébite | rel=r_associated | relid=0 | w=10 en:infarctus --- r_associated #0: 10 --> phlébite n1=en:infarctus | n2=phlébite | rel=r_associated | relid=0 | w=10 en:myocardial infarction --- r_associated #0: 10 --> phlébite n1=en:myocardial infarction | n2=phlébite | rel=r_associated | relid=0 | w=10 en:regulation of the cerebral circulation --- r_associated #0: 10 --> phlébite n1=en:regulation of the cerebral circulation | n2=phlébite | rel=r_associated | relid=0 | w=10 en:statins --- r_associated #0: 10 --> phlébite n1=en:statins | n2=phlébite | rel=r_associated | relid=0 | w=10 en:thrombolysis --- r_associated #0: 10 --> phlébite n1=en:thrombolysis | n2=phlébite | rel=r_associated | relid=0 | w=10 en:venoocclusive disease --- r_associated #0: 10 --> phlébite n1=en:venoocclusive disease | n2=phlébite | rel=r_associated | relid=0 | w=10 encéphalite due à un alphavirus transmis par les moustiques --- r_associated #0: 10 --> phlébite n1=encéphalite due à un alphavirus transmis par les moustiques | n2=phlébite | rel=r_associated | relid=0 | w=10 encéphalite due à un flavivirus transmis par les moustiques --- r_associated #0: 10 --> phlébite n1=encéphalite due à un flavivirus transmis par les moustiques | n2=phlébite | rel=r_associated | relid=0 | w=10 encéphalite due à un orthobunyavirus transmis par les moustiques --- r_associated #0: 10 --> phlébite n1=encéphalite due à un orthobunyavirus transmis par les moustiques | n2=phlébite | rel=r_associated | relid=0 | w=10 encéphalite due à un sous-groupe de virus de l'encéphalite à tiques --- r_associated #0: 10 --> phlébite n1=encéphalite due à un sous-groupe de virus de l'encéphalite à tiques | n2=phlébite | rel=r_associated | relid=0 | w=10 encéphalite à coltivirus transmise par les tiques --- r_associated #0: 10 --> phlébite n1=encéphalite à coltivirus transmise par les tiques | n2=phlébite | rel=r_associated | relid=0 | w=10 encéphalite à orbivirus transmise par les tiques --- r_associated #0: 10 --> phlébite n1=encéphalite à orbivirus transmise par les tiques | n2=phlébite | rel=r_associated | relid=0 | w=10 erythromelalgia --- r_associated #0: 10 --> phlébite n1=erythromelalgia | n2=phlébite | rel=r_associated | relid=0 | w=10 erythrosis --- r_associated #0: 10 --> phlébite n1=erythrosis | n2=phlébite | rel=r_associated | relid=0 | w=10 exploration de la fonction rénale --- r_associated #0: 10 --> phlébite n1=exploration de la fonction rénale | n2=phlébite | rel=r_associated | relid=0 | w=10 explorations de la fonction rénale --- r_associated #0: 10 --> phlébite n1=explorations de la fonction rénale | n2=phlébite | rel=r_associated | relid=0 | w=10 explorations fonctionnelles rénales --- r_associated #0: 10 --> phlébite n1=explorations fonctionnelles rénales | n2=phlébite | rel=r_associated | relid=0 | w=10 flagellés sanguins et tissulaires --- r_associated #0: 10 --> phlébite n1=flagellés sanguins et tissulaires | n2=phlébite | rel=r_associated | relid=0 | w=10 helminthe --- r_associated #0: 10 --> phlébite n1=helminthe | n2=phlébite | rel=r_associated | relid=0 | w=10 hormones et leurs métabolites et précurseurs a - g --- r_associated #0: 10 --> phlébite n1=hormones et leurs métabolites et précurseurs a - g | n2=phlébite | rel=r_associated | relid=0 | w=10 hormones et leurs métabolites et précurseurs h - s --- r_associated #0: 10 --> phlébite n1=hormones et leurs métabolites et précurseurs h - s | n2=phlébite | rel=r_associated | relid=0 | w=10 hormones et leurs métabolites et précurseurs t - z --- r_associated #0: 10 --> phlébite n1=hormones et leurs métabolites et précurseurs t - z | n2=phlébite | rel=r_associated | relid=0 | w=10 hypersplénisme --- r_associated #0: 10 --> phlébite n1=hypersplénisme | n2=phlébite | rel=r_associated | relid=0 | w=10 hypervolémie --- r_associated #0: 10 --> phlébite n1=hypervolémie | n2=phlébite | rel=r_associated | relid=0 | w=10 hypotension --- r_associated #0: 10 --> phlébite n1=hypotension | n2=phlébite | rel=r_associated | relid=0 | w=10 hémangiome --- r_associated #0: 10 --> phlébite n1=hémangiome | n2=phlébite | rel=r_associated | relid=0 | w=10 hémoconcentration --- r_associated #0: 10 --> phlébite n1=hémoconcentration | n2=phlébite | rel=r_associated | relid=0 | w=10 hémodilution --- r_associated #0: 10 --> phlébite n1=hémodilution | n2=phlébite | rel=r_associated | relid=0 | w=10 hémoglobine F persistante --- r_associated #0: 10 --> phlébite n1=hémoglobine F persistante | n2=phlébite | rel=r_associated | relid=0 | w=10 hémoglobinopathie --- r_associated #0: 10 --> phlébite n1=hémoglobinopathie | n2=phlébite | rel=r_associated | relid=0 | w=10 hémorragie intracranienne --- r_associated #0: 10 --> phlébite n1=hémorragie intracranienne | n2=phlébite | rel=r_associated | relid=0 | w=10 hémorragie intracrânienne --- r_associated #0: 10 --> phlébite n1=hémorragie intracrânienne | n2=phlébite | rel=r_associated | relid=0 | w=10 hémorragie nasale --- r_associated #0: 10 --> phlébite n1=hémorragie nasale | n2=phlébite | rel=r_associated | relid=0 | w=10 livedo reticularis --- r_associated #0: 10 --> phlébite n1=livedo reticularis | n2=phlébite | rel=r_associated | relid=0 | w=10 maladie cardio-vasculaire --- r_associated #0: 10 --> phlébite n1=maladie cardio-vasculaire | n2=phlébite | rel=r_associated | relid=0 | w=10 maladie de l'appareil cardio-vasculaire --- r_associated #0: 10 --> phlébite n1=maladie de l'appareil cardio-vasculaire | n2=phlébite | rel=r_associated | relid=0 | w=10 maladie de l'appareil cardiovasculaire --- r_associated #0: 10 --> phlébite n1=maladie de l'appareil cardiovasculaire | n2=phlébite | rel=r_associated | relid=0 | w=10 maladie de l'appareil circulatoire --- r_associated #0: 10 --> phlébite n1=maladie de l'appareil circulatoire | n2=phlébite | rel=r_associated | relid=0 | w=10 maladie infectieuse --- r_associated #0: 10 --> phlébite n1=maladie infectieuse | n2=phlébite | rel=r_associated | relid=0 | w=10 maladie transportée par une tique infectée --- r_associated #0: 10 --> phlébite n1=maladie transportée par une tique infectée | n2=phlébite | rel=r_associated | relid=0 | w=10 malaise vagal --- r_associated #0: 10 --> phlébite n1=malaise vagal | n2=phlébite | rel=r_associated | relid=0 | w=10 micro-angiopathie thrombotique --- r_associated #0: 10 --> phlébite n1=micro-angiopathie thrombotique | n2=phlébite | rel=r_associated | relid=0 | w=10 microangiopathie thrombotique --- r_associated #0: 10 --> phlébite n1=microangiopathie thrombotique | n2=phlébite | rel=r_associated | relid=0 | w=10 microsporidies sanguines et tissulaires --- r_associated #0: 10 --> phlébite n1=microsporidies sanguines et tissulaires | n2=phlébite | rel=r_associated | relid=0 | w=10 myélolipome --- r_associated #0: 10 --> phlébite n1=myélolipome | n2=phlébite | rel=r_associated | relid=0 | w=10 myélolipomes --- r_associated #0: 10 --> phlébite n1=myélolipomes | n2=phlébite | rel=r_associated | relid=0 | w=10 oedémateux (syndrome) --- r_associated #0: 10 --> phlébite n1=oedémateux (syndrome) | n2=phlébite | rel=r_associated | relid=0 | w=10 omovertébral (os) --- r_associated #0: 10 --> phlébite n1=omovertébral (os) | n2=phlébite | rel=r_associated | relid=0 | w=10 pancytopénies --- r_associated #0: 10 --> phlébite n1=pancytopénies | n2=phlébite | rel=r_associated | relid=0 | w=10 philobate --- r_associated #0: 10 --> phlébite n1=philobate | n2=phlébite | rel=r_associated | relid=0 | w=10 phimosis --- r_associated #0: 10 --> phlébite n1=phimosis | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébalgie --- r_associated #0: 10 --> phlébite n1=phlébalgie | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébangiome --- r_associated #0: 10 --> phlébite n1=phlébangiome | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébartérie --- r_associated #0: 10 --> phlébite n1=phlébartérie | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébartériectasie --- r_associated #0: 10 --> phlébite n1=phlébartériectasie | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébectasie --- r_associated #0: 10 --> phlébite n1=phlébectasie | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébectasie de la veine jugulaire interne --- r_associated #0: 10 --> phlébite n1=phlébectasie de la veine jugulaire interne | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébectomie ambulatoire --- r_associated #0: 10 --> phlébite n1=phlébectomie ambulatoire | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébite bleue --- r_associated #0: 10 --> phlébite n1=phlébite bleue | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébocavographie --- r_associated #0: 10 --> phlébite n1=phlébocavographie | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébodynie --- r_associated #0: 10 --> phlébite n1=phlébodynie | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébogramme --- r_associated #0: 10 --> phlébite n1=phlébogramme | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébogramme jugulaire --- r_associated #0: 10 --> phlébite n1=phlébogramme jugulaire | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébographie azygos --- r_associated #0: 10 --> phlébite n1=phlébographie azygos | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébographie cave inférieure --- r_associated #0: 10 --> phlébite n1=phlébographie cave inférieure | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébographie cave supérieure --- r_associated #0: 10 --> phlébite n1=phlébographie cave supérieure | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébographie cervicale --- r_associated #0: 10 --> phlébite n1=phlébographie cervicale | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébographie des sinus caverneux --- r_associated #0: 10 --> phlébite n1=phlébographie des sinus caverneux | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébotomes (fièvre à ) --- r_associated #0: 10 --> phlébite n1=phlébotomes (fièvre à ) | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébotomie --- r_associated #0: 10 --> phlébite n1=phlébotomie | n2=phlébite | rel=r_associated | relid=0 | w=10 polycythemia --- r_associated #0: 10 --> phlébite n1=polycythemia | n2=phlébite | rel=r_associated | relid=0 | w=10 polycythemia vera --- r_associated #0: 10 --> phlébite n1=polycythemia vera | n2=phlébite | rel=r_associated | relid=0 | w=10 produits décoratifs causant un effet toxique --- r_associated #0: 10 --> phlébite n1=produits décoratifs causant un effet toxique | n2=phlébite | rel=r_associated | relid=0 | w=10 protozoaires sanguins et tissulaires --- r_associated #0: 10 --> phlébite n1=protozoaires sanguins et tissulaires | n2=phlébite | rel=r_associated | relid=0 | w=10 périphérie (effet de) --- r_associated #0: 10 --> phlébite n1=périphérie (effet de) | n2=phlébite | rel=r_associated | relid=0 | w=10 schistocyte --- r_associated #0: 10 --> phlébite n1=schistocyte | n2=phlébite | rel=r_associated | relid=0 | w=10 sinus pericranii --- r_associated #0: 10 --> phlébite n1=sinus pericranii | n2=phlébite | rel=r_associated | relid=0 | w=10 splénomégalie --- r_associated #0: 10 --> phlébite n1=splénomégalie | n2=phlébite | rel=r_associated | relid=0 | w=10 splénomégalie congénitale --- r_associated #0: 10 --> phlébite n1=splénomégalie congénitale | n2=phlébite | rel=r_associated | relid=0 | w=10 syndrome adéno-cutanéo-muqueux --- r_associated #0: 10 --> phlébite n1=syndrome adéno-cutanéo-muqueux | n2=phlébite | rel=r_associated | relid=0 | w=10 syndrome de la crosse aortique --- r_associated #0: 10 --> phlébite n1=syndrome de la crosse aortique | n2=phlébite | rel=r_associated | relid=0 | w=10 tests d'exploration fonctionnelle rénale --- r_associated #0: 10 --> phlébite n1=tests d'exploration fonctionnelle rénale | n2=phlébite | rel=r_associated | relid=0 | w=10 tests hématologiques --- r_associated #0: 10 --> phlébite n1=tests hématologiques | n2=phlébite | rel=r_associated | relid=0 | w=10 thrombectomie --- r_associated #0: 10 --> phlébite n1=thrombectomie | n2=phlébite | rel=r_associated | relid=0 | w=10 thrombocytopénie-aplasie radiale (syndrome de) --- r_associated #0: 10 --> phlébite n1=thrombocytopénie-aplasie radiale (syndrome de) | n2=phlébite | rel=r_associated | relid=0 | w=10 thrombophlébite de la veine fémorale profonde --- r_associated #0: 10 --> phlébite n1=thrombophlébite de la veine fémorale profonde | n2=phlébite | rel=r_associated | relid=0 | w=10 trouble de la conduction du coeur --- r_associated #0: 10 --> phlébite n1=trouble de la conduction du coeur | n2=phlébite | rel=r_associated | relid=0 | w=10 trouble du rythme cardiaque --- r_associated #0: 10 --> phlébite n1=trouble du rythme cardiaque | n2=phlébite | rel=r_associated | relid=0 | w=10 truncus arteriosus --- r_associated #0: 10 --> phlébite n1=truncus arteriosus | n2=phlébite | rel=r_associated | relid=0 | w=10 tumeur --- r_associated #0: 10 --> phlébite n1=tumeur | n2=phlébite | rel=r_associated | relid=0 | w=10 tumeur à cellules claires --- r_associated #0: 10 --> phlébite n1=tumeur à cellules claires | n2=phlébite | rel=r_associated | relid=0 | w=10 tumeur à cellules claires de l'ovaire --- r_associated #0: 10 --> phlébite n1=tumeur à cellules claires de l'ovaire | n2=phlébite | rel=r_associated | relid=0 | w=10 ulcération --- r_associated #0: 10 --> phlébite n1=ulcération | n2=phlébite | rel=r_associated | relid=0 | w=10 vasa nervorum --- r_associated #0: 10 --> phlébite n1=vasa nervorum | n2=phlébite | rel=r_associated | relid=0 | w=10 vasa vasorum --- r_associated #0: 10 --> phlébite n1=vasa vasorum | n2=phlébite | rel=r_associated | relid=0 | w=10 vascularite généralisée --- r_associated #0: 10 --> phlébite n1=vascularite généralisée | n2=phlébite | rel=r_associated | relid=0 | w=10 vascularite systémique --- r_associated #0: 10 --> phlébite n1=vascularite systémique | n2=phlébite | rel=r_associated | relid=0 | w=10 vasculite --- r_associated #0: 10 --> phlébite n1=vasculite | n2=phlébite | rel=r_associated | relid=0 | w=10 vasculite systémique --- r_associated #0: 10 --> phlébite n1=vasculite systémique | n2=phlébite | rel=r_associated | relid=0 | w=10 vasospasme --- r_associated #0: 10 --> phlébite n1=vasospasme | n2=phlébite | rel=r_associated | relid=0 | w=10 Échocardiographie de contraste --- r_associated #0: 10 --> phlébite n1=Échocardiographie de contraste | n2=phlébite | rel=r_associated | relid=0 | w=10 écho planar (imagerie par) --- r_associated #0: 10 --> phlébite n1=écho planar (imagerie par) | n2=phlébite | rel=r_associated | relid=0 | w=10 épistaxis --- r_associated #0: 10 --> phlébite n1=épistaxis | n2=phlébite | rel=r_associated | relid=0 | w=10 érythermalgie --- r_associated #0: 10 --> phlébite n1=érythermalgie | n2=phlébite | rel=r_associated | relid=0 | w=10 érythromélalgie --- r_associated #0: 10 --> phlébite n1=érythromélalgie | n2=phlébite | rel=r_associated | relid=0 | w=10 étude de la fonction rénale --- r_associated #0: 10 --> phlébite n1=étude de la fonction rénale | n2=phlébite | rel=r_associated | relid=0 | w=10 phlébite des membres inférieurs --- r_associated #0: 7 --> phlébite n1=phlébite des membres inférieurs | n2=phlébite | rel=r_associated | relid=0 | w=7 phlébite au niveau du site de perfusion --- r_associated #0: 6 --> phlébite n1=phlébite au niveau du site de perfusion | n2=phlébite | rel=r_associated | relid=0 | w=6 phlébite au site d'implantation --- r_associated #0: 6 --> phlébite n1=phlébite au site d'implantation | n2=phlébite | rel=r_associated | relid=0 | w=6 phlébite cérébrale --- r_associated #0: 6 --> phlébite n1=phlébite cérébrale | n2=phlébite | rel=r_associated | relid=0 | w=6 Anti-vitamine K --- r_associated #0: 5 --> phlébite n1=Anti-vitamine K | n2=phlébite | rel=r_associated | relid=0 | w=5 Caillot de sang --- r_associated #0: 5 --> phlébite n1=Caillot de sang | n2=phlébite | rel=r_associated | relid=0 | w=5 Cardiopathie --- r_associated #0: 5 --> phlébite n1=Cardiopathie | n2=phlébite | rel=r_associated | relid=0 | w=5 Choc cardiogénique --- r_associated #0: 5 --> phlébite n1=Choc cardiogénique | n2=phlébite | rel=r_associated | relid=0 | w=5 Lymphangite --- r_associated #0: 5 --> phlébite n1=Lymphangite | n2=phlébite | rel=r_associated | relid=0 | w=5 Maladies cardiaques --- r_associated #0: 5 --> phlébite n1=Maladies cardiaques | n2=phlébite | rel=r_associated | relid=0 | w=5 Malformation cardiaque --- r_associated #0: 5 --> phlébite n1=Malformation cardiaque | n2=phlébite | rel=r_associated | relid=0 | w=5 Statines --- r_associated #0: 5 --> phlébite n1=Statines | n2=phlébite | rel=r_associated | relid=0 | w=5 Tuméfaction --- r_associated #0: 5 --> phlébite n1=Tuméfaction | n2=phlébite | rel=r_associated | relid=0 | w=5 absence d'inclusions d'hémoglobine H dans les globules rouges --- r_associated #0: 5 --> phlébite n1=absence d'inclusions d'hémoglobine H dans les globules rouges | n2=phlébite | rel=r_associated | relid=0 | w=5 absence de l'antigène luthérien sur les globules rouges --- r_associated #0: 5 --> phlébite n1=absence de l'antigène luthérien sur les globules rouges | n2=phlébite | rel=r_associated | relid=0 | w=5 accident cérébrovasculaire --- r_associated #0: 5 --> phlébite n1=accident cérébrovasculaire | n2=phlébite | rel=r_associated | relid=0 | w=5 accident vasculaire cérébral --- r_associated #0: 5 --> phlébite n1=accident vasculaire cérébral | n2=phlébite | rel=r_associated | relid=0 | w=5 affection cardio-vasculaire --- r_associated #0: 5 --> phlébite n1=affection cardio-vasculaire | n2=phlébite | rel=r_associated | relid=0 | w=5 agrégation plaquettaire anormale --- r_associated #0: 5 --> phlébite n1=agrégation plaquettaire anormale | n2=phlébite | rel=r_associated | relid=0 | w=5 angiopathie congophile --- r_associated #0: 5 --> phlébite n1=angiopathie congophile | n2=phlébite | rel=r_associated | relid=0 | w=5 angiopathie cérébrale amyloïde --- r_associated #0: 5 --> phlébite n1=angiopathie cérébrale amyloïde | n2=phlébite | rel=r_associated | relid=0 | w=5 anhémie --- r_associated #0: 5 --> phlébite n1=anhémie | n2=phlébite | rel=r_associated | relid=0 | w=5 aniso-poïkilocytose sur frottis sanguin --- r_associated #0: 5 --> phlébite n1=aniso-poïkilocytose sur frottis sanguin | n2=phlébite | rel=r_associated | relid=0 | w=5 anæmie --- r_associated #0: 5 --> phlébite n1=anæmie | n2=phlébite | rel=r_associated | relid=0 | w=5 anémie aplastique --- r_associated #0: 5 --> phlébite n1=anémie aplastique | n2=phlébite | rel=r_associated | relid=0 | w=5 anémie hypoplastique --- r_associated #0: 5 --> phlébite n1=anémie hypoplastique | n2=phlébite | rel=r_associated | relid=0 | w=5 anémie médullaire --- r_associated #0: 5 --> phlébite n1=anémie médullaire | n2=phlébite | rel=r_associated | relid=0 | w=5 anémie par aplasie médullaire --- r_associated #0: 5 --> phlébite n1=anémie par aplasie médullaire | n2=phlébite | rel=r_associated | relid=0 | w=5 anémie par atteinte isolée de la lignée rouge --- r_associated #0: 5 --> phlébite n1=anémie par atteinte isolée de la lignée rouge | n2=phlébite | rel=r_associated | relid=0 | w=5 aplasie de globules rouges purs --- r_associated #0: 5 --> phlébite n1=aplasie de globules rouges purs | n2=phlébite | rel=r_associated | relid=0 | w=5 aplasie des globules rouges purs --- r_associated #0: 5 --> phlébite n1=aplasie des globules rouges purs | n2=phlébite | rel=r_associated | relid=0 | w=5 aplasie isolée de la lignée rouge --- r_associated #0: 5 --> phlébite n1=aplasie isolée de la lignée rouge | n2=phlébite | rel=r_associated | relid=0 | w=5 aplasie primitive de la lignée rouge --- r_associated #0: 5 --> phlébite n1=aplasie primitive de la lignée rouge | n2=phlébite | rel=r_associated | relid=0 | w=5 apoplexie cérébrale --- r_associated #0: 5 --> phlébite n1=apoplexie cérébrale | n2=phlébite | rel=r_associated | relid=0 | w=5 arbovirus --- r_associated #0: 5 --> phlébite n1=arbovirus | n2=phlébite | rel=r_associated | relid=0 | w=5 arythmie --- r_associated #0: 5 --> phlébite n1=arythmie | n2=phlébite | rel=r_associated | relid=0 | w=5 autres phlébites et thromboses au cours de la grossesse et des suites de couches --- r_associated #0: 5 --> phlébite n1=autres phlébites et thromboses au cours de la grossesse et des suites de couches | n2=phlébite | rel=r_associated | relid=0 | w=5 circulation foetoplacentaire --- r_associated #0: 5 --> phlébite n1=circulation foetoplacentaire | n2=phlébite | rel=r_associated | relid=0 | w=5 circulation lymphatique --- r_associated #0: 5 --> phlébite n1=circulation lymphatique | n2=phlébite | rel=r_associated | relid=0 | w=5 circulation placentaire --- r_associated #0: 5 --> phlébite n1=circulation placentaire | n2=phlébite | rel=r_associated | relid=0 | w=5 circulation rénale --- r_associated #0: 5 --> phlébite n1=circulation rénale | n2=phlébite | rel=r_associated | relid=0 | w=5 coagulopathie intravasculaire disséminée --- r_associated #0: 5 --> phlébite n1=coagulopathie intravasculaire disséminée | n2=phlébite | rel=r_associated | relid=0 | w=5 coarctation aortique --- r_associated #0: 5 --> phlébite n1=coarctation aortique | n2=phlébite | rel=r_associated | relid=0 | w=5 coupure accidentelle, ponction, perforation ou hémorragie lors d'un prélèvement sanguin --- r_associated #0: 5 --> phlébite n1=coupure accidentelle, ponction, perforation ou hémorragie lors d'un prélèvement sanguin | n2=phlébite | rel=r_associated | relid=0 | w=5 dysrythmie cardiaque --- r_associated #0: 5 --> phlébite n1=dysrythmie cardiaque | n2=phlébite | rel=r_associated | relid=0 | w=5 dysrythmie cardiaque non précisée --- r_associated #0: 5 --> phlébite n1=dysrythmie cardiaque non précisée | n2=phlébite | rel=r_associated | relid=0 | w=5 débit sanguin --- r_associated #0: 5 --> phlébite n1=débit sanguin | n2=phlébite | rel=r_associated | relid=0 | w=5 déplétion volumique --- r_associated #0: 5 --> phlébite n1=déplétion volumique | n2=phlébite | rel=r_associated | relid=0 | w=5 en:coronary disease --- r_associated #0: 5 --> phlébite n1=en:coronary disease | n2=phlébite | rel=r_associated | relid=0 | w=5 en:heart condition --- r_associated #0: 5 --> phlébite n1=en:heart condition | n2=phlébite | rel=r_associated | relid=0 | w=5 en:intracardiac thrombus --- r_associated #0: 5 --> phlébite n1=en:intracardiac thrombus | n2=phlébite | rel=r_associated | relid=0 | w=5 excès de liquide organique --- r_associated #0: 5 --> phlébite n1=excès de liquide organique | n2=phlébite | rel=r_associated | relid=0 | w=5 excès de volume liquidien --- r_associated #0: 5 --> phlébite n1=excès de volume liquidien | n2=phlébite | rel=r_associated | relid=0 | w=5 exploration fonctionnelle renale --- r_associated #0: 5 --> phlébite n1=exploration fonctionnelle renale | n2=phlébite | rel=r_associated | relid=0 | w=5 fibrinoÏde --- r_associated #0: 5 --> phlébite n1=fibrinoÏde | n2=phlébite | rel=r_associated | relid=0 | w=5 hypertension artérielle pulmonaire --- r_associated #0: 5 --> phlébite n1=hypertension artérielle pulmonaire | n2=phlébite | rel=r_associated | relid=0 | w=5 hypertension pulmonaire --- r_associated #0: 5 --> phlébite n1=hypertension pulmonaire | n2=phlébite | rel=r_associated | relid=0 | w=5 hypovolémie --- r_associated #0: 5 --> phlébite n1=hypovolémie | n2=phlébite | rel=r_associated | relid=0 | w=5 ictus apoplectique --- r_associated #0: 5 --> phlébite n1=ictus apoplectique | n2=phlébite | rel=r_associated | relid=0 | w=5 ictus cérébral --- r_associated #0: 5 --> phlébite n1=ictus cérébral | n2=phlébite | rel=r_associated | relid=0 | w=5 infantile (psychose) --- r_associated #0: 5 --> phlébite n1=infantile (psychose) | n2=phlébite | rel=r_associated | relid=0 | w=5 inflammation simultanée de plusieurs vaisseaux sanguins ou lymphatiques --- r_associated #0: 5 --> phlébite n1=inflammation simultanée de plusieurs vaisseaux sanguins ou lymphatiques | n2=phlébite | rel=r_associated | relid=0 | w=5 intoxication par un excipient pharmaceutique --- r_associated #0: 5 --> phlébite n1=intoxication par un excipient pharmaceutique | n2=phlébite | rel=r_associated | relid=0 | w=5 lésion pseudo-tumorale de l'intestin --- r_associated #0: 5 --> phlébite n1=lésion pseudo-tumorale de l'intestin | n2=phlébite | rel=r_associated | relid=0 | w=5 lésion pseudo-tumorale de l'oesophage --- r_associated #0: 5 --> phlébite n1=lésion pseudo-tumorale de l'oesophage | n2=phlébite | rel=r_associated | relid=0 | w=5 lésion pseudo-tumorale de la peau --- r_associated #0: 5 --> phlébite n1=lésion pseudo-tumorale de la peau | n2=phlébite | rel=r_associated | relid=0 | w=5 lésion pseudo-tumorale du cerveau --- r_associated #0: 5 --> phlébite n1=lésion pseudo-tumorale du cerveau | n2=phlébite | rel=r_associated | relid=0 | w=5 lésion pseudo-tumorale du système nerveux --- r_associated #0: 5 --> phlébite n1=lésion pseudo-tumorale du système nerveux | n2=phlébite | rel=r_associated | relid=0 | w=5 maladie cérébrovasculaire aiguë mal définie --- r_associated #0: 5 --> phlébite n1=maladie cérébrovasculaire aiguë mal définie | n2=phlébite | rel=r_associated | relid=0 | w=5 maladie de Kawasaki --- r_associated #0: 5 --> phlébite n1=maladie de Kawasaki | n2=phlébite | rel=r_associated | relid=0 | w=5 maladie veino-occlusive --- r_associated #0: 5 --> phlébite n1=maladie veino-occlusive | n2=phlébite | rel=r_associated | relid=0 | w=5 méthémoglobinémie congénitale --- r_associated #0: 5 --> phlébite n1=méthémoglobinémie congénitale | n2=phlébite | rel=r_associated | relid=0 | w=5 non précisée, anémie aplasique --- r_associated #0: 5 --> phlébite n1=non précisée, anémie aplasique | n2=phlébite | rel=r_associated | relid=0 | w=5 pancytopénie --- r_associated #0: 5 --> phlébite n1=pancytopénie | n2=phlébite | rel=r_associated | relid=0 | w=5 parasite interne --- r_associated #0: 5 --> phlébite n1=parasite interne | n2=phlébite | rel=r_associated | relid=0 | w=5 pathologie du coeur --- r_associated #0: 5 --> phlébite n1=pathologie du coeur | n2=phlébite | rel=r_associated | relid=0 | w=5 pathologie infectieuse --- r_associated #0: 5 --> phlébite n1=pathologie infectieuse | n2=phlébite | rel=r_associated | relid=0 | w=5 phlébite du sinus basilaire --- r_associated #0: 5 --> phlébite n1=phlébite du sinus basilaire | n2=phlébite | rel=r_associated | relid=0 | w=5 phlébite du sinus longitudinal supérieur --- r_associated #0: 5 --> phlébite n1=phlébite du sinus longitudinal supérieur | n2=phlébite | rel=r_associated | relid=0 | w=5 phlébite et thrombophlébite non précisées des membres inférieurs --- r_associated #0: 5 --> phlébite n1=phlébite et thrombophlébite non précisées des membres inférieurs | n2=phlébite | rel=r_associated | relid=0 | w=5 phlébite suppurée --- r_associated #0: 5 --> phlébite n1=phlébite suppurée | n2=phlébite | rel=r_associated | relid=0 | w=5 réaction hémolytique transfusionnelle aiguë lors de la transfusion de sang Vel-positif --- r_associated #0: 5 --> phlébite n1=réaction hémolytique transfusionnelle aiguë lors de la transfusion de sang Vel-positif | n2=phlébite | rel=r_associated | relid=0 | w=5 schistosome aviaire --- r_associated #0: 5 --> phlébite n1=schistosome aviaire | n2=phlébite | rel=r_associated | relid=0 | w=5 spasme d'un muscle --- r_associated #0: 5 --> phlébite n1=spasme d'un muscle | n2=phlébite | rel=r_associated | relid=0 | w=5 spasme musculaire --- r_associated #0: 5 --> phlébite n1=spasme musculaire | n2=phlébite | rel=r_associated | relid=0 | w=5 statut du dépistage prénatal du groupe sanguin --- r_associated #0: 5 --> phlébite n1=statut du dépistage prénatal du groupe sanguin | n2=phlébite | rel=r_associated | relid=0 | w=5 surcharge liquidienne --- r_associated #0: 5 --> phlébite n1=surcharge liquidienne | n2=phlébite | rel=r_associated | relid=0 | w=5 syndrome adénocutanéomuqueux --- r_associated #0: 5 --> phlébite n1=syndrome adénocutanéomuqueux | n2=phlébite | rel=r_associated | relid=0 | w=5 syndrome de Kawasaki --- r_associated #0: 5 --> phlébite n1=syndrome de Kawasaki | n2=phlébite | rel=r_associated | relid=0 | w=5 test fonctionnel rénal --- r_associated #0: 5 --> phlébite n1=test fonctionnel rénal | n2=phlébite | rel=r_associated | relid=0 | w=5 tests de la fonction rénale --- r_associated #0: 5 --> phlébite n1=tests de la fonction rénale | n2=phlébite | rel=r_associated | relid=0 | w=5 tests fonctionnels rénaux --- r_associated #0: 5 --> phlébite n1=tests fonctionnels rénaux | n2=phlébite | rel=r_associated | relid=0 | w=5 thrombophlébite cérébrale puerpérale --- r_associated #0: 5 --> phlébite n1=thrombophlébite cérébrale puerpérale | n2=phlébite | rel=r_associated | relid=0 | w=5 thrombopénie liée à l'X --- r_associated #0: 5 --> phlébite n1=thrombopénie liée à l'X | n2=phlébite | rel=r_associated | relid=0 | w=5 thrombose de la veine ovarienne --- r_associated #0: 5 --> phlébite n1=thrombose de la veine ovarienne | n2=phlébite | rel=r_associated | relid=0 | w=5 trouble cardiovasculaire --- r_associated #0: 5 --> phlébite n1=trouble cardiovasculaire | n2=phlébite | rel=r_associated | relid=0 | w=5 tumeur du mésothélium et des tissus mous --- r_associated #0: 5 --> phlébite n1=tumeur du mésothélium et des tissus mous | n2=phlébite | rel=r_associated | relid=0 | w=5 vasculite leucocytoclastique --- r_associated #0: 5 --> phlébite n1=vasculite leucocytoclastique | n2=phlébite | rel=r_associated | relid=0 | w=5 zoonose --- r_associated #0: 5 --> phlébite n1=zoonose | n2=phlébite | rel=r_associated | relid=0 | w=5 en:cerebral phlebitis --- r_associated #0: 4 --> phlébite n1=en:cerebral phlebitis | n2=phlébite | rel=r_associated | relid=0 | w=4 non précisées phlébite et thrombophlébite des membres supérieurs --- r_associated #0: 4 --> phlébite n1=non précisées phlébite et thrombophlébite des membres supérieurs | n2=phlébite | rel=r_associated | relid=0 | w=4 séquelles de phlébite --- r_associated #0: 4 --> phlébite n1=séquelles de phlébite | n2=phlébite | rel=r_associated | relid=0 | w=4 en:phlebitis arm --- r_associated #0: 3 --> phlébite n1=en:phlebitis arm | n2=phlébite | rel=r_associated | relid=0 | w=3 non précisées phlébite et thrombophlébite des membres inférieurs --- r_associated #0: 3 --> phlébite n1=non précisées phlébite et thrombophlébite des membres inférieurs | n2=phlébite | rel=r_associated | relid=0 | w=3 phlébite et thrombophlébite de veine iliaque --- r_associated #0: 3 --> phlébite n1=phlébite et thrombophlébite de veine iliaque | n2=phlébite | rel=r_associated | relid=0 | w=3 phlébite et thrombophlébite des sinus veineux intracrâniens --- r_associated #0: 3 --> phlébite n1=phlébite et thrombophlébite des sinus veineux intracrâniens | n2=phlébite | rel=r_associated | relid=0 | w=3 phlébite septique du sinus caverneux --- r_associated #0: 3 --> phlébite n1=phlébite septique du sinus caverneux | n2=phlébite | rel=r_associated | relid=0 | w=3 phlébite septique du sinus latéral --- r_associated #0: 3 --> phlébite n1=phlébite septique du sinus latéral | n2=phlébite | rel=r_associated | relid=0 | w=3 phlébite superficielle dans une jambe --- r_associated #0: 3 --> phlébite n1=phlébite superficielle dans une jambe | n2=phlébite | rel=r_associated | relid=0 | w=3 phlébite d'effort du membre supérieur --- r_associated #0: 2 --> phlébite n1=phlébite d'effort du membre supérieur | n2=phlébite | rel=r_associated | relid=0 | w=2 phlébite du bras --- r_associated #0: 2 --> phlébite n1=phlébite du bras | n2=phlébite | rel=r_associated | relid=0 | w=2 phlébite du sinus sagittal inférieur --- r_associated #0: 2 --> phlébite n1=phlébite du sinus sagittal inférieur | n2=phlébite | rel=r_associated | relid=0 | w=2 phlébite et thrombophlébite intracrâniennes compliquant d'origine non pyogène --- r_associated #0: 2 --> phlébite n1=phlébite et thrombophlébite intracrâniennes compliquant d'origine non pyogène | n2=phlébite | rel=r_associated | relid=0 | w=2 phlébite infectieuse --- r_associated #0: 2 --> phlébite n1=phlébite infectieuse | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose au point d'injection --- r_associated #0: 2 --> phlébite n1=thrombose au point d'injection | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose d'un sinus lateral --- r_associated #0: 2 --> phlébite n1=thrombose d'un sinus lateral | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose d'un sinus veineux latéral --- r_associated #0: 2 --> phlébite n1=thrombose d'un sinus veineux latéral | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose d'une fistule d'hémodialyse --- r_associated #0: 2 --> phlébite n1=thrombose d'une fistule d'hémodialyse | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose d'une veine cérébrale --- r_associated #0: 2 --> phlébite n1=thrombose d'une veine cérébrale | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose d'une veine pulmonaire --- r_associated #0: 2 --> phlébite n1=thrombose d'une veine pulmonaire | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose de l'artère axillaire --- r_associated #0: 2 --> phlébite n1=thrombose de l'artère axillaire | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose de l'artère carotide primitive --- r_associated #0: 2 --> phlébite n1=thrombose de l'artère carotide primitive | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose de l'artère cérébrale moyenne --- r_associated #0: 2 --> phlébite n1=thrombose de l'artère cérébrale moyenne | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose de la fistule de l'hémodialyse --- r_associated #0: 2 --> phlébite n1=thrombose de la fistule de l'hémodialyse | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose de la veine poplitée --- r_associated #0: 2 --> phlébite n1=thrombose de la veine poplitée | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose de la veine splénique --- r_associated #0: 2 --> phlébite n1=thrombose de la veine splénique | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose des artères des membres --- r_associated #0: 2 --> phlébite n1=thrombose des artères des membres | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose des corps caverneux et de la verge --- r_associated #0: 2 --> phlébite n1=thrombose des corps caverneux et de la verge | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose des sinus caverneux --- r_associated #0: 2 --> phlébite n1=thrombose des sinus caverneux | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose des vaisseaux ombilicaux --- r_associated #0: 2 --> phlébite n1=thrombose des vaisseaux ombilicaux | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose du bras --- r_associated #0: 2 --> phlébite n1=thrombose du bras | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose du sinus latéral --- r_associated #0: 2 --> phlébite n1=thrombose du sinus latéral | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose intervilleuse --- r_associated #0: 2 --> phlébite n1=thrombose intervilleuse | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose non pyogène d'un sinus veineux intracrânien --- r_associated #0: 2 --> phlébite n1=thrombose non pyogène d'un sinus veineux intracrânien | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose veineuse cérébrale --- r_associated #0: 2 --> phlébite n1=thrombose veineuse cérébrale | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose veineuse hépatique --- r_associated #0: 2 --> phlébite n1=thrombose veineuse hépatique | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose veineuse musculaire --- r_associated #0: 2 --> phlébite n1=thrombose veineuse musculaire | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose veineuse mésentérique --- r_associated #0: 2 --> phlébite n1=thrombose veineuse mésentérique | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose veineuse mésentérique (Nom) --- r_associated #0: 2 --> phlébite n1=thrombose veineuse mésentérique (Nom) | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose veineuse portale --- r_associated #0: 2 --> phlébite n1=thrombose veineuse portale | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose veineuse profonde primaire du membre supérieur --- r_associated #0: 2 --> phlébite n1=thrombose veineuse profonde primaire du membre supérieur | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose veineuse profonde proximale --- r_associated #0: 2 --> phlébite n1=thrombose veineuse profonde proximale | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose veineuse puerpérale --- r_associated #0: 2 --> phlébite n1=thrombose veineuse puerpérale | n2=phlébite | rel=r_associated | relid=0 | w=2 thrombose veineuse superficielle du post-partum --- r_associated #0: 2 --> phlébite n1=thrombose veineuse superficielle du post-partum | n2=phlébite | rel=r_associated | relid=0 | w=2 TVC --- r_associated #0: 1 --> phlébite n1=TVC | n2=phlébite | rel=r_associated | relid=0 | w=1 en:cerebral arterial thrombosis --- r_associated #0: 1 --> phlébite n1=en:cerebral arterial thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=1 en:coronary thrombosis --- r_associated #0: 1 --> phlébite n1=en:coronary thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=1 en:deep vein thrombosis of lower limb --- r_associated #0: 1 --> phlébite n1=en:deep vein thrombosis of lower limb | n2=phlébite | rel=r_associated | relid=0 | w=1 en:deep venous thrombosis proximal --- r_associated #0: 1 --> phlébite n1=en:deep venous thrombosis proximal | n2=phlébite | rel=r_associated | relid=0 | w=1 en:iliac vein thrombosis --- r_associated #0: 1 --> phlébite n1=en:iliac vein thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=1 en:retinal vascular thrombosis --- r_associated #0: 1 --> phlébite n1=en:retinal vascular thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=1 en:sagittal sinus thrombosis --- r_associated #0: 1 --> phlébite n1=en:sagittal sinus thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=1 en:superficial venous thrombosis of upper extremity --- r_associated #0: 1 --> phlébite n1=en:superficial venous thrombosis of upper extremity | n2=phlébite | rel=r_associated | relid=0 | w=1 en:thrombosis of spermatic cord --- r_associated #0: 1 --> phlébite n1=en:thrombosis of spermatic cord | n2=phlébite | rel=r_associated | relid=0 | w=1 en:thrombosis of the popliteal vein --- r_associated #0: 1 --> phlébite n1=en:thrombosis of the popliteal vein | n2=phlébite | rel=r_associated | relid=0 | w=1 en:vertebral artery thrombosis --- r_associated #0: 1 --> phlébite n1=en:vertebral artery thrombosis | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite chimique --- r_associated #0: 1 --> phlébite n1=phlébite chimique | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite consécutive à une injection, une perfusion ou une transfusion --- r_associated #0: 1 --> phlébite n1=phlébite consécutive à une injection, une perfusion ou une transfusion | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite d'un sinus veineux intracrânien --- r_associated #0: 1 --> phlébite n1=phlébite d'un sinus veineux intracrânien | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite d'une veine saphène --- r_associated #0: 1 --> phlébite n1=phlébite d'une veine saphène | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite d'une veine tibiale --- r_associated #0: 1 --> phlébite n1=phlébite d'une veine tibiale | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite des veines profondes du membre inférieur --- r_associated #0: 1 --> phlébite n1=phlébite des veines profondes du membre inférieur | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite des veines superficielles des membres inférieurs --- r_associated #0: 1 --> phlébite n1=phlébite des veines superficielles des membres inférieurs | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite du confluent des sinus --- r_associated #0: 1 --> phlébite n1=phlébite du confluent des sinus | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite et thrombophlébite d'autres sites --- r_associated #0: 1 --> phlébite n1=phlébite et thrombophlébite d'autres sites | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite et thrombophlébite d'autres vaisseaux profonds des membres inférieurs --- r_associated #0: 1 --> phlébite n1=phlébite et thrombophlébite d'autres vaisseaux profonds des membres inférieurs | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite et thrombophlébite d'un autre site --- r_associated #0: 1 --> phlébite n1=phlébite et thrombophlébite d'un autre site | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite et thrombophlébite de la veine porte --- r_associated #0: 1 --> phlébite n1=phlébite et thrombophlébite de la veine porte | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite et thrombophlébite de localisation non précisée --- r_associated #0: 1 --> phlébite n1=phlébite et thrombophlébite de localisation non précisée | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite et thrombophlébite des vaisseaux profonds des membres inférieurs --- r_associated #0: 1 --> phlébite n1=phlébite et thrombophlébite des vaisseaux profonds des membres inférieurs | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite et thrombophlébite des vaisseaux profonds des membres supérieurs --- r_associated #0: 1 --> phlébite n1=phlébite et thrombophlébite des vaisseaux profonds des membres supérieurs | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite et thrombophlébite des vaisseaux superficiels des membres inférieurs --- r_associated #0: 1 --> phlébite n1=phlébite et thrombophlébite des vaisseaux superficiels des membres inférieurs | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite et thrombophlébite des vaisseaux superficiels des membres supérieurs --- r_associated #0: 1 --> phlébite n1=phlébite et thrombophlébite des vaisseaux superficiels des membres supérieurs | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite et thrombophlébite des veines superficielles des membres inférieurs --- r_associated #0: 1 --> phlébite n1=phlébite et thrombophlébite des veines superficielles des membres inférieurs | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite et thrombophlébite intracrâniennes et intrarachidiennes --- r_associated #0: 1 --> phlébite n1=phlébite et thrombophlébite intracrâniennes et intrarachidiennes | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite gestationnelle --- r_associated #0: 1 --> phlébite n1=phlébite gestationnelle | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite mécanique --- r_associated #0: 1 --> phlébite n1=phlébite mécanique | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite ou thrombophlébite pendant ou après une intervention --- r_associated #0: 1 --> phlébite n1=phlébite ou thrombophlébite pendant ou après une intervention | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite septique --- r_associated #0: 1 --> phlébite n1=phlébite septique | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite septique du sinus sagittal --- r_associated #0: 1 --> phlébite n1=phlébite septique du sinus sagittal | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite veineuse et thrombophlébite profonde --- r_associated #0: 1 --> phlébite n1=phlébite veineuse et thrombophlébite profonde | n2=phlébite | rel=r_associated | relid=0 | w=1 phlébite veineuse et thrombophlébite superficielle --- r_associated #0: 1 --> phlébite n1=phlébite veineuse et thrombophlébite superficielle | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombophlébite cérébrale --- r_associated #0: 1 --> phlébite n1=thrombophlébite cérébrale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombophlébite profonde de la jambe --- r_associated #0: 1 --> phlébite n1=thrombophlébite profonde de la jambe | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose aiguë du sinus sagittal supérieur --- r_associated #0: 1 --> phlébite n1=thrombose aiguë du sinus sagittal supérieur | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose aortique --- r_associated #0: 1 --> phlébite n1=thrombose aortique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose artérielle aigüe --- r_associated #0: 1 --> phlébite n1=thrombose artérielle aigüe | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose artérielle coronaire --- r_associated #0: 1 --> phlébite n1=thrombose artérielle coronaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose artérielle cérébelleuse --- r_associated #0: 1 --> phlébite n1=thrombose artérielle cérébelleuse | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose artérielle cérébrale --- r_associated #0: 1 --> phlébite n1=thrombose artérielle cérébrale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose artérielle d'un membre --- r_associated #0: 1 --> phlébite n1=thrombose artérielle d'un membre | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose artérielle de la jambe --- r_associated #0: 1 --> phlébite n1=thrombose artérielle de la jambe | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose artérielle de la moelle épinière --- r_associated #0: 1 --> phlébite n1=thrombose artérielle de la moelle épinière | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose artérielle de la rétine --- r_associated #0: 1 --> phlébite n1=thrombose artérielle de la rétine | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose artérielle du bras --- r_associated #0: 1 --> phlébite n1=thrombose artérielle du bras | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose artérielle mésentérique --- r_associated #0: 1 --> phlébite n1=thrombose artérielle mésentérique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose artérielle pulmonaire --- r_associated #0: 1 --> phlébite n1=thrombose artérielle pulmonaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose artérielle rénale --- r_associated #0: 1 --> phlébite n1=thrombose artérielle rénale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose au site de l'implant --- r_associated #0: 1 --> phlébite n1=thrombose au site de l'implant | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose au site de la ponction veineuse --- r_associated #0: 1 --> phlébite n1=thrombose au site de la ponction veineuse | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose au site de perfusion --- r_associated #0: 1 --> phlébite n1=thrombose au site de perfusion | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose au site de ponction veineuse --- r_associated #0: 1 --> phlébite n1=thrombose au site de ponction veineuse | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose aérienne --- r_associated #0: 1 --> phlébite n1=thrombose aérienne | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose capillaire --- r_associated #0: 1 --> phlébite n1=thrombose capillaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose cardiaque --- r_associated #0: 1 --> phlébite n1=thrombose cardiaque | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose carotidienne --- r_associated #0: 1 --> phlébite n1=thrombose carotidienne | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose compliquant la grossesse --- r_associated #0: 1 --> phlébite n1=thrombose compliquant la grossesse | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose coronaire --- r_associated #0: 1 --> phlébite n1=thrombose coronaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose coronaire intraluminale --- r_associated #0: 1 --> phlébite n1=thrombose coronaire intraluminale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose coronarienne --- r_associated #0: 1 --> phlébite n1=thrombose coronarienne | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose cérébro-vasculaire veineuse et du sinus --- r_associated #0: 1 --> phlébite n1=thrombose cérébro-vasculaire veineuse et du sinus | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'effort --- r_associated #0: 1 --> phlébite n1=thrombose d'effort | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'endoprothèse couverte aortique --- r_associated #0: 1 --> phlébite n1=thrombose d'endoprothèse couverte aortique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'origine congénitale --- r_associated #0: 1 --> phlébite n1=thrombose d'origine congénitale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'un point d'injection --- r_associated #0: 1 --> phlébite n1=thrombose d'un point d'injection | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'un sinus caverneux --- r_associated #0: 1 --> phlébite n1=thrombose d'un sinus caverneux | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'un sinus intracranien --- r_associated #0: 1 --> phlébite n1=thrombose d'un sinus intracranien | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'un sinus sagittal --- r_associated #0: 1 --> phlébite n1=thrombose d'un sinus sagittal | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'un sinus transverse --- r_associated #0: 1 --> phlébite n1=thrombose d'un sinus transverse | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'un sinus veineux intracrânien --- r_associated #0: 1 --> phlébite n1=thrombose d'un sinus veineux intracrânien | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'un vaisseau mésentérique --- r_associated #0: 1 --> phlébite n1=thrombose d'un vaisseau mésentérique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'une artère cérébelleuse --- r_associated #0: 1 --> phlébite n1=thrombose d'une artère cérébelleuse | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'une artère digitale --- r_associated #0: 1 --> phlébite n1=thrombose d'une artère digitale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'une artère hépatique --- r_associated #0: 1 --> phlébite n1=thrombose d'une artère hépatique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'une artère iliaque --- r_associated #0: 1 --> phlébite n1=thrombose d'une artère iliaque | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'une artère précérébrale --- r_associated #0: 1 --> phlébite n1=thrombose d'une artère précérébrale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'une artère pulmonaire --- r_associated #0: 1 --> phlébite n1=thrombose d'une artère pulmonaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'une artère rénale --- r_associated #0: 1 --> phlébite n1=thrombose d'une artère rénale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'une endoprothèse coronaire --- r_associated #0: 1 --> phlébite n1=thrombose d'une endoprothèse coronaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'une endoprothèse vasculaire --- r_associated #0: 1 --> phlébite n1=thrombose d'une endoprothèse vasculaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'une fistule artério-veineuse --- r_associated #0: 1 --> phlébite n1=thrombose d'une fistule artério-veineuse | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'une veine pelvienne --- r_associated #0: 1 --> phlébite n1=thrombose d'une veine pelvienne | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose d'une veine pénienne --- r_associated #0: 1 --> phlébite n1=thrombose d'une veine pénienne | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose dans le dispositif --- r_associated #0: 1 --> phlébite n1=thrombose dans le dispositif | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de cathéter --- r_associated #0: 1 --> phlébite n1=thrombose de cathéter | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de fistule artérioveineuse --- r_associated #0: 1 --> phlébite n1=thrombose de fistule artérioveineuse | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de greffe aiguë --- r_associated #0: 1 --> phlébite n1=thrombose de greffe aiguë | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de greffe vasculaire --- r_associated #0: 1 --> phlébite n1=thrombose de greffe vasculaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'aorte abdominale --- r_associated #0: 1 --> phlébite n1=thrombose de l'aorte abdominale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'aorte abdominale aiguë --- r_associated #0: 1 --> phlébite n1=thrombose de l'aorte abdominale aiguë | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'aorte thoracique --- r_associated #0: 1 --> phlébite n1=thrombose de l'aorte thoracique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère basilaire --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère basilaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère brachiale --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère brachiale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère carotide --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère carotide | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère carotide commune --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère carotide commune | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère carotide externe --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère carotide externe | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère carotide interne --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère carotide interne | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère centrale de la rétine --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère centrale de la rétine | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère cérébellaire --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère cérébellaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère cérébellaire postérieure et inférieure --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère cérébellaire postérieure et inférieure | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère cérébelleuse inférieure et postérieure --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère cérébelleuse inférieure et postérieure | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère cérébrale --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère cérébrale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère cérébrale antérieure --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère cérébrale antérieure | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère cérébrale postérieure --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère cérébrale postérieure | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère fémorale --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère fémorale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère hépatique --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère hépatique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère iliaque --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère iliaque | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère interventriculaire antérieure gauche --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère interventriculaire antérieure gauche | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère mésentérique --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère mésentérique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère poplitée --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère poplitée | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère pulmonaire --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère pulmonaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère rénale --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère rénale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère rétinienne --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère rétinienne | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère sous-clavière --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère sous-clavière | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère tibiale --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère tibiale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'artère vertébrale --- r_associated #0: 1 --> phlébite n1=thrombose de l'artère vertébrale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de l'oreillette gauche --- r_associated #0: 1 --> phlébite n1=thrombose de l'oreillette gauche | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la carotide --- r_associated #0: 1 --> phlébite n1=thrombose de la carotide | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la greffe artérioveineuse --- r_associated #0: 1 --> phlébite n1=thrombose de la greffe artérioveineuse | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la jambe --- r_associated #0: 1 --> phlébite n1=thrombose de la jambe | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la tunique vaginale --- r_associated #0: 1 --> phlébite n1=thrombose de la tunique vaginale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine axillaire --- r_associated #0: 1 --> phlébite n1=thrombose de la veine axillaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine cave --- r_associated #0: 1 --> phlébite n1=thrombose de la veine cave | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine cave inférieure --- r_associated #0: 1 --> phlébite n1=thrombose de la veine cave inférieure | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine cave supérieure --- r_associated #0: 1 --> phlébite n1=thrombose de la veine cave supérieure | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine centrale de la rétine --- r_associated #0: 1 --> phlébite n1=thrombose de la veine centrale de la rétine | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine hépatique --- r_associated #0: 1 --> phlébite n1=thrombose de la veine hépatique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine iliaque --- r_associated #0: 1 --> phlébite n1=thrombose de la veine iliaque | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine jugulaire --- r_associated #0: 1 --> phlébite n1=thrombose de la veine jugulaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine mesenterique superieure --- r_associated #0: 1 --> phlébite n1=thrombose de la veine mesenterique superieure | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine mésentérique --- r_associated #0: 1 --> phlébite n1=thrombose de la veine mésentérique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine ovarienne droite --- r_associated #0: 1 --> phlébite n1=thrombose de la veine ovarienne droite | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine portale --- r_associated #0: 1 --> phlébite n1=thrombose de la veine portale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine porte --- r_associated #0: 1 --> phlébite n1=thrombose de la veine porte | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine pénienne --- r_associated #0: 1 --> phlébite n1=thrombose de la veine pénienne | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine rénale --- r_associated #0: 1 --> phlébite n1=thrombose de la veine rénale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine rétinienne --- r_associated #0: 1 --> phlébite n1=thrombose de la veine rétinienne | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine sous clavière --- r_associated #0: 1 --> phlébite n1=thrombose de la veine sous clavière | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la veine sous-clavière --- r_associated #0: 1 --> phlébite n1=thrombose de la veine sous-clavière | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de la verge --- r_associated #0: 1 --> phlébite n1=thrombose de la verge | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de pontage aorto-coronarien --- r_associated #0: 1 --> phlébite n1=thrombose de pontage aorto-coronarien | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de shunt artérioveineux --- r_associated #0: 1 --> phlébite n1=thrombose de shunt artérioveineux | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de sinus caverneux --- r_associated #0: 1 --> phlébite n1=thrombose de sinus caverneux | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de sinus intra-crânien --- r_associated #0: 1 --> phlébite n1=thrombose de sinus intra-crânien | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de sinus intracrânien --- r_associated #0: 1 --> phlébite n1=thrombose de sinus intracrânien | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de sinus lateraux --- r_associated #0: 1 --> phlébite n1=thrombose de sinus lateraux | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de sinus sagittaux --- r_associated #0: 1 --> phlébite n1=thrombose de sinus sagittaux | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de tumeur --- r_associated #0: 1 --> phlébite n1=thrombose de tumeur | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de vaisseau coronaire --- r_associated #0: 1 --> phlébite n1=thrombose de vaisseau coronaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de vaisseaux coronaires --- r_associated #0: 1 --> phlébite n1=thrombose de vaisseaux coronaires | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de valve prothétique cardiaque --- r_associated #0: 1 --> phlébite n1=thrombose de valve prothétique cardiaque | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose de veine brachiocéphalique --- r_associated #0: 1 --> phlébite n1=thrombose de veine brachiocéphalique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose des artères cérébrales --- r_associated #0: 1 --> phlébite n1=thrombose des artères cérébrales | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose des artères du membre inférieur --- r_associated #0: 1 --> phlébite n1=thrombose des artères du membre inférieur | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose des artères du membre supérieur --- r_associated #0: 1 --> phlébite n1=thrombose des artères du membre supérieur | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose des corps caverneux --- r_associated #0: 1 --> phlébite n1=thrombose des corps caverneux | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose des organes génitaux de l'homme --- r_associated #0: 1 --> phlébite n1=thrombose des organes génitaux de l'homme | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose des petits vaisseaux de la peau --- r_associated #0: 1 --> phlébite n1=thrombose des petits vaisseaux de la peau | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose des sinus lateraux --- r_associated #0: 1 --> phlébite n1=thrombose des sinus lateraux | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose des sinus sagittaux --- r_associated #0: 1 --> phlébite n1=thrombose des sinus sagittaux | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose des sinus veineux cérébral --- r_associated #0: 1 --> phlébite n1=thrombose des sinus veineux cérébral | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose des sinus veineux cérébraux --- r_associated #0: 1 --> phlébite n1=thrombose des sinus veineux cérébraux | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose des sinus veineux intracrâniens --- r_associated #0: 1 --> phlébite n1=thrombose des sinus veineux intracrâniens | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose des veines cérébrales --- r_associated #0: 1 --> phlébite n1=thrombose des veines cérébrales | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose des veines hépatiques --- r_associated #0: 1 --> phlébite n1=thrombose des veines hépatiques | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose des veines intracrâniennes --- r_associated #0: 1 --> phlébite n1=thrombose des veines intracrâniennes | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose des vésicules séminales --- r_associated #0: 1 --> phlébite n1=thrombose des vésicules séminales | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du canal déférent --- r_associated #0: 1 --> phlébite n1=thrombose du canal déférent | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du cerveau --- r_associated #0: 1 --> phlébite n1=thrombose du cerveau | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du confluent des sinus --- r_associated #0: 1 --> phlébite n1=thrombose du confluent des sinus | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du cordon ombilical --- r_associated #0: 1 --> phlébite n1=thrombose du cordon ombilical | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du cordon spermatique --- r_associated #0: 1 --> phlébite n1=thrombose du cordon spermatique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du greffon --- r_associated #0: 1 --> phlébite n1=thrombose du greffon | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du pontage coronarien --- r_associated #0: 1 --> phlébite n1=thrombose du pontage coronarien | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du pénis --- r_associated #0: 1 --> phlébite n1=thrombose du pénis | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du scrotum --- r_associated #0: 1 --> phlébite n1=thrombose du scrotum | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du shunt --- r_associated #0: 1 --> phlébite n1=thrombose du shunt | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du sinus basilaire --- r_associated #0: 1 --> phlébite n1=thrombose du sinus basilaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du sinus caverneux --- r_associated #0: 1 --> phlébite n1=thrombose du sinus caverneux | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du sinus dural --- r_associated #0: 1 --> phlébite n1=thrombose du sinus dural | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du sinus intracranien --- r_associated #0: 1 --> phlébite n1=thrombose du sinus intracranien | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du sinus intracrânien --- r_associated #0: 1 --> phlébite n1=thrombose du sinus intracrânien | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du sinus longitudinal inférieur --- r_associated #0: 1 --> phlébite n1=thrombose du sinus longitudinal inférieur | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du sinus longitudinal supérieur --- r_associated #0: 1 --> phlébite n1=thrombose du sinus longitudinal supérieur | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du sinus pétreux --- r_associated #0: 1 --> phlébite n1=thrombose du sinus pétreux | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du sinus sagittal --- r_associated #0: 1 --> phlébite n1=thrombose du sinus sagittal | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du sinus sagittal inférieur --- r_associated #0: 1 --> phlébite n1=thrombose du sinus sagittal inférieur | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du sinus sagittal supérieur --- r_associated #0: 1 --> phlébite n1=thrombose du sinus sagittal supérieur | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du sinus transverse --- r_associated #0: 1 --> phlébite n1=thrombose du sinus transverse | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du sinus veineux cérébral au cours de la grossesse --- r_associated #0: 1 --> phlébite n1=thrombose du sinus veineux cérébral au cours de la grossesse | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du sinus veineux cérébral au cours de la puerpéralité --- r_associated #0: 1 --> phlébite n1=thrombose du sinus veineux cérébral au cours de la puerpéralité | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du testicule --- r_associated #0: 1 --> phlébite n1=thrombose du testicule | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du tronc basilaire --- r_associated #0: 1 --> phlébite n1=thrombose du tronc basilaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du tronc coeliaque --- r_associated #0: 1 --> phlébite n1=thrombose du tronc coeliaque | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du tronc cérébral --- r_associated #0: 1 --> phlébite n1=thrombose du tronc cérébral | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du tronc de l'artère coronaire droite --- r_associated #0: 1 --> phlébite n1=thrombose du tronc de l'artère coronaire droite | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose du tronc de l'artère coronaire gauche --- r_associated #0: 1 --> phlébite n1=thrombose du tronc de l'artère coronaire gauche | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose endocardique --- r_associated #0: 1 --> phlébite n1=thrombose endocardique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose et thrombophlébite d'un site non précisé --- r_associated #0: 1 --> phlébite n1=thrombose et thrombophlébite d'un site non précisé | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose gestationnelle --- r_associated #0: 1 --> phlébite n1=thrombose gestationnelle | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose infectieuse --- r_associated #0: 1 --> phlébite n1=thrombose infectieuse | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose intra-crânienne --- r_associated #0: 1 --> phlébite n1=thrombose intra-crânienne | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose intracardiaque --- r_associated #0: 1 --> phlébite n1=thrombose intracardiaque | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose intracrânienne --- r_associated #0: 1 --> phlébite n1=thrombose intracrânienne | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose intrapéricardique --- r_associated #0: 1 --> phlébite n1=thrombose intrapéricardique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose mésentérique --- r_associated #0: 1 --> phlébite n1=thrombose mésentérique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose non pyogène de sinus veineux intracrânien --- r_associated #0: 1 --> phlébite n1=thrombose non pyogène de sinus veineux intracrânien | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose non pyogène de veine cérébrale --- r_associated #0: 1 --> phlébite n1=thrombose non pyogène de veine cérébrale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose non pyogène du système veineux intracrânien --- r_associated #0: 1 --> phlébite n1=thrombose non pyogène du système veineux intracrânien | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose partielle --- r_associated #0: 1 --> phlébite n1=thrombose partielle | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose portale --- r_associated #0: 1 --> phlébite n1=thrombose portale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose porte --- r_associated #0: 1 --> phlébite n1=thrombose porte | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose post-opératoire --- r_associated #0: 1 --> phlébite n1=thrombose post-opératoire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose provoquée par l'héparine --- r_associated #0: 1 --> phlébite n1=thrombose provoquée par l'héparine | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose puerpérale --- r_associated #0: 1 --> phlébite n1=thrombose puerpérale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose pulmonaire --- r_associated #0: 1 --> phlébite n1=thrombose pulmonaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose septique --- r_associated #0: 1 --> phlébite n1=thrombose septique | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose septique des sinus veineux et veines intracrâniens ou intrarachidiens --- r_associated #0: 1 --> phlébite n1=thrombose septique des sinus veineux et veines intracrâniens ou intrarachidiens | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose sous-choriale --- r_associated #0: 1 --> phlébite n1=thrombose sous-choriale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose superficielle des veines --- r_associated #0: 1 --> phlébite n1=thrombose superficielle des veines | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose sur cathéter veineux central --- r_associated #0: 1 --> phlébite n1=thrombose sur cathéter veineux central | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose totale --- r_associated #0: 1 --> phlébite n1=thrombose totale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose vasculaire --- r_associated #0: 1 --> phlébite n1=thrombose vasculaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose vasculaire rérinienne --- r_associated #0: 1 --> phlébite n1=thrombose vasculaire rérinienne | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose vasculaire rétinienne --- r_associated #0: 1 --> phlébite n1=thrombose vasculaire rétinienne | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse au cours de la grossesse --- r_associated #0: 1 --> phlébite n1=thrombose veineuse au cours de la grossesse | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse cérébrale au cours de la grossesse --- r_associated #0: 1 --> phlébite n1=thrombose veineuse cérébrale au cours de la grossesse | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse cérébrale au cours de la puerpéralité --- r_associated #0: 1 --> phlébite n1=thrombose veineuse cérébrale au cours de la puerpéralité | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse d'un membre --- r_associated #0: 1 --> phlébite n1=thrombose veineuse d'un membre | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse de la rétine --- r_associated #0: 1 --> phlébite n1=thrombose veineuse de la rétine | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse du bras --- r_associated #0: 1 --> phlébite n1=thrombose veineuse du bras | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse du post-partum --- r_associated #0: 1 --> phlébite n1=thrombose veineuse du post-partum | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse néonatale --- r_associated #0: 1 --> phlébite n1=thrombose veineuse néonatale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse pelvienne --- r_associated #0: 1 --> phlébite n1=thrombose veineuse pelvienne | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde avant l'accouchement --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde avant l'accouchement | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde d'effort du membre supérieur --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde d'effort du membre supérieur | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde d'un membre --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde d'un membre | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde de l'aine --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde de l'aine | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde de la jambe --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde de la jambe | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde distale --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde distale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde du bras --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde du bras | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde du membre supérieur --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde du membre supérieur | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde du membre supérieur induite par l'effort --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde du membre supérieur induite par l'effort | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde du membre supérieur induite par l'exercice --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde du membre supérieur induite par l'exercice | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde du membre supérieur liée à l'effort --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde du membre supérieur liée à l'effort | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde du post-partum --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde du post-partum | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde fémorale --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde fémorale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde gauche --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde gauche | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde idiopathique du membre supérieur --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde idiopathique du membre supérieur | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde post-partum --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde post-partum | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde postopératoire --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde postopératoire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde primitive du membre supérieur --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde primitive du membre supérieur | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde récidivante --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde récidivante | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse profonde secondaire du membre supérieur --- r_associated #0: 1 --> phlébite n1=thrombose veineuse profonde secondaire du membre supérieur | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse pulmonaire --- r_associated #0: 1 --> phlébite n1=thrombose veineuse pulmonaire | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse rénale --- r_associated #0: 1 --> phlébite n1=thrombose veineuse rénale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse rétinienne --- r_associated #0: 1 --> phlébite n1=thrombose veineuse rétinienne | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse sai --- r_associated #0: 1 --> phlébite n1=thrombose veineuse sai | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse sai d'un membre --- r_associated #0: 1 --> phlébite n1=thrombose veineuse sai d'un membre | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse sous-durale --- r_associated #0: 1 --> phlébite n1=thrombose veineuse sous-durale | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse superficielle --- r_associated #0: 1 --> phlébite n1=thrombose veineuse superficielle | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse superficielle d'un membre --- r_associated #0: 1 --> phlébite n1=thrombose veineuse superficielle d'un membre | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse superficielle d'une jambe --- r_associated #0: 1 --> phlébite n1=thrombose veineuse superficielle d'une jambe | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse superficielle de la jambe --- r_associated #0: 1 --> phlébite n1=thrombose veineuse superficielle de la jambe | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose veineuse superficielle du bras --- r_associated #0: 1 --> phlébite n1=thrombose veineuse superficielle du bras | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombose ventriculaire cardiaque --- r_associated #0: 1 --> phlébite n1=thrombose ventriculaire cardiaque | n2=phlébite | rel=r_associated | relid=0 | w=1 thrombus intracardiaque --- r_associated #0: 1 --> phlébite n1=thrombus intracardiaque | n2=phlébite | rel=r_associated | relid=0 | w=1